Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Aapro M, Extermann M, Repetto L
Document related concepts
no text concepts found
Transcript
Quality of Life References
April 16, 2013
WARRANTY AND LIABILITY
User assumes all risks related to the use of any information provided in the qol bib or forms bank. Data
available on all instruments are provided "as is".
The providers of information disclaim any and all warranties, whether expressed or implied, including (without
limitation) any implied warranties of merchantability or fitness for a particular purpose. In no event shall Mayo
nor the authors providers of information be liable for any indirect, special, incidental, or consequential
damages arising out of any use of reliance of any information contained herein. Mayo nor the authors providers
of information assume any responsibility for failure or delay in updating or removing the information contained
herein.
Healthcare’s ‘third place’ – patient-centered healthcare – is life sciences’ future business focus, says
E&Y. Pharmaceutical Commerce.com – pages 17 and 32. May/June 2012.
Aapro M, Extermann M, Repetto L. Evaluation of the elderly with cancer. Ann Oncol. 2000;
11(Suppl 3):223-229.
Aapro MS, Dale DC, Blasi M, Sarokhan B, Ahmed F, Woodman RC. Epoetin alfa increases hemoglobin
levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy.
Support Care Cancer. 2006;14:1184-1194.
Aapro MS, Macciocchi A, Gridelli C. Palonosetron improves prevention of chemotherapy-induced
nausea and vomiting in elderly patients: results from two randomized, controlled clinical trials. J
Support Oncol. 2005;3(5):369-374.
Aapro M, Abraham I, Bokemeyer C, Ludwig H, MacDonald K, Soubeyran P, Turner M. The
background and methodology of the anaemia cancer treatment (A.C.T.) study: a global retrospective
study of practice patterns and outcomes in the management of anaemia in cancer patients and their
congruence with evidence-based guidelines. Support Care Cancer. 2008;16:193-200.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment
of cancer QLQ-C30: A quality of life instrument for use in international clinical trials in Oncology. J
Nat Cancer Inst. 1993;85(5):365-376.
Aaronson NK, Bartelink H, van Dongen JA, van dam FSAM. Evaluation of breast conserving therapy:
clinical, methodological and psychosocial perspectives. Eur J Surg Oncol. 1988;14:133-140.
Aaronson NK, Bullinger M, Ahmedzia S. A modular approach to quality-of-life assessment in cancer
clinical trials. Recent Results Cancer Res. 1988;111:231-241.
Aaronson NK, Calais da Silva F. Prospects for the future: quality of life evaluation in prostatic cancer
protocols. Prog Clin Biol Res. 1987;243B:501-512.
Aaronson NK, Calais de Silva F, deVoogt HJ. Subjective response criteria and quality of life. Prog
Clin Biol Res. 1988;269:261-273.
D:\478174570.doc
Aaronson NK, Cull A, Kaasa S, Sprangers MAG. The European Organization for Research Treatment
of Cancer (EORTC) modular approach to quality of life assessment in Oncology. Intern J Mental Hlth.
1994;23:75-96.
Aaronson NK, Meyerowitz BE, Bard M, et al. Quality of life research in oncology: past achievements
and future priorities. Cancer. 1991;67:839-843.
Aaronson NK, Muller M, Cohen PDA, et al. Translation, validation, and norming of the Dutch
language version of the SF-36 health survey in community and chronic disease populations. J Clin
Epidemiol. 1998;51(11):1055-1068.
Aaronson NK, van Dam FSAM, Polak CE, Zittoun R. Prospects and problems in European psychosocial
oncology: a survey of the EORTC study group on quality of life. J Psychosoc Oncol. 1986;41(4):4353.
Aaronson NK, Visser-Pol E, Leehouts GHMW, et al. Telephone-based nursing intervention improves
the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol. 1996.
14(3):984-996.
Aaronson NK. Assessing the quality of life of patients in cancer clinical trials: common problems and
common sense solutions. Euro J Cancer. 1992;28A:1304-1307.
Aaronson NK. Assessing the quality of life of patients with cancer: East meets West. Editorial Euro J
Cancer. 1988;34(6):767-769.
Aaronson NK. Assessment of quality of life and benefits from adjuvant therapies in breast cancer.
Recent Results Cancer Res. 1993;127:201-210.
Aaronson NK. Methodological issues in assessing the quality of life of cancer patients. Cancer.
1991;67:844-850.
Aaronson NK. Quality of life assessment in clinical trials: methodologic issues. Cont Clinical Trials.
1989;10:195-208S.
Aaronson NK. Quality of life research in cancer clinical trials: a need for common rules and language.
Oncology. 1990;4(5):59-66.
Aaronson NK. Quality of life: What is it? How should it be measured? Oncology. 1988;2(5):69-74.
Aaronson NK. Quantitative issues in health-related quality of life assessment. Health Policy.
1988;10:217-230.
Aaronson NK. The assessment of subjective response in prostatic cancer clinical research. Am J Clin
Oncol. 1988;11(suppl 2):S43-S47.
Aaronson, NK. The science of health outcomes measurement. Summary Paper, Drug Information
Association; June 23-25, 2004 Meeting.
D:\478174570.doc
Aaronson, NK, Martin JB, Taphoorn JB, Heimans JJ, Postma RJ, Gundy CM, Beute GN, Slotman BJ,
and Klein M. Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma, J. Clin.
Oncol. Nov 2011;29(32):4430-35
Aass N, Fossa SD, Dahl AA, Moe TJ. Prevalence of anxiety and depression in cancer patients seen at
the Norwegian Radium Hospital. Eur J Cancer. 1997;33(10):1597-1604.
Abadie E. Health-related quality of life evaluation in a regulatory file in Europe. Health-related quality
of life and patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus de la
4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany O,
Caulin C. October 2002.
Abernethy AP, Ahmad A, Zafar SY, Wheeler JL, Reese JB, Lyerly HK. Electronic patient-reported data
capture as a foundation of rapid learning cancer care. Medical Care. 2010;48(6):S32-S38.
Abernethy AP, Wheeler JL, Zafar SY. Management of gastrointestinal symptoms in advanced cancer
patients: the rapid learning cancer clinic model. Current Opinion in Supportive and Palliative Care.
2010;4:36-45.
Abernethy AP, Wheeler JL, Zafar SY. Detailing of gastrointestinal symptoms in cancer patients with
advanced disease: new methodologies, new insights, and a proposed approach. Current Opinion in
Supportive and Palliative Care. 2010;3:41-49.
Abernthy AP, Wheeler JL, Currow DC. Utility and use of palliative care screening tools in routine
oncology practice. Cancer J. 2010;16:444-60.
Abernethy AP, Etheredge LM, Ganz PA, Wallace P, German RR, Neti C, Bach PB, Murphy SB. RapidLearning System for Cancer Care. Journal of Clinical Oncology. 2010;28(27):4268-4724.
Abernethy AP, Herndon JE, Wheeler JL, Day JM, Hood L, Patwardhan M, Shaw H, Lyerly HK. Journal
of Pain and Symptom Management. 2009;37(6):1027-1038.
Abernethy AP, Herndon II JE, Wheeler JL, Patwardhan M, Shaw H, Lyerly HK, Weinfurt K. Improving
health care efficiency and quality using tablet personal computers to collect research-quality, patientreported data. Health Research and Education Trust. 2008;1975-1991.
Abernethy AP, Zafar SY, Uronis h, Wheeler JL, Coan A, Rowe K, Shelby RA, Fowler R, Herndon II JE.
Validation of the patient care monitor (version 2.0): a review of system assessment instrument for
cancer patients. Journal of Pain and Symptom Management. 2010;40(4):545-558.
Abernethy AP, Currow DC, Fazekas BS, Luszcz MA, Wheeler JL, Kuchibhatla M. Specialized palliative
care services are associated with improved short- and long-term caregiver outcomes. Support Care
Cancer. 2008;16:585-597.
Abdel-Khalek AM. Single-versus multi-item scales in measuring death anxiety. Death Studies.
1998;22(8):763-772.
Abrahm JL. Patient and Survivor Care. American Society of Clinical Oncology (2008 Annual Meeting
Summaries). 2008;pages 119-125.
D:\478174570.doc
Abrantes-Pais FN, Friedman JK, Lovallo WR, Ross ED. Psychological or physiological: why are
tetraplegic patients content? Neurology. 2007;69:261-267.
Ackerstaff AH, Hilgers FJM, Aaronson NK, Balm AJM, Van Zandwuk N. Improvements in respiratory
and psychosocial functioning following total laryngectomy by the use of a heat and moisture
exchanger. Ann Otol Rhinol Laryngol. 1993;102:878-883.
Ackerstaff AH, Hilgers FJM, Aaronson NK, Balm AJM. Communication, functional disorders and
lifestyle changes after total laryngectomy. Clin Otolaryngol. 1994;19:295-300.
Ackerstaff AH, Hilgers FJM, Aaronson NK, et al. Heat and moisture exchangers as a treatment option
in the post-operative rehabilitation of laryngectomized patients. Clin Otolaryngol. 1995;20:504-509.
ACOSOG (American College of Surgeons Oncology Group). Adverse Event Reporting Guidelines.
Version 3.0, September 21, 2006.
ACS News Center. Acupuncture may ease cancer pain – study: needles helped when drugs failed.
(Accessed on December 16, 2003 from http://health.yahoo.com/health/news/acs/ )
ACS News Center. Ritalin helps beat cancer fatique – small doses throughout day improve wellbeing. (Accessed December 16, 2003 from: http://health.yahoo.com/health/news/acs/ (As published
in the J Clin Oncol. 2003;21(23):4439-4443.)
ACS News Center. Vitamin D has role in colon cancer prevention – study outlines what increases,
cuts risk. (Accessed on December 16, 2003 from: http://health.yahoo.com/health/news/acs/ (As
published in JAMA 2003;290(22):2959–2967.)
Adams J, Silberman M, Musa D, Peele P. Recruiting older adults for clinical trials. Control Clin Trials.
1997;18:14-26.
Adams E, Boulton M, Rose PW, Lund S, Richardson A, Wilson , Watson EK. A qualitative study
exploring the experience of the partners of cancer survivors and their views on the role of primary
care. Support Care Cancer. 2012;20(11):2785-2794.
Adamsen L, Midtgaard J, Rorth M, et al. Feasibility, physical capacity, and health benefits of a
multidimensional exercise program for cancer patients undergoing chemotherapy. Support Care
Cancer. 2003;11:707-716.
Adamsen L, Quist M, Midtgaard J, et al. The effect of a multidimensional exercise intervention on
physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support
Care Cancer. 2006;14:116-127.
Addeo R, Nocera V, Faiola V, Vincenzi B, Ferraro G, Montella L, Guarrasi R, Rossi E, Cennamo G,
Tonini G, Capasso E, Santini D, Caraglia M, Del Prete S. Management of pain in elderly patients
receiving infusion of zoledronic acid for bone metastasis: a single-institution report. Support Care
Cancer. 2008;16:209-214.
Addington-Hall J, Kalra L. Measuring quality of life: who should measure quality of life? BMJ.
2001;322:1417-1420.
D:\478174570.doc
Addington-Hall JM, Altmann D, McCarthy M. Which terminally ill patients receive hospice in-patient
care? Social Sciences of Medicine. 1998;46:1011-1116.
Addington-Hall JM, MacDonald LD, Anderson HR. Randomized controlled trial of effects of
coordinating care for terminally ill cancer patients. BMJ. 1992;305:1317-1322.
Ader DN. Developing the Patient-Reported Outcomes Measurement Information System (PROMIS).
Medical Care. 2007;45(5):S1-S2.
Adjei AA, Reid JM, Diasio RB, Sloan JA, et al. Comparative pharmacokinetic study of continuous
venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid
tumors. J Clin Oncol. 2002;20(6):1683-1691.
Agarwala SS, Kirkwood JM. Adjuvant interferon treatment for melanoma. Hematol-Oncol Clin N Am.
1998;12(4):823-833.
Agel J, Rockwood T, Mundt JC, Greist JH, Swiontkowski M. Comparison of Interactive Voice
Response and written self-administered patient surveys for clinical research. Orthopedics.
2001;4(12):1155-1157.
Agha R, Kinahan K, Bennett C, Lacouture ME. Dermatologic Challenges in Cancer Patients and
Survivors. Oncology. 2007; 21 (12).
Agnihotri P, Telfer M, Butt Z, Jella A, Cella D, Kozma CM, Ahuja M, Riaz S, Akamah J. Chronic anemia
and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover
exploratory study with epoetin alfa. J Am Geriatr Soc. 2007 Oct;55(10):1557-65. Epub 2007 Aug 14.
Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ. Patients’ decision-making
process regarding participation in phase I oncology research. J Clin Oncol. 2006;24(27):4479-4484.
Agteresch HJ, Burgers SA, van der Gaast A, Wilson JHP, Dagnelie. Randomized clinical trial of
adenosine 5-triphosphate on tumor growth and survival in advanced lung cancer patients. AntiCancer Drugs. 2003;14:639-644.
Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related
fatigue in adults. Lancet. 2003;362:640–650.
Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN,
Kaufman PA. Longitudinal assessment of cognitive changes associated with adjuvant treatment for
breast cancer: impact of age and cognitive reserve. Journal of Clinical Oncology. 2010;28(29):44344440.
Ahles TA, Saykin AJ, Furstenberg CT, et al. Quality of life of long-term survivors of breast cancer and
lymphoma treated with standard-dose chemotherapy or local therapy. J Clin Oncol.
2005;23(19):4399-4405.
Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and Quality of Life in
Breast Cancer Survivors: The Iowa Women’s Health Study. Journal of Clinical Oncology.
2008;26(35):5689-5696.
D:\478174570.doc
Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M. A randomized, double-blind,
active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of
oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.
Palliative Medicine. 2011;26(1):50-60.
Ahola K, Gould R, Virtanen M, Honkonen T, Aromaa A, Lonnqvist J. Occupational burnout as a
predictor of disability pension: a population-based cohort study. Occupational and Environmental
Medicine. Nov. 2008;18 pages.
Aisa Y, Mori T, Kudo M, Yshima T, Kondo S, Yokoyama A, Ikeda Y, Okamoto S. Oral cryotherapy for
the prevention of high-dose melphalan-induced stomatitis in allogenic hematopoietic stem cell
transplant recipients. Support Care Cancer. 2005;13:266-269.
Aitken RCB. A growing edge of measurement of feelings. Proc Roy Soc Med. 1969;62:17-21.
Aitken RCB. Measurement of mood. Section of Measurement in Medicine. 1969;62:21-end.
Akbulut Aktekin L, Eser F, Malhan S, Oksuz E, Keskin D, Bodur H. A comparison of four different
HRQOL generic questionnaire in five different patient groups. Rheumatol Int. 2009;30(1):63-67.
Akechi T, Kugaya A, Ikamura H, Yamawaki S, Uchitomi Y. Fatigue and its associated factors in
ambulatory cancer patients: a preliminary study. J Pain Symptom Manage. 1999;17:42-48.
Akechi T, Okamura H, Yamawaki S, Uchitomi Y. Why do some cancer patients with depression desire
an early death and others do not? Psychosomatics. 2001;42(2):141-145.
Akechi T, Okamura H, Yamawaki S, Uchitomi Y. Predictors of patients' mental adjustment to cancer:
patient characteristics and social support. Br J Cancer. 1998;77(12):2381-2385.
Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y. Suicidality in terminally ill
Japanse patients with cancer. Cancer. 2004;100:183-191.
Akil H, Brenner S, Kandel E, Kendler KS, King M-C, Scolnick E, Watson JD, Zoghbi HY. The future of
psychiatric research: genomes and neural circuits. Science. 2010;327:1580-1581.
Akizuki N, Akechi T, Nakanishi T, et al. Development of a brief screening interview for adjustment
disorders and major depression in patients with cancer. Cancer. 2003;97:2605–2613.
Akizuki N, Yamawaki S, Akechi T, Nakano T, Uchitomi Y. Development of an impact hermometer for
use in combination with the distress thermometer as a brief screening tool for adjustment disorders
and/or major depression in cancer patients. J Pain Symptom Manage. 2005;29(1):91-99.
Aksnes LH, Hall KS, Jebsen N, Fossa SD, Dahl AA. Young survivors of malignant bone tumours in the
extremities: a comparative study of quality of life, fatigue, and mental distress. Supp Care Cancer
2007;15:1087-1096.
Aktas A, Walsh D, Rybicki L. Symptom clusters and prognosis in advanced cancer. Support Care
Cancer. 2012;20(11):2837-2843.
D:\478174570.doc
Alberg AJ, Singh S. Epidemiology of breast cancer in older women: implications for future
healthcare. Drugs and Aging. 2001;18(10):761-772.
Albert SM, Castillo-Castanada C, Jacobs DM, Sano M, Bell K, Merchant C, Small S, Stern Y. Proxyreported quality of life in Alzheimer’s patients: Comparison of clinical and population-based samples.
J Mental Hlth Aging. 1999;5(1):49-58.
Albert U-S, Koller M, Lorenz W, Kopp I, Heitmann C, Stinner B, Rothmund M, Schultz K-D, et al.
Quality of life profile: from measurement to clinical application. Breast. 2002;11:324-334.
Albertsen PC, Aaronson NK, Muller MJ, Keller SD, Ware JE. Health-related quality of life among
patients with metastatic prostate cancer. Urology. 1997;49:207-217.
Albertsen PC, Hanley JA, Barrows GH, PEnson DF, Kowalczyk PDH, Sanders MM, Fine J. Prostate
cancer and the Will Rogers phenomenon. J Natl Cancer Inst Monogr. 2005;97(17):1248-1253.
Albertsen PC. The prostate cancer conundrum. J Natl Cancer Inst. 2003;95(13):930-931.
Albrecht G. Using subjective health assessments in practice and policy-making. Health Care
Analysis. 1996;4:284-292.
Albrecht RR, Ewing SJ. Standardizing the administration of the Profile of Mood States (POMS):
Development of alternative word lists. J Personality. 1989;53(1):31-39.
Albrecht TL, Eggly SS, Gleason MEJ, Harper FWK, Foster TS, Peterson AM, Orom H, Penner LA,
Ruckdeschel JC. Influence of clinical communication on patients’ decision making on participation in
clinical trials. J Clin Oncol. 2008;26(16):2666-2673.
Alexander S, Minton O, Stone PC. Evaluation of Screening Instruments for Cancer-Related Fatigue
Syndrome in Breast Cancer Survivors. Journal of Clinical Oncology. 2009;27(8):1197-1201.
Alibhai SMH, Breunis H, Timilshina N, Marzouk S, Stewart D, Tannock I, Naglie G, Tomlinson G,
Fleshner N, Krahn M, Warde P, Duff Canning S. Impact of androgen-deprivation therapy on cognitive
function in men with nonmetastatic prostate cancer. Journal of Clinical Oncology.
2010;28(34):5030-5037.
Alibhai SMH, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, Krahn M, Fleshner NE,
Warde P, Duff Canning S, Klotz L, Naglie G. Impact of androgen-deprivation therapy on physical
function and quality of life in men with nonmetastatic prostate cancer. Journal of Clinical Oncology.
2010;28(34):5038-5045.
Allal AS, Bieri S, Pelloni A, et al. Sphincter-sparing surgery after preoperative radiotherapy for low
rectal cancers: feasibility oncologic results and quality of life outcomes. Br J Cancer. 2000;82
(6):1131-1337.
Allal AS, Sprangers MAG, Laurencet F, Reymonds MA, Kurtz JM. Assessment of long-term quality of
life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J
Cancer. 1999;80(10):1588-1594.
D:\478174570.doc
Allegra CJ, Hall R, Yothers G. Prevalence of burnout in the US Oncology Community: results of a
2003 survey. J Oncol Practice. 2005:140-147.
Allen SM, Shah AC, Nezu AM, et al. A problem-solving approach to stress reduction among younger
women with breast carcinoma: a randomized controlled trial. Cancer. 2002;94(12):3089-3100.
Allenby A, Matthews J, Beresford J, McLachlan SA. The application of computer touch-screen
technology in screening for psychosocial distress in an ambulatory oncology setting. Eur J Cancer
Care. 2002;11:245-253.
Allen-Mersh TG, Earlam S, Fordy C. Quality of life and survival with continuous hepatic-artery
floxuridine infusion for colorectal liver metastases. Lancet. 1994;344:1255-1260.
Allin KH, Bojesen SE, Nordestgaard BG. Baseline c-reactive protein is associated with incident cancer
and survival in patients with cancer. Journal of Clinical Oncology. 2009;27(13):2217-2224.
Allison PJ, Edgar L, Nicolau B, Archer J, Black M, Hier M. Results of feasability study for a psychoeducational intervention in head and neck cancer. Psycho-Oncol. 2004;13:482-485.
Allison PJ, Guichard C, Fung K, Gilain L. Dispositional optimism predicts survival status 1 year after
diagnosis in head and neck cancer patients. J Clin Oncol. 2003;21(3):543-548.
Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, Mosconi P, Rasmussen NK, Bullinger M, et
al. Health-related quality of life associateed with chronic conditions in eight countries; results from
the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13:283-298.
Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies.
Statistician. 1983;32:307-317.
Altman DG, Bland JM. Treatment allocation by minimization. BMJ. 2005;330(7949):843.
Altman DG, Goodman SN, Schroter S. How statistical expertise is used in medical research. JAMA.
2002;287(21):2817-2820.
Altman DG, Machin D. Current statistical issues in clinical cancer research. Statistical Issues in
Cancer Research (special editorial series). 1993.
Altman DG. Better reporting of randomized controlled trials: the CONSORT statement: Authors must
provide enough information for readers to know the trial was performed (editorial). BMJ.
1996;313(7057):570-571.
Altman DG. Statistics in medical journals. Stat Med. 1982;1:59-71.
Altman DG. Statistics in medical journals: developments in the 1980s. Stat Med. 1991;10:18971913.
Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of
instructions for authors. BMJ. 2005;330(7499):1056-1057.
D:\478174570.doc
Altman DG, Royston P. What do we mean by validating a prognostic model? Statist Med
2000;19:453-473.
Altschuler A, Rosenbaum E, Gordon P, Canales S, Avins A.L. Audio recordings of mindfulness-based
stress reduction training to improve cancer patients’ mood and quality of life – a pilot feasibility
study. Supportive Care in Cancer. 2012;20(6):1291-1298.
Altwein J, Ekman P, Barry M, et al. How is quality of life in prostate cancer patients influenced by
modern treatment? The Wallenberg Symposium. Urology. 1997;49:66-76.
Alwin DF. Feeling thermometers versus 7-point scales. Sociol Methods Res. 1997;25(3):318-340.
Amchin J, Perry S, Manevitz A, Cella D, Miller D. Interview assessment of critically ill patients
regarding resuscitation decisions: A case study in ethics research. General Hospital Psychiatry.
11(2):103-108.
American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and
cancer treatment guidelines. J Clin Oncol. 1996;14:671-679.
Ames SC, Jones GN, Howe JT, Brantley PJ. A prospective study of the impact of stress on quality of
life: an investigation of low-income individuals with hypertension. Ann Behav Med. 2001;23(2):
112–119.
Amichetti M, Caffo O, Arcicasa M, et al. Quality of life inpatients with ductal carcinoma in situ of the
breast treated with conservative surgery and postoperative irradiation. Breast Cancer Res Treat.
1999;54:109-115.
Amichetti M, Caffo O. Quality of life in patients with early stage breast carcinoma treated with
conservation surgery and radiotherapy: an Italian monoinstitutional study. Tumori. 2001;87:78-84.
Amin SH, Kuhle CL, Fitzpatrick LA. Comprehensive evaluation of the older woman. Mayo Clin Proc.
2003;78:1157-1185.
Anandarajah G, Hight E. Spirituality and medical practice: using the HOPE questions as a practical
tool for spiritual assessment. Am Fam Physician. 2001;63:81-89.
Anastasiadis AG, Davis AR, Sawczuk IS, et al. Quality of life aspects in kidney cancer patients: data
from a national registry. Support Care Cancer. 2003;11:700–706.
Ancoli–Isreal S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a
review. Eur J Cancer Care. 2001;10:245–255.
Andersen BL, Kiecolt-Glaser JK, Glaser R. A biobehavioral model of cancer stress and disease course.
Am Psychol. 1994;49:389-404.
Andersen MR, Urban N. Involvement in decision-making and breast cancer survivor quality of life.
Decision-Making. 1999;21(3):201-209.
D:\478174570.doc
Anderson AS, Caswell S, Wells M, Steele RJC, MacAskill S. “It makes you feel so full of Life” LiveWell,
a feasibility study of a personalized lifestyle programme for colorectal cancer survivors. Supportive
Care in Cancer. 2010;18(4):409-416.
Anderson BO. What outcomes matter to patients: a surgeon's perspective. Med Care.
2002;40(6):III-28-III-30.
Anderson H, Hopwood P, Prendiville J, Radford JA, Thatcher N, Ashcroft L. A randomized study of
bolus vs. continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell
lung cancer. Br J Cancer. 1994;67:1385-1390.
Anderson JP, Bush JW, Berry CC. Classifying function for health outcome and quality-of-life
evaluation. Med Care. 1986;24(5):454-469.
Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Reyes-Gibby CC, Cleeland CS. Fatigue
and sleep disturbance in patients with cancer, patients with clinical depression, and communitydwelling adults. J Pain Symptom Manage. 2003;25:307–318.
Anderson RB, Hollenberg NK, Williams GH. Physical symptoms distress index: a sensitive tool to
evaluate the impact of pharmacological agents on quality of life. Arch Intern Med. 1999;159:693700.
Anderson RT, Aaronson NK, Bullinger M, McBee WL. A review of the progress towards developing
health-related quality-of-life instruments for international clinical studies and outcomes research.
Pharmaeconomics. 1996;10(4):336-356.
Andreotti F, Testa L, Biondi-Zoccai G, Crea F. Aspirin plus warfarin compared to aspirin alone after
acute coronary syndromes; an updated and comprehensive meta-analysis of 25 307 patients. Eur
Heart J. 2006;27(5):519-526.
Andrich D. A rating formulation for ordered response categories. Psychometrika. 1978;43(4):561573.
Andrich D. Rating scales and Rasch measurement. Expert Review of Pharmacoeconomics & Outcomes
Research. 2011;11(5):571-585.
Andritsch E, Dietmaier G, Hofmann G, Zloklikovits S, Samonigg H. Global quality of life and its
potential predictors in breast cancer patients: an exploratory study. Support Care Cancer.
2007;15:21-30.
Andrykowski M, Bishop M, Hahn E, Cella D, Beaumont J, Brady M, Horowitz M, Sobocinski K, et al.
Long-term health-related quality of life, growth, and spiritual well-being following hematopoietic stem
cell transplantation. J Clin Oncol 2005;23(3):599-608.
Andrykowski M, Brady M, Henslee-Downey PJ. Psychosocial factors predictive of survival after
allogeneic bone marrow transplantation for leukemia. Psychosom Med. 1994;56:432-439.
Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and
spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23(3):599–608.
D:\478174570.doc
Andrykowski MA, Curran SL, Studts JL, et al. Psychosocial adjustment and quality of life in women
with breast cancer and benign breast problems: a controlled comparison. J Clin Epidemiol.
1996;49(8):827-834.
Andrykowski MA, Greiner CB, Altmaier EM, et al. Quality of life following bone marrow
transplantation: findings from a multicentre study. Br J Cancer. 1995;71(6):1322-1329.
Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of
rehabilitation intervention with their implication for required sample sizes using WOMAC and SF-36
quality of life measurement instruments in patients with osteoarthritis of the lower extremities.
Arthritis Care Res. 2001;45:384-391.
Annemans L, Strens D, Lox E, Petit C, Malonne H. Cost-effectiveness analysis of aprepitant in the
prevention of chemotherapy0induced nausea and vomiting in Belgium. Supportive Care in Cancer.
2008;16(8):905-916.
Annunziata MA, Giovannini L, Muzzatti B. Assessing the body image: relevance, application and
instruments for oncological settings. Supportive Care in Cancer. 2012;20(5):901-907.
Anonymous. Pain I. Basic concepts and assessment. Am J Nurs. 1966;66(5):1085-1108.
Antaki JF. Insanity of left ventricular assist therapy doing the same thing and expecting different
results. Circ Heart Fail. 2011;4:680-681.
Anthony T, Leitch AM, Hynan L, et al. Pretreatment Health-Related Quality of Life (HRQL) is
associated with surgical complications in patients with colorectal cancer. Proc Am Soc Clin Oncol.
2002:21 (abstr 997).
Anton PM, Partridge JA, Morrissy MJ. Cancer Caregivers’ perceptions of an exercise and nutrition
program. Supportive Care in Cancer. 2013;21(3):803-810.
Apfel CC, Kortila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of
postoperative nausea and vomiting. N Engl J Med. 2004;350;2441-2451.
Applegate WB, Blass JP, Williams TF. Instruments for the functional assessment of older patients. N
Engl J Med. 1990;322(17):1207-1214.
Appleton S, Watson M, Rush R, Garcia-Minaur S, Porteous M, Campbell J, Anderson E, Cull A. A
Randomized Controlled trial of a psychoeducational intervention for women at increased risk of breast
cancer. Br J Cancer. 2004;90:41-47.
Arenella C, Finke B, Domer T, Kaur JS, Merriman MP, Ousley A. Adaptation, dissemination, and
evaluation of a cancer palliative care curriculum for the Indian health system. J Palliat Care.
2010;26(1):15-21.
Argyriou AA, Polychronopoulos P, Koutras A, et al. Is advanced age associated with increased
incidence and severity of chemotherapy-induced peripheral neuropathy? Support Care Cancer.
2006;14:223-229.
D:\478174570.doc
Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Iconomou A, Kalofonos HP, Chroni E.
Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy.
Could it be predicted? Support Care Cancer. 2005;13:647-651.
Arikian SR, Suver J, Einarson T, Doyle J. Economic and quality of life outcomes: the four-step
pharmacoeconomic research model. Oncology. 1995;Nov Supplement. 33-?
Armstrong J. Advances in radiation technology can improve survival and quality of life for cancer
patients. Ir J Med Sci. 2001;170(1):63-68.
Armstrong JS. Derivation of theory by means of factor analysis or tom swift and his electric factor
analysis machine. Am Stat. 1967;21:17–21.
Armstrong JS. Tom Swift and his electric regression analysis machine: 1973. Psychol Rep. 1975;36,
806.
Armstrong FD. Proton-Beam Radiation Therapy and Health-Related Quality of Life in children with
CNS Tumors. Journal of Clinical Oncology. 2012;30(17):2028-2029.
Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Persistence of restrictions in quality of life from
the first to the third year after diagnosis in women with breast cancer. J Clin Oncol.
2005;23(22):4945-4953.
Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Quality of life in patients with colorectal cancer
1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol.
2004;22:4777-4784.
Arnold JMO, Sasson Z, Mathias S, Black WR, Gill JB, Higginson L, Huckell V, Klinke P, et al. Impact of
medical interventions on quality of life in cardiovascular disease: a consensus viewpoint. Can J
Cardiol. 1997;13(3):235-236.
Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, Martin SA, Barrett JA, Haig G. A
14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients
with fibromyalgia. The Journal of Pain. 2008;9(9):792-805.
Arnold R, Ranchor AV, Sanderman R, Kempen JIHM, Ormel J, Suurmeijer TPBM. The relative
contribution of domains of quality of life to overall quality of life for different chronic diseases. Qual
Life Res. 2004;13:883–896.
Aronowitz RA. When do symptoms become a disease? Ann Intern Med. 2001;1;134(9 Pt 2):803-808.
Arora N, McHorney CA. Patient preferences for medical decision making. Med Care.
2000;38(3):335–341.
Arora NK, Gustafson DH, Hawkins RP, McTavish F, Cella DF, Pingree S, Mendenhall JH, Mahvi DM.
Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma.
Cancer. 2001;92(5):1288-1298.
D:\478174570.doc
Arrington R, Cofrancesco J, Wu AW. Questionnaires to measure sexual quality of life. Qual Life Res.
2004;13:1643-1658.
Arroll B, Macgillivray S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I. Efficacy and tolerability of
tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary
care; a meta-analysis. Ann Fam Med. 2005;3:449-456.
Arterbery VE, Frazier A, Dalmia PR, Siefer J, Lutz M, Porter A. Quality of life after permanent
prostate implant. Sem Surg Oncol. 1997;61-64.
Arzouman JMR, Dudas S, Estwing Ferrans C, Holm K. Quality of life of patients with sarcoma postchemotherapy. Oncol Nurs Forum. 1991;18(5):889-894.
Asche C. Use of patient registry data in evaluating patient reported outcomes. ISPOR Connections.
2009;15(4):7-8.
Ashing-Giwa K. Quality of life of African-American and white long term breast carcinoma survivors.
Cancer. 1999;85:418-426.
Askew RL, Xing Y, Palmer JL, Cella D, Moye LA, Cormier JN. Evaluating minimal important
differences for the fact-melanoma quality of life. Value in Health. 2009;12(8):1144-50.
Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL, Whitehead M, Spaans JN, Graham
BC, Goss GD. Age and cormorbidity as independent prognostic factors in the treatment of non-small
cell lung cancer: A review of National Cancer Institute of Canada Clinical Trials Group Trials. J Clin
Oncol. 2008;26(1):54-59.
Assefi N, Sherman KJ, Jacobsen C, Goldberg J, Smith WR, Buchwald D. A randomized clinical trial of
acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med. 2005;143:10-19.
Astradsson E, Granath L, Heedman P-A, Starkhammer H. Cancer patients hospitalized for palliative
reasons. Symptoms and needs presented at a university hospital. Support Care Cancer.
2001;9(2):97–102.
Astrow AB, Wexler A, Texeira K, He MK, Sulmasy DP. Is failure to meet spiritual needs associated
with cancer patients’ perceptions of quality of care and their satisfaction with care? J Clin Oncol.
2007;25:5753-5757.
Atherton PJ, Sloan JA. Rising importance of patient-reported outcomes. Lancet Oncol.
2006;7(11):883-884.
Atherton PJ. Combining symptom and survival data. Curr Probl Cancer. 2006;30:307-318.
Atherton PJ. Analyzing the “correct” endpoint. Curr Probl Cancer. 2006;30:283-297.
Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the
Skindex-16 and common terminology criteria for adverse events to assess rash symptoms: results of
a pooled-analysis (N0993). Supportive Care in Cancer. 2012;20(8):1729-1735.
D:\478174570.doc
Atherton PJ, Halyard MY, Sloan JA, Miller RC, Deming RL, Tai THP, Stien KJ, Martenson Jr JA.
Assessment of patient-reported meausures of bowel function before and after pelvic radiotherapy: an
ancillary study of the North Center Cancer Treatment Group study N00CA. Supportive Care in
Cancer. 2013;21(4):1193-1200.
Atherton PJ, Smith T, Singh JA, Huntington J, Diekmann BB, Huschka M, Sloan JA. The relation
between cancer patient treatment decision-making roles and quality of life. Cancer. 2013;6 pages.
Atkinson A, Barsevick A, Cella D, Cimprich B, et al. NCCN Practice Guidelines for Cancer-Related
Fatigue. Oncology. 2000;14:151-161.
Au HJ, Karapetis CS, O’Callaghan CJ, Tu D, Moore MJ, Zalcberg JR, Kennecke H, Shapiro JD, Koski S,
Pavlakis N, Charpentier D, Wyld D, Jefford M, Knight GJ, Magoski NM, Brundage MD, Jonker DJ.
Health-related quality of life in patients with advanced colorectal cancer treated with Cetuximab:
overall and KRAS-specific results of the NCIC CTG and AGITG C0.17 trial. Journal of Clinical
Oncology. 2009;27(11):1822-1828.
Aubin M, Vexina L, Verreault R, Fillion L, Huon E, Lehmann F, Leduc Y, Bergeron R, Reinharz D, Morin
D. Family physician involvement in cancer care and lung cancer patient emotional distress and
quality of life. Supportive Care in Cancer. 2011;19(11):1719-1728.
Audrain J, Lerman C, Rimer B, Cella DF, Steffens R, Gomez-Caminero A, and the High risk Breast
Cancer Consortium. Awareness of heightened breast cancer risk among first degree relatives of
recently diagnosed breast cancer patients. Cancer Epidemiology, Biomarkers and Prevention .
1995;4:561-565.
Audrain J, Rimer B, Cella D, et al. Genetic counseling and testing for breastovarian cancer
susceptibility: What do women want? Journal of Clinical Oncology. 1998;16:133-138.
Audrain J, Rimer B, Cella D, et al. The impact of a brief coping skills intervention on adherence to
breast selt examinaiton among first-degree relatives of newly diagnosed breast cancer patients.
Psycho-Oncology. 1999;8:220-229.
Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain B, Balan S, Barker L, Rana J.
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with
chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol.
2004;22(7):1301-1307.
Auffray C, Adcock IM, Chung KF, Djukanovic R, Pison C, Sterk PJ. An integrative Systems Biology
Approach to Understanding Pulmonary Diseases. Chest. 2010;137:1410-1416.
Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare.
Genome Medicine. 2009;1(1):11 pages.
Aviles A, Delgado S, Nambo MJ, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a
controlled clinical trial. Oncology. 2005;69(3):256-260.
Avis NE, Smith KW, Hambleton RK, Feldman HA, Selwyn A, Jacobs A. Development of the
multidimenstional index of life quality: a quality of life measure for cardiovascular disease. Med Care.
1996;34(11):1102-1120.
Axelsson B, Sjoden PO. Assessment of quality of life in palliative care – psychometric properties of a
short questionnaire. Acta Oncol. 1999;38(2):229-237.
D:\478174570.doc
Axelsson B, Sjoden P-O. Quality of life of cancer patients and their spouses in palliative home care.
Palliat Med. 1998;12:29-39.
Ayanian JZ, Chrischilles EA, Wallace RB, et al. Understanding cancer treatment and outcomes: The
Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. Comments and
Controversies. 2004;22(15).
Ayanian JZ, Jacobsen PB. Enhancing research on cancer survivors. J Clin Oncol. 2006;24(32):51495153.
Ayash LJ, Wheeler C, Fairclough D, et al. Prognostic factors for prolonged progression-free survival
with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. J Clin
Oncol. 1995;13(8):2043-2049.
Azzone V, Frank RG, Pakes JR, Earle CC, Hassett MJ. Behavioral Health Sciences for Women Who
Have Breast Cancer. Journal of Clinical Oncology. 2009;27(5):706-712.
Baba M, Natsugoe S, Shimada M, et al. Does hoarseness of voice from recurrent nerve paralysis
after esophagectomy for carcinoma influence patient quality of life? J Am Coll Surg. 1999;188:231236.
Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that
should be laid to rest. JAMA. 2004;292:2765-2770.
Bachman JW. The patient-computer interview: a neglected tool that can aid the clinician. Mayo Clin
Proc. 2003;78:67-78.
Bacik J, Mazumdar M, Murphy BA, et al. The Functional Assessment of Cancer Therapy – BRM (FACT
– BRM): A new tool for the assessment of quality of life in patients treated with biologic response
modifiers. Qual Life Res. 2004;13:137–154.
Back A. Patient-physician communication in oncology: what does the evidence show? Oncology.
2006;20(1):67-74.
Back AL, et al. Teaching communication skills to medical oncology fellows. J Clin Oncol.
2003;21(12):2433-2436.
Bader JL. Cancer information on the internet: benchmarks for creating successful e-health
communication and tools for measuring success. ASCO 2004 Educational Book 351–358.
Badgwell BD, Smith K, Liu P, Bruera E, Curley SA, Cormier JN. Indicators of surgery and survival in
oncology inpatients requiring surgical evaluation for palliation. Supportive Care in Cancer.
2009;17(6):727-734.
Baecke JAH, Burema J, Fritjers JER. A short questionnaire for the measurement of habitual physical
activity in epidemiological studies. The American Journal of Clinical Nutrition. 1982;36:936-942.
D:\478174570.doc
Bagha SM, Macedo A, Jacks LM, Lo C, Zimmerman C, Rodin G, Li M. The utility of the Edmonton
Symptom Assessment Symptom in screening for anxiety and depression. Eur J Cancer Care (Engl).
2012 Jun 14. Epub ahead of print. (ABSTRACT ONLY)
Baghaei F, Rosmond M, Landen L, et al. Phenotypic and genotypic characteristics of women in
relation to personality traits. Int J Behav Med. 2003;10(4):364–378.
Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L. Oncologists' attitudes toward and practices in
giving bad news: an exploratory study. J Clin Oncol. 2002;20(8):2189-2196.
Bainbridge D, Seow H, Sussman J, Pond G, Martelli-Reid L, Herbert C, Evans W. Multidisciplinary
health care professionals’ perceptions of the use and utility of symptom assessment system for
oncology patients. Journal of Oncology Practice. 2011;7(1):19-23.
Baixauli J, Delaney CP, Wu JS, Remzi FH, Lavery IC, Fazio VW. Functional outcome and quality of life
after repeat ileal pouch-anal anastomosis for complications of ileoanal surgery. Dis Colon Rectum.
2004;47;2-11.
Bajetta E. Advanced breast cancer in elderly patients: which drug after tamoxifen? Tumori.
2002;88(1):S59-S60.
Bakas T, Champion V. Development and psychometric testing of the Bakas Caregiving Outcomes
Scale. Nurs Res. 1999;48(5):250–259.
Baker DW, Hays RD, Brook RH. Understanding changes in health status. Is the floor phenomenon
merely the last step of the staircase? Med Care. 1997;35(1):1-15.
Baker F, Curbow B, Wingard JR. Development of the Satisfaction with Life Domains Scale for Cancer.
J Psychosoc Oncol. 1993;10(3).
Baker F, Denniston M, Zabora J, Polland A, Dudley WN. A POMS short form for cancer patients:
psychometric and structural evaluation. Psycho-Oncol. 2002;11:273-281.
Baker F, Wingard JR, Curbow B, Zabora J, Jodrey D, Fogarty L, Legro M. Quality of life of bone
marrow transplant long-term survivors. Bone Marrow Trans. 1994;13:589-596.
Bakker W, Van Oosterom AT, Aaronson NK, Van Breukelen FJM, Bins MC, Hermans J. Vindesine,
cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality
of life. Eur J Cancer Clin Oncol. 1986;22(8)963-970.
Balboni TA, Vanderwerker LC, Block SD, Paulk E, Lathan CS, Peteet JR, Prigerson HG. Religiousness
and spiritual support among advanced cancer patients and associations with end-of-life treatment
preferences and quality of life. J Clin Oncol. 2007;25:555-560.
Balboni TA, Paulk ME, Balboni MJ, Phelps AC, Loggers ET, Wright AA, Block SD, Lewis EF, Peteet JR,
Prigerson HG. Provision of spiritual care to patients with advanced cancer: associations with medical
care and quality of life near death. Journal of Clinical Oncology. 2010;28(3):445-452.
D:\478174570.doc
Balboni MJ, Sullivan A, Amobi A, Phelps AC, Gorman DP, Zollfrank A, Peteet JR, Prigerson HG,
VanderWeele TJ, Balboni TA. Why is spiritual care infrequent at the end of life? Spiritual care
perceptions among patients, nurses, and physicians and the role of training. Journal of Clinical
Oncology. 2013;31(4):461-467.
Balducci L, Behe C. Pharmacology of chemotherapy in the older cancer patient. Cancer Control.
1999;6(5):466-470.
Balducci L, Extermann M, Carreco I. Management of breast cancer in older women. Cancer Control.
2001;8(5):431-441.
Balducci L, Extermann M. A practical approach to the older patient with cancer. Curr Probl Cancer.
2001;6-76.
Balducci L. Cancer-related anemia: special considerations in the elderly. Oncology. 2007;81-87?
Balducci L. Management of cancer in the elderly. Oncology. 2006;20:135-152.
Balducci L. New paradigms for treating elderly patients with cancer: the comprehensive geriatric
assessment and guidelines for supportive care. J Support Oncol. 2003;1:30-37.
Baldwin MW, Fehr B. On the instability of attachment style ratings. Pers Relatsh. 1995; 2(3):247261.
Ballatori E, Porzio G, Roila F, Ruggeri B, Mattei A, Cortesi E. Is there still a role for the uniscale
assessment of quality of life? Tumori. 2007;93(1):78-81.
Ballatori E, Roila F, Ruggeri B, betti M, Sarti S, soru G, Cruciani G, Maio MD, Andrea B, Deuson RR.
The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Support
Care Cancer. 2007;15:179-185.
Ballatori E. Unsolved problems in evaluating the quality of life of cancer patients. Ann Oncol.
2001;12(Suppl 3):S11-S13.
Ballinger AB, et al. Symptom relief and quality of life after stenting for malignant bile duct
obstruction. Gut. 1994;35:467-470.
Balneaves LG, Truant TLO, Kelly M, Verhoef MJ, Davison BJ. Briding the gap: decision-making
processes of women with breast cancer using complementary and alternative medicine (CAM).
Support Care Cancer. 2007;15:973-983.
Baracos VE. Clinical trials of cancer cachexia therapy, now and hereafter. Journal of Clinical
Oncology. 2013;31(10):1257-1258.
Barbera L, Seow H, Howell D, Sutradhar R, Earle C, Liu Y, Stitt A, Husain A, Sussman J, Dudgeon D.
Symptom burden and performance status in a population-based cohort of ambulatory cancer
patients. Cancer. 2010 Dec 15;116(24):5767-76.
D:\478174570.doc
Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ. Efficacy of complementary and alternative
medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol. 2006;24(34):54575464.
Bardwell WA, Major JM, Rock CL, et al. Health related quality of life in women previously treated for
early-stage breast cancer. Psycho-Oncol. 2004;13:595–604.
Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K, Pierce JP. Objective
cancer-related variables are not associated with depressive symptoms in women treated for earlystage breast cancer. J Clin Oncol. 2006;24(16):2420-2427.
Barg FK, Cooley M, Pasacreta J, Senay B, McCorkle R. Development of a self-administered
psychosocial cancer screening tool. Cancer Pract. 1994;2(4):288-296.
Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE. Current practice and knowledge
of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer.
2005;13:32-42.
Barnes EA, Bruera E. Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer.
2002; 12(5):424-428.
Barofsky I, Erickson P, Eberhardt M. Comparison of a single global item and an index of a multi-item
health status measure among persons with and without diabetes in the US. Qual Life Res.
2004;13:1671-1681.
Barofsky I, Erickson P, Eberhardt M. Comparison of multi-attribute and self-assessed health status
measures among persons with and without diabetes in the US general population. Paper given at
QOL workshop in Charleston SC, May 10-14, 1997.
Barofsky I. Patients’ rights, quality of life, and health care system performance. Qual Life Res.
2003;12:473-484.
Barofsky I. The cognitive sciences and quality of life assessment. Presented at the meeting of the
International Society of Quality of Life Research; Baltimore, MD: November 16, 1998.
Baron RS, Cutrona CE, Hicklin D, Russell DW, Lubaroff DM. Social support and immune function
among spouses of cancer patients. J Pers Soc Psychol. 1990;59(2):344-352.
Barrera M, D’Agostino N, Gammon J, Spencer L, Baruchel S. Health-related quality of life and
enrollment in phase i trials in children with incurable cancer. Palliat Support Care. 2005;3,191-196.
Barresi MJ, Shadbolt B, Byrne D, Stuart-Harris R. The development of the Canberra symptom
scorecard: a tool to monitor the physical symptoms of patients with advanced tumors. BMC Cancer.
2003;3:32.
Barrier PA, Li JT-C, Jensen NM. Two words to improve physician-patient communication: what else?
Mayo Clin Proc. 2003;78:211-214.
D:\478174570.doc
Barry MJ, Fowler Jr FJ, O'Leary MP, et al. The American Urological Association symptom index for
benign prostatic hyperplasia: The Measurement Committee of the American Urological Association. J
Urol. 1992;148:1549-1557.
Barsevick A, Whitmer K, Sweeney C, Nail LM. A pilot study examining energy conservation for cancer
treatment-related fatigue. Cancer Nurs. 2002;25:333-341.
Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M. I’m so tired: biological and genetic
mechanisms of cancer-related fatigue. Qual Life Res. 2010;19(10):1419-1427.
Barsky AJ. The paradox of health. N Engl J Med. 1988;318:414-418.
Bartko J, Carpenter W. On the methods and theory of reliability. J Nerv Ment Dis. 1976;163(5):
307-317.
Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM, et al.
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with
decreased libido; North Central Cancer Treatment Group Protocol N02C3. J Natl Cancer Inst.
2007;99:672-679.
Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden III JD, Kugler JW, Hoff KL,
Reddy PS, Rowland Jr KM, Riepl M, Christensen B, Loprinzi CL. A double-blind, placebo-controlled
trial of a topical treatment for chemotherapy-induced peripheral neurotherapy: NCCTG trial N06CA.
Supportive Care in Cancer. 2011;19(6):833-842.
Barton DL, Burger K, Novotny PJ, Fitch TR, Kohli S, Soori G, Wilwerding MB, Sloan JA, Kottschade LA,
Rowland Jr KM, Dakhil SR, Nikcevich DA, Loprinzi CL. The use of Ginkgo biloba for the prevention of
chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast
cancer, N00C9. Supportive Care in Cancer. 2013;21(4):1185-1192.
Basch E, Abernethy AP. Supporing clinical practice decisions with real-time patient-reported
outcomes. Journal of Clinical Oncology. 2011;29(8):954-956.
Basch E. The missing voice of patients in drug-safety reporting. The New England Journal of
Medicine. 2010;362;10:865-869.
Basch E, Minasian L, Burke L, Kwitkowski V, Seal B, Gorman M, Levy R. Panel 3: Symptom
Measurement in Clinical Trials. Issue Brief Conference on Clinical Cancer Research. November 2011,
9 pages.
Basch E, Abernethy A. Commentary: encouraging clinicians to incorporate longitudinal patientreported symptoms in routine clinical practice. Journal of Oncology Practice. 2011;7(1):23-25.
Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag
D. Patient online self-reporting of toxicity symptoms during chemotherapy. Journal of Clinical
Oncology. 2005;23(15):3552-3561.
D:\478174570.doc
Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Patient versus
clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for
adverse events: results of a questionnaire-based study. Lancet Oncol. 2006;7(11):903-909.
Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, et al. Long-term toxicity
monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin
Oncol. 2007;25(34):5374-5380.
Basche M, Byers T. Tumor characteristics and clinical outcome of elderly women with breast cancer.
J Natl Cancer Inst. 2001;93(1):64-66.
Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S, Gershenson DM.
Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol.
2001;19:1809-1817.
Basch E, Jia Xiaoyu, Heller G, Barz A, Sit L, Fruscione M, Appawu M, Iasonos A, Atkinson T, Goldfarb
S, Culkin A, Kris MG, Schrag D. Adverse symptom event reporting by patients vs clinicians:
relationships with clinical outcomes. J Natl Cancer Inst. 2009;101:1624-1632.
Bastani F, Hidarnia A, Kazemnejad A, Vafaei M, Kashanian M. A randomized controlled trial of the
effects of applied relaxation training on reducing anxiety and perceived stress in pregnant women. J
Midwifery Womens Health. 2005;50:e36-340.
Bastit L, Vandebroek A, Altintas S, Gaede B, Pinter T, Suto TS, Mossman TW, Smith KE,
Vansteenkiste JF. Randomized, multicenter, controlled trial comparing the efficacy and safety of
darbepoetin alfa administrated every 3 weeks with or without intravenous iron in patients with
chemotherapy-induced anemia. J Clin Oncol. 2008;26(10):1611-1618.
Batel-Copel LM, Kornblith AB, Batel PC, Holland JC. Do oncologists have an increasing interest in the
quality of life of their patients? A literature review of the last 15 years. Euro J Cancer. 1997;33:2932.
Bauer S, Lambert MJ, Nielsen S. Clinical significant methods: a comparison of statistical techniques.
J Pers Assess. 2004;82(1):60–70.
Baum M. What are the needs of patients diagnosed with cancer? Psycho-Oncology. 2004;13:850852.
Bausewein C, Le Grice C, Simon ST, Higginson IJ, on behalf of PRISMA. The use of two common
palliative outcome measures in clinical care and research: A systematic review of POS and STAS.
Palliative Medicine. 2011;25(4):304-313.
Bayley KB, London MR, Grunkemeier GL, Lansky DJ. Measuring the success of treatment in patient
terms. Med Care. 1995;33(4):AS226-AS235.
Bayliss MS, Dewey JE, Dunlap I, Batenhorst AS, Cady R, Diamond ML, Sheftell F. A study of the
feasibility of Internet administration of a computerized health survey: The headache impact test
(HIM). Qual Life Res. 2003;12:953–691.
D:\478174570.doc
Beacon HJ, Thompson SG. Multi-level models for repeated measurement data: application to quality
of life data in clinical trials. Stat Med. 1996;15:2717-2732.
Beadle GF, Yates PM, Najman MN, Clavarino A, Thomson D, Williams G, Kenny L, Roberts S, Mason
B, Schlect D. Illusions in advanced cancer: the effect of belief systems and attitudes on quality of
life. Psycho-Oncology. 2004;13:26–36.
Beal JE, Olson R, Lefkowitz L, et al. Long-term efficacy and safety of dronabinol for acquired
immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage. 1997;14(1):7-14.
Beardsley T. A war not won. Sci Am. 1994;130-138.
Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in
survivors of early-stage breast cancer. Arch Surg. 2002;137:1253-1257.
Beaver K, Bogg J, Luker K. Decision-making role preferences and information needs: a comparison
of colorectal and breast cancer. Health Expectations. 1999;2:266-276.
Beaver K, Luker K, Woods S. Primary care services received during terminal illness. Int J Palliat
Nurs. 2000;6(5):220-227.
Bech P, Allerup P, Maier W, Albus M, Lavori P, Ayuso JL. The Hamilton scales and the Hopkins
Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J
Psychiatry. 1992;160:206-11.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch
Gen Psychiatry. 1961;4:561-571.
Beck AT, Weissman A. The measurement of pessimism: the hopelessness scale.
J Consult Clin Psychol. 1974;42(6):861-865.
Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A. Psychometric Evaluation of the Pittsburgh
Sleep Quality Index in Cancer Patients. Journal of Pain and Symptom Management. 2004;27(2):1408.
Beck SL, Berger AM, Barsevick AM, Wong B, Stewart KA, Dudley WN. Sleep quality after initial
chemotherapy for breast cancer. Supportive Care in Cancer. 2010;18(6):679-690.
Becker G, Hatami I, Xander C, Dworschak-Flach B, Olschewski M, Momm F, Deibert P, Higginson IJ,
Blum HE. Palliative Cancer Care: an epidemiologic study. Journal of Clinical Oncology.
2011;29(6):646-650.
Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK,
Frank L, Waltrip R, Maroli A, Huang B, Sundy J. Quality of life and disability in patients with
treatment-failure gout. J Rheumatol. 2009;36(5):1041-8.
Bedard PL, Krzyzanowska MK, Pintilie M, Tannock IF. Statistical power of negative randomized
controlled trials presented at American Society for Clinical Oncology Annual Meetings. J Clin Oncol
2007;25(23):3482-3487.
D:\478174570.doc
Bedard G, Zeng L, Zhang L, Lauzon N, Holden L, Tsao M, Danjoux C, Barnes E, Sahgal A, Poon M,
Chow E. Minimal clinically important differences in the Edmonton Symptom Assessment System in
patients with advanced cancer. J Pain Symptom Manage. 2012 Nov 21. Epub ahead of print.
Beebe D, Finer E, Holmbeck G. Low-end specialty of four depression measures: findings and
suggestions for the research use of depression tests. J Pers Assess. 1996;67:272-284.
Beem EE, Maes S, Cleiren M, Schut HA, Garssen B. Psychological functioning of recently bereaved,
middle-aged women: the first 13 months. Psychol Rep. 2000;87(1):243-54.
Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting randomized controlled trials.
The CONSORT statement. JAMA. 1996;276(8):637-639.
Beitz B, Gnecco C, Justice R. Quality of life in clinical cancer trials: The U.S. Food and Drug
Administration Perspective. Monograph #20 of the J Nat Cancer Inst, NCI. 1996.
Bell DR, Tannock IF, Boyd NF. Quality of life in breast cancer patients. Br J Cancer.
1985;51(4):577-580.
Bell W. Taking issue with alternative medicine label: Letter to editor. Can J Public Health.
1997;88(5):336 & 345.
Bellizzi KM, Rowland JH, Arora NK, Hamilton AS, Farmer Miller M. Physical Activity and Quality of Life
in Adult Survivors of Non-Hodgkin’s Lymphoma. Journal of Clinical Oncology. 2009;27(6):960-966.
Ben-Arye E, Bar-Sela G, Frenkel M, Kuten A, Hermoni D. Is a biopsychosocial-spiritual approach
relevant to cancer treatment? a study of patients and oncology staff members on issues of
complementary medicine and spirituality. Support Care Cancer. 2006;14:147-152.
Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock JD, Myerson R, Anne R, Rosenthal
SA, Willett C. Impact of overall treatment time on survival and local control in patients with anal
cancer: a pooled data analysis of radiation therapy oncology group trials 87-04 and 98-11. Journal of
Clinical Oncology. 2010;28(34):5061-5066.
Benhaim DI, Lopchinsky R, Tartter PI. Lumpectomy with tomoxifen as primary treatment for elderly
women with early-stage breast cancer. Am J Surg. 2000;180:162-166.
Bennett CL, Chapman G, Elstein AS, et al. A comparison of perspectives on prostate cancer: analysis
of utility assessments of patients and physicians. Euro Urol. 1997;32(Suppl 3):86–88.
Bennett Johnson S, Baughcum AE, Carmichael SK, She J-X, Schatz DA. Maternal anxiety associated
with newborn genetic screening for Type 1 diabetes. Diabetes Care. 2004;27:392-397.
Benninghoff D, Tsien KC. Treatment and survival in breast cancer: a review of results. Br J Radiol.
1959;32:450-454.
Benoit A. Patient-reported outcomes and clinical practice. From Measurement instruments to
decision tools:much more than a simple change in format. Patient Reported Outcomes Newsletter.
2006; 36.
D:\478174570.doc
Benrud-Larson LM, Dewar MS, Sandroni P, Rummans T, Haythornwaite JA, Low P. Quality of life in
patients with postural tachycardia syndrome. Mayo Clin Proc. 2002;77:531-537.
Benson K, Hartz A. A comparison of observational studies and randomized, controlled trials. N Engl J
Med. 2000;342:1878-1886.
Benson T, Sizmur S, Whatling J, Arikan S, McDonald D, Ingram D. Evaluation of a new short generic
measure of health status: howRu. Inform Prim Care. 2010;18(2):89-101.
Beral V, Jaffe H, Weiss R. Cancer surveys: cancer, HIV, and AIDS. Eur J Cancer. 1991; 27(8):10571058.
Berdel WE, Knopf H, Fromm M, et al. Influence of phase I early clinical trials on the quality of life of
cancer patients: a pilot study. Anticancer Res. 1988;8(3):313-331.
Berg A, Lilleby W, Bruland OS, Foss SD. 10-year survival and quality of life in patients with high-risk
PN0 prostate cancer following definitive radiotherapy. Int J Radiation Oncology Biol Phys.
2007;69(4):1074-1083.
Bergenmar M, Johansson H, Wilking N. Levels of knowleges and perceived understanding among
participants in cancer clinical trials – factors related to the informed consent procedure. Clinical
Trials. 2011;8(1):77-84.
Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC, Agrawal S. One-year
outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue.
Journal of Clinical Oncology. 2009;27(35):6033-6040.
Berger AM, VonEssen S, Kuhn BR, Piper BF, Farr L, Agrawal S, Lynch JC, Higginbotham P. Feasibility
of a Sleep Intervention During Adjuvant Breast Cancer Chemotherapy. Oncology Nursing Forum.
2002;29(10):1431-41.
Berger AS. Arrogance among physicians. Acad Med. 2002;77(2):145-147.
Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular
supplement to the EORTC core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical
trials. Eur J Cancer. 1994;30A(5):635-642.
Bergman B, Aaronson NK. Quality-of-life and cost-effectiveness assessment in lung cancer. Curr
Opin Oncol. 1995;7:138-143.
Bergner M, Bobbitt R, Carter W, Gilson B. The sickness impact profile: Development and final
revision of a health status measure. Med Care. 1981;19(8):787-805.
Bergner M, Bobbitt R, Kressel S, Pollard W, Gilson B, Morris J. The sickness impact profile:
Conceptual formulation and methodology for the development of a health status measure. Int J
Health Serv. 1976;6(3):393-415.
Bergner M. Quality of life, health status, and clinical research. Med Care. 1989;27:S148-S156.
D:\478174570.doc
Bergstrasser E. Childhood cancer – are there predictors of parental well-being? Support Care
Cancer. 2007;15:799-800.
Bergus GR, Hartz AJ, Noyes Jr R, Ward MM, James PA, Vaughn T, et al. The limited effect of
screening for depressive symptoms with the PHQ-9 in rural family practices. J Rural Health.
2005;21:303-309.
Berkanovic E. The effect of inadequate language translation on Hispanics responses to health
surveys. AJPH. 1980;70(12):1273-1276.
Berkson J, Gage RP. Calculation of survival rates for cancer. Mayo Clin Proc. 1950;25(11):270-86.
Berkson J, Walters W, Gray HK, Priestley JT. Mortality and survival in cancer of the stomach: a
statistical summary of the experience of the Mayo Clinic. Mayo Clin Proc. 1952;27(8):137-51.
Bernhard J, Castiglione-Gertsch M, Hsu Schmitz S-F, et al. Quality of life in postmenopausal patients
with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line
hormonal treatment. Eur J Cancer. 1999;35(6):913-920.
Bernhard J, Cella D, Coates A, et al. Missing quality of life data in cancer clinical trials: serious
problems and challenges. Stat Med. 1998;17:517-532.
Bernhard J, Hurny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Senn
HJ, et al. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the
IBCSG approach. Ann Oncol. 1997;8;825-835.
Bernhard J, Lowry A, Mathys N, Herrmann R, Hurny C. Health related quality of life: a changing
construct? Qual Life Res. 1994;13:1187–1197.
Bernhard J, Maibach R, Thurlimann B, Sessa C, Aapro MS for the Swiss Group for Clinical Cancer
Research. Patients’ estimation of overall treatment burden: why not ask the obvious? J Clin Oncol.
2001;20:65-72.
Bernhard J, Peterson HF, Coates AS, et al. Quality of life assessment in international breast cancer
study group (IBCSG) trials: practical issues and factors associated with missing data. Stat Med.
1998;17:587-601.
Bernhard J, Sullivan M, Hurny C, Coates AS, Rudenstam C-M. Clinical relevance of single item quality
of life indicators in cancer clinical trials. Br J Cancer. 2002;84(9)1156-1165.
Bernhard J, Sullivan M, Hurny C, Coates AS, Rudenstam CM. Clinical relevance of single item quality
of life indicators in cancer clinical trials. Br J Cancer. 2001;84(9):1156-65.
Bernhardson B-M, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer
chemotherapy. Support Care Cancer. 2008;16:275-283.
Bernstein BJ, Grasso T. Prevalence of complementary and alternative medicine use in cancer
patients. Oncology. 2001;15:1267–1272.
D:\478174570.doc
Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life
to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology.
2002;35:704-708.
Berrak SG, Ozdemir N, Bakirci N, Turkkan E, Canpolat C, Beker B, Yoruk A. A double-blind,
crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed
nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy.
Support Care Cancer. 2007;15:1163-1168.
Berry DL, Blumenstein BA, Halpenny B, Wolpin S, Fann JR, Austin-Seymour M, Bush N, Karras BT,
Lober WB, McCorkle R. Enhancing patient-provider communication with the electronic self-report
assessment for cancer: a randomized trial. Journal of Clinical Oncology. 2011;29(8):1029-1035.
Berry DL, Trigg LJ, Lober WB, Karras BT, Galligan ML, Austin-Seymour M, Martin S. Computerized
Symptom and Quality-of-Life Assessment for Patients With Cancer Part I: Development and Pilot
Testing. Oncology Nursing Forum. 2004;31:E75-E83.
Berry DL, Moinpour CM, Jiang CS, Ankerst DP, et al. Quality of life and pain in advanced stage
prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and
estramustine to mitoxantrone and prednisone. J Clin Oncol. 2006;24(18):2828-2835.
Bertheussen GF, Oldervoll L, Kaasa S, Sandmel J-A, Helbostad JL. Measurement of physical activity
in cancer survivors-a comparison of the HUNT 1 Physical Activity Questionnaire (HUNT 1 PA-Q) with
the International Physical Activity Questionnaire (1PAQ) and aerobic capacity. Supportive Care in
Cancer. 2013;21(2):449-458.
Bertsch LA, Donaldson G. Quality of life analyses from vinorelbine (Navelbine) clinical trials of
women with metastatic breast cancer. Sem Oncol. 1995;22(2 Suppl 5):45-53, discussion 53-54.
Berzon RA, Donnelly MA, Simpson Jr RL, Simeon GP, Tilson, H.H. Quality of life bibliography and
indexes: 1994 update. Qual Life Res. 1995;4:547-569.
Berzon RA, Shumaker S. A critical review of cross national health-related quality of life instruments.
MAPI Quality of Life Newsletter. 1993:5;1-2.
Berzon RA, Shumaker. Evaluating health related quality of life measures for cross-national research.
Drug Inf J. 1994;28:63–67.
Berzon RA, Simeon GP, Simpson, Jr RL, Tilson HH. Quality of life bibliography and indexes; 1992
update. J Clin Res Drug Dev. 1993;7(4):203–242.
Bethoux F, Calmels P, Gautheron V, Minaire P. Quality of life of the spouses of stroke patients: a
prelimary study. Int J Rehab Res. 1996;19:291-299.
Bethoux F, Calmels P, Gautheron V. Changes in the quality of life of hemiplegic stroke patients with
time: a prelimary report. Am J Phys Med. 1999;78(1):19-23.
D:\478174570.doc
Beusterien KM, Ackerman SJ, Plante K, et al. The health-related quality-of-life impact of histamine
dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic
melanoma. Support Care Cancer. 2003;11:304-312.
Beusterien KM, Steinwald B, Ware Jr JE. Usefulness of the SF-36 Health Survey in measuring health
outcomes in the depressed elderly. J Geriatr Psychiatry Neurol. 1996; 9(1):13-21.
Beuth J, Ost B, Pakdaman A, et al. Impact of complementary oral enzyme application on the
postoperative treatment results of breast cancer patients: results of an epidemiological multicentre
retrolective cohort study. Cancer Chemotherapy Pharmacol. 2001;47(suppl):S45-S54.
Bezjak A, Adam J, Barton R, et al. Symptom response after palliative radiotherapy for patients with
brain metastases. Eur J Cancer. 2002;38(4):487-496.
Bezjak A, Lee CW, Ding K, Brundage M, Winton T, Graham B, Whitehead M, Johnson DH, Livingston
RB, Seymour L, Shepherd FA. Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage
Non-Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10. Journal of Clinical Oncology.
2008;26(31):5052-5059.
Bezjak A, Ng P, Skeel R, DePetrillo AD, Comis R, Taylor KM. Oncologists’ use of quality of life
information: results of a survey of Easter Cooperative Oncology Group physicians. Qual Life Res.
2001;10:1-13.
Bezjak A, Tayler KM, Ng P, Macdonald K, DePetrillo AD. Quality-of-life information and clinical
practice: the oncologist’s perspective. Prévention & contrôle en cancérologie. 1998;2(5):230-235.
Bezjak A, Tu D, Bacon M, et al. Quality of life in ovarian cancer patients: comparison of paclitaxel
plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. J Clin Oncol.
2004;22:4595-4603.
Bezjak A, Tu D, Seymour L, Clark G, Trajkovic A, Zukin M, et al. Symptom improvement in lung
cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of
Canada Clinical Trials Group Study BR.21. J Clin Oncol. 2006;24(24):3831-3837.
Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.
Effects of testosterone replacement with a nongenital, transdermal system, androderm, in human
immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab.
1999;83(9):3155-3162.
Bhasin S, Storer TW, Javanbakht M, et al. Testosterone replacement and resistance exercise in HIVinfected men with weight loss and low testosterone levels. JAMA. 2000; 283(6):763-770.
Bhat SR, Goodwin TL, Burwinkle TM, et al. Profile of daily life in children with brain tumors: An
assessment of health-related quality of life. J Clin Oncol. 2005;23:5493-5500.
Bhatia S, Jenney MEM, Wu E, et al. The Minneapolis-Manchester Quality of Life Instrument: reliability
and validity of the youth form. J Pediat. 2004;145:39-46.
D:\478174570.doc
Biau DJ, Ferguson PC, Turcotte RE, Chung P, Isler MH, Riad S, Griffin AM, Catton CN, O’Sullivan B,
Wunder JS. Adverse Effect of Older Age on the Recurrence of Soft Tissue
Sarcoma of the Extremities and Trunk. J Clin Oncol. Oct 2011;29(30):4029-35
Bieri D, Reeve RA, Champion D, Addicoat L, Ziegler JB. The faces pain scale for the self-assessment
of the severity of pain experienced by children: Development, initial validation, and preliminary
investigation for ratio scale properties. Pain. 1990;41(2):139-150.
Bindman AB, Keane D, Lurie N. Measuring health changes among severely ill patients. Med Care.
1990;28(12):1142-1152.
Bing EG, Hays RD, Jacobson LP, et al. Health-related quality of life among people with hiv disease:
results from the multicenter AIDS Cohort Study. Qual Life Res. 2000;9:55–63.
Bingener J, Sloan JA, Ghosh K, McConico A, Mariani A. Qualitative and quantitative analysis of
women’s perceptions of transvaginal surgery. Surgical Endoscopy. 2012;26(4):998-1004.
Biondo PD, Nekolaichuk CL, Stiles C, Fainsinger R, Hagen NA. Applying the Delphi process to
palliative care tool development: lessons learned. Supportive Care in Cancer. 2008;16(8):935-942.
Birbeck GL, Kim S, Hays RD, Vickrey BG. Quality of life measures in epilepsy: How well can they
detect change over time? Neurology. 2000;54:1822-1827.
Bird J. Selection of pain measurement tools. Nurs Standard. 2003;18(13):33-39.
Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski
KA, Rizzo JD, Wingard JR. The late effects of cancer and hematopoietic stem-cell transplantation on
spouse/partners compared with HCTsurvivors and survivor-matched controls. J Clin Oncol. 2007 Apr
10;25(11):1403-11.
Bitar R, Bezjak A, Mah K, Loblaw DA, Gotowiec A, Devins GM. Does tumor status influence cancer
patients’ satisfaction with the doctor-patient interaction? Support Care Cancer. 2004;12:34–40.
Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients:
validation of the European Organization for Research and Treatment Questionnaire-H&N35. J Clin
Oncol. 1999;17(3):1008-1019.
Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a
follow-up study 7 to 11 years after radiotherapy. Int J Radiant Oncol Biol Phys. 1994;4:847-856.
Bjordal K. Impact of quality of life measurement in daily clinical practice. Ann Oncol. 2004;15(Suppl
4):iv279-iv282.
Bjoreklett HG, Lindemalm C, Ojutkangas M-L, Berglund A, Letocha H, Strang P, Bergkvist L. A
randomized controlled trial of a support group intervention on the quality of life and fatigue in women
after primary treatment for early breast cancer. Supportive Care in Cancer. 2012;20(12:3325-3334.
D:\478174570.doc
Bjorner JB, Petersen MA, Groenvold M, et al. Use of item response theory to develop a shortened
version of the EORTC QLQ-C30 emotional functioning scale. Qual Life Res. 2004;13:1683-1697.
Bjorner JB. Developing tailored instruments: item banking and computerized adaptive assessment.
Summary Paper, Drug Information Association; June 23–25, 2004 Meeting.
Blach Rossen P, Fischer Pedersen A, Zachariae R, von der Maase H. Health-related quality of life in
long-term survivors of testicular cancer. Journal of Clinical Oncology. 2009;27(35):5993-5999.
Blackman SB, Lash TL, Fink AK, Ganz PA, Silliman RA. Advanced age and adjuvant tamoxifen
prescription in early-stage breast carcinoma patients. Cancer. 2002;95(12):2465-2472.
Blanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior
recommendations and associations with health-related quality of life: Results from the American
Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198-2204.
Bland JM, Altman DG. Comparing two methods of clinical measurement: A personal history. Int J
Epidemiol. 1995;24(3)7-14.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical
measurement. Lancet. 1986;307-310.
Bland KI, Scott-Conner CEH, Menck H, Winchester DP. Axillary dissection in breast-conserving
surgery for stage I and II breast cancer: a national cancer data base study of patterns of omission
and implications for survival. J Am Coll Surg. 1999;188(6):586-595.
Blasko JC, Ragde H, Luse RW, Sylvester JE, Cavar W, Grimm PD. Should brachythera be considered
therapeutic option for localized prostate cancer. Urolog Clin Am. 1996;23:633-650.
Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life
measurement in randomized clinical trials in surgical oncology. J Clin Oncol. 2006;24:3178-3186.
Blazeby JM, Williams MH, Alderson D, Farndon JR. Observer variation in assessment of quality of life
in patients with esophageal cancer. Br J Surg. 1995;82:1200–1203.
Blazer DG, Fillenbaum GG, Gold DT, Burchett BM, Hays JC. APOE epsilon4 as a predictor of subjective
quality of life in a biracial older person community sample. J Aging Hlth. 2003;15(4):645-60.
Bleiker EM, Hahn DE, Aaronson NK. Psychosocial issues in cancer genetics – current status and
future directions. Acta Oncol. 2003;42(4):276–286.
Bleiker EMA, Aaronson NK, Menko FH, et al. Genetic counseling for hereditary cancer: a pilot study
on experiences of patients and family members. Patient Educ Couns. 1997;32:107-116.
Blijlevens NMA, Land B. van’t, Donnelly JP, M’Rabet L, de Pauw BE. Measuring mucosal damage
induced by cytotoxic therapy. Support Care Cancer. 2004;12:227–233.
Bloch S, Love A, Macvean M, Duchesne G, Couper J, Kissane D. Psychological adjustment of men
with prostate cancer: a review of the literature. BioPsychoSocial Medicine. 2007;1:1-14.
D:\478174570.doc
Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J. Delayed nausea and vomiting
continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy
despite antiemetic treatment. J Clin Oncol. 2006;24(27):4472-4478.
Bloom J. Quality of life after cancer: A policy perspective. Cancer. 1991;67:855-859.
Blum D, Omlin A, Fearon K, Baracos V, Radbruch L, Kaasa S, Strasser F, European Palliative Care
Research Collaborative. Evolving classification systems for cancer cachexia: ready for clinical
practice? Supportive Care in Cancer. 2010;18(3):273-280.
Blumenschein K, Johannesson M. Incorporating quality of life changes in economic evaluations of
health care: an overview. Hlth Policy. 1996;36:155-166.
Blumenthal D. Academic-industrial relationships in the life sciences. N Engl J Med. 2003; 349(2):
2452–2459.
Blythe JG, Wahl TP. Debulking surgery: does it increase the quality of survival? Gynecol Oncol.
1982;14:396-408.
Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM. Decision-making about tamoxifen in women at
high risk for breast cancer: clinical and psychological factors. J Clin Oncol. 2004;22:44951-4957.
Bode R, Lai J-S, Dineen K, Cella D, Heinemann A, Shevrin D, Von Roenn J. Expansion of a physical
function item bank and development of an abbreviated form for use in clinical trials. J Appl
Measurement 2005;7(1):1-15.
Bode R. Pivoting items for construct definition. Rasch Measurement Transactions. 1997;11:3.
Bode RK, Cella D, Lai JS. Developing an initial physical function item bank from existing sources. J
Appl Meas. 2003;4(2):124-136.
Bode RK, Heinemann AW. An exploration of interdisciplinary ratings of functional assessment items.
Physical Medicine and Rehabilitation. 1997;11:407-424.
Bode RK, Lai JS, Cella D, Heinemann AW. Issues in the development of an item bank. Arch Phys
Med Rehabil. 2003;84(Supp 2).
Bodian CA, Freedman G, Hossain S, Eisenkraft JB, Beilin Y. The visual analog scale for pain.
Anesthesiology. 2001;95:1356-61.
Bodurka DC, Sun CC, Frumovitz MM. Quality of life in cervix cancer survivors – What matters the
most in the long-term? Gynecol Oncol. 2005;97:307-309.
Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety, and quality of life in
patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78:302-308.
Body JJ, Mancini I. Bisphosphonates for cancer patients: why, how, and when? Support Care
Cancer. 2002;10:399-407.
D:\478174570.doc
Boesen EH, Ross L, Frederiksen K, et al. Psychoeducational intervention for patients with cutaneous
malignant melanoma: a replication study. J Clin Oncol. 2005;23:1270-1277.
Boesen EH, Boesen SH, Frederiksen K, Ross L, Dahlstrom K, Schmidt G, Naested J, Krag C, Johansen
C. Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma:
A replication study. J Clin Oncol. 2007;25:5698-5703.
Bogaarts MPJ, Den Oudsten BL, Roukema JA, Van Riel JMGH, Beerepoort LV, De Vries J. The
psychosocial distress questionnaire-breast cancer (PDQ-BC) is a useful instrument to screen
psychosocial problems. Supportive Care in Cancer. 2012;20(8):1659-1665.
Bolton JE. Accuracy of recall of usual pain intensity in back pain patients. Pain. 1999;83:533-539.
Bomba PA. Enabling the Transition to Hospice through Effective Palliative Care. TCM 48. 2005
January/February;48-51.
Bond MR, Pilowsky I. Subjectivity assessment of pain and its relationship to the administration of
analgesics in patients with advanced cancer. J Psychosom Res. 1966;10(2):203-208.
Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A. Evaluation of an instrument to
assess the needs of patients with cancer. Am Cancer Soc. 2000;217-225.
Bonneterre J, Schraub S, Lecomte S, Mercier M. Quality of Life as an outcome in breast cancer.
Clinical Application. Pharmacoeconomics. 1996;9(Supplement 2):23-29.
Bonomi AE, Ajax M, Shikiar R, Halpern M. Cancer pain management: barriers, trends, and the role of
pharmacists. J Am Pharm Assoc. 1999;39:558–566.
Bonomi AE, Cella DF, Hahn EA, et al. Multilingual translation of the Functional Assessment of Cancer
Therapy (FACT) quality of life measurement system. Qual Life Res. 1996;5:309-320.
Bonomi AE, Cella. A cross-cultural adaptation of the Functional Assessment of Cancer Therapy
(FACT) Quality of Life Measurement System for use in European oncology clinical trials. Qual Life
Newsletter. 12: February/May 95.
Bonomi AE, Patrick DL, Bushnell DM, Martin M. Variance and dissent response: quality of life
measurement: will we ever be satisfied? J Clin Epidemiol. 2000;53:19–23.
Bonomi AE, Patrick DL, Bushnell DM, Martin M. Variance and Dissent Presentation: Validation of the
United States’ Version of the World Health Organization Quality of Life (WHOQOL) Instrument. J Clin
Epidemiol. 2000;53:1–12.
Bonomi AE, Shikiar R, West Legro M. Quality-of-life assessment in acute, chronic, and cancer pain: a
pharmacist’s guide. J Am Pharm Assoc. 2000;40:402–416.
Booth CM, Cescon DW, Wang L, Tannock IF, Krzyzanowska MK. Evolution of the Randomized
Controlled Trial in Oncology Over Three Decades. Journal of Clinical Oncology. 2008;26(33):54585464.
D:\478174570.doc
Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut.
2000;47(3):444-454.
Borggreven PA, Aaronson NK, Verdonck-de Leeuw IM, Muller MJ, Heiligers MLCH, de Bree R,
Langendij JA, Leemans CR. Quality of life after surgical treatment for oral and orpharyngeal cancer:
a prospective longitudinal assesment of patients recontructed by a microvascular flap. Oral Oncol
2007;43:1034-1042.
Borghede G, Karlsson J, Sullivan M. Quality of life in patients with prostatic cancer: results from a
Swedish population study. J Urol. 1997;58:1477-1486.
Bornbaum CC, Fung K, Franklin JH, Nichols A, Yoo J, Doyle PC. A descriptive analysis of the
relationship between quality of life and distress in individuals with head and neck cancer. Support
Care Cancer. 2012;20(9):2157-2165.
Borud EK, Alraek T, White A, Fonnebo V, Grimsgaard S. The effect of TCM acupuncture on hot
flushes among menopausal women (ACUFLASH) study: a study protocol of an ongoing multi-centre
randomised controlled clinical trial. BMC Complement Altern Med. 2007;7:6.
Bosch JL, Halpern EF, Gazelle GS. Comparison of preference-based utilities of the short-form 36
health survey and health utilities index before and after treatment of patients with intermittent
claudication. Med Decis Making. 2002;22:403–409.
Boscolo-Rizzo P, Da Mosto MC, Gava A, Marchiori C. Cervical lymph node metastases from occult
squamous cell carcinoma: Analysis of 82 cases. ORL. 2006;68:189-194.
Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A. Quality of life aspects of bladder cancer:
a review of the literature. Qual Life Res. 2003;12:675-688.
Bottomley A, Biganzoli L, Cufer T, et al. Randomized, controlled trial investigating short-term healthrelated quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as
first-line chemotherapy in patients with metastatic breast cancer: European Organization for
Research and Treatment of Cancer Breast Group, investigational drug branch for breast cancer and
the new drug development group study. J Clin Oncol. 2004;22:2576–2586.
Bottomley A, Efficace F, Thomas R, Vanvoorden V, Ahmedzai S. H. Health-related quality of life in
non-small-cell lung cancer: methodologic issues in randomized controlled trials. J Clin Oncol.
2003;21(15):2982-2992.
Bottomley A, Therasse P, Piccart M, et al. Health-related quality of life in survivors of locally
advanced breast cancer: an international randomized controlled phase III trial. Lancet. 2005;6:287294.
Bottomley A, Therasse P. Quality of life in patients undergoing systemic therapy for advanced breast
cancer. Lancet Oncol. 2002;3:620-628.
Bottomley A, Vachalec S, Bjordal K, Blazeby J, Clechtner H, Ruyskart P on behalf of the European
Organization for Research, Treatment of Cancer Quality of Life Group. The development and
utilization of the European Organization for Research and Treatment of Cancer Quality of Life Group
item bank. Eur J Cancer. 2002;38:1611–1614.
D:\478174570.doc
Bottomley A, Vanvoorden V, Flechtner H, Therasse P, on behalf of the EORTC Quality of Life Group
and the EORTC Data Center. The challenges and achievements involved in implementing Quality of
Life Research in cancer clinical trials. Eur J Cancer. 2003;39:275-285.
Bottomley A. The development of the Bottomley Cancer Social Support Scale. Eur J Cancer Care.
1995;4:127-132.
Bottomley A, Coens C, Efficace F, Gaafar R, Manegold C, Burgers S, Vincent M, Legrand C, van
Meerbeeck JP. Symptoms and patient-reported well-being: Do they predict survival in malignant
pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: Randomized Phase III
study of cisplatin with or without ralitrexed in patients with malignant pleural mesothelioma. J Clin
Oncol. 2007;25:5770-5776.
Bouchard TJ, Hur YM. Genetic and environmental influences on the continuous scales of the MyersBriggs type indicator: an analysis based on twins reared apart. J Pers. 1998;66(2):135-149.
Bouchard TJ, Loehlin JC. Genes, evolution, and personality. Behavioral Genetics. 2001;31(3):243273.
Bouchard TJ, Lykken DT, McGue M, Segal NL, Tellegen A. Sources of human psychological
differences: the Minnesota Study of twins reared apart. Science. 1990;250(4978):223-228.
Bouchard TJ, McGue M, Lykken D, Tellegen A. Intrinsic and extrinsic religiousness: genetic and
environmental influences and personality correlates. Twin Res. 1999;2:88-98.
Bouchet C, Guillemin F, Briancon S. Nonspecific effects in longitudinal studies: impact on quality of
life measures. J Clin Epidemiol. 1996;49(1):15-20.
Bouchet C, Guillemin F, Paul-Dauphin A, Briancon S. Selection of quality-of-life measures for a
prevention trail: a psychometric analysis. Control Clin Trials. 2000;21:30-43.
Bourbeau J, Rouleau MY, Boucher S. Randomized controlled trial of inhaled corticosteroids in
patients with chronic obstructive pulmonary disease. Thorax. 1998;53:477-82.
Bouvette M, Fothergill-Bourbonnais F, Perrault A. Implementation of the pain and symptom
assessment record (PSAR). J Adv Nurs. 2002;40(6):685-700.
Bower JE. Treating Cancer-Related Fatigue: The search for interventions that target those most in
need. Journal of Clinical Oncology. 2012;30(36):4449-4450.
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms
after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common
underlying mechanism? Journal of Clinical Oncology. 2011;29(26):3517-3522.
Bower JE, Ganz PA, Aziz N, Fahey JL, Cole SW. T-cell homeostasis in breast cancer survivors with
persistent fatigue. J Natl Cancer Inst. 2003;95:1165-1168.
Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer
survivors. Psychosom Med. 2002;64:604-611.
D:\478174570.doc
Bowie JV, Syndnor KD, Granot M, Pargament KI. Spirituality and coping among survivors of prostate
cancer. J Psychosoc Oncol. 2003;22(2): 41-56.
Bowling A, Windsor J. Discriminative power of the health status questionnaire 12 in relation to age,
sex, and longstanding illness: findings from a survey of households in Great Britain. J Epidemiol
Community Health. 1997;51(5):564-573.
Boyer JG, Earp JL. The Development of an instrument for assessing the quality of life of people with
diabetes: diabetes 39. Med Care. 1997;35(5):440-453.
Boza RA, Milanes F, Slater V, Garrigo L, Rivera CE. Patient noncompliance and overcompliance.
Postgrad Med. 1987;81(4):163-170.
Bozcuk H, Dalmis B, Samur M, Ozdogan M, Artac M, Savas B. Quality of life in patients with
advanced non-small cell lung cancer. Cancer Nurs. 2006;29(2):104-110.
Bozcuk H, Erdogan V, Eken C, et al. Does awareness of diagnosis make any difference to quality of
life? determinants of emotional functioning in a group of cancer patients in Turkey. Support Care
Cancer. 2002;10:51–57.
Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW. Derivation and properties of a Brief Health
Status Assessment instrument for use in HIV disease. J Acquired Immunodeficiency Syndrome.
1995;8:253-255.
Bozzette SA, Hays RD, Berry SH, Kanouse DE. A perceived health index for use in persons with
advanced HIV disease: derivation, reliability and validity. Med Care. 1994;32(7):716-731.
Bozzetti F, Mariani L, Lo Vullo S, The SCRINIO Working Group, Amerio ML, Biffi R, Caccialanza R,
Capuano G, Correja I, Cozzaglio L, Di Leo A, Di Cosmo L, Finocchirao C, Gavazzi C, Giannoni A,
Magnanini P, Mantovani G, Pellegrini M, Rovera GM, Rovera L, Sandri G, Tinivella M, Vievani E. The
nutrional risk in oncology: a study of 1,453 cancer outpatients. Supportive Care in Cancer.
2012;20(8):1919-1928.
Brace C, Schmocker S, Huang H, Victor JC, McLeod RS, Kennedy ED. Physician’s awareness and
attitudes toward decision aids for patients with cancer. Journal of Clinical Oncology.
2010;28(13):2286-2292.
Bradley J, Dempster M, Wallace E, Elborn S. The adaptations of a quality of life questionnaire for
routine use in clinical practice: the Chronic Respiratory Disease Questionnaire in cystic fibrosis. Qual
Life Res. 1999;8:65-71.
Brady MJ, Cella DF, Mo F, et al. Reliability and Validity of the Functional Assessment of Cancer
Therapy-Breast Quality-of-Life Instrument. J Clin Oncol. 1997;15(3):974-986.
Brady MJ, Peterman AH, Fitchett G, Mo M, Cella, D. A Case for Including Spirituality in Quality of Life
Measurement in Oncology. Psycho-Oncology. 1999;417-428.
Brady MJ, Cella DF. Helping patients live with their cancer. Patient Care. 1995;30:41-51.
D:\478174570.doc
Brandberg Y, Sandelin K, Erikson S, Jurell G, et al. Psyhological Reasctions, quality of Life, and Body
Image After Bilateral Prophylactic mastectomy in Women At High Risk for Breast Cancer: A
Prospective 1-Year Follow-Up Study. J Clin Oncol. 2008;26(24):3943-3949.
Brandberg Y, Michelson H, Nilsson B, et al. Quality of life in women with breast cancer during the
first year after random assignment to adjuvant treatment with marrow-supported high-dose
chemotherapy with cyclophosphamide, thiotepa, and carbolatin or tailored therapy with fluorouracil,
epirubicin, and cyclophosphamide: Scandinavian breast group study 9401. J Clin Oncol.
2003;21(19):3659-3664.
Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical
prostatectomy. Br J Urol. 1995;75(1):48-53.
Braun DP, Gupta D, Staren ED. Predicting survival in prostate cancer: the role of quality of life
assessment. Supportive Care in Cancer. 2012;20(6):1267-1274.
Braun MS, Richman SD, Thompson L, Daly CL, Meade AM, Adlard JW, Allan JM, Parmar MKB, Quirke
P, Seymour MT. Association of molecular markers with toxicity outcomes in a randomized trial of
chemotherapy for advanced colorectal cancer: The FOCUS Trial. Journal of Clinical Oncology.
2009;27(33):5519-5528.
Brauntsein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, et al.
Safety and efficacy of a testosterone patch for the treatment of hypoactiave sexual desire disorder in
surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med.
2005;165:1582-1589.
Braverman ER. The religious medical model: holy medicine and the spiritual behavior inventory.
South Med J. 1987;80(4):415-420.
Brazier J, Jones N, Kind D. Testing the validity of the EuroQol and comparing it with the SF-36 health
survey questionnaire. Qual Life Res. 1993;2:169-180.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the
SF-36. J Health Econ. 2002;21:271-292.
Breems DA, Sonneveld P, de Man RA, Leebeek FWG. Successful treatment of systematic amyloidosis
with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and
autologous stem cell reinfusion. Eur J Haematol. 2004;72:181-185 .
Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J. A randomized, double-blind, placebo-controlled
trial of psychostimulants for the treatment of fatigue in ambulatory patients with human
immunodeficiency virus disease. Arch Intern Med. 2001;161:411-420.
Breitbart W, Rosenfeld B, Passik SD. The Network Project. A multi disciplinary cancer education and
training program in pain management, rehabilitation, and psychosocial issues. J Pain Symptom
Manage. 1998;15:18-26.
Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness and desire for hastened death in
terminally ill patients with cancer. JAMA. 2000;284:2907-2911.
D:\478174570.doc
Breitbart W. Spirituality and meaning in supportive care: spirituality- and meaning-centered group
psychotherapy interventions in advanced cancer. Support Cancer Care. 2002;10:272-280.
Breitbart W. What can we learn from the death of Terri Schiavo? Palliat Support Care. 2005;3:1-3.
Bren L. The importance of patient-reported outcomes … It’s all about the patients. FDA Consumer.
2006;Nov/Dec:27-32.
Brewer JK. Behavioral Genetics of the Depression/Cancer Correlation: A Look at the Ras Oncogene
Family and the “Cerebral Diabetes Paradigm”. J Molecular Neurosc. 2008;35(3):307-322.
Brezden CB, Phillips K-A, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer
patients receiving adjuvant chemotherapy. J Clin Oncol. 2000;18:2695-2701.
BRFSS Coordinators – The Center for Disease Control and Prevention. Health-related quality of life
measures – United States, 1993. JAMA. 1995;273(14):1084–1085.
Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to
prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial. Lancet.
2000;356(9240):1480-1485.
Brillhart B, Bach CA. Studying the Quality of Life and Life Satisfaction among Persons with Spinal
Cord Injury Undergoing Urinary Management. Rehab Nurs. 2004;29(4).
Brink TL, Yesavage JA, Lum O, Heersema PH, Adey M, Rose TL. Screening Tests for Geriatric
Depression. Clinical Gerontologist. 1982;1(1):37-43.
Broberger E, Sprangers M, Tishelman C. Do internal standards of quality of life change in lung
cancer patients? Nurs Res. 2006;55(4):274-282.
Broderick JE, Schwartz JE, Vikingstad G, Pribbernow M, Grossman S, Stone AA. The accuracy of pain
and fatigue items across different reporting periods. Pain 2008. (article in press)
Broderick JE, Schwartz JE. Interference with activities due to pain and fatigue: accuracy of ratings
across different reporting periods. Qual Life Res. 2010;19:1163-1170.
Brodman K, Erdmann AJ Jr, Lorge I, Wolff HG. The Cornell Medical Index-Health Questionnaire: VI.
The relation of patient’s’ complaints to age, sex, race, and education. J Gerontology. 1953;8(3):339342.
Brody BA. When are placebo-controlled trials no longer appropriate? Control Clin Trials.
1997;18:602-612.
Brody DS, Lerman CE, Wolfson HG, Caputo GC. Improvement in physicians’ counseling of patients
with mental health problems. Arch Intern Med. 1990;150:993-998.
Broeckel JA, Jacobsen PB, Balducci L, Horton J, Lyman GH. Quality of life after adjuvant
chemotherapy for breast cancer. Breast Cancer Res Treat. 2000;62:141-150.
D:\478174570.doc
Broers S, Hengeveld M, Kaptein AD, Le Cessie S, van de Loo F, Vries T. Are pretransplant
psychological variables related to survival after bone marrow transplantation? A prospective study of
123 consecutive patients. J Psychosom Res. 1998;45(4):341-351.
Brouwers C, Denollet J, de Jonge N, Caliskan K, Kealy J, Pedersen SS. Patient-reported outcomes in
left ventricular assist device therapy. A systematic review and recommendations for clinical research
and practice. Circ Heart Fail. 2011;4:714-723.
Brown J, Thorpe H, Napp V, Fairlamb DJ, Gower NH, Milroy R, Parmar MKB, et al. J Clin Oncol.
2005;23(30):7417-7427.
Brown JA, Von Roenn JH. Symptom management in the older adult. Clin Geriatr Med.
2004;20(4):621-640.
Brown JE, King MT, Butow PN, Dunn SM, Coates AS. Patterns over time in quality of life, coping and
psychological adjustment in late stage melanoma patients: An application of multilevel models. Qual
Life Res. 2000;9:75-85.
Brown JH, Henteleff P, Barakat S, Rowe CJ. Is it normal for terminally ill patients to desire death?
Am J Psychiatry. 1986;143:208-211.
Brown JK. A systematic review of the evidence on symptom management of cancer-related anorexia
and cachexia. Oncol Nurs Forum. 2002;29:517–532.
Brown JS, Rawlinson ME, Hilles NC. Life satisfaction and chronic disease: Exploration of a theoretical
model. Med Care. 1981;29:1136-1146.
Brown L, Payne S, Royle G. Patient initiated follow up of breast cancer. Psycho-Oncology. 2002;
11:346-355.
Brown LF, Kroenke K, Theobald DE, Wu J. Comparison of SF-36 vitality scale and Fatigue Symptom
Inventory in assessing cancer-related fatigue. Supportive Care in Cancer. 2011;19(8):1255-1260.
Brown PD, Buckner JC, O’Fallon JR, Iturria NL, et al. Effects of radiotherapy on cognitive function in
patients with low-grade glioma measured by the Folstein mini-mental state examination. J Clin
Oncol. 2003;21(13)2519-2524.
Brown PD, Jensen AW, Felten SJ, Ballman KV, Schaefer PL, Jaeckle KA, Cerhan JH, Buckner JC.
Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J
Clin Oncol. 2006;24(34):5427-5433.
Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, et al.
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact
of the extent of resection on quality of life and survival. Neurosurgery. 2005;57:495-504.
Brown R, Butow P, Wilson-Genderson M, Bernhard J, Ribi K, Juraskova I. Meeting the decisionmaking preferences of patients with breast cancer in oncology consultations: impact on decisionrelated outcomes. Journal of Clinical Oncology. 2012;30(8):857-862.
D:\478174570.doc
Brown V, Sitzia J, Richardson A, Hughes J, Hannon H, Oakley C. The development of the
Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the
symptom experiences of patients receiving cytotoxic chemotherapy. Int J Nurs Stud. 2001;38:497510.
Brucker P, Cella D. Measuring self-reported sexual function in men with prostrate cancer. Urology.
2003;62(4):596-606.
Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for
the functional assessment of cancer therapy – General (FACT-G). Eval Health Prof.
2005;28(2):192-211.
Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C. Patient-controlled
methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary
report. J Clin Oncol. 2003;21:4439–4443.
Bruera E, El Osta B, Valero V, Driver LC, Pei B-L, Shen L, Poulter VA, Palmer JL. Donepezil for cancer
fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2007;25(23):3475-3481.
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System
(ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):69.
Bruera E, Palmer JL, Bosnjak S, et al. Methadone versus morphine as a first-line strong opioid for
cancer pain: a randomized, double-blind study. J Clin Oncol. 2004;22:185–192.
Bruera E, Sala R, Antonieta Rico M, et al. Effects of parenteral hydration in terminally ill cancer
patients: a preliminary study. J Clin Oncol. 2005;23:2366-2371.
Bruera E, Schmitz B, Pither J, Neumann CM, Hanson J. The frequency and correlated of dyspnoea in
patients with advanced cancer. J Pain Symptom Manage. 2000;19(5):357–362.
Bruera E, Sloan P, Mount B, Scott J, Suarez-Almazor M. A randomized, double-blind, double-dummy,
crossover trial comparing the safety and efficacy of oral sustained-release hydromophone with
immediate-release hydromorphone in patients with cancer pain. J Clin Oncol. 1996;14:1713–1717.
Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G, Baracos V. Effect of fish oil on
appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a doubleblind, placebo-controlled study. J Clin Oncol. 2003;21(1):129-134.
Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL. Patient-controlled
methylphenidate for cancer fatigue: a double-blind, randmonized, placebo-controlled trial. J Clin
Oncol. 2006;24(13):2073-2078.
Bruera E, Willey JS, Ewert-Flannagan PA, et al. Pain intensity assessment by bedside nurses and
palliative care consultants: a retrospective study. Support Care Cancer. 2005;13:228-231.
Brufsky A, Garker WG, Beck JT, Carroll R, Tan-Chiu E, Seidler C, Hohneker J, et al. Zoledronic acid
inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer. J
Clin Oncol. 2007;25:829-836.
D:\478174570.doc
Brundage M, Feldman-stewart D, Leis A, Bezjak A, Degner L, Velji K, et al. Communicating quality of
life information to cancer patients: a study of six presentation formats. J Clin Oncol.
2005:23(28):6949-6956.
Brundage M, Leis A, Bezjak A, Feldman-Stewart D, Degner L, Velji K, Zetes-Zanatta L, Tu D, Ritvo P,
Pater J. Cancer patients’ preferences for communicating clinical trial quality of life information: a
qualitative study. Qual Life Res. 2003;12:395-404.
Brundage MD, Davidson JR, Mackillop WJ. Trading treatment toxicity for survival in locally advanced
non-small cell lung cancer. J Clin Oncol. 1997;15(1):330-340.
Brunelli C, Constantini M, Giulio PD. Quality of life evaluation: when do terminal cancer patients and
health care providers agree? J Pain Symptom Manage. 1998;15:151–158.
Brunello A, Sandri R, Exterman M. Multidimensional geriatric evaluation for older cancer patients as a
clinical and research tool. Cancer Treatment Reviews. 2009;35:487-492.
Bruner DW, Movsas B, Konski A, Roach M, Bondy M, Scarintino C, Scott C, Curran W. Outcomes
research in cancer clinical trial cooperative groups: The RTOG model. Quality of Life Research.
2004;13;1025-1041.
Bruner DW. Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical
trials? J Clin Oncol 2007;25(34):5345-5347.
Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS,
Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G; National Cancer Institute. Issues and
challenges with integrating patient-reported outcomes in clinical trials supported by the National
Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007 Nov 10;25(32):5051-7.
Review.
Bruner DW, Movsas B, Konski A, et al. Outcomes research in cancer clinical trial cooperative groups:
The RTOG model. Qual Life Res. 2004;13:1025–1041.
Bruner DW, Nolte SA, Shahin MS, Huang HQ, Sobel E, Gallup D, Cella D; Gynecologic Oncology
Group. Measurement of vaginal length: Reliability of the vaginal sound--a Gynecologic Oncology
Group study. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1749-55.
Brunier G, Graydon J. A comparison of two methods of measuring fatigue in patients on chronic
haemodialysis: Visual analogue vs. Likert scale. Int J Nurs Stud. 1996;33(3):338-348.
Bryant D, Stratford P, Marx R, Walter S, Guyatt G. Patients can provide a valid assessment of quality
of life, functional status, and general health on the day they undergo knee surgery. Journal of Bone
and Joint Surgery: American Volume. 2008;90(2):264-270.
Bryce CL, Loewenstein G, Arnold RM, Schooler J, Wax RS, Angus DC. Quality of death: assessing the
importance placed on end-of-life treatment in the intensive-care unit. Med Care. 2004;42:423-431.
Buchanan DR, O’Mara A, Kelaghan JW, Minasian LM. Quality-of-life assessment in the symptom
management trials of the National Cancer Institute – Supported Community Clinical Oncology
Program. J Clin Oncol. 2005;23(3):591-598.
D:\478174570.doc
Buchanan DR, O’Mara A, Kelaghan JW, Sgambati M, McCaskill-Stevens W, Minasian L. Challenges
and recommendations for advancing the state-of-the-science of quality-of-life assessment in
symptom management trials. Cancer. 2007;110:1621-1628.
Buchanan D, Milroy R, Baker L, Thompson AM, Levack PA. Perceptions of anxiety in lung cancer
patients and their support network. Supportive Care in Cancer. 2010;18(1):29-36.
Buehler JA, Lee HJ. Exploration of home care resources for rural families with cancer. Cancer
Nursing. 1992:15(4):299-308.
Bufford RK, Paloutzian RF, Ellison CW. Norms for the Spiritual Well-Being Scale. J Psychol Theol.
1991;19:56-70.
Bukberg J, Penman D, Holland J. Depression in hospitalized cancer patients. Psychosomatic Med.
1984;46(3):199-212.
Bukowski R, Cella D, Gondek K, Escudier B; Sorafenib TARGETs Clinical Trial Group. Effects of
sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study
in renal cancer. Am J Clin Oncol. 2007;30(3):220-227.
Bukstein DA. Incorporating quality of life data into managed care formulary decisions: a case study
with salmeterol. Am J Manag Care. 1997;3(11):1701-1706.
Bull AA, Meyerowitz BE, Hart S, Mosconi P, Apolone G, Liberati A. Quality of life in women with
recurrent breast cancer. Breast Cancer Res Treat. 1999;54:47-57.
Bullinger M, Alonso J, Apolone G, et al. Translating health status questionnaires and evaluating their
quality: the IQOLA project approach. J Clin Epidemiol. 1998;51(11):913-923.
Bullinger M, Anderson R, Cella D, Aaronson N. Developing and evaluating cross-cultural instruments
from minimum requirements to optical models. Qual Life Res. 1993;2:451-459.
Bullinger M, Anderson R, Cella D, Aaronson N. Developing and evaluating cross-cultural instruments:
from minimum requirements to optical models. Edited by Shumaker SA and Berzon R. Rapid
Communications. 1995;83-92.
Bultz BD, Thorne S, Fitch MI. Who owns emotional care of the cancer patient? Oncology Exchange.
2004;3(2):32–35.
Burhansstipanov L, Krebs LU, Seals BF, Bradley AA, Kaur JS, Iron P, Dignan MB, Thiel C, Gamito E.
Native American breast cancer survivor’s physical conditions and quality of life. Cancer.
2010;116(6):156-71.
Burke LB, Kennedy DL, Miskala PH, Papadopoulos EJ, Trentacosti AM. The Use of Patient-Reported
Outome Measures in the Evaluation of Medical Products for Regulatory Approval. Clinical
Pharmacology & Therapeutics 2008; 84(2):281-283.
Burke L, Piault E. Patient-reported measures in drug development: FDA perspective. health-related
quality of life and patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus
D:\478174570.doc
de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany
O, Caulin C. October 2002.
Burns CM, Craft PS, Roder DM. Does emotional support influence survival? Findings from a
longitudinal study of patients with advanced cancer. Support Care Cancer. 2005;13:295-302.
Burns CM, Dixon T, Broom D, Smith WT, Craft PS. Family caregiver knowledge of treatment intent in
a longitudinal study of patients with advanced cancer. Support Care Cancer. 2003:11:629-637.
Burris H, Awada A, Jones S, et al. Phase I study of the novel epothilone BMS-247550 administered
weekly in patients with advanced malignancies. ASCO 2002 Poster Presentation.
Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with
gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J
Clin Oncol. 1997;15(6):2403-2413.
Burroughs TE, Lentine KL, Takemota SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish SD,
Schnitzler MA. Influence of early posttransplatation prednisone and calcineurin inhibitor sdosgages
on the incident of new-onset diabetes. Clin J Am Soc Nephrol. 2007;2:517-523.
Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with earlystage breast cancer. New Engl J Med. 1999;340(22):1733-1739.
Busch E, Kemeny M, Fremgen A, Osteen RT, Winchester DP, Clive RE. Patterns of breast cancer in
the elderly. Cancer. 1996;78(1):101-111.
Bussing A, Matthiessen PF, Ostermann T. Engagement of patients in religious and spiritual practices:
Confirmatory results with the SpREUK-P 1.1 questionnaire as a tool of quality of life research. Health
Qual Life Outcomes. 2005;53.
Butler L, Bacon M, Carey M, Zee B, Tu D, Bezjak A. Determining the relationship between toxicity
and quality of life in an ovarian cancer chemotherapy clinical trial. J Clin Oncol. 2004;22(12): 2461–
2468.
Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus
JL, Muir JC, Cella D. Use of a single-item screening tool to detect clinically significant fatigue, pain,
distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. 2008;35(1):20-30.
Epub 2007 Oct 23.
Butt Z, Wagner LI, Beaumont JL, Paice JA, Straus JL, Peterman AH, Carro G, Von Roenn JH, Shevrin
D, Cella D. Longitudinal screening and management of fatigue, pain, and emotional distress
associated with cancer therapy. Support Care Cancer. 2007;16:151-159.
Butt Z, Webster K, Eisenstein A, Beaumont J, Eton D, Masters G, Cella D. Quality of life in lung
cancer: the validity and cross-cultural applicability of the Functional Assessment of Cancer Therapy
Lung Scale. Hematol/Oncol Clin N Amer 2005;19:389-420.
Buxton J, White M, Osoba D. Patients’ experiences using a computerized program with a touchsensitive video monitor for the assessment of health-related quality of life. Qual Life Res
1998;7:513-519.
D:\478174570.doc
Buyse M, Burzkowski T, Carroll K, Michiels S, Sargent DJ, Miller lL, Elfring LF, Pignon J-P, Piedbois P.
Progression-free survival is a surrogate for survival in advanced colorectal cancer. J Clin Oncol
2007;25(33):5218-5224.
Buyse M, Piedbois P. On the relationship between response to treatment and survival time. Stat
Med. 1996;15(24):2797-2812.
Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P for the Meta-Analysis
Group in Cancer. Relation between tumour response to first-line chemotherapy and survival in
advanced colorectal cancer: a meta-analysis. Lancet. 2000;356:373-78.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a
new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
Byerly MJ, Nakonezny PA, Fisher R, Magouirk B, Rush AJ. An empirical evaluation of the Arizona
sexual experience scale and a simple one-item screening test for assessing antipsychotic-related
secual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophrenia
Research 2006; 81(2-3):311-6.
Byrne C, Griffin A, Blazeby J, Conroy T, Efficace F. Health-related quality of life as a valid outcome in
the treatment of advanced colorectal cancer. EJSO 2007;33:S95-S104.
Brundage MD. Is seeing believing? Journal of Clinical Oncology. 2010;28(5):711-712.
Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, Bastuji-Garin S, Culine S,
Paillaud E. Comprehensive Geriatric Assessment in the Decision-Making process in elderly patients
with cancer: ELCAPA Study. Journal of Clinical Oncology. 2011;29(27):363-3642.
Cairns J. Measuring health outcomes. BMJ. 1996;313(7048):6.
Caissie A, Culleton S, Nguyen J, Zhang L, Zeng L, Holden L, Dennis K, Chan E, Jon F, Tsao M,
Danjoux C, Sahgal A, Barnes E, Koo K, Chow E. EORTC QLQ-C15-PAL quality of life scores in patients
with advanced cancer referred for palliative radiotherapy. Supportive Care in Cancer.
2012;20(4):841-848.
Calhoun E, Welshman E, Chang C-H, Lurain J, Fishman D, Hunt T, Cella D. Psychometric evaluation
of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity
(FACT/GOG-Ntx) questionnaire for patients receiving systematic chemotherapy. International Journal
of Gynecologic Cancer. 2003;13(6):741-748.
Calkins DR, Rubenstein LV, Cleary PD, Davies AR, Jette AM, Fink A, Kosecoff J, Young RT, Brook RH,
DeLeBlanco TL. Functional disability screening of ambulatory patients: a randomized controlled trial
in a hospital-based group practice. J Gen Intern Med. 1994;9:590-592.
Calman KC. Quality of life in cancer patients: an hypothesis. J Med Ethics. 1984;10:124-127.
Calmels P, Bethoux F, Roche G, Fayolle-Minon I, Picano-Gonard C. Evaluation of the handicap and
the quality of life in spinal cord injuries: study in a population of 58 patients living at home [article
in French]. Ann Phys Med Rehabil. 2003;46:233-240.
D:\478174570.doc
Calmels P, Ebermeyer E, Bethoux F, Gonard C, Fayolle-Minon I. Relationship between burden of care
at home and functional indpenedence level after stroke [article in French]. Ann Phys Med Rehabil.
2002;45:105-113.
Cameron CL, Cella D, Herndon II JE, Kornblith A, Zuckerman E, et al. Persistent symptoms among
survivors of Hodgkin’s Disease: an explanatory model based on classical conditioning. Health
Psychology. 2001;20(1):71-75.
Campbell J, Prochazka AV, Yamashita T, Gopal R. Predictors of persistent burnout in internal
medicine residents: a prospective cohort study. Acad Med. 2010;85:1630-4.
Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of recreational physical
activity and leisure time spent sitting with colorectal cancer survival. Journal of Clinical Oncology.
2013;31(7):876-885.
Campbell S, Whyte F. The quality of life of cancer patients participating in phase I clinical trials using
SEIQoL-DW. J Adv Nurs. 1999;30(2):335-343.
Campion EW. Lexapro escitalopram oxalate; The isomer of Celexa (citalopram HBr) Forest
Pharmaceuticals, Inc. New Engl J Med. 2002;346(12):872-874.
Camps C, Iranzo B, Bremnes RM, Sirera R. Anorexia-cachexia syndrome in cancer: implications of
the ubiquitin-proteasome pathway. Support Care Cancer. 2006;14:1173-1183.
Canam C, Acorn S. Quality of life for family caregivers of people with chronic health problems.
Rehab Nurs. 1999;24(5):192-196.
Canning D, Rosenberg JP, Yates P. Therapeutic relationships in specialist palliative care nursing
practice. International Journal of Palliative Nursing. 2007;13(5):222-229.
Cappelleri JC, Bushmakin AG, McDermott AM, Sadosky AB, Petrie CD, Martin S. Psychometric
properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Health
Qual Life Outcomes. 2009;7:54.
Cappelleri JC, Rosen RC, Smith MD, et al. Some developments on the International Index of Erectile
Function (IIEF). Drug Inf J. 1999;33:179–190.
Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile
function domain of the international index of erectile function. Urology. 1999;54:346–351.
Caraceni A, Brunelli C, Martini C, Zecca E, De Conno F. Cancer pain assessment in clinical trials. a
review of the literature (1999-2002). J Pain Sympt Manage. 2005; 29(5):507-519.
Caraceni A, Gangeri L, Martini C, et al. Neurotoxicity of interferon- in melanoma therapy. Cancer.
1998; 83:482-489.
Caraceni A, Zecca E, Bonezzi C, et al. Gabapentin for neuropathic cancer pain: a randomized
controlled trial from the gabapentin cancer pain study group. J Clin Oncol. 2004;22:2909–2917.
D:\478174570.doc
Carels RA. The association between disease severity, functional status, depression and daily quality
of life in congestive heart failure patients. Qual Life Res. 2004;13:63–72.
Carey M, Jefford M, Schofield P, Kelly S, Krishnasamy M, Aranda S. Development and evaluation of
an audiovisual information resource to promote self-management of chemotherapy side-effects.
Support Care Cancer. 2006;14:361-368.
Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC. The prognostic effects of performance
status and quality of life scores on progression-free survival and overall survival in advanced ovarian
cancer. Gynecologic Oncology. 2008;108:100-105.
Carlens E, Dahlstrom G, Nou E. Comparative measurements of quality of survival of lung cancer
patients after diagnosis. Scand J Resp Dis. 1970;51:268-275.
Carlson LE, Bultz BD, Morris DG. Individualized quality of life, standardized quality of life, and
distress in patients undergoing a phase I trial of the novel therapeutic reolysin (reovirus). Health
Qual Life Outcomes. 2005;3:7.
Carlson LE, Bultz BD. Cancer distress screening needs, models, and methods. J Psychosom Res.
2003;55:403–409.
Carlson LE, Bultz BD. Efficacy and medical cost offset of psychosocial interventions in cancer care:
making the case for economic analyses. Psycho-Oncology. 2004;13:837-849.
Carlson LE, Bultz BD. Efficacy vs cost of psychococial: An evidence-based call for action. Can Clin
Oncol. 2002;1(2):34-39,49-51.
Carlson LE, Groff SL, Maciejewski O, Bultz BD. Screening for distress in lung and breast cancer
outpatients: a randomized controlled trial. Journal of Clinical Oncology. 2010;28(33):4884-4891.
Carlson LE, Speca M, Hagen N, Taenzer P. Computerized quality-of-life screening in a cancer pain
clinic. J Palliat Care. 2001;1;7(1):46-52.
Carlson LE, Ursuliak Z, Goodey E, Angen M, Speca M. The effects of a mindfulness meditation-based
stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow up.
Support Care Cancer. 2001;9:112–123.
Carlsson M, Arman M, Backman M, Hamrin E. Perceived quality of life and coping for Swedish
women with breast cancer who choose complementary medicine. Cancer Nurs. 2001;24(5):395-401.
Carlsson ME, Rollison B. A comparison of patients dying at home and patients dying at a hospice:
Sociodemographic factors and caregivers’ experiences. Palliat Support Care. 2003;1:33-39.
Carmack Taylor CL, Badr H, Lee JH, Fossella F, Pisters K, Gritz ER, Schover L. Lung Cancer Patients
and Their Spouses: Psychological and Relationship Functioning Within 1 Month of Treatment
Initiation. Ann Behav Med. 2008:36:129-140.
D:\478174570.doc
Carney S, Koetters T, Cho M, West C, Paul SM, Dunn L, Aouizerat BE, Dodd M, Cooper B, Lee K, Wara
W, Swift P, Miaskowski C. Differences in sleep disturbance parameters between oncology outpatients
and their family caregivers. Journal of Clinical Oncology. 2011;29(8):1001-1006.
Carnrike CLM Jr, Carey MP. Assessing nausea and vomiting in adult chemotherapy patients: review
and recommendations. Ann Behav Med. 1990:79-85.
Carnrike GLM, Brantley PJ, Bruce B, et al. Test-retest reliability and concurrent validity of the Morrow
Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related
nausea and vomiting. J. Psychopathol Behav Assess 1988;10:107-116.
Caron M, Emery M-P, Marquis P, Acquadro C, Piault E. The PROLabels Database: a new on-line tool
to explore the PRO claims included in approved medicinal products labels. PRO Newsletter.
2006;37:22-23.
Carpenter JS, Andrykowski MA, Sloan P, et al. Postmastectomy/postlumpectomy pain in breast
cancer survivors. J Clin Epidemiol. 1998;51(12):1285-1292.
Carpenter JS, Gilchrist JM, Chen K, Gautam S, Freedman RR. Hot flashes core body temperature,
and metabolic parameters in breast cancer survivors. Menopause. 2004;11:375-581.
Carpenter JS, Monhan PO, Azzouz F. Accuracy of subjective hot flush reports compared with
continuous sternal skin conductance monitoring. Obstet Gynecol. 2004;104(6):1322-1326.
Carpenter JS. State of the science: hot flashes and cancer. Part I: definition, scope, impact,
physiology, and measurement. J Palliat Med. 2005;8(4):782-788.
Carpenter JS, Flockhart D. Flash Points. J Clin Oncol. 2007;25(35):5546-5547.
Carpenter M, Alberg A, Gray KM, Saladin ME. Motivating the unmotivated for health behavior
change: a randomized trial of cessation induction for smokers. Clinical Trials. 2010;7(2):157-166.
Carr AJ, Gibson B, Robinson PG. Measuring quality of life: Is quality of life determined by
expectations or experience? BMJ. 2001;332:1240-1243.
Carr AJ, Higginson IJ. Are quality of life measures patient centered? BMJ. 2001;322:1357-1360.
Carr AJ, Thompson PW, Kirwan JR. Quality of life measures. Br J Rheum. 1996;35:275-281.
Carr DB, Goudas LC, Balk EM, Bloch R, Ionnidis JPA, Lau J. Evidence report on the treatment of pain
in cancer patients. J Natl Cancer Inst Monogr. 2004;32:23-31.
Carranza-Lira S, Fragoso-Diaz N, MacGregor-Gooch AL, Garduno-Hernandez MP, Rios-Calderon K,
Aparicio H. Vaginal dryness assessment in postmenopausal women using pH test strip. Maturitas.
2003;45:55–58.
Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL. Yoga of awareness program for
menopausal symptoms in breast cancer survivors: results from a randomized trial. Supportive Care in
Cancer. 2009;17(10):1301-1310.
D:\478174570.doc
Carter J, Saltzman A, Chen D, et al. Quality of life assessment in gynaecological cancer patients. Aus
N Z J Obst Gyne. 1995;35(3):293-297.
Carter KJ, Ritchey NP, Castro F, Caccamo LP, Kessler E, Erickson BA. Analysis of three DecisionMaking methods: a breast cancer patient as a model. Med Dec-Making. 1999;19(1):4957.
Carter KJ, Ritchey NP, Castro F, et al. Treatment of early-stage breast cancer in the elderly: A
health-outcome-based approach. Med Dec Making. 1998;18(2):213-219.
Casarett D, Abrahm JL. Patients with cancer referred to hospice versus a program: patient
characteristics, needs for care, and survival. J Clin Oncol. 2001;19:2057–2063.
Casarett DJ, Fishman JM, Lu HL, O’Dwyer PJ, Barg FK, Naylor MD, Asch DA. The Terrible Choice: ReEvaluating Hospice Eligibility Criteria for Cancer. Journal of Clinical Oncology. 2009;27(6):953-959.
Casarett DJ, Karlawish J, Hirschman KB. Are hospices ready to participate in palliative care research?
Results of a national survey. J Palliat Med. 2002;5(3):397-406.
Casarett DJ, Karlawish JHT. Are special ethical guidelines needed for palliative care research? J Pain
Symptom Manage. 2000;20(2):130-139.
Case RAM, Coghill C, Hartley JL, Pearson JT. The Truth About Death. The Chester Beatty Research
Institute Serially Abridged Life Tables, England and Wales, 1841-1960, Part 1, Tables, Preface and
Notes. 1962, pp. xxvi+87, Chester Beatt Research Institute, Royal Cancer Hospital, London n.p.
Caserta MS, Lund DA, Wright SD. Exploring the caregiver burden inventory (CBI): further evidence
for a multidimensional view of burden. Intl J Aging and Human Dev. 1996;43(1):21-34.
Cashin WE, Downey RG. Using global student rating items for summative evaluation. J Educ
Psychol. 1992;84(4):563-572.
Caspi A, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT
gene. Science 2003:301, 386.
Cassileth BR, Lusk EJ, Guerry D, et al. Survival and quality of life among patients receiving unproven
as compared with conventional cancer therapy. N Engl J Med. 1991;324:1180-1185.
Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C. Psychosocial correlates of survival in advanced
malignant disease? N Engl J Med. 1985;312:1551-1555.
Cassileth BR, Lusk EJ, Strouse TB. Psychosocial status in chronic illness: a comparative analyses of
sex diagnostic groups. N Engl J Med. 1984;311:506-511.
Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer
center. J Pain Symptom Manage. 2004:28(3):244–249.
Cassileth BR. Letter. J Clin Oncol. 1989;7:542-543.
Cassileth B. Martin Abeloff and the quality-of-life movement. Oncology. 2008;22(6):657-658.
D:\478174570.doc
Castleton K, Fong T, Wang-Gillam A, Waqar MA, Jeffe DB, Kehlenbrink L,Gao F, Govindan R. A
survey of Internet utilization among patients with cancer. Supportive Care in Cancer.
2011;19(8):1183-1190.
Caubet J-F. Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial. J
Natl Cancer Inst. 1999;91(4):381-382.
Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R,
Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG,
Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri
S, Valsecchi MG, the CI-PeriNomS Group. The chemotherapy-induced peripheral neuropathy
outcome measures standardization study: from consensus to the first validity and reliability findings.
Annals of Oncology. 2013;24:454-462.
Cella DF. Description of the Functional Assessment of Cancer Therapy (F.A.C.T.) Scales. Quality of
Life Newsletter 5.
Cella D, Beaumont JL, Webster KA, Lai J-S, Elting L. Measuring the concerns of cancer patients with
low platelet counts; the Functional Assesment of Cancer Therapy – Thrombocytopenia (FACT-Th)
questionnaire. Support Care Cancer. 2006;14:1220-1231.
Cella D, Bron D. The effect of Epoetin Alfa on quality of life in anemic cancer patients. Cancer
Practice. 1999;7(4):177-182.
Cella D, Brucker P. Introduction to the issue; including a model of health-related quality of life. Eval
Health Prof 2005;28(2):117-121.
Cella D, Bullinger M, Scott S, Barofsky I. Group vs individual approaches to understanding the clinical
significance of differences or changes in quality of life. Mayo Clin Proc. 2002;384-392.
Cella D, Chang C-H, Wright B, Von Roenn J, Skeel R. Defining higher order dimensions of selfreported health: Further evidence for a two-dimensional structure. Eval Health Professions
2005;28(2):122-141.
Cella D, Eton DT, Fairclough DL, et al. What is a clinically meaningful change on the Functional
Assessment of Cancer Therapy-Lung (FAXT-L) Questionnaire? Results from Eastern Cooperative
Oncology Group (ECOG) Study 5592. J Clin Epidemiol. 2002;55:265-295.
Cella D, Eton D, Hensing TA, Masters GA, Parasuraman B. Relationship between symptom change,
objective tumor meausurements, and performance status during chemotherapy for advanced lung
cancer. Clinical Lung Cancer. 2008;9(1):51-58.
Cella D, Eton DT, Lai J-S, Peterman A. Combining anchor and distribution based methods to derive
clinically meaningful differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and
Fatigue Scales. Manuscript.
Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A; ATAC Trialistsa9 Group. Quality of life
of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after
completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat
2006;100(3):273-84. Epub 2006 Jun 21.
D:\478174570.doc
Cella D, Fallowfield LJ. Recognition and management of treatment-related side effects for breast
cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 2008;107(2):167-80.
Epub 2007 Sep 18.
Cella D, Faoolowfield. Glaxo Wellcome Introduces the Benefact Quality of Life (QOL) Database.
Quality of Life Newsletter 13.
Cella D, Garfield DH, Govindan R, et al. Quality of life considerations in patients with advanced lung
cancer. Semin Oncol. 2004;31(suppl 11):16-20.
Cella D, Gershon R, Lai JS, Choi S. The future of outcomes measurement: item banking, tailored
short-forms, and computerized adaptive assessment. Qual Life Res 2007;16 Suppl 1:133-141. Epub
2007 Mar 31.
Cella D, Hahn E, Peterman A, Change C-H, Yount S. Cancer control research at the Center on
Outcomes, Research & Education. The Journal of the Robert H. Lurie Comprehensive Cancer Center
of Northwestern University. 2000;7(2):29-34.
Cella D, Herbst R, Lynch T, Prager D, Belani C, Schiller J, Heyes A, Ochs J, et al. Clinically meaningful
improvement in symptoms and quality of life for patients with non-small cell lung cancer receiving
Gefitinib in a randomized controlled trial. J Clin Oncol 2005;23(13):2946-2954.
Cella D, Hughes C, Peterman A, Chang C-H, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, marcus
A, Lerman C. A Brief Assessment of Concerns Associated with Genetic Testing for Cancer: The
Multidimensional Impact of Cancer Risk Assessment (MICRA) Questionnaire. Health Psychology.
2002;21(6):564-572.
Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and
quality of life in anemic cancer patients: Results from five randomized clinical trials. Annals of
Oncology. 2004;15:979-986.
Cella D, Lai J-S. CORE item banking program: Past, present and future. Quality of Life Newsletter.
2004;Fall:5-8.
Cella D, Lai J, and Item Banking Investigators Center on Outcomes, Research and Education (CORE)
Quality of Life Newsletter Special Issue – Item Banking 5–8; Fall 2004.
Cella D, Land SR, Chang CH, Day R, Costantino JP, Wolmark N, Ganz PA. Symptom measurement in
the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of
symptoms for midlife women. Breast Cancer Res Treat. 2007 Sep 13; [Epub ahead of print]
Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the
management of fatigue. Oncology. 1998;12:369-377.
Cella D, Petrylak D, Fishman M, Teigland C, Young J, Mulani P. Quality of life in men with metastatic
hormone-refactory prostate cancer: how does astrasentan influence quality of life. Eur Urol
2006;49(5):781-789.
Cella D, Pulliam J, Fuchs H, et al. Evaluation of pain associated with oral mucositis during the acute
period following administration of high-dose chemotherapy. Cancer. 2003;98(2):406-12.
D:\478174570.doc
Cella D, Wagner L, Cashy J, Hensing TA, Yount S, Lilenbaum RC. Should health-related quality of life
be measured in cancer symptom management clinical trials? Lessons learned using the functional
assessment of cancer therapy. J Natl Cancer Inst Monogr. 2007;(37):53-60. Review.
Cella D, Webster K. Linking outcomes management to quality-of-life measurement. NCCN Proc
Oncol. 1997;11(11A):232-235.
Cella D, Webster K. Quality of life and treatment value in the management of hematologic
malignancies. Seminars in Oncology. 1999;26(5):34-42.
Cella D, Yount S, Brucker PS, Du H, Bukowski R, Vogelzang N, Bro WP. Development and validation
of a scale to measure disease-related symptoms of kidney cancer. Value Health. 2007;10(4):285-93.
Cella D, Yount S, Du H, Dhanda R, Gondek K, Langefeld K, George J, Bro W, Kelly C, Bukowski R.
Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index
(FKSI). J Support Oncol 2006;4(4):191-199.
Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M;
PROMIS Cooperative Group. The Patient-Reported Outcomes Measurement Information System
(PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care.
2007;45(5 Suppl 1):S3-S11.
Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional
Assessment of Chronic Illness Therapy Fatigue Scale Relative to Other Instrumentation in Patients
with Rheumatoid Arthritis. J Rheumatol, 2005;32(5):811-819.
Cella D, Zagari MJ, Vandoros C, Gagnon DD, Hurtz HJ, Nortier JWR. Epoetin alfa overcomes much of
the quality of life (QOL) deficit seen in anemic cancer patients as confirmed by comparison with the
qol scores of a demographically representative population sample. For the Epoetin Alfa Study Group,
2002.
Cella D. Assessment methods for quality of life in cancer patients: the FACIT measurement system.
International Journal of Pharmaceutical Medicine. 2000;14(2):78-81.
Cella D. Factors influencing quality-of-life in cancer patients: anemia and fatigue. Sem Oncol.
1998;25(3)7:43-46.
Cella D. Quality of life and clinical decisions in chemotherapy-induced anemia.
Oncology (Williston Park). 2006 Jul;20(8 Suppl 6):25-8. Review.
Cella D. Quality of life considerations in patients with advanced lung cancer. Sem Oncol. 2004;
31(suppl 11):16-20.
Cella D. Quality of life outcomes: Measurement and validation. Oncology 1996; 10(11, Suppl.):233246
Cella D. The Effects of Anemia and Anemia treatment on the quality of life of people with cancer.
Oncology. 2002;16,9(Suppl. 10):125-132.
Cella D. the FACT-L and LCS assess quality of life and meaningful symptom improvement in lung
canceer. Seminars in Oncology. 2004;31(3)(Suppl. 9):11-15.
D:\478174570.doc
Cella D. The FDA and the person with cancer: give PROs a chance. Oncology (Williston Park).
2006;20(4):436.
Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: A new tool for the
assessment of outcomes in cancer anemia and fatigue. Seminars in Hematology. 1997; 34(3, Suppl
2):13-19.
Cella D. To the Editor: What do global quality of life questions really measure? Insights from
Hobday et al. and the “Do something” rule. J Clin Oncol. 2003;21(16):3178.
Cella D. Clinically meaningful improvement in symptoms and quality of life for patients with nonsmall cell lung cancer receiving gefitinib in a randomized controlled trial. J Clin Oncol. 2005;23:29462954.
Cella D. Quality of life in cancer patients experiencing fatigue and anemia. Anemial in Oncology.
1998; March, 2-4.
Cella D, Lai J.-S, Stone A. Self-reported fatigue: one dimension or more? Lessons from the
Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT-F) questionnaire. Supportive
Care in Cancer. 2011;19(9):1441-1450.
Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries J, Bruce B, Rose M. The
Patient-Reported Outcomes Measurement Information System (PROMIS). Progress of an NIH
Roadmap Cooperative Group During its First Two Years. Medical Care. 2007;45(5):S3-S11.
Cella DF. Quality of Life Assessment. New Developments in Medicine and Drug Therapy.
1992;1(2):22.
Cella DF, Bonomi AE. Measuring quality of life. Cancer Management: A Multidisciplinary Approach.
1998 (v. 2nd ed):807-814.
Cella DF, Bonomi AE, Leslie WT, Von Roenn J, Tchekmedyian N S. Quality of life and nutritional wellbeing: measurement and relationship. Oncology. 1993;7(11)Suppl:105-111.
Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the
functional assessment of cancer therapy – lung (FACT-L) quality of life instrument. Lung Cancer.
1995;12:199-220.
Cella DF, Bonomi AE. Measuring quality of life. Cancer Manage. (year/issue) 775-787.
Cella DF, Bonomi AE. Measuring quality of life: 1995 update. Oncology. 1995;9(11) Suppl:47-60.
Cella DF, Cherin EA. Quality of life during and after cancer treatment. Compr Ther. 1988;14(5): 6975.
Cella DF, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed idagnostic
criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385-3391.
D:\478174570.doc
Cella DF, Dineed K, Arnason B, et al. Validation of the Functional Assessment of Multiple Sclerosis
quality of life instrument. Neurology. 1996;47:129-139.
Cella DF, Hernandez L, Bonomi AE, et al. Spanish language translation and initial validation of the
Functional Assessment of Cancer Therapy (FACT) quality of life instrument. Medical Care.
1998;36(9):1407-1418.
Cella DF, Jacobsen PB, Hymowitz P. A comparison of the inter-test accuracy of two short forms of
the WAIS-R. J Clin Psychology. 1985;41(4):544-546.
Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silbergarb PM, Rafla SA. Brief POMS measure of distress
for cancer patients. J Chronic Dis. 1987;40(10):939-942.
Cella DF, McCain NL, Peterman AH, Mo F, Wolen D. Development and validation of the Functional
Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life
Res. 1996;5:450-463.
Cella DF, Orav EJ, Kornblith AB, et al. Socioeconomic status and cancer survival. J Clin Oncol.
1991;9(8):1500-1509.
Cella DF, Orofiamma B, Holland JC, et al. The relationship of psychological distress, extent of
disease, and performance status in patients with lung cancer. Cancer. 1987;60(7):1661-1667.
Cella DF, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the
management of fatigue. Oncology. 1998;12(114):369-377.
Cella DF, Tross S, Orav EJ, Holland JC, Silberfarb PM, Rafla S. Mood states of patients after the
diagnosis of cancer. J Psychosoc Oncol. 1989;7:45-54.
Cella DF, Tross S. Psychological adjustment to survival from Hodgkin's disease. J Cons Clin Psychol.
1986;54(5):616-622.
Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: Development
and validation of the general measure. J Clin Oncol. 1993;11:570-579.
Cella DF, Zagari MJ, Vandoros C, Gagnon DD, Huntz, HJ, Nortier JWR. Epoetin alfa treatment results
in clinically significant improvements in quality of life (QOL) in anemic cancer patients when
referenced to the general population. J Clin Oncol. 2003;21(2):366-373.
Cella DF, Tulsky DS. Measuring quality of life today: methodological aspects. Oncology. 1990;4
(5):29-38.
Cella DF. The concept of quality of life: palliative care and quality of life. Rech Soins Infirm.
2007;(88):25-31. French. (Publication not available.)
Cella DF. The psychology of adjustment in patients with cancer. Innovations in Oncology.
1988;4(1):15-16. (Publication not available.)
D:\478174570.doc
Cella DF. Functional status and quality of life: current views on measurement and intervention.
selected papers from: First National Conference on Cancer Nursing Research; Am Cancer Soc. 1989.
Cella DF. Manual: Functional Assessment of Cancer Therapy (FACT) Scales, 1992.
Cella DF. Quality of life outcomes: measurement and validation. Oncology. 1996;10(11)Suppl:233246.
Cella DF. Quality of life: concepts and definition. J Pain Symptom Manage; 1994;9:186-192.
Cella DF. Quality of life: the concept. J Palliat Care. 1992;8(3):8-13.
Cella DF. Helping Patients Cope with Cancer. The article reviewed. Oncology. 1989;3(11):129-130.
Cella DF. The modified WAIS-R: An extension and revision. J Clin Psychology. 1984;40(3):801-804.
Cella DF, Pratt A, Holland JC. Persistent anticipatory nausea, vomiting and anxiety in cured Hodgkin’s
disease patients after completion of chemotherapy. American Journal of Psychiatry. 1986;143:641643.
Cella DF, Perry SW. Reliability and concurrent validity of three visual analogue mood scales.
Psychological Reports. 1986;59:827-833.
Cella DF, Tross S. Psycologiclal adjustment to survival from Hodgkin’s disease Journal of Consulting
and Clinical Psychology. 1986; 54:616-622.
Cella DF. Cancer survival: Psychosocial and public issues. Cancer Investigation. 1987;5(1):59-67.
Cella DF, Cella C. Cancer survivors: The silver lining and the cloud. Rx: Being Well. 1987;5(2):1824. (Publication/company no longer exists. Can not get article.)
Cella DF, Tross S. Death anxiety in caner survival: A preliminary cross validation study. Journal of
Personality Assessment. 1987;51:451-461.
Cella DF, DeWolfe AS, Fitzgibbon M. Ego-identity status, identification, and decision making style in
late adolescents. Adolescence. 1987;22(88):849-861.
Cella DF, Perry SW, Kulchycky S, Goodwin C. Stress and coping in relatives of burn patients: A
longitudinal study. Hospital and Community Psychiatry . 1988;39(2):159-166.
Cella DF, Perry SW, Poag ME, Amand R, Goodwin C. Depression and stress responses in parents of
burned children. Journal of Pediatric Psychology. 1988;13(1):87-99.
Cella DF, Cherin EA. Quality of life during and after cancer treatment. Comprehensive Therapy.
1988;14(5):69-75.
Cella DF, Lesko L. Cancer survivors: Watch for signs of stress even years later. Primary Care and
Cancer, Oncology Roungs: advances in the management of cancer patients, 49, 1988.
D:\478174570.doc
Cella DF, Tan C, Sullivan M, Weinstock L, Alter R, Jow D. Identifying survivors of pediatric hodgkin’s
disease who need psychological interventions. Journal of Psychosocial Oncology. 1988;5(4):83-96.
Cella DF. The psychology of adjustment in patients with cancer. Innovations in Oncology.
1988;4(1):15-16.
Cella DF, Mahon SM, Donovan MI. Cancer recurrence as a traumatic event. Behavioral Medicine.
1990;16(1):15-22.
Cella DF. Health promotion in oncology: A cancer wellness doctrine. Journal of Psychosocial
Oncology. 1990;8(1):17-31.
Cella DF. Don’t believe everything you read: Psychoneuroimmunology and the person with life
threatening illness. In Berndtson K & Maish M. Review of Biopsychosocial Medicine, Rush Medical
College, 1991.
Cella DF. The economics of cancer survival. Contemporary Oncology. 1992;2(6):55-62. (Publication
not available.)
Cella DF. Psychological issues in patients with cancer. Current Practive of Medicine vol 3. XII:
1996;19.1-19.7. (Vol. 3) Current Medicine, Inc., Philadelphia, PA (distributed by Churchill Livingstone,
Inc., NY, NY).
Cella DF. Psychological issues in patients with cancer. Current Practice of Medicine. 1999;2(7):13511357. (Publication not available.)
Cella DF. Survival in cancer patients and socioeconomic status. La Chirurgia Toracica. 1992;45:1-4.
Italian.
Cella DF, Tulsky DS, Sarafian B, Thomas Jr CR, Thomas Sr CR. Culturally relevant smoking
prevention for minority youth. Journal of School Health. 1992;62:377-380.
Cella DF. Overcoming difficulties in demonstrating health outcome benefits. Journal of Parental and
Enteral Nutrition. 1992;16(6):106S-111S.
Cella DF. Health Promotion in Oncology. Journal of Health Care Chaplaincy. 1992;4(1/2):87-101.
Cella DF, Tulsky DS. Quality of life in cancer: Definition, purpose and method of measurement.
Cancer Investigation. 1993;11:327-336.
Cella DF, Yellen SB. Cancer support groups: The state of the art. Cancer Practice. 1993;1(1):5661.
Cella DF, Sarafian B, Snider P, Yellen SB, Winicour P. Evaluation of a community based cancer
support group. Psycho-Oncology. 1993;2:123-132.
Cella DF, Wiklund I, Shumaker SA, Aaronson NK. Integrating health-related quality of life into crossnational clinical trials. Quality of Life Research. 1993;2:433-440.
D:\478174570.doc
Cella DF, Lloyd S. Data collection strategies for patient-reported information. Quality Management in
Health Care. 1994;2(4):28-35.
Cella DF. Methods and problem in measuring quality of life. Supportive Care in Cancer. 1995;3:1122.
Cella DF, VonRoenn J, Lloyd S, Browder HP. The Bristol-Myers anorexia/chachexia recovery
instrument (BACRI): A brief assessment of patients’ subjective response to treatment for
anorexia/cachexia. Quality of Life Research. 1995;4:221-231.
Cella DF. Measuring quality of life in palliative care. Seminars in Oncology. 1995;22(2):73-81.
Cella D, Patel J. Improving health-related quality of life in non-small-cell lung cancer with current
treatment options. Clinical Lung Cancer. 2008;9(4):206-212.
Cesari M, Onder G, Zamboni V, Manini T, Shorr RI, Russo A, Bernabei R, Pahor M, Landi F. Physical
function and self-rated health status as predictors of mortality: results from longitudinal analysis in
the ilSIRENTE study. BMC Geriatrics. 2008;8(34):9 pages.
Chambers A, Routledge T, Pilling J, Scarci M. In elderly patients with lung cancer is resection
justified in terms of morbidity, mortality and residual quality of life? Interactive Cardiovascular and
Thoracic Surgery. 2010;10(6):1015-1021.
Chambers CT, Johnston C. Developmental differences in children’s use of rating scales. J Pediatr
Psychol. 2002;27(1):27-36.
Chambers SK, Lynch BM, Aitken J, Baade P. Relationshiip over time between psychological distress
and physical activity in colorectal cancer survivors. Journal of Clinical Oncology. 2009;27(10):16001606.
Chambers SK, Foley E, Galt E, Ferguson M, Clutton S. Mindfulness groups for men with advanced
prostate cancer: a pilot study to assess feasibility and effectiveness and the role of peer support.
Supportive Care in Cancer. 2012;20(6):1183-1192.
Chamlin S, Cella D, Frieden I, Williams M, Mancini A, Lai J-S, Chren M-M. Development of the
childhood atopic dermatitis impact scale (CADIS): Initial validation of a quality-of-life measure for
young children with atopic dermatitis and their families. J Investigative Dermatol. 2005;125
(6):1106-11.
Chamlin S, Mattson C, Frieden I, Williams M, Mancini A, Cella D, Chren M. The price of pruritus:
Sleep disturbance and co-sleeping in atopic dermatitis. Arch Ped Adol Med 2005;159:745-750.
Champion V, Williams S, Miller A, Reuille K, et al. Quality of life in long=term survivors of ovarian
germ cell tumors: A Gynecologic Oncology Group Study. Gynecol Oncol. 2007;105(3):687-694.
Chan CLW, Wang C-W, Ho RTH, Ng S-M, Chan JSM, Ziea ETC, Wong VCW. A systematic review of
the effectiveness of qigong exercise in supportive cancer care. Supportive Care in Cancer.
2012;20(6):1121-1134.
D:\478174570.doc
Chan K, Revicki DA. Changes in surrogate laboratory markers, clinical endpoints and health-related
quality of life in patients infected with the human immunodeficiency virus. Eval Health Profess.
1998;21:265-281.
Chan YM, Ngan HYS, Li BYG, et al. A longitudinal study on quality of life after gynecologic cancer
treatment. Gynecol Oncol. 2001;83:10–19.
Chandler SW, Payne R. Computerized tools to assess and manage cancer pain. Highlights in
Oncology Practice. 1997;14(4):114-117.
Chang B, Wu AW, Hansel NN, Diette GB. Quality of life in tuberculosis: A review of the English
language literature. Qual Life Res. 2004;13:1633-1642.
Chang CH, Cella D, Clarke S, Heinemann AW, Von Roenn JH, Harvey R. Should symptoms be scaled
for intensity, frequency, or both? Palliat Supp Care. 2003;1:51-60.
Chang CH, Cella D. Equating health-related quality of life instruments in applied oncology settings.
Philadelphia: Hanley & Belfus, Inc: Physical Medicine and Rehabilitation: State of the are reviews.
1997; 11(2):397-406.
Chang C-H, Cella D, Masters GA, Laliberte N, O’Brien P, Peterman A, Shevrin D. Real-time clinical
application of quality of life assessment in Lung Cancer. Clinical Lung Cancer. 2002;4(2):104-109.
Chang C-H, Wright B, cella D, Hays R. the SF-36 Physical and Mental health Factors were confirmed
in cancer and HIV/AIDS patients. Journal of Clinicla Epidemiology. 2007;60:68-72.
Chang C-H. Developing tailored instruments: Item banking and computerized adaptive assessment.
summary paper, Drug Information Association; June 23–25, 2004 Meeting.
Chang J, Couture F, Young S, McWatters K-L, Lau CY. Weekly Epoetin Alfa maintains hemoglobin,
improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J
Clin Oncol. 2005;23:2597-2605.
Chang JA, Lin CC. A longitudinal study of the role of patient-reported outcomes on survival
prediction of palliative cancer inpatients in Taiwan. Supportive Care in Cancer. 2009;17(10):12851294.
Chang S, Long ST, Kutikova L, et al. Estimating the cost of cancer: results on the basis of claims
data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin
Oncol. 2004;22:3524–3530.
Chang VT, Hwang SD, Corpion C, Feuerman M. Validation of the Memorial Symptom Assessment
Scale Short Form (MSAS-SF). Proc ASCO. 1997;16:47a.
Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The Memorial Symptom Assessment
Scale Short Form (MSAS-SF): validity and reliability. Cancer. 2000;89:1162-1171.
Chang VT, Hwang SS, Feurman M. Symptom and quality of life survey of medical oncology patients
at a Veterans Affairs Medical Center: a role for symptom assessment. Cancer. 2000;88:1175–1183.
D:\478174570.doc
Chang VT, Hwang SS, Feurman M. Validation of the Edmonton Symptom Assessment Scale. Cancer.
2000;88(9):2164–2171.
Chang VT, Ingham J. Symptom control. Cancer Investigation. 2003;21(4):564-578.
Chang YJ, Lee JS, Lee CG, Lee WS, Lee KS, Bang S-M, Wang XS, Mendoza TR, Cleeland CS, Yun YH.
Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007;15:891-896.
Chapman CR, Donaldson GW, Jacobson RC, Hautman B. Differences among patients in opioid selfadministration during bone marrow transplantation. Pain. 1997;71:213-223.
Chapman JW, Etezadi-Amoli J, Selby PJ, Boyd NF, Dalley D. Statistical ramifications of linear
analogue scales in assessing the quality of life of cancer patients. Biostat. 1987:51-60.
Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean?
(or it takes at least two to tango). Soc Sci Med. 1997;44(5):681-692.
Charles CA, Whelan T, Gafni A, Willan A, Farrell S. Shared treatment decision making: What does it
mean to physicians? J Clin Oncol. 2003;21(5):932-936.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity
in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
Chassany O, Duracinsky M. Health-related quality of life in asthma and COPD. Health-related quality
of life and patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus de la
4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany O,
Caulin C. October 2002.
Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: The example
of health-related quality of life: A European guidance document for the improved integration of
health-related quality of life assessment in the drug regulatory process. Drug Info J. 2002;36:209238.
Chassany O. Health-related quality of life: why its measure is nowadays unavoidable? health-related
quality of life and patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus
de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany
O, Caulin C. October 2002.
Chauhan, C. Optimists doing something different: a patient’s view of geneQOL research. Qual Life
Res. Accepted January 19, 2010.
Chauhan C. The perception of perception. J Clin Oncol 2007;25(16):2329-2330.
Chauhan C, Eppard W, Perroti J. The patient advocate perspective on assessing the clinical
significance for quality-of-life measures. J Cancer Integ Med. 2004:2(4):155 – 157.
Chawla S, Mohanti BK, Saxena S, Bahadur S, Rath GK. Quality of life assessment in head and neck
cancer patients. Radiotherapy and Oncology ’95: Association of Radiation Oncologists of India, 16 th
Annual Meeting and Roentgen Centenary Celebration; February 2-4, 1995; Kerala, India; p. 228.
D:\478174570.doc
Chen PW. When Optimism is Unrealistic. New York Times. March 3, 2011.
Chen E, Khan L, Zhang L, Nguyen J, Cramarossa G, Tsao M, Danjoux C, Barnes E, Sahgal A, Holden
L, Jon F, Dennis K, Culleton S, Chow E. Symptom clusters in patients with bone metastases – a
reanalysis comparing different statistical methods. Support Care Cancer. 2012;20(11):2811-2820.
Chen RC, Clark JA, Talcott JA. Individualizing quality-of-life outcomes reporting: how localized
prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual
function. Journal of Clinical Oncology. 2009;27(24):3916-3922.
Chen M-L, Chu L, Chen H-C. Impact of cancer patients’ quality of life on that of spouse caregivers.
Supp Care Cancer. 2004;12:469–475.
Chen M-L, Tseng H-C. Symptom clusters in cancer patients. Support Care Cancer. 2006;14:825830.
Cheng JD, Hitt J, Koczwara B, Schulman KA, Burnett CT, et al. Impact of quality of life on patient
expectations regarding phase I clinical trials. J Clin Oncol. 2000;18(2):421-428.
Cheng S. Subjective quality of life in the planning and evaluation of programs. Eval Program Plann.
1988;11:123-134.
Cherny NI, Portenoy R. Cancer pain management. Cancer. 1993;72(11)Suppl:3393-3415.
Cheung Y-B, Wong L-C, Tay M-H, Toh C-K, Koo W-H, Epstein R, Goh C. Order effects in the
assessment of quality of life in cancer patients. Qual Life Res. 2004:13:1217–1223.
Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician
expectations for cancer survivorship care. Journal of Clinical Oncology. 2009;29(15):2489-2495.
Cheung WY, Neville BA, Earle CC. Associations among cancer survivorship discussions, patient and
physician expectations, and receipt of follow-up care. Journal of Clinical Oncology.
2010;28(15):2577-2583.
Cheung YT, Tan EH-J, Chan A. An evaluation on the neuropsychological tests used in the assessment
of postchemotherapy cognitive changes in breast cancer survivors. Supportive Care in Cancer.
2012;20(7):1361-1376.
Cheville AL, Beck LA, Petersen TL, Marks RS, Gamble GL. The detection and treatment of cancerrelated functional problems in an outpatient setting. Supportive Care in Cancer. 2009;17(1):61-68.
Cheville AL, Shen T, Chang M, Basford JR. Appropriateness of the treatment of fatigued patients with
stage IV cancer. Supportive Care in Cancer. 2013;21(1):229-234.
Cheville AL, Sloan JA, Northfelt DW, Jillella AP, Wong GY, Bearden III JD, Liu H, Schaefer PL,
Marchello BT, Christensen BJ, Loprinzi CL. Use of a lidocaine patch in the management of
postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study
(N01CB). Supportive Care in Cancer. 2009;17(4):451-460.
D:\478174570.doc
Chibaudel B, Bonnestain F, Shi Q, Buyse M, Tournigand C, Sargent DL, Allegra CJ, Goldberg RM, and
de Gramont A. Alternative End Points to Evaluate a Therapeutic Strategy in Advanced Colorectal
Cancer: Evaluation of Progression-Free Survival, Duration of Disease Control, and Time to
Failure of Strategy—An Aide et Recherche en Cancećrologie Digestive Group Study. Journal of
Clinical Oncology. Nov 2011;29(31):4189-98.
Chochinov HM, Hack T, Hassard T, Kristjanson LJ, McClement S, Harlos M. Dignity in the terminally
ill: a cross-sectional, cohort study. Lancet. 2002;360:2026-2030.
Chochinov HM, Hack T, McClement S, Kristjanson L, Harlos M. Dignity in the terminally ill: a
developing empirical model. Soc Sci & Med. 2002;54:433-443.
Chochinov HM, Hassard T, McClement S, Hack T, Kristjanson LJ, Harlos M, Sinclair S, Murray A.
Journal of Pain and Symptom Management. 2007;12:1-9.
Chochinov HM, Kristjanson LJ, Hack TF, Hassard T, McClement S, Harlos M. Burden to others and
the terminally ill. J Pain Symp Manage 2007.
Chochinov HM, Wilson KG, Enns M, et al. Desire for death in the terminally ill. Am J Psychiatry.
1995;152:1185-1191.
Chochinov HM, Wilson KG, Enns M, Lander S. Depression, hopelessness, and suicidal ideation in the
terminally ill. Psychosomatics. 1998;39:366-370.
Chochinov HM. Dignity-Conserving Care—A new model for palliative care: Helping the patient feel
valued. JAMA. 2002;287(17):2253-2260.
Chochinov HM. Dying, dignity, and new horizons in palliative end-of-life care. Cancer J Clinicians.
2006;56,2:84-101.
Choi T-Y, Lee MS, Kim T-H, Zaslawski C, Ernst E. Acupuncture for the treatment of cancer pain: a
systematic review of randomized clinical trials. Supportive Care in Cancer. 2012;20(6):1147-1158.
Choiniere M, Melzack R, Girard N, Rondeau J, Paquin MJ. Comparisons between pateints’ and nurses’
assessment of pain and medication efficacy in sever burn injuries. Pain. 1990;40:143-152.
Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, Tannock I. Predictive Model for
Survival in Patients With Advanced Cancer. Journal of Clinical Oncology. 2008;26(36):5863-5867.
Chow E, Fan G, Hadi S, Filipczak L. Symptom clusters in cancer patients with bone metastases.
Support Care Cancer 2007;15:1035-1043.
Chow SC, Ki F. On statistical characteristics of quality of life assessment. J Biopharm Stat. 1994;
4:1-17.
Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-oflife measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105-110.
D:\478174570.doc
Chrischilles EA, Pendergast JF, Kahn KL, Wallace RB, Moga DC, Harrington DP, Kiefe CI, Weeks JC,
West DW, Zafar SY, Fletcher RH. Adverse events among the elderly receiving chemotherapy for
advanced non-small-cell lung cancer. Journal of Clinical Oncology. 2010;28(4):620-627.
Christakis NA, Iwashyna TJ. The Health impact of health care on families: a matched chohort study
of hospice use be decedents and mortality outcomes in surviving, widowed spouses. Soc Sci Med.
2003;57:465–475.
Christie JM, Simmonds M, Palt R, Coluzzi P, Busch MA, Nordbrock E, Portenoy RK. Dose-titration,
multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in
cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol. 1998;12:3238-3245.
Chujo M, Mikami I, Takashima S, et al. A feasibility study of psychosocial group intervention for
breast cancer patients with first recurrence. Support Care Cancer. 2005;13:503-514.
Chvetzoff G, Tannock IF. Placebo effects in oncology. J Natl Cancer Inst. 2003;95(1):19-29.
Cimprich B, Ronis DL, Martinez-Ramos G. Age at diagnosis and quality of life in breast cancer
survivors. Cancer Pract. 2002;10(2):85-93.
Cirillo M, Venturini M, Ciccarelli L, Coati F, Bortolami O, Verlato G. Clinician versus nurse symptom
reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during
chemotherapy: results of a comparison based on patient’s self-reported questionnaire. Annals of
Oncology. 2009;20:1929-1935.
Citron ML, Kaplan R, Parris WCV, Croghan MK, Herbst LH, Rosenbluth RJ, Reder RF, Slagle NS, et al.
Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.
Cancer Investigation 1998;16(8):562-571.
Clancy CM, Lawrence W. Is outcomes research on cancer ready for prime time? Med Care.
2002:40(6) (Supplement):III-92-III-100.
Clark A, Fallowfield L. Quality of life measurements in patients with malignant disease: a review. J R
Soc Med. 1986;79:165-169.
Clark EB, Curtis JR, Luce JM, et al. Quality indicators for end-of-life care in the intensive care unit.
Crit Care Med. 2003;31(9):2255–2262.
Clark JA, Inui TS, Silliman RA, Bokhour et al. Patients’ perceptions of quality of life after treatment
for early prostate cancer. J Clin Oncol. 2003;21:3777-3784.
Clark JA, Rieker P, Propert KJ, Talcott JA. Changes in quality of life following treatment for early
prostate cancer. Urology. 1999;53:161-168.
Clark JA, Talcott JA. Confidence and uncertainty long after initial treatment for early prostate cancer:
survivors’ views of cancer control and the treatment decisions they made. J Clin Oncol.
2006;24(27):4457-4463.
Clark MM, Bostwick JM, Rummans TA. Group and individual treatment strategies for distress in
cancer patients. Mayo Clin Proc. 2003;78:1538–1543.
D:\478174570.doc
Clark MM, Novotny PJ, Patten CA, Rausch SM, Garces YI, Jatoi A, Sloan JA, Yang P. Motivational
readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer
2008 (in press).
Clark PE, Schover LR, Uzzo RG, Hafex KS, Rybicki LA, Novick AC. Quality of life and psychological
adaptation after surgical treatment for localized renal cell carsinoma: impact of the amount of
remaining renal tissue. Elsevier Science, Inc. 2001:252-256.
Clark TG, Altman DG, DeStavola BL. Quantification of the completeness of follow-up. Lancet.
2002;359:1309-1310.
Clark MM, Vickers KS, Hathaway JC, Smith M, Looker SA, Petersen LR, Pinto BM, Rummans TA,
Loprinzi CL. Physical activity in patients with advanced-stage cancer actively receiving chemotherapy.
Supportive Oncology. 2007;5(10):487-493.
Clark MM, Rummans TA, Sloan JA, Jensen A, Atherton PJ, Frost MH, Richardson JW, Bostwick JM,
Johnson ME, Hanson JM, Brown PD. Quality of life of caregivers of patients with advanced-stage
cancer. American Journal of Hospice & Palliative Medicine. 2006;23(3):185-191.
Clarke C. Medicine and history: Professor Sir Ronald Fisher, FRS. BMJ. 1990;301(6766):1446-1448.
Classen C, Butler LK, Koopman C, et al. Supportive-expressive group therapy and distress in patients
with metastatic breast cancer. Arch Gen Psychiatry. 2001;58:494-501.
Clauser SB. Use of cancer performance measures in population health: a macro-level perspective. J
Natl Cancer Inst Monogr. 2004;33:142–154.
Clayton MJ, Butow PN, Tattersall MHN, Devine FJ, Simpson JM, Aggarwal G, Clark KJ, Currow DC,
Elliott lM, et al. Randomized controlled trial of a prompt list to help advanced cancer patients and
their caregivers to ask questions about prognosis and end-of-life care. J Clin Oncol. 2007;25(6):715723.
Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I,
Hofstetter WL, Putnam Jr JB, Vaporciyan AA. Automated symptom alerts reduce postoperative
symptom severity after cancer surgery: a randomized controlled clinical trial. Journal of Clinical
Oncology. 2011;29(8):994-1000.
Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to
shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer.
2003;97:2919–2925.
Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer.
N Engl J Med. 1994;330(9):592–596.
Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients. The M.D.
Anderson Symptom Inventory. Cancer. 2000;89:1634-1646.
Cleeland CS, Mendoza TR, Wang XS, Woodruff JF, Palos GR, Richman SP, Nazario A, Lynch GR, Liao
K-P, Mobley GM, Lu C. Levels of symptom burden during chemotherapy for advanced lung cancer:
D:\478174570.doc
differences between public hospitals and a tertiary cancer center. Journal of Clinical Oncology.
2011;29(21):2859-2865.
Cleeland CS, Reyes-Gibby CC. When is it justified to treat symptoms? Measuring symptom burden.
Oncology. 2002;(Huntingt) 16(9 Suppl 10):64-70.
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med
Singapore. 1994;23:129-138.
Cleeland CS, Shacham S, Dahl JL, Orrison W. CSF beta-endorphin and the severity of pain.
Neurology. 1984;34:378-380.
Cleeland CS. Assessment of pain in cancer. J Natl Cancer Inst Monogr. 2004;32:79.
Clemens KE, Klaschik E. Dyspnoea associated with anxiety—symptomatic therapy with opioids in
combination with lorazepam and its effect on ventilation in palliative care patients. Support Care
CancerI. 2011;19(12):2027-33.
Clough-Gorr KM, Ganz PA, Silliman RA. Older breast cancer survivors: factors associate with change
in emotional well-being. J Clin Oncol. 2007;25(11):1334-1340.
Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA. Older breast cancer survivors: geriatric
assessment domains are associated with poor tolerance of treatment adverse effects and predict
mortality over 7 years of follow-up. Journal of Clinical Oncology. 2010;28(3):380-386.
Clover K, Carter GL, Mackinnon A, Adams C. Is my patient suffering clinically significant emotional
distress? Demonstration of a probabilities approach to evaluating algorithms for screening for
distress. Supportive Care in Cancer. 2009;17(12):1455-1462.
Coates A, Dillenbeck CF, McNeil DR, Kaye SB, Sims K, Fox RM, Woods RL, Milton GW, Solomon J,
Tattersall MHN. On the receiving end-II. Linear analogue self-assessment (LASA) in evaluation of
aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol.
1983:19(11):1633-1637.
Coates A, Gebski V, Bishop JF, Jeal PN, Woods RI, Snyder R, Tattersall HN, Byrne M, Harvey V, Gill G,
Simpson J, Drummond R, Browne J, van Cooten R, Forbes JF. Improving the quality of life during
chemotherapy for advanced breast cancer: a comparison of intermittent and continuous treatment
strategies. N Engl J Med. 1987;317(24):1490-1495.
Coates A, Porzsolt F, Osoba D. Quality of life in Oncology Practice: prognostic value of EORTC QLQC30 scores in patients with advanced malignancy. Eur J Cancer. 1997; 33:1025-1030.
Coates A, Thomson D, McLeod GRM, Hersey P, Gill PG, Olver IN, Kefford R, Lowenthal RM, Beadle G,
Walpole E. Prognostic value of quality of life score in a trial of chemotherapy with or without
interferon in patients with metastatic malignant melanoma. Eur J Cancer. 1993:29A(12):1731–1734.
Coates AS, Gebski V, Signorini D, et al. Prognostic value of quality-of-life scores during
chemotherapy for advanced breast cancer. Aust N Z Breast Cancer Trials Group. J Clin Oncol.
1992;10:1833-1838.
D:\478174570.doc
Coates AS, Hurny C, Peterson HF, Bernhard J, Castiglione-Gertsch M, Gelber RD, Goldhirsch A.
Quality-of-life scores predict outcome in metastatic but not early breast cancer. J Clin Oncol.
2000;18:3768-3774.
Cocks K, King MT, Velikova G, St-James MM, Fayers PM, Brown JM. Evidence-based guidelines for
determination of sample size and interpretation of the European Organisation for the research and
treatment of cancer quality of life questionnaire core 30. Journal of Clinical Oncology.
2011;29(1):89-96.
Coeytaux RR, Kaufman JS, Chao R, Mann JD, Devellis RF. Four methods of estimating the minimal
important difference score were compared to establish a clinically significant change in Headache
Impact Test. J Clin Epidemiol. 2006 Apr;59(4):374-80.
Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: A systematic review of the
literature. Am J Med Genet part A. 2010;152A:1136-1156.
Cohen HJ, Feussner JR, Weinberger M, Carnes M, Hamdy RC, Hsieh F, Phibbs C, Lavori P. A
controlled trial of inpatient and outpatient geriatric evaluation and management. New Engl J Med.
2002;346:905-912.
Cohen L, deMoor C, Parker PA, Amato RJ. Quality of life in patients with metastatic renal cell
carcinoma participating in a phase I trial of an autologous tumor-derived vaccine. Urologic Oncol.
2002;7:119-124.
Cohen L, deMoor CA, Eisenberg P, Ming EE, Hu H. Chemotherapy-induced nausea and vomiting –
incidence and impact on patient quality of life at community oncology settings. Support Care Cancer.
2007;15:497-503.
Cohen MZ, Musgrave CF, McGuire DB, Strumpf NE, Munsell MF, Mendoza TR, Gips M. The cancer
pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom
severity, and knowledge and attitudes on pain and pain control. Support Care Cancer.
2005;13:708-714.
Cohen MZ, Williams L, Knight P, Snider J, Hanzik K, Fisch MJ. Symptom masquerade: understanding
the meaning of symptoms. Support Care Cancer. 2005;12:184–190.
Cohen R. QOLLTI-F: measuring family carer quality of life. Palliat Med. 2006;20:755-767.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav.
1983;24(4):385-96.
Cohen SR, Mount BJ. Living with cancer: “good” days and “bad” days—what produces them? Am
Cancer Soc. 2000;1854-1865.
Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Tong K. Validity of the McGill Quality of Life
Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the
importance of the existential domain. Palliat Med. 1997;11(1):3-20.
D:\478174570.doc
Cohen SR, Mount BM. Quality of life in terminal illness: defining and measuring subjective well being
in the dying. J Palliat Care. 1992;8(3):40–45.
Cohen SR. Defining and measuring quality of life in palliative care. Palliat Care. 2001;5:137-156.
Cohen MZ, Slomka J, Pentz RD, Flamm AL, Gold D, Herbst RS, Abbruzzese JL. Phase I participants’
views of quality of life and trial participation burdens. Support Care Cancer. 2007;15:885-890.
Cohen SR, Mount BM, Strobel MG, Bui F. The McGill quality of life questionnaire: a measure of
quality of life appropriate for people with advanced disease. A preliminary study of validity and
acceptability. Palliative Medicine. 1995;9:207-219.
Cohen SR, Hassan SA, Lapointe BJ, Mount BM. Quality of life in HIV disease as measured by the
McGill quality of life questionnaire. AIDS. 1996;10:1421-1427.
Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E,
Miller MC, Doyle GV, Tissing H, Terstappen LWMM, Meropol NJ. Relationship of circulating tumor
cells to tumor response, progression-free survival, and overall survival in patients with metastatic
colorectal cancer. J Clin Oncol. 2008;26(19):3213-3221.
Coia LR, Aaronson N, Linggood R, Loeffler J, Priestman TJ. A report of the consensus workshop
panel on the treatment of brain metastases. Int J Rad Oncol Biol Phys. 1992;23:223-237.
Cole BF, Gelber RD, Anderson KM. Parametric approaches to quality-adjusted survival analysis.
Biometrics. 1994;50:621-631.
Cole BF, Gelber RD, Gelber S, Mukhopadhyay P. A Quality-Adjusted Survival (Q-TWIST) Model for
evaluating treatments for advanced stage cancer. J Biopharm Stat. 2004;14(1):111–124.
Cole BF, Gelber RD, Goldhirsch A. A quality-adjusted survival meta-analysis of adjuvant
chemotherapy for premenopausal breast cancer. Stat Med. 1995;14:1771-1784.
Cole BF, Gelber RD, Goldhirsch A. Cox regression models for quality adjusted survival analysis. Stat
Med. 1993;12:975-987.
Cole BF, Gelber RD, Kirkwood JM, Goldhirsch A, Barylak E, Borden E. Quality-of-life-adjusted survival
analysis of interferon alfa-2b adjuvant treatment of high-risk resected coetaneous melanoma: An
Eastern Cooperative Oncology Group Study. J Clin Oncol. 1996;14(10):2666-2673.
Cole BF, Solal-Celigny P, Gelber RD, et al. Quality-of-life adjusted survival analysis of interferon alfa2b treatment for advanced follicular lymphoma: An aid to clinical decision making. J Clin Oncol.
1998;16:2339-2344.
Cole R, Larson J. The effct of measurement of the contralateral hip if the spine is not included in the
bone mineral density analysis. J Clin Densitom. 2006;9(2):210-216.
Colgrove LA, Kim Y, Thompson N. The effect of spirituality and gender on the quality of life of
spousal caregivers of cancer survivors. Ann Behav Med. 2007;33(10):90-98.
D:\478174570.doc
Collado-Hidalgo A, Bower JE, Ganz PA, Irwin MR, Cole SW. Cytokine gene polymorphisms and
fatigue in breast cancer survivors: Early findings. Brain, Behavior, and Immunity. 2008;22:11971200.
Collette L, van Andel G, Bottomley A, et al. Is baseline quality of life useful for predicting survival
with horomone-refractory prostate cancer? A pooled analysis of three studies of the European
Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol.
2004;22:3877– 3885.
Colligan RC, Offord KP. Contemporary norms for the Wiggins Content Scales: a 45-year update.
Journal of Clinical Psychology. 1988;44(1):23-32.
Colligan RC, Rasmussen NH, Agerter DC, Offord KP, Malinchoc M, O’Byrne MM, Benson JT. The
MMPI-2: A contemporary normative study of Midwestern family medicine outpatients. Journal of
Clinical Psychology in Medican Settings. 2008;15(2):98-119.
Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in
millimeters? Pain. 1997;72(1-2):95-7.
Conill C, Verger E, Henriques I. Symptom prevalence in the last week of life. J Pain Symptom
Manage. 1997;14(6):328–331.
Conn VS, Hafdahl AR, Porock DC, McDaniel R, Nielsen PJ. A meta-analysis of exercise interventions
among people treated for cancer. Support Care Cancer. 2006;14(7):699-712.
Conn VS, Hafdahl AR, Porock DC, McDaniel R, Nielsen PJ. A meta-analysis of exercise interventions
among people treated for cancer. Erratum. 2007;15:1441-1442.
Connor SR, Pyenson B, Fitch K, Spence C, et al. Comparing hospice and nonhospice patient survival
among patients who die within a three-year window. Journal of Pain and Symptom Management.
2007;33(3):233-246.
Conroy T, Marchal F, Blazeby JM. Quality of life in patients with oesophageal and gastric cancer: An
overview. Oncology. 2006;70:391-402.
Contopoulous-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JPA. Reporting and interpretation of SF-36
outcomes in randomized trials: systematic review. BMJ. 2009;339:6 pages.
Cook D, Guyatt G, Wong E, et al. Regular versus as-needed short-acting inhaled beta-agonist
therapy for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:85-90.
Cook NR. Imputation strategies for blood pressure data nonignorably missing due to medication use.
Clin Trials. 2006;3:411-420.
Cooley ME, Sarna L, Brown JK, Williams RD, Chernecky C, Padilla G, et al. tobacco use in women
with lung cancer. Ann Behav Med. 2007;33(3):242-250.
Coons SJ. Health-related quality of life: let’s measure and report it appropriately. Editorial. Clin Ther
2007;29(12):2746.
D:\478174570.doc
Coons SJ, Alabdulmohsin SA, Draugalis JR, Hays RD, Reliability of an Arabic version of the rAND-36
health survey and its equivalence to the US-English version. Med Care. 1998;36(3):428-432.
Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E.
Recommendations on evidence needed to support measurement equivalence between electronic and
paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task
force report. Value in Health. 2009;12(4):419-429.
Coons SJ, Kaplan RM. Assessing health-related quality of life: application drug therapy. Clin Ther.
1992;14(6):850-858.
Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments.
Pharmacoeconomics. 2000;17(1):13-35.
Corkrey R, Parkinson L. Interactive Voice Response: review of studies 1989–2000. Behav Res
Methods Instrum Comput. 2002;34(3):342–353.
Corless IB, Kenneally Nicholas P, Nokes KM. Issues in cross-cultural quality of life research. J Nurs
Scholarsh. 2001;33(1):15–20.
Cormier J, Davidson L, Xing Y, Webster K, Cella D. Measuring quality of life in patients with
melanoma: Development of the FACT-Melanoma subscale. J Support Oncol, 2005;3(2):139-145.
Corn BW, Moughan J, Knisely JP, Fox SW, Chakravarti A, Yung WK, Curran WJ, Robins HI, Brachman
DG, Henderson RH, Mehta MP, Movsas B. Prospective evaluation of quality of life and neurocognitive
effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without
thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118. Int J Radiat Oncol Biol Phys.
2008 May;71(1):71-8.
Coscarelli CA, Ganz PA, Heinrich RL. Cancer rehabilitation evaluation system-short form (CARES-SF).
Cancer. 1991;68:1406-1413.
Costagliola D. What statistical plan for health-related quality of life? Health-related quality of life and
patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus de la 4e Journee
de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany O, Caulin C.
October 2002.
Costantini M, Toscani F, Gallucci M. Terminal cancer patients and timing of referral to palliative care:
a multicenter prospective cohort study. J Pain Symptom Manage. 1999;18:243–252.
Costanzo F, Gasperoni S, Di Costanzo F. Should adjuvant chemotherapy be used in elderly women
(>70 years) with breast cancer? Contra. Tumori. 2002;88(1)(Suppl 1):S91-S92.
Coster S, Poole K, Fallowfield LJ. The validation of a quality of life scale to assess the impact of arm
morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat. 2001;68:273-282.
Cotton DJ, Powderly WG, Feinberg J, et al. Guidelines for the design and conduct of AIDS clinical
trials. Clin Infect Dis. 1993;16:816-822.
D:\478174570.doc
Coulter A. Patient information and shared decision-making in cancer care. British Journal of Cancer.
2003;89:S15-S16.
Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, Tankel K, Basi S,
Chua N, Mazurek A, Reiman T. Randomized controlled trial of the effects of aerobic exercise on
physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009 Sep
20;27(27):4605-12. Epub 2009 Aug 17.
Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C,
Vallance JK, Lane K, Yasui Y, Segal RJ. Moderators of the effects of exercise training in breast cancer
patients receiving chemotherapy: a randomized controlled trial. Cancer. 2008 Apr 15;112(8):184553.
Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of
exercise training in postmenopausal breast cancer survivors: Cardiopulmonary and quality of life
outcomes. J Clin Oncol. 2003;21(9):1660-1668.
Couser GP. Challenges and opportunities for preventing depression in the workplace: a review of the
evidence supporting workplace factors and interventions. Journal of Occupational Environmental
Medicine. 2008;50(4):411-427.
Cousins R, Davies ADM, Turnbull CJ, Playfer JR. Assessing caregiving distress: A conceptual analyis
and a brief scale. Br J Clin Psychol. 2002;41:387–403.
Cox A, Jenkins V, Catt S, Langridge C, Fallowfield L. Inofrmation needs and experiences: an audit of
UK cancer patients. Eur J Oncol Nurs. 2006;10(4):263-272.
Cox AC, Fallowfield LJ, Jenkins VA. Communication and informed consent in phase I trials: a review
of the literature. Support Care Cancer. 2006;14:303-309.
Cox DR, Fitzpatrick R. Quality-of-life Assessment: Can we keep it simple? J R Statis Soc. 1992;
155:353-393.
Cox K, Bergen A, Norman I. Exploring consumer views of care provided by the Macmillan nurse
using the critical incidence technique. J Adv Nurs. 1993;19:408-415.
Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer
patient: pain and other symptoms during the last four week of life. J Pain Symptom Manage.
1990;5:83–93.
Coyle N, Goldstein ML, Passik SD, Fishman B, Portenoy R. Development and validation of a patient
needs assessment tool (PNAT) for oncology clinicians. Cancer Nurs. 1996;19:81-92.
Coyne JC, Pajak TF, Harris J, Konski A, Movsas B, Ang K, Watkins Bruner D. Emotional Well-Being
Does Not Predict Survival in Head and Neck Cancer Patients. American Cancer Society.
2007;110(11):2568-2575.
Craig T, Comstock G, Geiser P. The quality of survival in breast cancer: a case-control comparison.
Cancer. 1974;33:1451-1457.
D:\478174570.doc
Crane P, Gibbons L, Narasimhaly K, Lai J-S, Cella D. Rapid detection of differential item functioning
in assessments of health-related quality of life: The Functional Assessment of Cancer Therapy.
Quality of Life Research. 2007;16(1):101-114.
Crawford ED, Bennett CL, Stone NN, et al. Comparison of Perspectives on Prostate Cancer: Analyses
of Survey Data. Elsevier Science, Inc. 1997;366-372.
Crawford J, Cella D, Cleeland CS, et al. Relationship Between Changes in Hemoglobin Level and
Quality of Life During Chemotherapy in Anemic Cancer Patients Receiving Epotein Alfa Therapy.
Cancer. 2002;95:888–895.
Crawford J, Duch DS, Gralla RJ, Hillner BE, Hollen PJ, Vokes EE. Pharmacoeconomics, Quality of Life,
and Combination Modalities in Non-Small Cell Lung Cancer: A Panel Discussion (Part 2). Sem Oncol.
1996;23(2)Suppl 5:53-55.
Crawford J. Epoetin alpha for improving quality of life in lung cancer patients. Anemia & Quality of
Life in Oncology. 2002;5(1):2-4.
Crawford J. Erythropoiesis-stimulating protein support and survival. Oncology (Suppl).
2006;20(8):39-43.
Creagan ET. Attitude and disposition: Do they make a difference in cancer survival? Mayo Clin Proc.
1997;72:160-164.
Creed F, Ratcliffe J, Fernandez L, et al. Health-related quality of life and health care costs in severe,
refractory irritable bowel syndrome. Ann Intern Med. 2001;134(9 Pt 2):860-868.
Crevenna R, Zettinig G, Keilani M, Posch M, Schmidinger M, Pirich C, Nuhr M, Quittan M, Fialka-Moser
V, Dudczak R. Quality of life in patients with non-metastatic differentiated thyroid cancer under
thyroxine supplementation therapy. Support Care Cancer. 2003;11:597-603.
Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, Yann Tsai W, Hershman DL.
Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase
inhibitor-associated joint symptoms in women with early-stage breast cancer. Journal of Clinical
Oncology. 2010;28(7):1154-1160.
Crivellari D. Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG
experience. Tumori. 2002;88(1)(Suppl 1):S81-S82.
Croghan IT, Schroeder DR, Hays JT, et al. Nicotine dependence treatment: perceived health status
improvement with 1-year continuous smoking abstinence. Eur J Public Health. Advance Access; May
19, 2005.
Croog SH, Levine S, Testa MA, et al. The effects of anti-hypertensive therapy on the quality of life.
N Engl J Med. 1986;314(26):1657-1664.
Crook JM, Gomez-Iturriaga A, Wallace K, Ma C, Fung S, Alibhai S, Jewett M, Fleshner N. Comparison
of Health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial
Radiation Intervention Trial. Journal of Clinical Oncology. 2011;29(4):362-368.
D:\478174570.doc
Crosby RD, Kolotkin RK, Williams GR. Defining clinically meaningful change in health-related quality
of life. J Clin Epidemiol. 2003;56:395–407.
Crosby RD, Kolotkin RL, Williams GR. An integrated method to determine meaningful changes in
health-related quality of life. J Clin Epidemiol. 2004;57:1153-1160.
Crothers MK, Tomter HD, Garske JP. The relationships between satisfaction with social support,
affect balance, and hope in cancer patients. J Psychosocial Oncol. 2005;23(4):103-118.
Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ. L-Carnitine Supplementation for the
Management of Fatigue in Patients with Cancer: An Eastern Cooperative Oncology Group Phase III,
Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Oncology.
2012;30(31):3864-3869.
Cualin C. Health-Related Quality of Life and Evaluation for French Marketing Authorisation (AMM).
Health-Related Quality of Life and Patient-Reported Outcomes: Scientific and Useful Outcome
Criteria. Comptes rendus de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris.
Main Authors: Chassany O, Caulin C. October 2002.
Cull A, Gould A, House A, Smith A, Strong V, Velikova G, Wright P, Selby P. Validating automated
screening for psychological distress by means of computer touchscreens for use in routine oncology
practice. Br J Cancer. 2001;85(12);1842–1849.
Cullen J, Schwartz MD, Lawrence WF, Selby JV, Mandelblatt JS. Short-Term Impact of Cancer
Prevention and Screening Activities on Quality of Life. J Clin Oncol. 2004;22(5):943–952.
Culos-Reed SN, Robinson JW, Lau H, Stephenson L, Keats M, Norris S, Kline G, Faris P. Physical
activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week
intervention. Supportive Care in Cancer. 2010;18(5):591-600.
Cunningham WE, Bozzette SA, Hays RD, Kanouse DE, Shapiro MF. Comparison of Health-Related
Quality of Life in Clinical Trial and Nonclinical Trial Human Immunodeficiency Virus-Infected Cohorts.
Med Care. 1995;33(4)Suppl:AS15-AS25.
Cunningham WE, Burton TM, Hawes-Dawson J, Kington RS, Hays RD. Use of Relevancy Rating by
Target Respondents to Develop Health-Related Quality of Life Measures: An Example with AfricanAmerican elderly. Qual Life Res. 1999;8:749–768.
Cunningham WE, Hays RD, Burton TM, Kington RS. Health status measurement performance and
health status differences by age, ethnicity, and gender: assessment in the medical outcomes study. J
Health Care Poor Underserved. 2000;11(1):58-76.
Cunningham WE, Hays RD, Ettl MK, et al. The prospective effect of access to medical care on healthrelated quality-of-life outcomes in patients with symptomatic HIV disease. Med Care. 1998;
36(3):295-306.
Cunningham WE, Hays RD, Williams KW, Beck CK, Dixon WJ, Shapiro MF. Access to medical care
and health-related quality-of-life for low-income persons with symptomatic human immunodeficiency
virus. Med Care. 1995;7:739-754.
D:\478174570.doc
Cunningham WE, Mosen DM, Hays RD, Andersen RM, Shapiro MF. Access to community-based
medical services and number of hospitalizations among patients with HIV disease: are they related?
J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:327-335.
Cunningham WE, Mosen DM, Morales LS, Andersen RM, Shaprio MF, Hays RD. Ethnic and Racial
Differences in Long-Term Survival From Hospitalization For HIV Infection. J Health Care Poor
Underserved. 2000:11(2):163–178.
Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of
life in patients with symptomatic HIV disease. Am J Med. 1998;104:129-136.
Cunny KA, Perri M. Single-item vs. multiple-item measures of health-related quality of life. Psychol
Rep. 1991;69(1):127-130.
Curraan D, Fossa S, Aaronson N, Kiebert G, Keuppens E, Hall R. Baseline quality of life of patients
with advanced prostate cancer. Euro J Cancer. 1997;33(11):1809-1814.
Curran D, Aaronson N, Standaert B, et al. Summary measures and statistics in the analysis of quality
of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study. Euro J
Cancer. 2000;36:834-844.
Curran D, Giralt J, Harari PM, Ang KK, Cohen RB, Kies MS, Jassem J, Baselga J, et al. Quality of life
in head and neck cancer patietns after treatment with high-dose radiotherapy alone or in combination
with cetuximab. J Clin Oncol 2007;25(16):2191-2197.
Curran D, van Dongen JP, Aaronson NK, et al. Quality of life of early-stage breast cancer patients
treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801. Euro
J Cancer. 1998;34(3):307-314.
Curran SL, Andrykowski MA, Studts JL. Short form of the profile of mood states (POMS-SF):
Psychometric information. Psychol Assess. 1995;7(1):80-83.
Curry C, Cossich T, Matthews JP, Beresford J, McLachian SA. Uptake of psychosocial referrals in an
outpatient cancer setting: improving service accessibility via the referral process. Support Care
Cancer. 2002;10:549-555.
Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new
findings from the fatigue coalition. Oncologist. 2000;5:353-360.
Curtis JR, Patrick DL, Engelberg RA, Norris K, Asp C, Byock I. A Measure of the Quality of Dying and
Death: Initial Validation Using After-Death Interviews with Family Members. Journal of Pain and
Symptom Management. 2002;24(1):17-31.
Curtis WJ, Cicchetti D. Moving research on resilience into the 21st century: theoretical and
methodological considerations in examining the biological contributors to resilience. Dev
Psychopathol. 2003;15(3):773-810.
Cutler SJ. International symposium on end results of cancer therapy. Computation of survival rates.
Natl Cancer Inst Monogr. 1964;15:381-5.
D:\478174570.doc
D’Angelo D, Mastroianni C, Vellone E, Alvaro R, Casale G, Latina R, De Marinis MG. Palliative care
quality indicators in Italy. What do we evaluate? Support Care Cancer. 2012;20(9):1983-1989.
D’Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and functional status measures in
patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1996;122:482-487.
Da Silva, FC, Fossa SD, Aaronon NK, et al. The quality of life of patients with newly diagnosed M1
prostate cancer: experience with EORTC clinical trial 30853. Eur J Cancer. 1996;32A(1):72–77.
Daaleman TP, Frey BB. The Spirituality Index of Well-Being: a new instrument for health-related
quality-of-life research. Ann Fam Med. 2004;2(5).
Dahele M, Wall L. To the editor: Optimizing end points and outcomes in cancer-associated wasting.
In reply: Jatoi A, Loprinzi C. J Clin Oncol. 2005;23:2871-2873.
Dahl AA, Fredrik Haaland C, Mykletun A, et al. Study of anxiety disorder and depression in long-term
survivors of testicular cancer. J Clin Oncol. 2005;23:2389-2395.
Dahl JL. Pain: impediments and suggestions for solutions. J Natl Cancer Inst Monogr. 2004;32:124126.
Dale O, Hagen KB. Despite technical problems personal digital assistants outperform pen and paper
when collecting patient diary data. J Clin Epidemiol. 2007;60(1):8-17.
Daley Aj, Crank H, Saxton JM, Mutrie N, Coleman R, Roalfe A. Randomized trial of exercise therapy
in women treated for breast cancer. J Clin Oncol. 2007;25(13):1713-1721.
Daltroy L, Larson M, Eaton H, Phillips C, Liang M. Discrepancies between self-reported and observed
physical function in the elderly: the influence of response shift and other factors. Soc Sci Med.
1999;48:1549-1561.
Damush TM, Hays RD, DiMatteo MR. Stressful life events and health-related quality of life in college
students. Journal of College Student Development . 1997;38(2):181-190.
Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a
general population of cancer patients receiving chemotherapy. Qual Life Res. 1997;6:151-158.
Danjoux C, Gardner S, Fitch M. Prospective evaluation of fatigue during a course of curative
radiotherapy for localized prostate cancer. Support Care Cancer. 2007;15:1169-1176.
Danoff B, Kramer S, Irwin P, Gottlieb A. Assessment of the quality of life in long term survivors after
definitive radiotherapy. Am J Clin Oncol. 1983;6:339-345.
Darga LL, Magnan M, Mood D, Hryniuk WM, DiLaura NM, Djuric Z. Quality of life as a predictor of
weight loss in obese, early-stage breast cancer survivors. Oncol Nurs Forum. 2007 Jan;34(1):86-92.
Darling G, Eton D, Sulman J, Casson A, Cella D. Validation of the Functional Assessment of Cancer
Therapy Esophageal Cancer Subscale FACT-E. Cancer. 2006;107(4):854-863.
D:\478174570.doc
Daugherty CK, Hlubocky FJ. What are Terminally Ill Cancer Patients Told About Their Expected
Deaths? A Study of Cancer Physicians’ Self-Reports of Prognosis Disclosure. Journal of Clincical
Oncology. 2008;26(36):5988-5993.
Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess
pain in cancer and other diseases. Pain. 1983;17:197-210.
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer. 1982; 50:1913-1918.
Davidson B, Blum D, Cella D, Hamilton H, Nail L, Waltzman R. Communicating about chemotherapyinduced anemia. Journal of Supportive Oncology. 2007;5(1):36-40,46.
Davidson NE. Tracking 35 years of progress against breast cancer. Oncology. 2008;22(6):593-595.
Davidson SE, Trotti A, Ataman OU, Seong J, Lau FN, Motta NW, Jeremic B. Improving the capture of
adverse event data in clinical trials: The role of the international atomic energy agency. Int J
Radiation Oncology Biology and Physics. 2007;69(4):1218-1221.
Davidson-Grimwood SR, Snelgrove D, Ungar WJ. The development of an interview guide for use in
dyad child-parent health-related quality of life assessment. PRO Newsletter. 2006;37:12-14.
Davies E, Higginson IJ. Communication, information and support for adults with malignant cerebral
glioma: a systematic literature review. Support Care Cancer. 2003;11:21-29.
Davies SM, Shu XO, Weisdorf DJ, et al. Quality of life after successful unrelated donor bone marrow
transplant: comparison with sibling donor transplant. Blood. 1994;84(10, Suppl):394a.
Davis C, Cohen R, Apolinsky F. Providing social support to cancer patients: a look at alternative
methods. J Pscyhosocial Oncol. 2005;23(1):75-85.
Davis K, Cella D. Assessing quality of life in oncology clinical practice: a review of barriers and critical
success factors. J Clin Outcomes. 2002;9(6):327-332.
Davis K, Yount S, Wagner L, Cella D. Measurement and management of health-related quality of life
in lung cancer. Clin Adv Hematol & Oncol 2004;2(8):533-540.
Davis MP, Dreicer R, Walsh D, Lagman R, LeGrand SB. Appetite and cancer-associated anorexia: a
review. J Clin Oncol. 2004;22(8):1510–1517.
Davis MP, Walsh D, Lagman R, Yavuzsen T. Early satiety in cancer patients: a common and
important but underrecognized symptom. Support Care Cancer. 2006;14(7):693-698.
Davis MP. Does trazodone have a role in palliating symptoms? Support Care Cancer. 2007;15:221224.
Davis MP. Palliative medicine research: barriers and hurdles. J Cancer Pain Sympt Palliat.
2005;1(3):33-38.
D:\478174570.doc
Davis KM, Lai J-S, Hahn EA, Cella D. Conducting routine fatigue assessments for use in clinical
oncology practice: patient and provider perspectives. Support Care Cancer. 2008;16:379-386.
Davis SR, Moreau M, Kroll R, Bourchard C, Panay N, Gass M, Braunstein GD, Linden Hirschberg A,
Rodenberg C, Pack S, Koch H, Moufarege A, Studd J. Testosterone for Low Libido in Postmenopausal
Women Not Taking Estrogen. N Engl J Med. 2008;359:2005-17.
Davison BJ, Degner LF. Empowerment of men newly diagnosed with prostate cancer. Cancer Nurs.
1997;187-196.
Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom
assessment system (ESAS) in haemodialysis patients. Nephrology Dialysis Transplantation.
2006;21:3189-3195.
Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient reported outcome
measures in healthcare settings. BMJ. 2010;340:c186 (7 pages).
Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Health-related quality of life
and tamoxifen in breast cancer prevention: a report for the National Surgical Adjuvant Breast and
Bowel Project P-1 Study. J Clin Oncol. 1999;17(9):2659-2669.
de Arriba J-J, Nerin C, Ortiz MC, del Soto Sesma M, Beltran S, Vila B. Symptom Scores and Delirium
in Advanced Cancer. Journal of Clinical Oncology. 2011;29(20):2833.
De Boer AGEM, Spruijt RJ, Sprangers MAG, de Haes JCJM. Disease-specific quality of life: is it one
construct? Qual Life Res. 1998;7:135-142.
De Boer AGEM, Stalmeier PFM, van Sandick JW, van Lanschot JJB, Sprangers MAG. Is a 1-item VAS
measure as responsive as the SF-20 or RSCL? Presented ISOQOL; Barcelona, SP; 1999.
De Boer AGEM, van Lanschot JJB, Stalmeier PFM, et ak. Is a single-item visual analogue scale as
valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res.
2004;13:311–320.
De Boer AGEM, van Lanschot JJB, van Sandick JW, et al. Quality of life after transhiatal compared
with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 2004;
22(20):4202–4208.
De Boer JB, Sprangers MAG, Aaronson NK, Lange JMA, Van Dam FSAM. The feasibility, reliability and
validity of the EOTC QLQ-C30 in assessing the quality of life of patients with a symptomatic HIV
infection or AIDS (CDCIV). Psychol Health. 1994;9:65-77.
De Boer JB, Van Dam FS, Sprangers MA, Frissen PH, Lange JM. Longitudinal study on the quality of
life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferonalpha. AIDS. 1993;7(7):947-953.
De Boer JB, Van Dam FSAM, Sprangers MAG. Health-related quality-of-life evaluation in HIV-infected
patients. Pharmacoeconomics. 1995;8(4):291-304.
D:\478174570.doc
De Champlain AF. A primer on classical test theory and item response theory for assessments in
medical education. Med Educ. 2010 Jan;44(1):109-17.
Dechamps A, Diolez P, Thiaudiere E, Tulon A, Onifade C, Vuong T, Helmer C, Bourdel-Marchasson I.
Effects of exercise programs to prevent decline in health-related quality of life in highly deconditioned
institutionalized elderly persons: a randomized controlled trial. Arch Intern Med. 2010;170:162-169.
De Conno F, Caraceni A, Gamba A, Mariani L, Abbattista A, Brunelli C, et al. Pain measurement in
cancer patients: a comparison of six methods. Pain. 1994;57:161-166.
De Conno F, Caraceni A, Groff L, Brunelli C, Donati I, Tamburini M, & Ventafridda V. Effect of home
care on the place of death of advanced cancer patients. Eur J Cancer Care. 1996;32A(7):11421147.
de Raaf PJ, de Klerk C, Timman R, Busschbach JJV, Oldenmenger WH, van der Rijt CCD. Systematic
monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer:
a randomized controlled trial. Journal of Clinical Oncology. 2013;31(6):716-723.
De Haan RJ, Aaronson N, Limburg M, Hewer RL, van Crevel H. Measuring quality of life in stroke.
Stroke. 1993;24(2):320-327.
De Haan RJ, Limburg M, Bossuyt P, Van der Meulen J, Aaronson N. The clinical meaning of rankin
“handicap” grades after stroke. Stroke. 1995;26(11):2027-2030.
De Haan RJ, Limburg M, Van der Meulen JHP, Jacobs HM, Aaronson NK. Quality of life after stroke.
Impact of stroke type and lesion location. Stroke. 1995;26(3):402-408.
De Haes J, Curran D, Young T, et al. Quality of life evaluation in oncological clinical trials-the EORTC
model. Euro J Cancer. 2000;36:821-825.
De Haes JCJM, Van Knippenberg FCE. The quality of life of cancer patients: a review of the
literature. Soc Sci Med. 1985;20(80):809-817.
De Haes JCJM, Van Oostrom MA, Welvaart K. The effect of radical and conserving surgery on the
quality of life of early breast cancer patients. Eur J Surg Oncol. 1986;12:337-342.
De Haes JCJM, Welvaart K. Quality of life after breast cancer surgery. J Surg Oncol. 1985;28:123125.
De Haes, Olschewski, Kafuman M, Schumacher M, Jonat W, Sauerbrei W. Quality of life in goserlintreated versus cyclophosphamide + methotrexate + fluorouracil – treated premenopausal and
perimenopausal patients with node-positive, early breast cancer: The Zoladex Early Breast Cancer
Research Association Trialists Group. J Clin Oncol. 2003;21:4510–4516.
De Lissovoy G. Measuring the burden of illness for end-stage renal disease: Some heavy lifting
required. Kidney International. 2007;72:1045-1047.
De Moor MH, Stubbe JH, Boomsma DI, De Geus EJ. Exercise participation and self-rated health: do
common genes explain the association? European Journal of Epidemiology. 2007;22(1):27-32.
D:\478174570.doc
De Santis M, Bellmunt J, Mead G, Kerst JM, Leahy M, Maroto P, Skonexzna I, Marreaud S, de Wit R,
Sylvester R. Randomized Phase II/III trial assessing gemcitabine/carboplatin and
methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer “unfit” for cisplatinbased chemotherapy: Phase II-results of EORTC Study 30986. Journal of Clinical Oncology.
2009;27(33):5634-5639.
De Vivo MJ, Richards JS, Stover SL, Go BK. Spinal cord injury: rehabilitation adds life to years. West
J Med. 1991;154:602-606.
De Wit R, van Dam R, Hanneman M, Zandbelt L, et al. Evaluation of the use of a pain diary in
chronic cancer pain patients at home. Pain. 1999;79(1):89-100.
Deary IJ, Whiteman MC, Pattie A, et al. Cognitive change and the APOE epsilon 4 allele. Nature.
2002;29;418(6901):932.
Decker GM, DeMeyer ES, Kisko DL. Measuring the maintenance of daily life activities using the
Functional Living Index-Emesis (FLIE) in patients receiving moderately emetogenic chemotherapy. J
Support Oncol 2006;4(1):35-41.
Deeken JF, Taylor KL, Mangan P, Yabroff KR, Ingham JM. Care for the caregivers: a review of selfreport instruments developed to measure the burden, needs, and quality of life of informal
caregivers. J Pain Symptom Manage. 2003;26(4):922–953.
Degner L, Sloan J. Symptom distress in newly diagnosed ambulatory cancer patients and as a
predictor of survival in lung cancer patients. J Pain Symptom Manage. 1995;10:423–431.
Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29(3):2143.
Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to
play? J Clin Epidemiol. 1992;45(9):941-950.
Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a
predictor of survival in lung cancer. J Pain Symptom Manage. 1995;10(6):423-431.
Degner LF. Preferences to participate in treatment decision making: the adult model. J Ped Oncol
Nurs. 1998;15(3):3-9.
DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for Prevention of Dementia: A
Randomized Controlled Trial. JAMA. 2008;300(19):2253-2262.
Del Fabbro E, Dev R, Hui D, Palmer L, Bruera E. Effects of melatonin on appetite and other
symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial.
Journal of Clinical Oncology. 2013;31(10):1271-1276.
Dell DD. Cachexia in patients with advanced cancer. Clin J Oncol Nurs. 2002;6:235–238.
Delgado-Guay MO, Bruera E. Management of pain in the older person with cancer (Part 1:
Pathophysiology, pharmacokinetics, and Assessment). Oncology. 2007; 22 (1).
D:\478174570.doc
Delgado-Guay MO, Bruera E. Management of pain in the older person with cancer (Part 2:
Treatment Options). Oncology. 2008;22(2):148-152.
Demark-Wahnefried W, Morey MC, Sloane R, Snyder DC, Miller PE, Hartman TJ, Cohen HJ. Reach
out to enhance wellness home-based diet-exercise intervention promotes reproducible and
sustainable long-term improvements in health behaviors, body weight, and physical functioning in
older, overweight/obese cancer survivors. Journal of Clinical Oncology. 2012;30(19):2354.2361.
Demark-Wahnefired W, Clipp, EC, Morey MC, Pieper CF, Sloane R, Clutter Snyder D, Cohen HJ.
Lifestyle intervention development study to improve physical function in older adults with cancer:
outcomes from project LEAD. J Clin Oncol. 2006;24(21):3465-3473.
Demark–Wahnefried W, Morey MC, Clipp EC, et al. Leading the way in exercise and diet (project
LEAD): intervening to improve function among older breast and prostate cancer survivors. Control
Clin Trials. 2003;2:206-223.
DeMets DL, Pocock SJ, Julian DG. The agonizing negative trend in monitoring of clinical trials.
Lancet. Review. 1999;354(9194):1983-1988.
Demitri GD, Kris M, Wade J, Degos L, Cella D for the Procrit Study Group. Quality-of-life benefit in
chemotherapy patients treated with epotein alfa is independence of disease response or tumor type:
results from a prospective community oncology study. J Clin Oncol. 1998;16:3412–3425.
Denekamp J. Is any single in situ assay of tumour response adequate? Br J Cancer. 1980;41(Suppl
IV):56-63.
Deng J, Ridner SH, Murphy BA, Dietrich MS. Preliminary development of a lymphedema symptom
assessment scale for patients with head and neck cancer. Supportive Care in Cancer.
2012;20(8):1911-1918.
Deng G, Vickers A, Yeung KS, Cassileth BR. Acupuncture: integration into cancer care. J Soc Integr
Oncol. 2006;4(2):86-92.
Deng G, Vickers A, Yeung KS, Cassileth BR. Randomized, controlled trial of acupuncture for the
treatment of hot flashes in breast cancer patients. J Clin Oncol 2007;25(35):5584-5590.
Derogar M, Lagergren P. Health-Related Quality of Life among 5-year survivors of esophageal cancer
surgery: a prospective population-based study. Journal of Clinical Oncology. 2012;30(4):413-418.
Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in
metastatic breast cancer. JAMA. 1979;242(14):1504-1508.
Desai NS, Poindexter GB, Miller Monthrope Y, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-oflife instrument for pruritus. J Am Acad Dermatol. 2008;59(2):234-244.
DeSalvo KB, Jones TM, Peabody J, McDonald J, Fihn S, Fan V, He J, Muntner P. Health Care
Expenditure Prediction With a Single Item, Self-Rated Health Measure. Medical Care. 2009;47(4):18.
D:\478174570.doc
Desbiens NA, Mueller-Rizner N, Connors AF, Wenger NS. The relationship of nausea and dyspnea to
pain in seriously ill patients. Pain. 1997;71:149-156.
Desbiens NA, Mueller-Rizner N. How well do surrogates assess the pain of seriously ill patients? Crit
Care Med. 2000;28(5):1347-1352.
Deschler DG, Walsh KA, Friedman S, Hayden R. Quality of life assessment in patients undergoing
head and neck surgery as evaluated by lay caregivers. Laryngoscope. 1999;109:42-46.
Detmar SB, Aaaronson NK. Quality of life assessment in daily clinical oncology practice: a feasibility
study. Eur J Cancer. 1998;34(8):1181–1186.
Detmar SB, Aaronson NK, Wever LDV, Muller M, Schornagel JH. How are you feeling? Who wants to
know? Patients’ and oncologists’ preferneces for discussing health-related quality-of-life issues. J
Clin Oncol. 2000;18:3295-3301.
Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK. Health-related quality-of-life
assessments and patient-physician communication: a randomized controlled trial. JAMA.
2002;288(23):3027-3034.
Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK. Role of health-related quality of life
in palliative chemotherapy treatment decisions. J Clin Oncol. 2002;20(4):1056-1062.
Detmar SB, Muller MJ, Wever LDV, Schornagel JH, Aaronson NK. Patient-physician communication
during outpatient palliative treatment visits: an observational study. JAMA. 2001;285(10):13511357.
Deutch J, Kolhouse JF. Assessment of gastrointestinal function and response to megesterol acetate
in subjects with gastrointestinal cancers and weight Loss. Support Care Cancer. 2004;12:503–510.
Devinsky O, Vickrey BG, Cramer J, et al. Development of the quality of life in epilepsy inventory.
Epilepsia. 1995;36:1089-1104.
DeVon HA, Estwing Ferrans C. The psychometric properties of four quality of life instruments used in
cardiovascular populations. J Cardiopulm Rehabil. 2003;23:122-138.
DeWalt DA, Rothrock N, Yount S, Stone AA. Evaluation of Item Candidates. The PROMIS Qualitative
Item Review. Medical Care. 2007;45(5):S12-S21.
Deyo RA, Carter WB. Strategies for improving and explaning the application of health status
measures in clinical settings. Med Care. 1992;30(5):MS176-MS186.
Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures:
statistics and strategies for evaluation. Control Clin Trials. 1991;12:142S-158S.
Deyo RA, Inui TS. Toward clinical applications of health status measures: sensitivity of scales to
clinically important changes. Health Sci Res. 1984;19(3)275-289.
D:\478174570.doc
Deyo RA, Patrick DL. Barriers to the use of health status measures in clinical investigation, patient
care, and policy research. Med Care. 1989;27(3):S254-S268.
Deyo RA. Pitfalls in measuring the health status of Mexican Americans: comparative validity of the
English and Spanish sickness impact profile. Amer J Publ Hlth. 1984;74(6):569-573.
Dharma-Wardene M, Au H-J, Hanson J, Dupere D, Hewitt J, Feeny D. Baseline FACT-G score is a
predictor of survival for advanced lung cancer. Qual Life Res. 2004;13:1209–1216.
Di Costanzo F, Gasperoni S, Di Costanzo F. Should adjuvant chemotherapy be used in elderly women
(greater than or equal to 70 years) with breast cancer? Contra. Tumori. 2002;Supp 1, 88(1):S91–
S92.
Diener E, Chan MY. Happy people live longer: subjective well-being contributes to health and
longevity. Health Benefits of Happiness. 2010;63 pages.
Dijkers M. Measuring quality of life: methodological issues. Am J Phys Med Rehab. 1999;78
(3):286-300.
Dileo C. Effects of music and music therapy on medical patients: a meta-analysis of the research and
implications for the future. J Soc Integr Oncol. 2006;4(2)67-70.
Dilts DM, Sandler AB, Cheng SK, Crites JS, Ferranti LB, Wu AY, Finnigan S, Friedman S, Mooney M,
Abrams J. Steps and time to process clinical trials at the cancer therapy evaluation program. Journal
of Clinical Oncology. 2009;27(11):1761-1766.
Dimeo FC, Stieglitz R-D, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the
fatigue and psychologic status of cancer patients during chemotherapy. Cancer. 1999;85:22732277.
Dimsdale JE, Ball ED, Carrier E, Wallace M, Hohman P, Mulroney C, Shaikh F, Natarajan L. Effect of
eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic
malignancies. Support Care Cancer. 2011;19(12):2015-20.
Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W. The influence of xerostomia after
radiotherapy on quality of life. Support Care Cancer. 2008;16:171-179.
Dirmaier J, Zaun S, Koch U, Harfst T, Schultz H. Psychometric properties of the EORTC quality of life
questionnaire in inpatient cancer rehabiliation in Germany. Palliat Support Care. 2004;2:115-124.
Ditunno Jr JF, Formal CS. Chronic spinal cord injury. N Engl J Med. 1994;330:550-556.
Djarv T, Blazeby JM, Lagergren P. Predictors of postoperative quality of life after esophagectomy for
cancer. Journal of Clinical Oncology. 2009;27(12):1963-68.
Djarv T, Metcalfe C, Avery KNL, Lagergren P, Blazeby JM. Prognostic value of changes in healthrelated quality of life scores during curative treatment for esophagogastric cancer. Journal of Clinical
Oncology. 2010;28(10):1666-1670.
D:\478174570.doc
Dobrez D, Cella D, Pickard S, Lai J-S, Nickolov N. Estimation of patient preference based utility
weights from the FACT-G. Value in Health. 2007;10(4):266-272.
Dobrez DG, Cella D, Calhoun E, Fishman D. Assessing utilities for use in cost-effectiveness analyses:
the case of ovarian cancer screening and treatment. Oncology Economics. 2000;1(8):43-48.
Doctor JN. Thoughts on the validity of a new QALY estimator. ISPOR Connections. 2010;16(1):4-7.
Dodd M, Janson S, Facione N, et al. Advancing the science of symptom management. J Adv Nurs.
2001;33(5):668–676.
Dodd MJ, Miaskowski C, Lee, KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr.
2004;32;76-78.
Donahue RMJ. A summary statistic for measuring change from baseline. J Biopharm Stat.
1997;7(2):287-299.
Donaldson GW, Moinpour CM. Individual differences in quality-of-life treatment response. Med Care.
2002;40(6)(Supplement):III-39-III-53.
Donaldson MS. Taking stock of health-related quality-of-life measurment in oncology practice in the
United States. J Natl Cancer Inst Monogr. 2004;33:155–167.
Donatti C, Wild D, Hareendran A. The use of conceptual models, conceptual frameworks and
endpoint models to support label claims of treatment benefit using patient reported outcomes.
ISPOR Connections. 2008;14(2):9-12.
Donnelly S, Rybicki L, Walsh D. Quality of life measurment in the palliative management of advanced
cancer. Support Care Cancer. 2001;9:361–365.
Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: identification of clinical and
research priorities by assessment of prevalence and severity. J Palliat Care. 1995;11(1):27-32.
Donnelly S, Walsh D. Quality of life assessment in advanced cancer. Palliat Med. 1996;10(4):275283.
Donnelly S, Walsh D. The symptoms of advanced cancer. Sem Oncol. 1995;22(2 Suppl 3):67-72.
Donnelly S, Walsh TD. Low-dose megestrol acetate for appetite stimulation in advanced cancer. J
Pain Symptom Manage. 1995;10(3):182-183.
Donovan K, Sanson-Fisher RW, Redman S. Measuring quality of life in cancer patients. J Clin Oncol.
1989;7(7):959-968.
Donovan MA, Drasgow F, Probst TM. Does computerizing paper-and-pencil job attitude scales make
a difference? Journal of Applied Psychology. 2000;85:305-313.
Dorans NJ. Linking scores from multiple instruments. Summary Paper, Drug Information
Association; June 23–25, 2004 Meeting.
D:\478174570.doc
Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P. Is the EuroQol a valid measure of healthrelated quality of life after stroke? Stroke. 1997;28:1876-1882.
Dorn HF. Presentation of results in the treatment of cancer: The calculation of survival and cure
rates. Br J Radiol. 1951;24(282):295-299.
Dornelles Rosa D. Cancer survivorship: today and tomorrow; handbook of cancer survivorship.
JAMA. 2007;298(14):1700-1701.
Dorrepaal KL, Aaronson NK, van Dam FSAM. Pain experience and pain management among
hospitalized cancer patients: A clinical study. Cancer. 1989;63:593-598.
Dorval M, Patenaude AF, Schneider KA, et al. anticipated versus actual emotional reactions to
disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing
programs. J Clin Oncol. 2000;18:2135-2142.
Doty JM, Gossman D, Kudrimoti M, Valentino J, Arnold A, Spring PM. Analysis of unknown primary
carcinomas metastatic to the neck: Diagnosis, treatment, and outcomes. The Journal of the
Kentucky Medical Association. 2006;104(2):57-64.
Douglas JR. Survival curves as a means of investigating cancer. Med J Aust. 1957;44(16):536-543.
Douillard JY, Giaccone G, Horai T, et al. Improvement in disease-related symptoms and quality of life
in patients with advanced non-small-cell lung cancer (NSCLC) Treated with ZD1839 (‘IRESSA’) (Ideal
1). ASCO 2002 Poster Presentation.
Dow LA, Matsuyama RK, Ramakrishnan V, Kuhn L, Lamont EB, Lyckholm L, Smith TJ. Paradoxes in
advanced care planning: the complex relationship of oncology patients, their physicians, and advance
medical directives. Journal of Clinical Oncology. 2010;28(2):299-304.
Doward L, McKenna S, Meads D, Twiss J, Eckert B. The development of patient-reported outcome
indices for multiple sclerosis (PRIMUS). Mult Scler. 2009;15:1092-1102.
Downey L, Diehr P, Standish LJ, Patrick DL, Kozak L, Fisher D, Congdon S, Lafferty WE. Might
massage or guided meditation provide “means to a better end”? Primary outcomes from an efficacy
trial with patients at the end of life. J Palliat Care. 2009;25(2):100-108.
Doyle C, Crump M, Pintilie M, Oza AM. Does palliative chemotherapy palliate? Evaluation of
expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J
Clin Oncol. 2001;19:1266-1274.
Dranitsaris G, Maroun J, Shah A. Severe chemotherapy-induced diarrhea in patients with colorectal
cancer: a cost of illness analysis. Support Care Cancer. 2005;13:318-324.
Dressman HK, Berchuck A, Chan G, Zhai J, Bild A, Sayer R, Cragun J, Clarke J, Whitaker RS, Li L, et
al. An integrated genomic-based approach to indivualized treatment of patients with advanced-stage
ovarian cancer. J Clin Oncol. 2007;25(5):517-525.
D:\478174570.doc
Drettner B, Ahlbom A. Quality of life and state of health for patients with cancer in the head and
neck. Acta Otolaryngol. 1983;96:307-314.
Drummond M. Introducing economic and quality of life measuresments into clinical studies. Ann
Med. 2001;33(5):344-349.
Duarte Souza JF, Lajolo PP, Pinczowski H, del Giglio A. Adjunct dipyrone in association with oral
morphine for cancer-related pain: the sooner the better. Support Care Cancer. 2007;15:1319-1323.
Du KL, Bae K, Movsas B, Yan Y, Bryan C, Bruner DW. Impact of marital status and race on outcomes
of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials. Supportive Care in
Cancer. 2012;20(6):1317-1326.
Du Pen SL, Du Pen AR, Polissar N, et al. Implementing guidelines for cancer pain management:
Results of a randomized controlled clinical trial. J Clin Oncol. 1999;17:361-370.
Dudgeon DJ, Harlos M, Clinch JC. The Edmonton Symptom Assessment Scale (ESAS) as an audit
tool. J Palliat Care. 1999;15(3):14-19.
Dueck A, Sloan JA, Frost MH, Halyard MY, Wenzel L. Patient-reported outcomes: update on the
Mayo-FDA joint meeting publication. Psycho-Oncol 2007;16:S3-S4. [Abstract]
Duffy SA, Terrell JE, Valenstein M, Ronis DL, Copeland LA, Connors M. Effect of smoking, alcohol,
and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry.
2002;24:140-147.
Dugan W, Passik SD, McDonald M, Theobald D. The use of the Zung self-rating depression rating
scale as a screening tool in cancer patients. Psycho-Oncology. 1998;7:483-493.
DuHamel KN, Mosher CE, Winkel G, Labay LE, Rini C, Markarian Meschian Y, Austin J, Greene PB,
Lawsin CR, Rusiewicz A, Grosskreutz CL, Isola L, Moskowitz CH, Papadopoulos EB, Rowley S,
Scigliano E, Burkhalter JE, Hurley KE, Bollinger AR, Redd WH. Randomized clinical trial of telephoneadministered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress
symptoms after hematopoietic stem-cell transplantation. Journal of Clinical Oncology.
2010;28(23):3754-3761.
Duijts SFA, van Beurden M, Oldenburg HAS, Hunter MS, Kieffer JM, Stuiver MM, Gerritsma MA,
Menke-Pluymers BE, Plaisier PQW, Rijna H, Lopes Cardozo AMF, Timmers G, van der Meij S, van der
Veen H, Bijker N, de Widt-Levert LM, Geenen MM, Heuff G, van Dulken EJ, Boven E, Aaronson NK.
Journal of Clinical Oncology. 2012;30(33):4124-4133.
Dunlap B, Paice JA. Chemotherapy-induced peripheral neuropathy: a need for standardization in
measurement. The Journal of Supportive Oncology. 2006;4(8):398-9.
Dupont A, Wheeler J, Herndon II JE, Coan A, Zafar SY, Hood L, patwardhan M, Shaw HS, Lyerly HK,
Abernethy AP. Use of tablet personal computers for sensitive patient-reported information.
Supportive Oncology. 2009;7(3):91-97.
D:\478174570.doc
Dupuis B. Health-related quality of life studies and French Transpereny Committee. Health-related
quality of life and patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus
de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany
O, Caulin C. October 2002.
Durand J-P, Mir OP, Coriat R, Cessot A, Pourchet S. Goldwasser F. Validation of the Cochin Risk
Index Score (CRIS) for life expectancy prediction in terminally ill cancer patients. Supportive Care in
Cancer. 2012;20(4):857-864.
Durna EM, Crowe SM, Leader LR, Eden JA. Quality of life of breast cancer survivors: the impact of
hormonal replacement therapy. Climacteric. 2002;5:266-276.
Dusek JA, Out HH, Wohlhueter AL, Bhasin M, Zerbini LF, Joseph MG, Benson H, Libermann TA.
Genomic counter-stress changes induced by the relaxation response. PloS One. 2008;3(7):pages 18.
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen
RR, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain.
2005;113:9-19.
Dworkin RH, Turk DC, Wyrwich KW, beaton D, Cleeland CS, Farrar JT, Haythornthewaite JA, Jensen
MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R,
Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott
MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M,
Schamder KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S. Interpreting the
clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT Recommendations.
Pain. 2007;
Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D,
Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R. Development and initial
validation of an expanded and revised version of the Short-Form McGill Pain Questionnaire (SF—
MPQ-2). Pain. 2009;144(issues 1-2):35-42.
Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K,
Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S,
Jadad AR, Jay GW, Kalliomaki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ,
Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve BB, Rhodes T, Sampaio C,
Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J. Research design considerations for
confirmatory chronic pain clinical trials: IMMPACT recommendations. PAIN. 2010;149:177-193.
Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN,
Rappaport BA, Rowbotham MC, Backonja M-M, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowen
P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R,
Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice ASC, Sampaio C, Skljarevski V,
Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Wiliams J,
Witter J, Ziegler D. Considerations for improving assay sensitivity in chronic pain clinical trials:
IMMPACT recommendations. PAIN. 2012;153:1148-1158.
Dy GK, Adjei AA. Novel targets for lung cancer therapy: part I. J Clin Oncol. 2002;20(12):28812894.
D:\478174570.doc
Dy GK, Adjei AA. Novel targets for lung cancer therapy: part II. J Clin Oncol. 2002;20(13):3163028.
Dy SM. Health Sciences Research. American Society of Clinical Oncology (2008 Annual Meetings
Summaries) 2008;pages 77-83.
Dy SM, Asch SM, naeim A, Sanati H, Walling A, Lorenz K. Evidence-Based Standards for Cancer Pain
Management. J Clin Oncol. 2008;26(23):3879-3885.
Dy SM, Lorenz K, Naeim A, Santi H, Walling A, Asch S. Evidence-Based recommendations for Cancer
Fatigue, Anorexia, Depression and Dyspnea. J Clin Oncol. 2005;26(23):3886-3895.
Dyrbye LN, Szydlo DW, Downing SM, Sloan JA, Shanafelt TD. Development and preliminary
psychometric properties of a well-being index for medical students. BMC Medical Education.
2010;10:9 pages.
Dyrbye LN, Massie FS Jr, Eacker A, Harper W, Power D, Durning SJ, Thomas MR, Moutier C, Satele D,
Sloan J, Shanafelt TD. Relationship between burnout and professional conduct and attitudes among
US medical students. JAMA 2010 Sep 15;304(11):1173-80.
Dyrbye LN, Thomas MR, Harper W, Massie Jr. FS, Power DV, Eacker A, Szydlo DW, Novotny PJ, Sloan
JA, Shanafelt TD. The learning environment and medical student burnout: a multicentre study.
Medical Education. 2009;43:274-282.
Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the
quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21(6):1133-1138.
Earle CC. Do unto others . . . J Clin Oncol. 2006;24(21):3331-3332.
Earle CC. Cancer survivorship research and guidelines: Maybe the cart should be beside the horse.
J Clin Oncol. 2007;25(25):3800-3801.
Earle CC, Ganz PA. Cancer survivorship care: don’t let the perfect be the enemy of the good.
Journal of Clinical Oncology. 2012;30(30):3764-3767.
Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of Cancer Care
near the End of Life: Is Is a Quality-of-Care Issue? J Clin Oncol. 2008;23(23):3860-3866.
Earp JA, Ennett ST. Conceptual models for health education research and practice. Health Ed Res.
1991;692):163-171.
Ebbert JO, Wyatt KD, Hays JT,Klee EW, Hurt RD. Varenicline for smoking cessation: efficacy, safety,
and treatment recommendations. Patient Preference and Adherence. 2010:4:355-362.
Eberhardt B, Dilger S, Musial F, Wedding U, Weiss T, Miltner, WHR. Medium-term effects of
chemotherapy in older cancer patients. Support Care Center. 2006;14:216-222.
Edelstyn GA, MacRae KD, MacDonald FM. Improvement of life quality in cancer patients undergoing
chemotherapy. Clin Oncol. 1979;5:43-49.
D:\478174570.doc
Edgell ET, Coons SJ, Carter WB, et al. A review of health-related quality-of-life measures used in
end-stage renal disease. Clin Ther. 1996;18(5):887-938.
Editorial. And now this. Lancet. 1996;349(9044):1.
Editorial. Doing better, feeling worse. Lancet. 1990;336(8722):1037-1038.
Editorial. Quality of life and clinical trials. Lancet. 1995;346(8966):1-2.
Editorial. Quality of life. Lancet. 1991;338(8763):350-351.
Edlund M, Tancredi LR. Quality of life: an ideological critique. Perspect Biol Med. 1985;28:591-607.
Edmonds PM, Stuttaford JM, Penny J, Lynch AM, Chamberlain J. Do hospital palliative care teams
improve symptom control? Use of a modified STAS as an evaluation tool. Palliat Med. 1998;12:345351.
Edwards B, Clarke V. The psychological impact of a cancer diagnosis on families: the influence of
family functioning and patients’ illness characteristics on depression and anxiety. Psycho-Oncology.
2004;13:562–576.
Edwards B, Ung L. Quality of life instruments for caregivers of patients with cancer: a review of their
psychometric properties. Cancer Nurs. 2002;25(5):342–349.
Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 19731999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94(10):27662792.
Efficace F, Bottomley A, Osoba D, et al. Beyond the development of Health-Related Quality of Life
(HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer trials. Does HRQOL
evaluation in prostate cancer research inform clinical decision making? J Clin Oncol. 2003;21
(18):3502-3511.
Efficace F, Bottomley A, Smith EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smith JH, et al. Is
a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell
lung cancer patients ? A multivariate analysis of prognostic factors of EORTC study 08975. Ann
Oncol 2006;17:1698-1704.
Efficace F, Therasse P, Piccart MJ, et al. Health-related quality of life parameters as prognostic
factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol.
2004;22:3381–3388.
Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M,
Bottomley A, Garufi C, Focan C, Giacchetti S, Levi F. Validation of patient’s self-reported social
functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients:
Results of an International Study by the Chronotherapy Group of the Eruopean Organisation for
Research and Treatment of Cancer. J Clin Oncol. 2008;26(12):2020-2026.
D:\478174570.doc
Efron B, Gong G. A leisurely look at the bootsrap, jackknife and cross-validation. Am Stat.
1983;37:36-48.
Efron B. Better bootstrap confidence intervals. J Am Stat Assc. 1987;82:171-200.
Eichler HG, Mavros P, Geling O, Hunsche E, Kong S. Association between health-related quality of life
and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks treatment with antiinflammatory agents. Int J Clin Pharmacol Ther. 2005 May;43(5):209-16.
Einhorn LH, Brames MJ, Dreicer R, Nichols CR, Cullen Jr MT, Bubalo J. Palonosetron plus
dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving
multiple-day cisplatin chemotherapy for germ cell cancer. Support Care Cancer. 2007;15:1293-1300.
Eisbruch A, Rhodus N, Rosenthal D, et al. How should we measure and report radiotherapy-induced
xerostomia? Sem Rad Oncol. 2003;13(3):226-34.
Eisenbergh H, Cutler SJ, Axtell L. Survival patters for some forms of cancer. Transactions of the
Association of Life Insurance Medical Directors of America. 1964;47:126-146.
El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel JS, Mitchell SL, Chang Y, Barry MJ,
Volandes AE. Use of video to facilitate end-of-life discussions with patients with cancer: a
randomized controlled trial. Journal of Clinical Oncology. 2010;28(2):305-310.
Elam JL, Carpenter JS, Shu XO, boyapati S, Friedmann-Gilchrist J. Methodological issues in the
investigation of ginseng as an intervention for fatigue. Clin Nurs Spec. 2006;20(4):183-189.
Elani HW, Allison PJ. Coping and psychological distress among head and neck cancer patients.
Supportive Care in Cancer. 2011;19(11):1735-1742.
Elkins G, Marcus J, Stearns V, Perfect M, Rajab MH, Ruud C, Palamara L, Keith T. Randomized Trial
of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors. Journal of
Clinical Oncology. 2008;26(31):5022-5026.
Ell K, Nishimoto R, Mantell J, Hamovitch M. Longitudinal analysis of psychological adaptation among
family members of patients with cancer. J Psychosomatic Res. 1988;32:429-438.
Ell K, Sanchez K, Vourlekis B, et al. Depression, correlates of depression and receipt of depression
care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23:3052-3060.
Elliott TE, Renier CM, Palcher JA. Chronic pain, depression, and quality of life: correlations and
predictive value of the SF-36. Pain Med. 2003;4(4):331-339.
Ellis BH, Bannister WM, Cox JK, Fowler BM, Shannon ED, Drachman D, Adams RW, Giordana LA.
Utilization of the propensity score method: an exploratory comparison of proxy-completed to selfcompleted responses in the Medicare health outcomes survey. Health Qual Life Outcomes.
2003;1:47.
Ellis J, Lin J, Walsch A, Lo C, Shepherd FA, Moore M, Li M, Gagliese L, Zimmermann C, Rodin G.
Predictors of Referral for Specialized Psychosocial Oncology Care in Patients With Metastatic Cancer:
D:\478174570.doc
The Contributions of Age, Distress, and Marital Status. Journal of Clinical Oncology. 2009;27(5):699705.
Ellison CW. Spiritual well-being: conceptualization and measurement. J Psychol Ther. 1983;11
(4):330-340.
Elmqvist MA, Jordhoy MS, Bjordal K, Kaasa S, Jannert M. Health-related quality of life during the last
three months of life in patients with advanced cancer. Supportive Care in Cancer. 2009;17(2):191198.
Elo A-L, Leppanen A, Jahkola A. Validity of a single-item measure of stress symptoms. Scand J Work
Environ Health. 2003;29(6):444-451.
El-Omar E, Banerjee S, Wirz A, McColl KEL. The Glasgow Dyspepsia Score – a tool for the global
measurement of dyspepsia. Eur J Gastroenterol Hepatol. 1996;8:967-971.
Emanual EJ, Schnipper LE, Kamin DY, Levinson J, Lichter AS. The costs of conducting clinical
research. J Clin Oncol. 2003;21(22):4145–4150.
Emery M-P, Perrier L-L, Acquadro C. Patient-reported outcome and quality of life instruments
database (PROQOLID): frequently asked questions. Health and Quality of Life Outcomes.
2005;3(12):6 pages.
Enas GG, Andersen JS. Enhancing the value delivered by statisticians throughout drug discovery and
development: putting statistical science into regulated pharmaceutical innovation. Stats Med.
2001;20:2697-2708.
Enblom A, Bergius Axelsson B, Steineck G, Hammar M, Borjeson S. One third of patients with
radiotherapy-induced nausea consider their antiemetic treatment insufficient. Supportive Care in
Cancer. 2009;17(1):23-32.
Engel GL. The need for a new medical model: a challenge for biomedicine. Science.
1977;196(4286):129-136.
Engels R, Van Der Zwaluw CS. Gene-environment interactions and health behaviours: Opportunities
for European health psychology. The European Health Psychologist. 2008;10:59-61.
Enoch MA. Pharmacogenomics of alcohol response and addiction. Am J Pharmacogenomics.
2003;3(4):217–232.
Epoetin alfa offers clinically significant improvements in the quality of life of anaemic cancer patients.
Curr Med Res Opin 2005;21(Supp 2):S12-S15. [Source: Cella D, Zagari MJ, Vandoros C, et al.
Epoetin alfa treatment results in clinically significant improvements in quality of life in anaemic cancer
patients when referenced to the general population. J Clin Oncol 2003:21:366-373.]
Epplein M, Zheng Y, Zheng W, Chen Z, Gu K, Penson D, Lu W, Shu Xiao-Ou. Quality of life after
breast cancer diagnosis and survival. Journal of Clinical Oncology. 2011;29(4):406-412.
D:\478174570.doc
Epstein J, Beaumont J, Gwede C, Trotti A, et al. Longitudinal evaluation of the oral mucositis weekly
questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer
2007;109(9):1914-1922.
Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, Osoba D. Quality of life
and oral function following radiotherapy for head and neck cancer. Head Neck. 1999;21:1-11.
Epstein YM, Rosenberg HS. Assessing infertility information on the Internet: challenges and possible
solutions. Fertil Steril. 2005 Mar;83(3):553-5.
Eraker SA, Polister P. How decisions are reached: physician and patient. Ann Intern Med.
1982;97:262-268.
Erasmus JJ, Gladish GW, Broemeling L, et al. Interobserver and intraobserver variability in
measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor
response. J Clin Oncol. 2003;21(13):2574-2582.
Eremenco S, Benjamin A, Cella D. A comprehensive method for the translation and cross-cultural
validation of health status questionnaires. Eval Health Prof 2005;28(2):212-232.
Eremenco S, Kline Leidy N. The problem of platforms in e-PRO administration: is there a solution to
the integrity-efficiency dilemma? ISPOR Connections. 2010;16(2):6-7.
Erickson P. A health outcomes framework for assessing health status and quality of life: enhanced
data for decision making. J Natl Cancer Inst Monogr. 2004;33:168–177.
Eriksson MK, Hagberg L, Lindholm L, Malmgren-Olsson E-B, Osterlind J, Eliasson M. Quality of life and
cost-effectiveness of a 3-year trial of lifestyle intervention in primary health care. Arch Intern Med.
2010;170:1470-1479.
Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of
randomized clinical trials. Supportive Care in Cancer. 2009;17(4):333-338.
Ernst T, Chang L, Corray D, et al. The effects of tamoxifen and estrogen on brain metabolism in
elderly women. J Natl Cancer Inst. 2002;94(8):592-597.
Escalante CP. Treatment of cancer-related fatigue: an update. Support Care Cancer. 2003;11:7983.
Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with
locally recurrent rectal cancer. J Clin Oncol. 2002;20:4361–4367.
Espallargues M, Valderas JM, Alonso J. Provision of feedback on perceived health status to health
care professionals. A systematic review of its impact. Med Care. 2000;38(2):175-186.
Esper P, Heidrich D. Symptom clusters in advanced illness. Semin Oncol Nurs. 2005;21(1):20-28.
D:\478174570.doc
Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate
cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50:
920-928.
Esper P, Redman BG. Supportive care, pain management, and quality of life in advanced prostate
cancer. [Review] Urologica Clinics N Am. 1999;26(2):375-389.
Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly H-L,
Paul J. Randomized Controlled Clinical Effectiveness Trial of Cognitive Behavior Therapy Compared
With Treatment As Usual for Persistent Insomnia in Patients With Cancer. Journal of Clinical
Oncology. 2008;26(28):4651-4658.
Esposito M, Campora E, Repetto M, et al. Regional pharmcokinetic selectivity of intraperitoneal
cisplatin on ovarian cancer. Oncology. 1988;45:69-73.
Essink-Bot M, Krabbe PF, Bonsel GJ, Aaronson NK. An empirical comparison of four generic health
Status Measures. (Nottingham Health Profile, the Medical Outcomes Study 36-Item Short-Form
Health Survey, the COOP/WONCA Charts, and The Euro Qol Instrument). Med Care. 1997;
35(5):522-537.
Eton D, Cella D, Bacik J, Motzer R. A brief symptom index for advanced renal cell carcinoma. Health
and Quality of Life Outcomes. 2006;4(68).
Eton D, Lai J-S, Cella D, Reeve B,Talcott J, Clark J, McPherson C, Litwin M, Moinpour C. Data pooling
and analysis to build a preliminary item bank: An example using bowel function in prostate cancer.
Eval Health Prof 2005;28(2):142-159.
Eton DT, Bauer BA, Sood A, Yost KJ, Sloan Ja. Patient-reported outcomes in studies of
complementary and alternative medicine: problems, solutions, and future directions. Explore.
2011;7(5):314-319.
Eton DT, Beebe TJ, Hagen PT. Halyard MY, Montori VM, Naessens JM, Sloan JA, Thompson CA, Wood
DL. Harmonizing and Consolidating the Measurement of Patient-Reported Outcomes at Mayo Clinic.
A Position Statement for the Center for the Science of Health Care Delivery. 2012 December; 48
pages.
Eton D, Yost K, Cella D. Future trends in patient reported outcomes (PRO) assessment for advanced
lung cancer patients receiving targeted therapy. Clinical Lung Cancer. 2006;8(2):99-109.
Eton DT, Cella D, Fairclough DL, Bonomi P, Johnson DH. What is a clinically meaningful change on
the functional assessment of cancer therapy-lung questionnaire: analysis of eastern cooperative
oncology group 5592 data. Anemia & Qual Life Oncol. 2002;5(1):5-8.
Eton DT, Fairclough DL, Cella D, Yount SE, Bonomi P, Johnson DH. Early change in patient-reported
health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by
baseline report: results from Eastern Cooperative Oncology Group Study 5592. Journal of Clinical
Oncology. 2003;21(8):1536-1543.
D:\478174570.doc
Eton DT, Cella D, Yost KJ, et al. A combination of distribution and achor-based approaches
determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin
Epidemiol. 2004;57:898-910.
Eton DT, Koffler K, Cella D, Eisenstein A, Astin JA, Pelletier KR, Riley D. Developing a self-report
outcome measure for complementary and alternative medicine. Explore: J Sci Heal 2005;1(3):177185.
Etzioni R, Riley G F, Ramsey S D, Brown M. measuring costs: administrative claims data, clinical
trials, and beyond. Med Care. 2002;40(6)(Supplement):III-63-III-72.
European Medicines Agency. Evaluation of medicines for human use. Committee for Medicinal
Products for Human Use (CHMP). Reflection paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medicinal products. Retrieved from:
http://www.emea.eu.int/pdfs/human/ewp/13939104en.pdf
European Organization (The) for research and treatment of cancer breast cancer-specific quality-oflife questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14
(10):2756-2768.
EuroQol Group, The. Cross-cultural adaptation of health measures. Health Policy. 1991;19:33-44.
EuroQol Group, The. EuroQol—A new facility for the measurement of health-related quality-of-life.
Health Policy. 1990;16:199-208.
Evangelista LS, Sarna L, Brecht ML, Padilla G, Chen J. Health perceptions and risk behaviors of lung
cancer survivors. Heart Lung. 2003;32(2):131-139.
Evans S, Greenhalgh J, Connelly J. Selecting a mental health needs assessment scale: guidance on
the critical appraisal of standardized measures. J Eval Clin Pract 2000;6(4):379-393.
Evans C, McCarthy M. Referral and survival of patients accepted by a terminal care support team. J
Epidemiol Community Health. 1984;38:310-314.
Evans DL, Staab JP, Petitto JM, et al. Depression in the medical setting: Biophsychological
interactions and treatment considerations. J Clin Psychiatry. 1999;60:40-55.
Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group. The quality of
life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA. 1990;263:825830.
Evans RW. Quality of life assessment and the treatment of end-stage renal disease. Transplantation
Reviews. 1990;4:28-51.
Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H,
Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Fanelli FR, Schambelan M,
Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: A new definition. Clinical Nutrition.
2008;27(6):793-799.
D:\478174570.doc
Ewing G, Todd C, Rogers M, Barclay S, McCabe J, Martin A. Validation of a symptom measure
suitable for use among palliative care patients in the community: CAMPAS-R. J Pain Symptom
Manage. 2004;27(4):287-299.
Exterman M. Comprehensive geriatric assessment basics for older patients with cancer. J Clin Oncol.
2007;25(14):1824-1831.
Exterman M. Comprehensive geriatric assessment basics for the cancer professional. J Oncol Manag.
2003;12(2):13-17.
Exterman M. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control.
2003;10(6):463-468.
Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clinic N Am.
2000;14(1):63-77.
Extermann M, Balducci L, Lyman GH. What threshold for adjuvant therapy in older breast cancer
patients? J Clin Oncol. 2000;18(8):1709-1717.
Eyapsch E, Williams JI, Wool-Dauphinee S, et al. Gastrointestinal quality of life index: development,
validation and application of a new instrument. Br J Surg. 1995;82:216-222.
Eyigor S, Eyigor C, Uslu R. Assessment of pain, fatigue, sleep and quality of life (QOL) in elderly
hospitalized cancer patients. Archives of gerontology and geriatrics. 2010;51(3):e57-61.
Ezzo J, Vickers A, Richardson MA, et al. Acupuncture-point stimulation for chemotherapy-induced
nausea and vomiting. J Clin Oncol. 2005;23:7188-7198.
Fagnoni P, Limat S, Chaigneau L, Guardiola Em, Briaud S, Schmitt B, Merrouche Y, Pivot X, WoronoffLemsi M-C. Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer.
Support Care Cancer. 2006:14:1030-1037.
Fainsinger RL, Nekolaichuk CL. A “TNM” classification system for cancer pain: The Edmonton
Classification System for Cancer Pain (ECS-CP). Support Care Cancer. 2008;16:547-555.
Fainsinger RL, Fairchild A, Nekolaichuk C, Lawlor P, Lowe S, Hanson J. Is Pain Intensity a Predictor
of the Complexity of Cancer Pain Management? Journal of Clinical Oncology. 2009;27(4):585-590.
Fairclough D, Peterson H, Cella D, Bonomi P. Comparison of several model-based methods for
analyzing incomplete quality of life data in cancer clinical trials. Stats Med. 1998;17:781-796.
Fairclough D, Peterson HF, Chang V. Why are missing quality of life data a problem in clinical trials
of cancer therapy? Stat Med. 1998;17:667–677.
Fairclough DL, Cella DF. Functional Assessment of Cancer Therapy (FACT-G) Non-response to
individual questions. Qual Life Res. 1996;5:321-329.
Fairclough DL, Fetting JH, Cella D, Wonson W, Moinpour CM. Quality of life and quality adjusted
survival for breast cancer patients receiving adjuvant therapy. Qual Life Res. 1999;8:723-731.
D:\478174570.doc
Fairclough DL, Gagnon DD, Zagari MJ, Marschner N, Dicato M. Evaluation of quality of life in a clinical
trial with nonrandom dropout: The effect of epoetin alfa in anemic cancer patients. Qual Life Res.
2003;12:1013-1027.
Fairclough DL. Summary measures and statistics for comparison of quality of life in a clinical trial of
cancer therapy. Stats Med. 1997;16:1197-1209.
Fairclough DL, Cella DF. Eastern Cooperative Oncology Group (ECOG). Journal of the National
Cancer Institute. 1996;20:73-75.
Fakhoury WKH. Satisfaction with palliative care: what should we be aware of? Int J Nurs Stud.
1998;35:171–176.
Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R. Effects of psycho-oncologic interventions
on emotional distress and quality of life in adult patients with cancer: systematic review and metaanalysis. Journal of Clinical Oncology. 2013;31(6):782-793.
Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal
women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J
Clin Oncol. 1994;22:4261–4271.
Fallowfield L. Quality of life in breast cancer--results from three cancer research campaign studies.
Acta Clin Belg Suppl. 1993;15:19-23.
Fallowfield L. Quality of quality-of-life data. Lancet. 1996;348(9025):421-442.
Fallowfield L. Quality of life issues in relation to the aromatase inhibitor. J Steroid Biochem Mol Biol.
2007 Aug-Sep;106(1-5):168-72. Epub 2007 May 24.
Fallowfield LJ, Bliss JM, Porter LS, et al. Quality of life in the intergroup exemestane study: a
randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in
postmenopausal women with primary breast cancer. J Clin Oncol. 2006;24:910-917.
Fallowfield LJ, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal
women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J
Clin Oncol. 2004;22(21):4261-4271.
Fallowfield LJ, Harper P. Health-related quality of life in patients undergoing drug therapy for
advanced non-small-cell lung cancer. Lung Cancer. 2005;48:365-377.
Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women
undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscase for the
FACT-B. Breast Cancer Res Treat. 1999;55:189-199.
Fan G, Filipczak L, Chow E. Symptom clusters in cancer patients: a review of the literature. Current
Oncology. 2007;14(5):173-179.
Fan HGM, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S, Tannock IF. A randomised,
placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive
D:\478174570.doc
dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer.
2008;16:577-583.
Fanciullo GJ, Jamison RN, Chawarski MC, Baird JC. Reliability and validity of an interactive computer
method for rating quality of life. Pain Med. 2003;4(3):257-268.
Fang F-M, Tsai W-L, Chien C-Y, Chen H-C, Hsu H-C, Huang T-L, Lee T-F, Huang H-Y, Lee C-H.
Pretreatment quality of life as a predictor of distant metastasis and survival for patients with
nasopharyngeal carcinoma. Journal of Clinical Oncology. 2010;28(28):4384-4389.
Fann JR, Alfano CM, Roth-Roemer S, Katon WJ, Syrjala KL. Impact of delirium on cognition, distress,
and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol.
2007;25(10):1223-1231.
Farkas J, Nabb S, Zaletel-Kragelj L, Cleland JGF, Lainscak M. Self-rated health and mortality in
patients with chronic heart failure. European Journal of Heart Failure. published March 28, 2009.
Farrar JT, Berlin JA, Strom BL. clinically important changes in acute pain outcome measures: a
validation study. J Pain Symptom Manage. 2003; 25(5):406–411.
Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in
pain outcome measures. Pain. 2000;88:287–294.
Farrar JT, Young Jr JP, LaMoreauz, L, Werth, JL, Poole RM. Clinical importance of changes in chronic
pain intensity measured on an 11-point rating scale. Pain. 2001;94:149-158.
Farrar JT. What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain. 2000;(2
Suppl):S106-12.
Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E. Oral transmucosal fentanyl citrate:
Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer
patients. J Natl Cancer Inst. 1998;90:611-616.
Farrell C, Brearley SG, Pilling M, Molassiotis A. The impact of chemotherapy-related nausea on
patients’ nutritional status, psychologoical distress and quality of life. Supportive Care in Cancer.
2013;21(1):59-66.
Farsides B, Dunlop RJ. Measuring quality of life: Is there such a thing as a life not living? BMJ.
2001;322:1481-1483.
Fayers PM, Hand,DJ. Causal variables, indicator variables and measurement scales: an example from
quality of life. J Royal Stat Soc A. 2002;165:1-21.
Fayers PM, Hopwood P, Harvey A, Girling D, Machin D, Stephens R. Quality of life assessment in
clinical trials – guidelines and a checklist for protocol writers: the U.K. Medical Research Council
Experience. Euro J Cancer. 1997;33(1):20-28.
Fayers PM. IRT: The Way Forward. Summary Paper, Drug Information Association. June 23–25,
2004 Meeting.
D:\478174570.doc
Fayers PM. Quality-of-life measurement in clinical trials – the impact of casual variables. J Biopharm
Stat. 2004;14(1):155–176.
Fayers PM, Sprangers MAG. Understanding self-rated health – Commentary. The Lancet.
2002;359:187-188.
Fearon KCH, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD. Double-blind,
placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer
cachexia. J Clin Oncol. 2006;24(21):3401-3407.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N,
Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S,
Baracos VE. Definitioin and classification of cancer cachexia: an international consensus. Lancet
Oncology. 2011;12:489-495.
Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer
cachexia. Nat Rev Clin Oncology. 2013;10:90-99.
Feeny D, Blanchard CM, Mahon JL, et al. The stability of utility scores: test-restest reliability and the
interpretation of utility score in elective total hip arthoplasty. Qual Life Res. 2004;13:15-22.
Feeny D, Furlong W, Saigal S, Sun J. Comparing directly measured standard gamble scores to HUI2
and HUI3 utility scores: group- and individual-level comparison. Soc Sci Med. 2004;58:799-809.
Feeny D, Furlong W, Torrance GW, et al. Multi-attribute and single-attribute utility functions for the
health utilities index mark 3 system. Med Care. 2002;40(2):113-128.
Feeny D. The Health Utilities Index: A tool for assessing health benefits. Patient Reported Outcomes
Newsletter. 2005;34.
Feinstein AR. Benefts and obstacles for development of health status assessment measures in clinical
settings. Med Care. 1992;30(5):MS50-MS56.
Feinstein AR. Indexes of contrast and quantitative significance for comparisons of two groups. Stats
Med. 1999;18:2557-2581.
Feld R. Quality of life assessment in patients with carcinoma of the lung. Chest Suppl.
1989;96(1):S105-S107.
Felder-Puig R, di Gallo A, Waldenmair M, Gadner H, Topf R. The TCCS – a short measure to
evaluation treatment-related coping and compliance in hospitalized childhood cancer patients and
their primary caregivers. Support Care Cancer. 2004;12:41–47.
Feldman-Stewart D, Brundage MD, Hayter C, Groome P, Nickel JC, Downes H, MacKillop WJ. What
questions do patients with curable prostate cancer want answered? Med Decis Making. 2000;20:719.
Feldman-Stewart D, Brundage MD, Nickel JC, MacKillop WJ. The information required by patients
with early-stage prostate cancer in choosing their treatment. BJU Intl. 2001;87:218-223.
D:\478174570.doc
Feldman-Stewart D, Kocovski N, McConnell BA, Brundage MD, MacKillop WJ. Perception of
quantitative information for treatment decisions. Med Dec Making. 2000;20:228-238.
Feldstein ML. Quality-of-life-adjusted survival for comparing cancer treatments. Cancer Suppl.
1991;67:851-854.
Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Davis Pentz R, Barfield RC, Baker JN, Santor D,
Weijer C, Kodish E. Proving Research Results to Participants: Attitudes and Needs of Adolescents and
Parents of Children With Cancer. Journal of Clinical Oncology. 2009;27(6):878-883.
Fernandez-Ortega P, Caloto MT, Chirveches E, Marquilles R, San Francisco J, Quesada A, Suarez C,
Zorrilla I, Gomez J, Zabaleta P, Nocea G, Llombart-Cussac A. Chemotherapy-induced nausea and
vomiting in clinical practice: impact on patients’ quality of life. Supportive Care in Cancer.
2012;20(12):3141-3148.
Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. ANS Adv
Nurs Sci. 1985;8:15-24.
Ferrans CE. Development of a conceptual model of quality of life. Clarifying Concepts in Nurs Res.
1999;110-121.
Ferrans CE. Conceptualizations of quality of life in cardiovascular research. Progress in
Cardiovascular Nurs. 1992;7(1):2-6.
Ferrans CE. Quality of life as an outcome of cancer care. Cancer Nursing: Principles and Practice.
(5th ed.) 2000;243-258.
Ferrans CE. Definitions and conceptual models of quality of life. Outcomes Assessment in Cancer:
Measures, Methods, and Application. Edited by Joseph Lipscomb, Carolyn Gotay, and Claire Snyder.
2005, page 14-30.
Ferrans CE, Zerwic JJ, Wilbur JE, Larson JL. Conceptual model of health-related quality of life.
Journal of Nursing Scholarship. 2005;37(4):336-342.
Ferreira K, Kimura M, Teixeira MJ. The WHO analgesic ladder for cancer pain control, twenty years
of use. How much pain relief does one get from using it? Support Care Cancer. 2006;14:10861093.
Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res.
1995;4(6):523-531.
Ferrell BR, Dow KH, Leigh S, Ly J, Gulasekaram P. Quality of life in long-term cancer survivors.
Oncol Nurs Forum. 1995;22(6):915-922.
Ferrell BR, Grant M, Padilla G, Vemuri S, Rhiner M. The experience of pain and perceptions of quality
of life: validation of a conceptual model. Hospice J. 1991;7(3):9-24.
D:\478174570.doc
Ferrell BR, Grant M, Schmidt GM, et al. The meaning of quality of life for Bone Marrow Transplant
survivors. Part 1. The impact of Bone Marrow Transplant on quality of life. Cancer Nurs. 1992;
15(3):153-160.
Ferrell BR, Grant M, Schmidt GM, et al. The meaning of quality of life for bone marrow transplant
survivors. Part 2. Improving quality of life for bone marrow transplant survivors. Cancer Nurs.
1992;15(4):247-253.
Ferrell BR, Wisdom C, Wenzl C, Brown J. Effects of controlled-released morphine on quality of life for
cancer pain. Oncol Nurs Forum. 1989;16(4):521-526.
Ferrell BR, Wisdom C, Wenzl C. Quality of life as an outcome variable in the management of cancer
pain. Cancer. 1989;63:2321-2327.
Ferrell BR. Issues in end-of-life care: Collaboration for quality. Presented at ASCO, 1999.
Ferrell BR. The quality of lives: 1,525 voices of cancer. Oncol Nurs Forum. 1996;23(6):909–916.
Ferris FD, Bruera E, Cherny N, Cummings C, Currow D, Dudgeon D, JanJan N, Strasser F, von Gunten
CF, Von Roenn JH. Palliative cancer care a decade later: accomplishments, the need, next steps –
from the American Society of Clinical Oncology. Journal of Clinical Oncology. 2009;27(18):30523058.
Festing MFW, Altman DG. Guidelines for the design and statistical analysis of experiments using
laboratory animals. Ilar J. 2002;43(4):244-58.
Fetting JH. Evaluating quality and quantity of life in breast cancer adjuvant trials. J Clin Oncol.
1988;6(12):1795-1797.
Fetting JH, Gray R, Fairclough DL, et al. Sixteen-week multidrug regimen vs. Cyclophosphamide,
Doxorubicin, and Fluorouracil (CAF) as adjuvant therapy for node positive, receptor negative breast
cancer: an intergroup study. Journal of Clinical Oncology. 1998;16(7):2382-2391.
Feyer P, Kleeberg UR, Steingraber M, Gunther W, Behrens M. Frequency of side effects in outpatient
cancer care and their influence on patient satisfaction – a prospective survey using the PASQOC
questionnaire. Support Care Cancer. 2008;16:567-575.
Fielding S, Fayers P, Ramsay C. Predicting missing quality of life data that were later recovered: an
empirical comparison of approaches. Clinical Trials. 2010;7(4):333-342.
Figueiredo MI, Cullen J, Hwang Y-T, Rowland JH, Mandelblatt JS. Breast cancer treatment in older
women: does getting what you want improve your long-term body image and mental health. J Clin
Oncol. 2004;22(19):4002–4409.
Figueiredo MI, Fries E, Ingram KM. The role of disclosure patterns and unsupportive social
interactions in the well-being of breast cancer patients. Psycho-Oncol. 2004;13:96–105.
Finch WH, French BF. Detection of crossing differential item functioning: a comparison of four
methods. Educational and Psychological Measurement. 2007;67(4):565-582.
D:\478174570.doc
Fine E, Reid C, Shengelia R, Adelman RD. Directly observed patient-physician discussions in palliative
and end-of-life care: a systematic review of the literature. Journal of Palliative Medicine.
2010;13(5):595-603.
Fine LJ. Overview of the Talk. Summary Paper, Drug Information Association; June 23–25, 2004
Meeting.
Fine PG, Busch MA. Characterization of breakthrough pain by hospice patients and their caregivers.
Journal of Pain and Symptom Management. 1998;16(3):179-183.
Finkelstein DM, Cassileth BR, Bonomi PD, et al. A pilot study of the Functional Living Index-Cancer
(FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. Am J Clin Oncol.
1988;11(6):630-633.
Finlay AY, Khan G. Dermatology Life Quality Index (DLQI) -- a simple practical measure for routine
clinical use. Clin Exper Dermatol. 1994;19:210-216.
Finlay AY. Quality of life assessments in dermatology. Sem Cutan Med Surg. 1998;17(4):291-296.
Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol.
1997;136(3):305-314.
Finlay AY. Skin disease disability: measuring its magnitude. Keio J Med. 1998;47(3):131-134.
Finlay E, Shreve S, Casarett D. Nationwid Veterans Affairs Quality Meausure for Cancer: The Family
Assessment of Treatment at End of Life. Journal of Clinical Oncology. 2008;26(23):3838-3844.
Finlay IG, Dunlop R. Quality of life assessment in palliative care. Ann Oncol. 1994;5(1):13-18.
Finlayson TL, Moyer CA, Sonnad SS. Assessing symptoms, disease severity, and quality of life in the
clinical context: A theoretical framework. Am J Manag Care. 2004;10(5):336-344.
Fisch M. Treatment of depression in cancer. J Natl Cancer Inst Monogr. 2004;32:105-111.
Fisch MJ, Loehrer PJ, Kristeller J, et al. Fluoxetine versus placebo in advanced cancer outpatients: a
double-blinded trial of the Hoosier Oncology Group. J Clin Oncol. 2003;21:1937-1943.
Fisch MJ, Titzer ML, Kristeller JL, et al. Assessment of quality of life in outpatients with advanced
cancer: the accuracy of clinician estimations and the relevance of spiritual well-being – A Hoosier
Oncology Group Study. J Clin Oncol. 2003;21(14):2754-2759.
Fisch MJ, Lee J-W, Weiss M, Wagner LI, Chang T, Cella D, Manola JB, Minasian LM, McCaskill-Stevens
W, Mendoza TR, Cleeland CS. Prospective, observational study of pain and analgesic prescribing in
medical oncology outpatients with breast, colorectal, lung, or prostate cancer. Journal of Clinical
Oncology. 2012;30(16):1980-1988.
Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ. Anxiety, depression, and pain: differences by
primary cancer. Supportive Care in Cancer. 2010;18(7):801-810.
D:\478174570.doc
Fish LS, Lewis BE. Quality of life issues in the management of ovarian cancer. Sem in Oncol.
1999;26(1 Suppl):32-39.
Fitch MI Osoba D, Iscoe N, Szala JP. Predicting psychological distress in patients with cancer:
conceptual basis and reliability evaluation of a self-report questionnaire. Anticancer Res.
1995;15:1533-1542.
Fitzgibbon ML, Cella DF, Sweeney JA. Redundancy in measures of depression. Journal of Clinical
Psychology. 1988;44:372-374.
Fitzgibbon ML, Cella DF, Humfleet G, Griffin E, Sheridan K. Motor slowing in asymptomatic HIV
infection. Perceptual and Motor Skills. 1989;68:1331-1338.
Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in
clinical trials. Health Technology Assessment. 1998;2(14).
Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health
care. I: Applications and issues in assessment. BMJ. 1992;305(6861):1074-1077.
Fitzsimmons D, George S, Payne S, Johnson CD. Differences in perception of quality of life issues
between health professionals and patients with pancreatic cancer. Psycho-Oncol. 1999;8(2):135143.
Flaherty JA, Gaviria FM, Pathak D, et al. Developing instruments for cross-cultural psychiatric
research. Nerv Mental Dis. 1988;176(5):257-263.
Flaugher R. The many definitions of test bias. Am Psychol. 1978;3:671-679.
Fleer J, Hoekstra JH, Sleijfer DT, Tuinman MA, Klip EC, Hoekstra-Weebers JEHM. Quality of life of
testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and
life events. Support Care Cancer. 2006;14:251-259.
Fleishman JA, Sherbourne CD, Crystal S, Collins RL, Kelly M, Bozzette SA. Coping, conflictual social
interactions, social support, and mood among HIV-infected persons. Am J Community Psychol.
2000;28(4):421–453.
Fleishman JA. Using MIMIC models to assess the influence of differential item functioning. Summary
Paper, Drug Information Association. June 23–25, 2004 Meeting.
Fleishman SB, Khan H, Homel P, Suhail MF, Strebel-Amrhein R, Mohammad F, Mahajan D, Rosenwald
V, Guarino MJ, Mirzoyev T, Wozniak TF, Suppiah K. Testosterone levels and quality of life in diverse
male patients with cancers unrelated to androgens. Journal of Clinical Oncology. 2010;28(34):50545060.
Fleishman SB. Treatment of symptom clusters: pain, depression, and fatigue. J Natl Cancer Inst
Monogr. 2004;32:119-123.
D:\478174570.doc
Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, et al. Phase III trial of doxorubicin plus cisplatin
with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A Gynecologic
Oncology Group Study. Journal of Clinical Oncology. 2004;22(11):2159-2166.
Fleming ID, Fleming MD. Breast cancer in elderly women. Cancer. 1994;74(7)(Suppl):2160-2164.
Fleming TR, Harrington DP, O'Brien PC. Designs for group sequential tests. Control Clin Trials.
1984;5:348-361.
Fleming TR, Sharples K, McCall J, Moore A, Rodgers A, Stewart R. Maintaining confidentiality of
interim data to enhance trial integrity and credibility. Clinical Trials. 2008;5:157-167.
Fletcher A, Fore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health
care. II: Design, analysis, and interpretation. BMJ. 1992;305(6862):1145-1148.
Fletcher AE, Bulpitt CJ, Chase D, et al. Quality of life on three antihypertensive treatments: cilazapril,
atenolol, nifedipine. Hypertension. 1992;19:499-507.
Flood E, Beusterien K, Green H, Shikiar R, Baran R, Cella D. Psychometric evaluation of the
osteoporosis patient treatment satisfaction questionnaire (OPSAT-Q), a measure to assess
satisfaction with bisphosphonate treatment in postmenopausal women. Hlth Qual Life Outcomes
2006;4(42).
Florin J, Ehrenberg A, Ehnfors M. Clinical decision-making: Predictors of patient participation in
nursing care. Journal of Clinical Nursing. 2008;17:2935-2944.
Flynn KE, Dombeck CB, DeWitt EM, Schulman KA, Weinfurt KP. Using item banks to construct
measures of patient reported outcomes in clinical trials: investigator perceptions. Clinical Trials
(Journal of the Society for Clinical Trials). 2008;5(6):575-586.
Fogarty LA, Curbow BA, Wingard JR, McDonnell K, Somerfield MR. Can 40 seconds of compassion
reduce patient anxiety? J Clin Oncol. 1999;17:371-379.
Foley K. 9.2. Pain assessment and cancer pain syndromes. 9 symptom management, pp. 310-331.
Foley KM. Treatment of cancer-related pain. J Natl Cancer Inst Monogr. 2004;32:103.
Follwell M, Burman D, Le LW, Wakimoto K, Seccareccia D, Bryson J, Rodin G, Zimmermann C. Phase
II Study of an Outpatient Palliative Care Intervention in Patients With Metastatic Cancer. Journal of
Clinical Oncology. 2009;27(2):206-13.
Fordham S, Dowrick C. Is care of the dying improving? The contribution of specialist and nonspecialist to palliative care. Fam Pract. 1999;16(6):573–529.
Forsythe LP, Helzlsouer KJ, MacDonald R, Gallicchio L. Daytime sleepiness and sleep duration in
long-term cancer survivors and non-cancer controls: results from a registry-based survey study.
Supportive Care in Cancer. 2012;20(10):2425-2432.
D:\478174570.doc
Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, Liang MH. Do lupus
disease activity measures detect clinically important change? J Rheumatol. 2000;27:1421–1428.
Fortner B, Okon T, Schwartzberg L, Tauer K, Houts AC. The cancer care monitor: psychometric
content evaluation and pilot testing of a computer administered system for symptom screening and
quality of life in adult cancer patients. J Pain Symptom Manage. 2003;26(6):1077–1092.
Fortner B. Impact of less frequent injections on patients, caregivers, and practices. Oncology
(Suppl). 2006;20(8):33-38.
Fortner BV, Schwartzberg L, Tauer K, Houts AC, Hackett J, Stolshek BS. Impact of chemotherapyinduced neutropenia on quality of life: a prospective pilot investigation. Support Care Cancer.
2005;13:522-528.
Fossa SD, Aaronson N, da Silva FC, Denis L, Newling D, Hosbach G, Kaakhus O. Quality of life in
patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer. Euro Urol.
1989;16:335-339.
Fossa SD, Aaronson N, de Voogt HJ, da Silva FC. Assessment of quality of life and subjective
response criteria in patitnes with prostatic cancer. Prog Clin Biol Res. 1990;357:199-202.
Fossa SD, Aaronson NK, Newling D, van Cangh PJ, Denis L, Kurth KH, de Pauw M. Quality of life and
treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer. 1990;26(11:12):11331136.
Fossa SD, Curran D, Aaronson NK, et al. Quality of life of patients with newly diagnosed poor
prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the
EORTX Phase III Trial 30893. Euro Urol. 2000;37:541-551.
Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular
cancer. J Clin Oncol. 2003;1249–1254.
Fossa SD, de Wit R, Roberts JT, et al. Quality of life in good prognosis patients with metastatic germ
cell cancer: a prospective study of the European Organization for research and treatment of cancer
genitourinary group/medical research council testicular cancer study group (30941/TE20). J Clin
Oncol. 2003;21(6):1107-1118.
Fossati R, Confalonieri C, Mosconi P, Pistotti V, Apolone G. Quality of life in randominzed trials of
cytotoxic or hormonal treatment of advanced breast cancer. Is there added value? Breast Cancer
Research and Treatment. 2004;87:233-243.
Fossella F, Pereira JR, von Pawel J, et al. Randomized, multinational, phase III study of Docetaxel
plus Platinum combinations versus Vinorelbine plus Cisplatin for advanced non-small-cell lung cancer:
the TAX 326 study group. J Clin Oncol. 2003;21(16):3016-3024.
Fowler FJ Jr, Barry MJ, Lu-Yao GL, Roman A, Wasson J, Wennberg JE. Patient reported complications
and follow-up treatment after radical prostatectomy. Urology. 1993;42:622-629.
D:\478174570.doc
Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AG, Hanley D. Symptom status and quality
of life following prostatectomy. JAMA. 1988;259:3018-3022.
Fowler FJ, Coppola KM, Teno JM. Methodological challenges for measuring quality of care at the end
of life. J Pain Symptom Manage. 1999;17(2):114–119.
Fox S. Preliminary psychometric testing of the Fox Simple Quality-of-Life Scale. J Neuroscience
Nurs. 2004;36(3):157-166.
Franklin HR, Simonetti GPC, Dubbelman AC, et al. Toxicity Grading Systems: A comparison between
the who scoring system and the common toxicity criteria when used for nausea and vomiting. Ann
Oncol. 1994;5:113–117.
Franks PJ, Salisbury C, Bosenquet N, et al. The level of need for palliative care: a systematic review
of the literature. Palliat Med. 2000;14:93–104.
Frank-Stromberg M, Wright P. Ambulatory cancer patients’ perception of the physical and
psychosocial changes in their lives since the diagnosis of cancer. Cancer Nurs. 1984;117–130.
Frank-Stromberg M. Reaction to the diagnoses of cancer questionnaire: development and
psychometric evaluation. Nurs Res. 1989;38(6):364-369.
Fransson P, Bergstrom P, Lofroth PO, Widmark A. Prospective evalution of urinary and intestinal side
effects after BeamCath® stereotactic dose-escalated radiotherapy of prostate cancer. Radiother
Oncol. 2002;63:239-248.
Fransson P, Damber JE, Tomic R, Modig H, Nyberg G, Widmark A. Quality of life and symptoms in a
randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer.
2001;92:3111-3119.
Fransson P, Widmark A. Late side effects unchanged 4-8 years after radiotherapy for prostate
carcinoma. Cancer. 1999;85:678-688.
Franzen L, Nyman J, Hagberg H, Jakobsson M, Sorbe B, Nyth AL, Lomberg H, Henriksson R. A
randomized placebo controlled study with ondansetron in patients undergoing fractionated
radiotherapy. Annal Oncol. 1996.
Frazier LM, Miller VA, Horbelt DV, Delmore JE, Miller BE, Averett EP. Employment and Quality of
Survivorship Among Women With Cancer: Domains Note Captured by Quality of Life Instruments.
Cancer Control. 2009;16(1):57-65.
Freed MM. Quality of life: the physician's dilemma. Arch Phys Med Rehab. 1984;65:109-111.
Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, McCaskill-Stevens
W. Benefit/Risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for
women age 50 years or older. Journal of Clinical Oncology. 2011;29(17):2327-2333.
Freedman LS. Tables of the number of patients required in clinical trials using the Log Rank Test.
Stats Med. 1982;1:121-129.
D:\478174570.doc
Freifeld AG, Sepkowitz KA. No Place Like Home? Outpatient Management of Patients With Febrile
Neutropenia and Low Risk. J. Clin. Oncology. Oct 2011;29(30); 3952–54.
French MT, Mauskopf JA. A quality-of-life method for estimating the value of avoided morbidity. Am
J Publ Hlth. 1992;82:1553-1555.
Frey BS. Happy people live longer. Science. 2011;331:542-3.
Freyer G, Ligneau B, Schulumberger M, et al. Quality of life in patients at risk of medullary thyroid
carcinoma and followed by a comprehensive medical network: trends for future evaluations. Ann
Oncol. 2001;(10):1461–1465.
Frick E, Rieg-Appleson C, Tyroller M, Bumeder I. J Psychosocial Oncol. 2005;23(4):15-34.
Fried TR, Bradley EH, Towle VR, Phil M, Allore H. Understanding the treatment preferences of
seriously ill patients. New Engl J Med. 2002;346(14):1061-1066.
Fries J, Bruce B, Cella D. The promise of PROMIS: The new sciences behind patient-reported
outcomes. Clin Exper Rheumatol 2005;23:S53-57.
Fries JF. The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ),
and issues mandating development of a toxicity index. Control Clin Trials. 1991;12(4 Suppl):106S117S.
Frisch MB, Cornell J, Villanueva M, Retzlaff PJ. Clinical validation of the quality of life inventory: a
measure of life satisfaction for use in treatment planning and outcome assessment. Psychol
Assessment 1992:4(1):92-101.
Frisk J, Kallstrom A-C, Wall N, Fredrikson M, Hammar M. Acupuncture improves health-related
quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes. Supportive Care in
Cancer. 2012;20(4):715-724.
Froehlich F, Thorens J, Schwizer W, et al. Sedation and analgesia for colonoscopy: patient tolerance,
pain, and cardiorespiratory parameters. Gastrointestinal Endoscopy. 1997;45(1):1-9.
Fromme EK, Eilers KM, Mor M, Hsieh Y-C, Beer TM. How accurate is clinician reporting of
chemotherapy adverse effects? a comparison with patient-reported symptoms from the quality-of-life
questionnaire C30. J Clin Oncol. 2004;22:3485–3490.
Fromme EK, Kenworthy-Heinige T, Hribar M. Developing an easy-to-use tablet computer application
for assessing patient-reported outcomesin patients with cancer. Supportive Care in Cancer.
2011;19(6):815-822.
Frost M, Bonomi AE, Cappelleri jc, Schunemann HJ, Moynihan TJ, Aaronson NK, and the Significance
Consensus Meeting Group. Applying quality-of-life data formally and systematically into clinical
practice. Mayo Clin Proc 2007;82(10):1214-1228.
D:\478174570.doc
Frost M, Bonomi AE, Estwing-Ferrans C, Wong GY, Hays RD, Clinical Significance Consensus Meeting
Group. Patient, Clinician and population perspectives on determining the clinical significance of
quality of life scores. Mayo Clin Proc. 2002;488-494.
Frost M, Durazo A, Sumathi J, Schoonover A, Novotny P, Zahasky KA. Multidisciplinary healthcare
delivery model for women with breast cancer: patient satisfaction and physical and psychosocial
adjustment. Oncol Nurs Forum. 1999;26(10):1673-1680.
Frost MH, Johnson ME, Atherton PJ, Petersen WO, Dose AM, Kasner MJ, Burger KN, Sloan JA, Pipe
TB. Spiritual well-being and quality of life of women with ovarian cancer and their spouses . The
Journal of Supportive Oncology. 2012;10(2):72-80.
Fryback DG, Craig BM. Measuring economic outcomes of cancer. J Natl Cancer Inst Monogr.
2004;(33)134–141.
Fukuoka Y, Lindgren TG, Rankin SH, Cooper BA, Carroll DL. Cluster analysis: a useful technique to
identify elderly cardiac patients at risk for poor quality of life. Qual Life Res. 2007;16:1655-1663.
Funk GF, Karnell LH, Dawson CJ, et al. Baseline and post-treatment assessment of the general
health status of head and neck cancer patients compared with United States population norms. Head
Neck. 1997;19(8):675-683.
Funk GF, Karnell LH, Smith RB, Christensen AJ. Clinical significance of health status assessment
measures in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130:825-829.
Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing
health-related quality of life in clinical studies. Ann Med. 2001;33:375-384.
Furman WL, Luo X, Fairclough D, et al. Phase I trial of subcutaneous interleukin-1 alpha in children
with malignant solid tumors. Med Pedia Oncol. 1997;28:444-450.
Gabrijel S, Grize L, Helfenstein E, Brutsche M, Grossman P, Tamm M, Kiss A. Receiving the diagnosis
of lung cancer: Patient recall of information and satisfaction with physician communication. J Clin
Oncol. 2008;26(2):297-302.
Gaddis GM. Does the reference really support that assertion? The potential for citing research
reports out of context. Acad Emergency Med. 2002;8(3):276-277.
Gaertner J, Wolf J, Frechen S, Klein U, Scheicht D, Hellmich M, Toepelt K, Glossmann J-P, Ostgathe
C, Hallek M, Voltz R. Recommending early integration of palliative care – does it work? Supportive
Care in Cancer. 2012;20(3):507-514.
Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: does age make a
difference in what happens to women with breast cancer? J Clin Oncol. 2004;22:3458–3465.
Gagnon EM, Recklitis CJ. Parents’ decision-making preferences in pediatric oncology: the relationship
to health care involvement and complementary therapy use. Psycho-Oncol. 2003;12(5):442-52.
D:\478174570.doc
Gajdos C, Tartter PI, Bleisweiss IJ, Lopchinsky RA, Berstein JL. The consequesnce of undertreating
breast cancer in the elderly. J Am Coll Surg. 2001;192(6):698-707.
Gall TL. Relationship with God and the quality of life of prostate cancer survivors. Qual Life Res.
2004;13:1357–1368.
Gallagher LM, Huston MJ, Nelson KA, Walsh D, Steele, AL. Music therapy in palliaitve medicine.
Support Care Cancer. 2001;9:156–161.
Gallagher LM, Lagman R, Walsh D, Davis MP, LeGrand SB. The clinical effects of music therapy in
palliative medicine. 2006;14:859-866.
Gallant MD, Coutts LM. Evaluation of an oncology outpatient orientation program: patient
satisfaction and outcomes. Support Care Cancer. 2003;11:800–805.
Gallup DG, Cella DF. Gynecologic Oncology Group (GOG). Journal of the National Cancer Institute.
1996;20:77-78.
Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise
program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer
without bone metastases: a randomized controlled trial. Journal of Clinical Oncology.
2010;28(2):340-347.
Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12
health survey in nine countries: Results from the IQOLA Project. J Clin Epidemiol. 1998;51:11711178.
Gandek, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12
health survery in nine countries: results from the IQOLA project. J Clin Epidemiol. 1998;51(11):
1171–1178.
Ganguli M, Belle S, Ratcliff G, Seaberg E, Huff FJ, von der Porten K, Kuller LH. Sensitivity and
specificity for dementia of population-based criteria for cognitive impairment: The MoVIES Project. J
Gerontology. 1993;48(4):M152–M161.
Ganiats TG, Miller CJ, Kaplan RM. Comparing the quality-adjusted life-year output of two treatment
arms in a randomized trial. Med Care. 1995;33(4):Suppl. AS245-AS254.
Ganiats TG, Palinkas LA, Kaplan RM. Comparison of quality of well-being scale and functional status
index in patients with atrial fibrillation. Med Care. 1992; 30(10):958-964.
Ganiats TG, Sieber WJ, Weisman M. Self-reported cost of illness and health-related quality of life.
best practices and benchmarking in healthcare. 1997;2(2):57-62.
Ganz P, Guadognoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA. Breast cancer in older
women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol.
2003;21(21):4027-4033.
D:\478174570.doc
Ganz P. Monitoring the physical health of cancer survivors: a survivorship-focused medical history. J
Clin Oncol. 2006;24(32):5105-5111.
Ganz P. The quality of life after breast cancer – solving the problem of lymphedema. New Engl J
Med. 1999;340:383-385.
Ganz PA. Cancer Survivorship: Today and Tomorrow. The New England Journal of Medicine.
2007;357(21):2209-2210.
Ganz PA. Cancer Survivorship: Today and Tomorrow. Psycho-Oncology. 2008;17:627.
Ganz PA. Cancer Survivorship: Today and Tomorrow. JAMA. 2007;298(14):1700-1.
Ganz PA. Assessing the quality and value of quality-of-life measurement in breast cancer clinical
trials. JNCI. 2011;103(3):3 pages.
Ganz PA, Day R, Costantino J. Compliance with quality of life data collection in the national surgical
adjuvant breast and bowel project (NSABP) breast cancer prevention trial. Stats Med. 1998;17;613622.
Ganz PA, Day R, Ware JE, Redmond C, Fisher B. Base-line quality-of-life assessment in the national
surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst. 1995;
87(18):1372-1382.
Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in longterm, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002;94 (1):3949.
Ganz PA, Greendale GA. Female sexual desire – beyond testosterone. J Natl Cancer Inst. 2007:659661 [editorial].
Ganz PA, Haskell CM, Figlin A, La Soto N, Siaus J. Estimating the quality of life in clinical trial of
patients with metastatic lung cancer using the Functional Living Index-Cancer. Cancer. 1988;61
(4):849-856.
Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer:
first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004;96:376–387.
Ganz PA, Kwan L, Stanton AL, Bower JE, Belin TR. Physical and psychosocial recovery in the year
after primary treatment of breast cancer. Journal of Clinical Oncology. 2011;29(9):1101-1109.
Ganz PA, Land SR, Geyer Jr CE, Cecchini RS, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN,
Polikoff JA, Vogel VG, Erban JK, Livingston RB, Perez EA, Mamounas EP, Wolmark N, Swain SM.
Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated
with adjuvant therapy on the NSABP B-30 trial. Journal of Clinical Oncology. 2011;29(9):1110-1116.
Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in
lung cancer. Cancer. 1991;67:3131–3135.
D:\478174570.doc
Ganz PA, Litwin MS. Editorial: Prostate cancer: The price of early detection. J Clin Oncol.
2001;19:1587-1588.
Ganz PA, Moinpour CM, Pauler DK, et al. Health status and quality of life in patients with early-stage
hodgkin’s disease treated on Southwest Oncology Group Study 9133. J Clin Oncol. 2003;21(18):
3512-3519.
Ganz PA, Polinsky ML, Schag CAC, Heinrich RL. Rehabilitation of patients with primary breast cancer:
Assessing the impact of adjuvant therapy. Rec Res Can Res. 1989;115:244-254.
Ganz PA, Schag CAC, Cheng HL. Assessing the quality of life: A study in newly-diagnosed breast
cancer patients. J Clin Epidemiol. 1990;43(1):75-86.
Ganz PA, Schag CC, Heinrich RL. The psychological impact of cancer on the elderly: A comparison
with younger patients. J Am Geriatrics Soc. 1985;33:429-435.
Ganz PA, Schagm CAC, Lee JJ, Polinsky ML, Tan SJ. Breast conservation versus mastectomy: Is
there a difference in psychological adjustment or quality of life in the year after surgery? Cancer.
1992;69:1729-1738.
Ganz PA. Impact of tamoxifen adjuvant therapy on symptoms, functioning and quality of life. J Natl
Cancer Inst Mono. 2001;30:130-134.
Ganz PA. Quality of life and the patient with cancer: Individual and policy implications. Cancer.
1994(B);74;1445-1452.
Ganz PA. What outcomes matter to patients: a physician-researcher point of view. Med Care.
2002;40(6)(Supplement):III-11-III-19.
Ganzini L, Gooy ER, Miller LL, Harvath TA, Jackson A, Delorit MA. Nurses’ experiences with hospice
patients who refuse food and fluids to hasten death. New Engl J Med. 2003;349(4):359-365.
Garattini S, Chalmers I. Patients and the public deserve big changes in evaluation of drugs. BMJ.
2009;338:804-807.
Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, Palmer JL, Cohen L. Systematic Review of
Acupuncture in Cancer Care: A Synthesis of the Evidence. Journal of Clinical Oncology.
2013;31(7):952-960.
Garcia-Arosta S. The European Regulatory Issues on Quality of Life Assessment Group Guidance:
some critical comments. Drug Inf J. 2003;37:355-356.
Gardner A, Mattiuzzi G, Faderl S, Borthakur G, Garcia-Manero G, Pierce S, Brandt M, Estey E.
Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction
Therapy for Acute Myeloid Leukemia. Journal of Clinical Oncology. 2008;26(35):5684-5688..
Gardner DG, Cummings LL, Dunham RB, Pierce JL. Single-item versus multiple-item measurement
scales: An empirical comparison. Educ Psycholog Measurement. 1998;58(6):898-915.
D:\478174570.doc
Garrity TF, Somes GW, Marx MB. Factors influencing self-assessment of health. Soc Sci Med.
1978;12:77-81.
Garssen B, Goodkin K. On the role of immunological factors as mediators between psychosocial
factors and cancer progression. Review. Psychiatry Res. 1999;85(1):51-61.
Gasparini G, Gion M. Molecular-targeted anticancer therapy: challenges related to study design and
choice of proper endpoints. Cancer J. 2000;6(3):117–131.
Gattellari M, Ward JE. Measuring men’s preferences for involvement in medical care: getting the
question right. Journal of Evaluation in Clinical Practice. 2005;11(3):237-246.
Geels P, Eisenhauer E, Bezjak A, Zee B, Day A. Palliative effect of chemotherapy: Objective tumor
response is associated with symptom improvement in patients with metastatic breast cancer. J Clin
Oncol. 2000;18:2395-2405.
Gehring K, Sitskoorn MM, Gundy CM, Sikkes SAM, Klein M, Postma TJ, van den Bent MJ, Beute GN,
Enting RH, Kappelle AC, Boogerd W, Veninga T, Twijnstra A, Boerman DH, Taphoorn MJB, Aaronson
NK. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. Journal of
Clinical Oncology. 2009;27(22):3712-3722.
Geiger AM, West CN, Nekhlyudov L, et al. Contentment with quality of life among breast cancer
survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006;24:1350-1356.
Geiser F, Hahn C, Conrad R, Liedtke R, Sauerbruch T, Schmidt-Wolf I, Glasmacher A. Interaction of
psychological factors and the effect of epoetin alfa treatment in cancer patients on hemoglobin and
fatigue. Support Care Cancer. 2007;15:273-278.
Gelber RD, Cole BF, Gelber S, Goldhirsch A. Comparing treatments using quality-adjusted survival:
the Q-Twist method. Am Stat. 1995;49(2):161–169.
Gelber RD, Cole BF, Goldhirsch A, et al. Adjuvant chemotherapy plus tamoxifen compared with
tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
Lancet. 1996:347:1066-1071.
Gelber RD, Gelman RS, Goldhirsch A. A quality-of-life-orientated endpoint for comparing therapies.
Biometrics. 1989;45:781-795.
Gelber RD, Goldhirsch A, Cavalli F. Quality-of-life-adjusted evaluation of adjuvant therapies for
operable breast cancer. Ann Intern Med. 1991;114:621-628.
Gelber RD, Goldhirsch A, Cole BF, Wieand HS, Schroeder G, Krook, JE. A quality-adjusted time
without symptoms or toxicity (Q-Twist) analysis of adjuvant radiation therapy and chemotherapy for
resectable rectal cancer. J Natl Cancer Inst. 1996;88(15):1039-1045.
Gelber RD, Goldhirsch A, Cole BF. Evaluation of effectiveness: Q-TWiST. Cancer Treat Rev.
1993;19(Supplement A):73-84.
D:\478174570.doc
Gelber RD, Goldhirsch A, Cole BF. Parametric extrapolation of survival estimates with applications to
quality of life evaluation of treatments. Control Clin Trials. 1993;14:485-499.
Gelber RD, Goldhirsch A. A new endpoint for the assessment of adjuvant therapy in postmenopausal
woman with operable breast cancer. J Clin Oncol. 1986;1772-1779.
Gelber RD, Goldhirsch A. Comment. Stat Med. 1992;11:439-441.
Gelber RD, Lenderking WR, Cotton DJ, et al. Quality-of-life evaluation in a clinical trial of zidovudine
therapy in patients with mildly symptomatic HIV infection. Ann Int Med. 1992;116:961-966.
Gelfand GA, Finley RJ. Quality of life with carcinoma of the esophagus. World J Surg. 1994;18:399405.
Gelfman LP, Morrison RS. Research funding for palliative medicine. J Palliat Med 2008;11(1):36-39.
Gelin MN, Zumbo BD. Differential item functioning results may change depending on how an item is
scored: an illustration may change depending on how an item is scored: an illustration with the
center for epidemiologic studies depression scale. Educational and Psychological Measurement.
2003;63(1):65.
Gemke RJBJ, Bonsel GJ. Reliability and validity of a comprehensive health status measure in a
heterogeneous population of children admitted to intensive care. J Clin Epidemiol 1996;49(3):327333.
Genc A, Can G, Aydiner A. The efficiency of the acupressure in prevention of the chemotherapyinduced nausea and vomiting. Supportive Care in Cancer. 2013;21(1):253-262.
Georges J-J, Onwuteaka-Philipsen BD, van der Heidi A, van der Wal G, va der Maas PJ. Symptoms,
treatment and „dying peacefully“ in terminally ill cancer patients: a prospective study. Support Care
Cancer. 2005;13:160-168.
Gerber LH, Stout N, McGarvey C, Soballe P, Shieh C-y, Diao G, Springer BA, Pfalzer LA. Factors
predicting clinically significant fatigue in women following treatment for primary breast cancer.
Supportive Care in Cancer. 2011;19(10):1581-1592.
German PS, Shapiro S, Skinner EA, Von Korff M, Klein LE, Turner RW, Teitelbaum ML, Burke B, Burns
BJ. Detection and management of mental health problems of older patients by primary care
providers. JAMA. 1987;257:489-493.
Gerretsen P, Myers J. The Physician: A Secure Base. Journal of Clinical Oncology.
2008;26(32):5294-5296.
Gershon R, Cella D, Dineen K, Rosenbloom S, Peterman A, Lai J-S. Item response throry and health
related quality of life in cancer. Expert Review of Pharmacoeconomics and Outcomes Research.
2003;3(6):783-791.
Gerstle DS, All AC, Wallace DC. Quality of life and chronic nonmalignant pain. Pain Manag Nurs.
2001;2(3):98–109.
D:\478174570.doc
Giacalone A, Polesel J, De Paoli A, Colussi AM, Sartor I, Talamini R, Tirelli U. Assessing cancerrelated fatigue: the psychometric properties of the revised piper fatigue scale in Italian cancer
patients. Supportive Care in Cancer. 2010;18(9):1191-1198.
Giannousi Z, Gioulbasanis I, Pallis AG, Xyrafas A, Dalliani D, Kalbakis K, Papadopoulos V, Mavroudis
D, Georgoulias V, Papadndreou CN. Nutritional status, acute phase response and depression in
metastatic lung cancer patients: correlations and association prognosis. Supportive Care in Cancer.
2012;20(8):1823-1829.
Giannin L, Cole BF, Panzini I, Snyder R, Holmberg SB, Byrne M, Crivellari D, Colleoni M, Aebi S,
Simoncini E, Pagani O, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS, Ravaioli A. Anemia
during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from
two trials of the International Breast Cancer Study Group. Support Care Cancer. 2008;16:67-74.
Gibbons F. Social comparison as a mediator of response shift. Soc Sci Med. 1999;48:1517-1530.
Gibson MK, Li Y, Murphy B, Hussain MHA, DeConti RC, Ensley J, Forastiere AA. Randomized phase
III evaluation of cisplatin plus fluoriouracil versus cisplatin plus paclitaxel in advanced head and neck
cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol.
2005;23(15):3562-3597.
Gielissen MFM, Wiborg JF, Verhagen CAHHVM, Knoop H, Bleijenberg G. Examing the role of physical
activity in reducing postcancer fatigue. Supportive Care in Cancer. 2012;20(7):1441-1448.
Giesler RB, Miles BJ, Cowen ME, Kattan MW. Assessing quality of life in men with clinically localized
prostate cancer: Development of a new instrument for use in multiple settings. Qual Life Res.
2000;9:645-665.
Giesler RB, Williams S.D. Opportunities and challenges: Assessing quality of life in clinical trials. J
Natl Cancer Inst. 1998;90:1498-1499.
Gilbody SM, House AO, Sheldon T. Routine administration of health-related quality of life and needs
assessment instruments to improve psychological outcome – a systematic review. Psychol Med.
2002;32;1345-1356.
Gilbody SM, House AO, Sheldon T. Routinely administered questionnaires for depression and
anxiety: a systematic review. BMJ. 2001;322:406-409.
Gill A, Daines P, Selby D. What do symptom scores mean: observations on discrepancies when
defining symptoms using words and numbers. Eur J Oncol Nurs. 2010;14(5):435-8. Epub 2010 May
27.
Gill D, Hatcher S. Antidepressants for depression in medical illness. The Cochrane Database of
Systematic Reviews. 2004;Vol 1.
Gill TM, Feinstein AR. A critical appraisal of the quality-of-life measurements. JAMA 1994;272:619626.
D:\478174570.doc
Giordano A, Mattarozzi K, Pucci E, Leone M, Casini F, Collimedaglia L, Solari A. Participation in
medical decision-making: Attitudes of Italians with multiple sclerosis. Journal of the Neurological
Sciences. 2008;275(1-2):86-91.
Giorgi F, Cellerino R, Gramazio A, Tummarello D, Menichetti ET, Giordani P, Antognoli S, Carle F, Piga
A. Assessing quality of life in patients with cancer: A comparison of a visual-analogue and a
categorical model. Am J Clin Oncol . 1996;19(4):394-399.
Girgis A, Breen S, Stacey F, Lecathelinais C. Impact of two supportive care interventions on anxiety,
depression, quality of life, and unmet needs in patients with nonlocalized breast and colorectal
cancers. Journal of Clinical Oncology. 2009;27(36):6180-6190.
Given B, Given C, Azzouz F, Stommel M. Physical functioning of elderly cancer patients prior to
diagnosis and following initial treatment. Nurs Res. 2001;50(4):222-232.
Given B, Given C, Sikorskii A, et al. Establishing mild, moderate and severe scores for cancer related
symptoms: How consistent and clinically meaningful are interference based severity cut points?
Journal of Pain and Symptom Management. 2008;35(2):126-135.
Given B, Given CW, McCorkle R, Kozachik S, Cimprich B, Rahbar MH. Pain and fatigue management:
results of a nursing randomized clinical trial. Oncol Nurs Forum. 2002;29(6):949-966.
Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioral intervention on reducing symptom
severity during chemotherapy. J Clin Oncol. 2004;22:507–516.
Given CW, Sikorskii A, Tamkus D, Given B, You M, McCorkle R, Champion V, Decker D. Managing
Symptoms Among Patients With Breast Cancer During Chemotherapy: Results of a Two-Arm
Behavioral Trial. Journal of Clinical Oncology. 2008;26(36):5855-5862.
Gladis MM, Gosch EA, Dishuk NM, Crits-Christoph P. Quality of life: Expanding the scope of clinical
significance. J Cont Clin Psychol. 1999;67(3):320-331.
Glare P, Eychmueller S, McMahon P. Diagnostic accuracy of the palliative prognostic score in
hospitalized patients with advanced cancer. J Clin Oncol. 2004;22:4771-4776.
Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M. Systematic review of the efficacy of
antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer.
2004;12:432–440.
Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy
with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer
chemotherapy in community onoclogy practice. J Clin Oncol. 1997;15:1218–1234.
Glaspy J, Vadhan-Raj S, Patel R, et al. Randomized comparison of every-2-week darbepoetin alfa
and weekly epoetin alfa for the treatment of chemotherapy-induuced anemia: The 20030125 Study
Group Trial. J Clin Oncol. 2006;24(15):2290-2297.
Glaspy J. Optimizing the dose and schedule of darbepoetin alfa in patients with chemotherapyinduced anemia. Oncology (Suppl). 2006;20(8):29-32.
D:\478174570.doc
Glaspy JA, Ludwig H, Cella D. Next generation growth factors: Anemia. Oncology Spectrums.
2002;3(2) (Suppl. 1):49-56.
Glastein E, Makuch RW. Illusion and reality: practical pitfalls in interpreting clinical trials. J Clin
Oncol. 1984;2(5):488-497.
Glasziou PP, Cole BF, Gelber RD, Hilden J, Simes RJ. Quality adjusted survival analysis with repeated
quality-of life- measures. Stat Med. 1998;17:1215-1229.
Glasziou PP, Simes RJ, Gelber RD. Quality adjusted survival analysis. Stat Med. 1990; 9:1259-1276.
Glaus A, Knipping C, Morant R, et al. Chemotherapy-induced nausea and vomiting in routine
practice: a European perspective. Support Care Cancer. 2004;12:708-715.
Glick H A, Shpall EJ, LeMaistre CF, et al. Empirical criteria for the selection of quality-of-life
instruments for the evaluation of peripheral blood progenitor cell transplantation. Int J Technol
Assess Health Care. 1998;14(3):419-430.
Glimelius B, Hoffman K, Olafsdottir Pahlman L, Sjoden P, Wennbert A. Quality of life during cytostatic
therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens.
Eur J Cancer Clin Oncol. 1989;25(5):829-835.
Globe DR, Hays RD, Cunningham WE. Associations of clinical parameters with health-related quality
of life in hospitalized persons with HIV disease. AIDS Care. 1999;11(1):71-86.
Gluud C, Sorensen TIA. Organisation of a clinical trial unit – a proposal. Fundam Clin Pharmacol.
1998;12:298-305.
Gnant MFX, Mlineritsch B, Luschin-Ebengruth G, Grampp S, Knessmann H, et al. Zoledronic acid
prevents cancer treatment-induced bone loss in premenopausal women receiving adjubant endocrine
therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal
Cancer study Group. J Clin Oncol. 2007;25(7):820-828.
Goddard G, Karibe H, McNeill C. Reproductivity of Visual Analog Scale (VAS) pain scores to
mechanical pressure. J Craniomandibular Pract. 2004;22(3):250–256.
Godden DRP, Robertson JM. The value of patient feedback in the audit of TMJ arthoscopy. Br Dent
J. 2000;188(1):37-39.
Goddijn P, Bilo H, Meadows K, Groenier K, Feskens E, Meyboom-de Jong B. The validity and
reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapy. Qual
Life Res. 1996;5:433-442.
Godette K, Mondry TE, Johnstone PAS. Can manual treatment of lymphedema promote metastasis?
J Soc Integr Oncol. 2006;4(1):8-12.
Goebel S, Strenge H, Mehdorn HM. Acute stress in patients with brain cancer during primary care.
Supportive Care in Cancer. 2012;20(7):1425-1434.
D:\478174570.doc
Goelz T, Wuensch A, Stubernrauch S, Ihorst G, de Figueiredo M, Bertz H, Wirsching M, Fritzsche K.
Specific training program improves oncologists’ palliative care communication skills in a randomized
controlled trial. Journal of Clinical Oncology. 2011;29(25):3402-3407.
Goetz MP, Loprinzi CL. A hot flash on tamoxifen metabolism. J Natl Cancer Inst. 2003;95:17341735.
Goldberg DP, Hillier VF. A scaled version of the general health question. Psychol Med. 1979;9:139–
145.
Goldberg GR, Morrison RS. Pain management in hospitalized cancer patients: a systematic review. J
Clin Oncol. 2007;25(13):1792-1801.
Goldberg ST, Chiang L, Selina N, Hamarman S. Patient perceptions about chemotherapy-induced
oral mucositis: implication for primar/secondary prophylaxis strategies. Support Care Cancer.
2004;12(7):526-530.
Golden WE. Health status measurement: implementation strategies. Med Care. 1992;30(5):MS187MS195.
Goldman Sher T, Cella D, Leslie W, Bonomi P, Taylor IV S, Serafian B. Communication Differences
Between Physicians and Their Patients in an Oncology Setting. Journal of Clinical Psychology in
Medical Settings. 1997;4(3):281-293.
Goldhirsch A, Gelber RD, Simes RJ, Glasziou P, Coates AS. Costs and benefits of adjuvant therapy in
breast cancer: a quality-adjusted survival analysis. J Clin Oncol. 1989;7:36-44.
Goldsmith G, Brodwick M. Assessing the functional status of older patients with chronic illness. Fam
Med. 1989;21:48-41.
Goldstein MK, Miller DE, Garber AM. Quality of life assessment software for computer inexperienced
older adults: multimedia utility elicitation for activities of daily living. Proceedings/AMIA/Annual
Symposium. 2002;295–299.
Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomized controlled trial of
respiratory rehabilitation. Lancet. 1997;344:1394-1397.
Golledge J, Wiggins JE, Callam MJ. Age-related variation in the treatment and outcomes of patients
with breast carcinoma. Cancer. 2000;88(2):369-374.
Gollust SE, Thompson RE, Gooding HC, Biesecker BB. Living with achondroplasia: attitudes toward
population screening and correlation with quality of life. Prenat Diagn. 2003;23:1003–1008.
Gollust SE, Thompson RE, Gooding HC, Biesecker BB. Living with achondroplasia in an average-sized
world: an assessment of quality of life. Am J Med Genet. 2003;120A(4):447-58.
Gonin R, Lloyd S, Cella D. Establishing equivalence between scaled measures of quality of life. Qual
Life Res. 1996;5:20-26.
D:\478174570.doc
Goodman SN, Zahurak ML, Piantadosi S. Some practical improvements in the continual reassessment
method for phase I studies. Stat Med. 1995;14:1149–1161.
Goodman SN. Toward evidence-based medical statistics. the P value fallacy. Ann Intern Med.
1999;130(12):995-1004.
Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality of life measurement in
randomized clinical trials in breast cancer: taking stock. J Natl Cancer Inst. 2003;95(4):263-281.
Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in
metastatic breast cancer. New Engl J Med. 2001;345(24):1719-1725.
Goodwin PJ. Health-related quality of life and psychosocial status in breast cancer prognosis:
analysis of multiple variables. J Clin Oncol. 2004;22:4184–4192.
Goodwin PJ. Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide
adjuvant treatment decisions in breast cancer? J Clin Oncol. 2003;21(24):4474–4475.
Gopalkrishnan RV, Kang DC, Fisher PB. Molecular markers and determinants of prostate cancer
metastasis. J Cell Physiol. 2001:189(3):245-56.
Gordan JD, Chay W-Y, Kelley RK, Ko AH, Choo S-P, Venook AP. “And What Other Medications Are
You Taking?” Journal of Clinical Oncology. 2011;29(11):e288-e291.
Gore SM. Integrated reporting of quality and length of life--A statistician's perspective. Eur Heart J.
1988;9:228-234.
Gorin SS, Krebs P, Badr H, Janke EA, Jim HSL, Spring B, Mohr DC, Berendsen MA, Jacobsen PB.
Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. Journal of Clinical
Oncology. 2012;30(5):539-547.
Gotay CC, Moinpour CM, Moody-Thomas S, et al. Behaviorial science research in the cooperative
group setting: the Southwest Oncology Group Experience. J Natl Cancer Inst. 2000;92(17):1381–
1387.
Gotay CC, Moinpour CM, Unger JM, Jiang CS, Coleman D, Martino S, Parker BJ, Bearden JD, et al.
Impact of a peer-delivered telephone intervention for women experiencing a breast cancer
recurrence. J Clin Oncol. 2007;25(15):2093-2099.
Gotay CC, Stern JD. Assessment of psychological functioning in cancer patients. Psychosocial
Resource Variables in Cancer Studies. 1995;13:123-160.
Gotay CC. Assessing cancer-related quality of life across a spectrum of applications. J Natl Cancer
Inst. Monographs 2004;33:126–133.
Gotay CC. Quality of life in patients who survive a dire prognosis compared to control cancer
survivors. Psycho-Oncol. 2004;13:882-892.
D:\478174570.doc
Gotay CC. Social psychological factors in placebo-controlled clinical trials. J Clin Oncol.
2008;26(8):1206-1207.
Gotay CC, Kawamoto CT, Bottemley A, Efficace F. The prognostic significance of patient-reported
outcomes in cancer clinical trials. J Clin Oncol. 2008;26(8):1355-1363.
Gough IR, Furnival CM, Schilder L, Grove W. Assessment of the quality of life of patients with
advanced cancer. Euro J Cancer Clin Oncol. 1983;19(8):1161-1165.
Gower NH, Rudd RM, Ruiz de Elvira MC, et al. Assessment of ‘quality of life’ using a daily diary card
in a randomised trial of chemotherapy in small-cell lung cancer. Ann Oncol. 1995;6(6):575-580.
Gracovetsky SA, Newman NM, Richards MP, Asselin S, Lanzo VF, Marriott A. Evaluation of clinician
and machine performance in the assessment of low back pain. Spine. 1998;23(5):568-575.
Grady D, Macer J, Kristof M, Shen H, Tagliaferri M, Creasman J. Is a shorter hot flash diary just as
good as a 7-day diary? Menopause: The Journal of the North American Menopause Society.
2009;16(5):932-936.
Graf J, Koch M, Dujardin R, Kersten A, Janssens U. Health-related quality of life before, 1 month
after, and 9 months after intensive care in medical cardiovascular and pulmonary patients. Crit Care
Med. 2003;31:2163-2169.
Graff W, Pahlman L, Bergstrom R, Glimelius B. The relationship between an objective response to
chemotherapy and survival in advanced colorectal cancer. Br J Cancer. 1994;70(3):559–563.
Graham C, Bond SS, Gerkovich MM, Cook MR. Use of the McGill pain questionnaire in the
assessment of cancer pain: replicability and consistency. Pain. 1980;8:377-387.
Gralla RJ, Edelman MJ, Detterbeck FC, Jahan TM, Loesch DM, Limentani SA, Govindan R, Peng G,
Monberg MJ, Obasaju CK, Socinski MA. Assessing quality of life following neoadjuvant therapy for
early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung
Cancer Symptom Scale (LCSS). Supportive Care in Cancer. 2009;17(3):307-314.
Gralla RJ, Hollen PJ, Eberley S, Cox C, et all. Quality of Life score predicts both response and survival
in patients receiving chemotherapy for non-small cell lung cancer [abstract]. Support Care Cancer.
1995;3:378-79.
Gralla RJ, Kim YS, Lynch T, et al. First-line Docetaxel-Carboplatin (DCb) of Docetaxel-Cisplatin (DC)
versus Vinorelbine-Cisplatin (VC) provide better quality of life in advanced non-small cell lung cancer
(NSCLC) patients: results from a multinational Phase III Study. ASCO 2002 Poster Presentation.
Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: evidence-based,
clinical practice guidelines. J Clin Oncol. 1999;17(9):2971-2994.
Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winert EP, Bonner J, Demetri GD, Curran Jr
W, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH,
Sawaya R, Schuchter LM, Sweetenham JW, Vahda LT, Davidson NE, Schilsky RL, Lichter AS. Clinical
D:\478174570.doc
cancer advances 2007: Major research advances in cancer treatment, prevention, and screening – A
report from the American Society of Clinical Oncology. J Clin Oncol. 2008;26(2):313-325.
Granda-Cameron C, Viola SR, Lynch MP, Polomano RC. Measuring patient-oriented outcomes in
palliative care: functionality and quality of life. Clin J Oncol Nurs. 2008;12(1):65-77.
Grande GE, Addinton-Hall JM, Todd CJ. Place of death and access to home care services are certain
patient groups at a disadvantage? Soc Sci Med. 1998;47:565-579. J Clin Oncol. 1999;17(9):29712994.
Grande GE, Todd CJ, Barclay SIG, Farquar MC. Does hospital at home for palliative care facilitate
death at home? Randomized controlled trial. BMJ. 1999;319:1472–1475.
Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI. Effect of prevention
strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated
decision analysis. J Clin Oncol. 2002;20(10):2520-2521.
Grann VR, Jacobson JS. Population screening for cancer-related germline gene mutations. Lancet
Oncol. 2002;3(6):341-8.
Grant M, Ferrell B, Dean G, Uman G, Chu D, Krouse D. Revision and psychometric testing of the City
of Hope Quality of Life Ostomy Questionnaire. Qual Life Res. 2004;13:1445–1457.
Grant M, Elk R, Ferrell B, Morrison S, von Gunten CF. Current status of palliative care-clinical
implementation, education, and research. A Cancer Journal for Clinicians. 2009;59:327-332.
Grant CS, Ingle JN, Suman VJ, Dumesic DA, Wickerham DL, Gelber RD, Flynn PJ, Weir LM, Intra M,
Jones WO, Perez EA, Hartmann LC. Menstrual cycle and surgical treatment of breast cancer: findings
from the NCCTG N9431 study. Journal of Clinical Oncology. 2009;27(22):3620-3626.
Gravel J, Opatrny L, Shapiro S. The intention-to-treat approach in randomized controlled trials: Are
authors saying what they do and doing what they say? Society for Clinical Trials. 2007;4:350-356.
Gray SW, Hlubocky FJ, Ratain MJ, Daugherty CK. Attitudes toward research participation and
investigator conflicts of interest among advanced cancer patients participating in early phase clinical
trials. J Clin Oncol 2007;25(23):3488-3494.
Grealish L, Lomasney A, Whiteman B. A nursing intervention to modify the distressing symptoms of
pain and nausea in patients hospitalized with cancer. Cancer Nurs. 2000;23:237-243.
Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M. Treatment-related fatigue and serum
interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom
Manage. 1993;8:196–200.
Greenberg DB. Barriers to the treatment of depression in cancer patients. J Natl Cancer Inst
Monogr. 2004;32:127-135.
Greendale GA, Silverman SL, Hays RD, et ak. Health-related quality of life in osteoporosis clinical
trials. Calcified Tissue Int. (Editorial). 1993;53:75-77.
D:\478174570.doc
Greene D, Nail LM, Fieler VK, Dudgeon D, Jones LS. A comparison of patient-reported side effects
among three chemotherapy regimens for breast cancer. Cancer Pract. 1994;2(1):57-62.
Greene PB, Philip EJ, Poppito SR, Schnur JB. Mindfulness and psychosocial care in cancer: Historical
context and review of current and potential applications. Palliative and Supportive Care.
2012;10(4):287-294.
Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care. Ann Intern Med.
1985;102:520-528.
Greenfield S, Nelson EC. Recent deveoopments and future issues in the use of health status
assessment measures in clinical settings. Med Care. 1992;30(5):MS23-MS41.
Greenhalgh J, Long AF, Brettle AJ, Grant MJ. Reviewing and selecting outcome measures for use in
routine practice. J Eval Clin Pract. 1998;4(4):339-350.
Greenhalgh J, Long AF, Flynn F. The use of patient reported outcome measures in routine clinical
practice: lack of impact or lack of theory? Soc Sci Med. 2005;60:833-843.
Greenhalgh J, Meadows K. The effectiveness of the use of patient-based measures of health in
routine practice in improving the process and outcomes of patient care: A literary review. J Eval Clin
Pract. 1999;5(4):401-416.
Greenwald HP, Bonica JJ, Bergner M. The prevalence of pain in four cancers. Cancer. 1987;60:
2563-2569.
Greenwald HP. Interethnic differences in pain perception. Pain. 1991;44:157-163.
Greenwald HP. The specificity of quality-of-life measures among the seriously ill. Med Care.
1987;25(7):642-651.
Greer JA, Piri WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS, Gallagher ER, Temel JS. Effect of
early palliative care on chemotherapy use and end-of-life care in patients with metastic non-small-cell
lung cancer. Journal of Clinical Oncology. 2012;30(4):394-400.
Greer S. Can psychological therapy improve the quality of life of patients with cancer? Br J Cancer.
1989;59:149-151.
Greer S. Patients’ adjustment to cancer: the mental adjustments to cancer (MAC) scale vs. clinical
ratings. J Psychosom Res. 1989;33(3):373-377.
Greiner L, Buhr B, Phelps D, Ward S. A palliative care needs assessment of health care institutions in
Wisconsin. J Palliat Med. 2003;6(4)543-552.
Greisinger AJ, Lorimor RJ, Aday LA, Winn RJ, Baile WF. Terminally ill cancer patients, their most
important concerns. Cancer Pract. 1997;5(3):147–154.
Greisinger AJ, Weitzner MA, Lorimor RJ, et al. Development of a quality of life module for endstage
cancer patients. Proc Ann Meet Am Soc Clin Oncol. 1995;14:A1641.
D:\478174570.doc
Greiss Jr FC, Linton EB, Lock FR, Rhyne AL. The statistical evaluation of cancer survival. Am J
Obstet Gynecol. 1964;90:703-14.
Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 Year of outpatient multidisciplinary pulmonary
rehabilitation: a randomized controlled trial. Lancet. 2000;355:362-368.
Griggs JJ, Culakova E, Sorvero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC,
Lyman GH. J Clin Oncol. 2007;25(3):277-284.
Gripp S, Moeller S, Boke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Budach W, et al.
Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and selfrated anxiety and depression. J Clin Oncol 2007;25(22):3313-3320.
Gritz ER, Carmack CL, de Moor C. First year after head and neck cancer: quality of life. J Clin Oncol.
1999;17(1):352-360.
Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM.
Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol.
2005;23:1902-1910.
Groenvold M, Fayers PM, Sprangers MAG, et al. Anxiety and depression in breast cancer patients at
low risk of recurrence compared with the general population: a valid comparison? J Clin Epidemiol.
1999;52(6):523-530.
Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 quality of
life questionnaire through combined qualitative and quantitative assessment of patient-observer
agreement. J Clin Epidemiol. 1997;50:441-450.
Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and patterns of symptoms in patients with
cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain
Symptom Manage. 1994;9:372-382.
Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective
evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64:107–114.
Gronlund B, Hansen HH, Hogdall C, Hogdall EV, Engelhom SA. Do CA125 response criteria
overestimate tumour response in second-line treatment of epithelial ovarian carcinoma? Br J Cancer.
2004;26:377-382.
Gronlund B, Hogdall C, Hilden J, Engelholm SA, Hogdall EVS, Hansen HH. Should CA-125 response
criteria be preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for prognostication
during second-line chemotherapy of ovarian carcinoma? J Clin Oncol. 2004;22:4051-4058.
Groopman J. God at the beside. N Engl J Med. 2004;350(12):1176–1178.
Gross MW, Altscher R, Brandtner M, Hausser-Mischlich H, Kiricuta I, Siegmann AD, Engenhart-Cabillic
R. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of
glioblastomas with topotecan (hycamtin). Strahlenther Onkol. 2001;177(12):656-661.
D:\478174570.doc
Gross CR, Kreitzer MJ, Reilly-Spong M, Winbush NY, Schomaker EK, Thomas W. Mindfulness
meditation training to reduce symptom distress in transplant patients: rationale, design, and
experience with a recycled waitlist. Clinical Trials. 2009;6(1):76-89.
Grossardt BR, Bower JH, Geda YE, Colligan RC, Rocca WA. Pessimistic, anxious, and depressive
personality traits predit all-cause mortality: The Mayo Clinic cohort study of personality and aging.
Psychosomatic Medicine. 2009;71:pgs 1-10.
Grossi F, Belvedere O, Fasola G, et al. Tumor measurements on computed tomographic images of
non-small cell lung cancer were similar among cancer professionals from different specialties. J Clin
Epidem. 2004;57:804-808.
Grothey A, Goldberg RM. A review of oxaliplatin and its clinical use in colorectal surgery. Expert
Opin Pharmacother. 2004;5(10):2159-2170.
Grothey A, Marshall JL. Optimizing palliative treatment of metastatic colorectal cancer in the era of
biologic therapy. Oncology. 2007; 553
Groutz A, Blaivas JG, Chaikin DC, et al. Noninvasive outcome measures of urinary incontinence and
lower urinary tract symptoms: a multicenter study of micturition diary and pad tests. J Urol.
2000;164(3 part 1):698-701.
Grov EK, Fossa SD, Dahl AA. Insomnia in elderly cancer survivors-a population-based controlled
study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health
Survey of North-Trondelag County (HUNT-2). Supportive Care in Cancer. 2011;19(9):1319-1326.
Grube BJ, Hansen NM, Ye W, Herlong T, Giuliano AE. Surgical management of breast cancer in the
elderly. Am J Surg. 2001;182:359-364.
Grumann MM, Spiegel D. Living in the face of death: interviews with 12 terminally ill women on
home hospice care. Palliat Support Care. 2003;1:23-32.
Grunberg S, Chua D, Maru A, Dinis J, DeVandry S, Boice JA, Hardwick JS, Beckford E, Taylor A,
Carides A, Roila F, Herrstedt J. Single-dose fosaprepitant for the prevention of chemotherapyinduced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study
protocol – EASE. Journal of Clinical Oncology. 2011;29(11):1495-1501.
Grunberg SM, Boutin N, Ireland A, Miner S, Silveira J, Ashikaga T. Impact of nausea/vomiting (N/V)
on quality of life (QOL) as a visual analogue scale (VAS)-derived utility score (US). Proc Annu Meet
Am Soc Clin Oncol. 1995;14:A896.
Grunberg SM, Groshen S, Steingass S, Zaretsky S, Meyerowitz B. Comparison of conditional quality of
life terminology and visual analogue scale measurements. Qual Life Res. 1996;5:65-72.
Grunberg SM, Hansen M, Deuson RR, et al. Incidence of chemotherapy-induced nausea and emesis
after modern antiemetics. Cancer. 2004;100:2261-2268.
D:\478174570.doc
Grunberg SM, Osoba D, Hesketh PJ, Gralla RJ, Borjeson S, Rapoport BL, du Bois A, Tonato M.
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity – an
update. Support Care Cancer. 2005;13:80-84.
Grunberg SM, Vanden Burgt J, Berry S, et al. Prevention of delayed nausea and vomiting: carryover
effect analysis of pooled data from 2 phase III studies of palonosetron. Proc Am Soc Clinic Oncol.
2004;23:738. Abstract 8051.
Grunberg SM. Consistent definitions of tumor response. J Clin Oncol. 1986;4(4):609-610.
Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, Joy AA, Provencher L, Rayson D,
Rheaume DE, Porter GA, Paszat LF, Pritchard KI, Robidoux A, Smith S, Sussman J, Dent S, Sisler J,
Wiernikowski J, Levine MN. Evaluating survivorship care plans: results of a randomized, clinical trial
of patients with breast cancer. Journal of Clinical Oncology. 2011;29(36):4755-4762.
Grunfeld E, Folkes A, Urquhart R. Do Available Questionnaires measure the Communications Factors
That patients and Families Consider Important at End of Life? J Clin Oncol. 2008;26(23):3874-3878.
Grunfeld E, Zitzelsberger L, Coristine M, Whelan TJ, Aspelund F, Evans WK. Job stress and job
satisfaction of cancer care workers. Psycho-Oncol. 2005;14:61-69.
Grunfeld EA, Maher EJ, Browne S, et al. Advanced breast cancer patients’ perceptions of decision
making for palliative chemotherapy. J Clin Oncol. 2006;24:1090-1098.
Guadagnoli E, Mor V. Measuring cancer patients' affect: revision and psychometric properties of the
Profile of Mood States (POMS). Psychol Assess. 1989;1(2):150-154.
Guadagnoli E, Shapiro C, Gurwitz JH, et al. Age-related paterns of care: evidence against ageism in
the treatment of early-stage breast cancer. J Clin Oncol. 1997;15(6):2338-2344.
Guarino P, Peduzzi P, Donta ST, et al. a multicenter two by two factorial trial of cognitive behavioral
therapy and aerobic exercise for gulf war veterans’ illnesses: design of a veterans affairs cooperative
study. Elsevier Science Inc. 2001;23:310-332.
Gudex C, Dolan P, Kind P, Williams A. Health state valuations from the general public using the
Visual Analogue Scale. Qual Life Res. 1996;5:521-531.
Guell R, Casan P, Sangenis M, Morante F, Belda J, Guyatt GH. Quality of life in patients with chronic
respiratory disease: the spanish version of the Chronic Respiratory Questionnaire (CRQ). Eur Respir
J. 1998;11(1):55-60.
Guitera V, Munoz P, Castillo J, Pascual J. Quality of life in chronic daily headache: a study in a
general population. Neurology. 2002;58:1062–1065.
Gujral S, Avery KNL, Blazeby JM. Quality of life after surgery for colorectal cancer: clinical
implications of results from randomised trials. Support Care Cancer. 2008;16:127-132.
Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KNL, Sylvester P, Koller M, Sprangers MAG,
Blazeby JM, on behalf of the European Organisation for Research and Treatment of Cancer Quality of
D:\478174570.doc
Life Group. Assessing quality of life in patients with colorectal cancer: An update of the EORTC
quality of life questionnaire. European Journal of Cancer. 2007;43:1564-1573.
Gulati GL, Hyun BH. The automated CBC. A current perspective. Hematol-Oncol Clin N Am.
1994;8(4):593-603.
Guldin M-B, Vedsted P, Zachariae R, Olesen F, Bonde Jensen A. Complicated gried and need for
professional support in family caregivers of cancer patients in palliative care: a longitudinal cohort
study. Supportive Care in Cancer. 2012;20(8):1679-1685.
Gunnars B, Nygren P, Glimelius B. Assessment of quality of life during chemotherapy. Acta Oncol.
2001;40(2/3):175-184.
Guo H, Fine PG, Mendoza TR, Cleeland CS. A preliminary study of the utility of the brief hospice
inventory. J Pain Symptom Manage. 2001;22(2):637-648.
Gupta D, Granick J, Grutsch JF, Lis CG. The prognostic association of health-related quality of life
scores with survival in breast cancer. Support Care Cancer. 2007;15:387-393.
Gupta D, Lis CG, Grutsch FJ. The relationship between dyspnea and patient satisfaction with quality
of life in advanced cancer. Support Care Cancer. 2007;15(5):533-538.
Gupta D, Lis CG, Grutsch JF. Perceived cancer-related financial difficulty: implications for patient
satisfaction with quality of life in advanced cancer. Support Care Cancer. 2007;15:387-393.
Gupta D, Lis CG, Vashi PG, Lammersfeld CA. Impact of improved nutritional status on survival in
ovarian cancer. Supportive Care in Cancer. 2010;18(3):373-382.
Gustafson DH, Hawkins R, Boberg E, et al. Impact of a patient-centered, computer-based health
information/support system. Am J Prev Med. 1998;16(1):1-9.
Gustafsson M, Edvardsson T, Ahlstrom G. The relationship between function, quality of life and
coping in patients with low-grade gliomas. Support Care Cancer. 2006;14:1205-1212.
Guyatt G, Townsend M, Berman L, Keller J. A comparison of likert and visual analogue scales for
measuring change in function. J Chronic Dis. 1987;40(12):1129-1133.
Guyatt G, Walter S, Norman G. Measuring change over time: Assessing the usefulness of evaluative
instruments. J Chronic Dis. 1987;40:171-178.
Guyatt GH, Berman LB, Townsend M, Puglsey SO, Chambers LW. A measures of quality of life for
clinical trials in chronic lung disease. Thorax. 1987;42:773-778.
Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Can
Med Assoc J. 1986;134:889-895.
Guyatt GH, Cook DJ. Commentary. Health status, quality of life, and the individual. JAMA.
1994;272(8):630-631.
D:\478174570.doc
Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status
measurement: a clarification. J Clin Epidemiol. 1989;42(5):403-408.
Guyatt GH, Drummond M, Feeny D, Tugwell P, Stoddart G, Haynes R.B, Bennett K, LaBelle R.
Guidelines for the clinical and economic evaluation of health care technologies. Soc Sci Med.
1986;22:393-408.
Guyatt GH, Feeny D, Patrick D. Issues in quality-of-life measurement in clinical trials. Control Clin
Trials. 1991;12:81S-90S.
Guyatt GH, Ferrans CE, Halyard MY, Revicki DA, Symonds TL, Varricchio CG, Kotzeva A, Valderas JM,
et al. Exploration of the value of health-related quality-of-life information from clinical research and
into clinical practice. Mayo Clin Proc 2007;82(10):1229-1239.
Guyatt GH, King Dr, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of
health related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol.
1999;52:187–192.
Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement
properties? J Clin Epidemiol. 1992;45:1341-1345.
Guyatt GH, Mitchell A, Molloy DW, Capretta R, Horsman J, Griffith L. Measuring patient and relative
satisfaction with level or aggressiveness of care and involvement in care decisions in the context of
life threatening illness. J Clin Epidemiol. 1995;48:1215-1224.
Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting
Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc.
2002;77(4):371-383.
Guyatt GH, Veldhuyzen Van Zanten SJO, Feeny DH, Patrick DL. Measuring quality of life in clinical
trials: a taxonomy and review. Can Med Assoc J. 1989;140:1441-1448.
Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration
of patient-reported outcome measures: a meta-analytic review. Value in Health. 2008;11(2):322333.
Gwede CK, Small BJ, Munster PN, Andrykowski MA, Jacobsen PB. Exploring the differential
experience of breast cancer treatment-related symptoms: a cluster analytic approach. Supportive
Care in Cancer. 2008;16(8):925-934.
Gysels M, Higginson IJ. Interactive technologies and videotapes for patient education in cancer care:
systematic review and meta-analysis of randomized trials. Support Care Cancer. 2007;14:7-20.
Gysels M, Richardson A, Higginson IJ. Communication training for health professionals who care for
patients with cancer: a systematic review of training methods. Support Care Cancer. 2005;13:356366.
Gysels M, Richardson A, Higginson IJ. Communication training for health professionals who care for
patients with cancer: a systematic review of effectiveness. Support Care Cancer. 2004;12:692–700.
D:\478174570.doc
Haas B. A multidisciplinary concept analysis of quality of life. Western J Nurs Res. 1999;21(6): 728742.
Haas BK. Clarification and integration of similar quality of life concepts. Image. J Nurs Scholarship.
1999;31(3):215-220.
Haberman MR, Woods NF, Packard NJ. Demands of chronic illness: reliability and validity assessment
of a demands-of-illness inventory. Holistic Nurs Pract. 1990;5(1):25-35.
Hack TF, Carlson L, Butler L, Degner LF, Jakulj F, Pickles T, Dean Ruether J, Weir L. Facilitating the
implementation of empirically valid interventions in psychosocial oncology and supportive care.
Supportive Care in Cancer. 2011;19(8):1097-1106.
Hack TF, Chochinov HM, Hassard T, Kristjanson LJ, McClement S, Harlos M. Defining dignity in
terminally ill cancer patients: a factor-analytic approach. Psycho-Oncol. 2004;13:700–708.
Hack TF, Degner LF. Coping responses following breast cancer diagnosis predict psychological
adjustment three years later. Psycho-Oncol. 2004;13:235–247.
Hack TF, Pickles T, Bultz BD, Ruether JD, Weir LM, Degner LF, Mackey JR. Impact of providing
audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite,
randomized, controlled trial. J Clin Oncol. 2003;21(22):4138–4144.
Hackbarth M, Haas N, Fotopoulou C, Lichtenegger W, Sehouli J. Chemotherapy-induced
dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a
prospective study. Support Care Cancer. 2008;16:267-273.
Hacker E. Exercise and quality of life: strengthening the connections. Clin J Oncol Nurs. 2009
Feb;13(1):31-9.
Haddock MG, Sloan JA, Bollinger JW, Soori G, Steen PD, Martenson JA. Patient assesment of bowel
function during and after pelvic radiotherapy: results of a prospective phase II North Central Cancer
Treatment Group clinical trial. J Clin Oncol. 2007;25(1):1255-1259.
Hadi S, Fan G, Hird AE, Kirou-Mauro A, Filipczak LA, Chow E. Symptom Clusters in Patients with
Cancer with Metastatic Bone Pain. Journal of Palliative Medicine. 2008;11(4):591-599.
Hadley J, Mitchell JM, Mandelblatt J. Medicare fees and small area variations in breast-conserving
surgery among elderly women. Med Care Res Review. 2001;58(3):334-360.
Hadorn DC, Hays RD, Uebersax J, Hauber T. Improving task comprehension in the measurement of
health state preferences: a trial of informational cartoon figures and a paired-comparison task. J Clin
Epidemiol. 1992;45(3):233-243.
Hadorn DC, Hays RD. Multitrait-multimethod analysis of health-related quality-of-life measures. Med
Care. 1991;29(9):829-840.
Haenszel W, Chiazze Jr L. Survival experience of cancer patients enumerated in morbidity surveys. J
Natl Cancer Inst. 1965;34:85-101.
D:\478174570.doc
Hagelin CL, Seiger A, Furst CJ. Quality of life in terminal care – with special reference to age, gender
and marital status. Support Care Cancer. 2006;14:320-328.
Hagelin CL, Wengstrom Y, Furst CJ. Patterns of fatigue related to advanced disease and radiotherapy
in patients with cancer – a comparative cross-sectional study of fatigue intensity and characteristics.
Supportive Care in Cancer. 2009;17(5):519-526.
Hagerty RG, Butwo PN, Ellis PA, et al. Cancer patient preferences for communication of prognosis in
the metastatic setting. J Clin Oncol. 2004;22(9):1721-1730.
Hagell P, Hogland A, Reimer J, Eriksson B, Knutsson I, Widner H, Cella D. Measuring fatigue in
Parkinson’s disease: A psychometric study of two brief generic fatigue questionnaires. Journal of
Pain and Symptom Management. 2006;32(5):420-432.
Haghighat S, Akbari ME, Holakouei K, Rahimi A, Montazeri A. Factors predicting fatigue in breast
cancer patients. Support Care Cancer. 2003;11:533-538.
Hagstromer M, Oja P, Sjostrom M. The international physical activity questionnaire (OPAQ): a study
of concurrent and construct validity. Public Health Nutr. 2006;9(6):755-62.
Hahn E, Cella D. Health outcomes assessment in vulnerable populations : measurement challenges
and recommendations. Archives of Physical Medicine and Rehabilitation. 2003 ;84(Suppl2) :S35S42.
Hahn E, Cella D, Bode R, Gershon R, Lai J-S. Item banks and their potential applications to health
status assessment in diverse populations. Medical Care. 2006 ;44(11)(Suppl 3) :S189-S197.
Hahn EA, Bode RK, Du H, Cella D. Evaluating linguistic equivalence of patient-reported outcomes in a
cancer clinical trial. Clin Trials. 2006;3:280-290.
Hahn EA, Cella D, Dobrez D, et al. The talking touchscreen: a new approach to outcomes
assessment in low literacy. Psycho-Oncol. 2004;13:86-95.
Hahn EA, Cella D, Chassany O, Fairclough DL, Wong GY, Hays RD, and the Clinical Significance
Consensus Meeting group. Precision of health-related quality-of-life data compared with other clinical
measures. Mayo Clin Proc 2007;82(10):1244-1254.
Hahn EA, Holzner B, Kemmler G, Sperner-Unterweger B, Hudgens S, Cella D. Cross-cultural
evaluation of health status using item response theory: FACT-B comparisons between Austrian and
U.S. breast cancer patients. Eval Health Prof 2005;28(2):233-259.
Hahn EA, Webster KA, Cella D, Fairclough DL. Missing data in quality of life research in Eastern
Cooperative Oncology Group (ECOG) clinical trials: Problems and solutions. Statistics in Medicine.
1998;17:547-559.
Haiderali A, Menditto L, Good M, Teitelbaum A, Wegner J. Impact on daily functioning and
indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US
population. Supportive Care in Cancer. 2011;19(6):843-852.
D:\478174570.doc
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative
properties among disease-specific questionnaires for measuring health-related quality of life patients
with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:785-90.
Hakamies-Blomquist L, Luoma M-L, Sjostrom J, et al. Quality of life in patients with metastatic breast
cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre
randomised phase III trial by the Scandinavian Breast Group. Euro J Cancer. 2000;36:1411-1417.
Hakamies-Blomqvist L, Luoma ML, Sjostrom J, et al. Timing of quality of life (QOL) assessments as a
source of error in oncology trials. J Advanced Nurs. 2001;35(5):709-716.
Halabi S, Vogelzang NJ, Kornblith AB, Ou S-S, Kantoff PW, Dawson NA, Small EJ. Pain predicts
overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol.
2008;26(15):2544-2549.
Halbert C, Schwartz M, Wenzel L, Narod S, Peshkin B, Cella D, Lerman C. Predictors of cognitive
appraisals following genetic testing for BRCA1 and BRCA2 mutations. Journal of Behavioral Medicine.
2004;27(4):373-392.
Hales S, Zimmerman C, Rodin. The quality of dying and death. Arch Intern Med. 2008;168:912918.
Hall A, A’Hern R, Fallowfield L. Are we using appropriate self-report questionnaires for detecting
anxiety and depression in women with early breast cancer? Eur J Cancer. 1999;35(1):79-85.
Hall MF. Patient satisfaction or acquiescence? Comparing mail and telephone survey results. J
Health Care Marketing. 1995;15:54-61.
Halpern-Silveira D, Susin LRO, Borges LR, Paiva SI, Assuncao MCF, Gonzalez MC. Body weight and
fat-free mass changes in a cohort of patients receiving chemotherapy. Supportive Care in Cancer.
2010;18(5):617-626.
Halyard MY, Jatoi A, Sloan JA, Bearden JD, Vora SA, Atherton PJ, Perez eA, Soori G, et al. Does zinc
sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of the
Phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group
(N01C4). Int J Radiat Oncol Biol 2007;67(5):1318-1322.
Hambleton, RK. The Traditional and Modern Approaches to Outcomes Measurement. Summary
Paper, Drug Information Association; June 23-25, 2004 Meeting.
Hamidou Z, Dabakuyo TS, Bonnetain F. Impact of response shift on longitudinal quality-of-life
assessment in cancer clinical trials. Expert Rev. Pharmacoeconomics Outcomes Res. 2011;11(5):549559.
Hammerlid E, Persson L, Sullivan M, Westin T. Quality-of-life effects of psychosocial intervention in
patients with head and neck cancer. Otolaryngology Head Neck Surg. 1999;120(4):507-516.
Hammond KA. Dietary and clinical assessment. Nutrition Care. (1998) chapter 16:353-379.
D:\478174570.doc
Han R, Yang YM, Dietrich J, Luebke A, Mayer-Proschel M, Noble M. Systemic 5-fluorouracil treatment
causes a syndrome of delayed myelin destruction in the central nervous system. Journal of Biology.
2008;7;12.2-12.22.
Hanks HW, Robbins M, Sharp D, et al. The impact study: a randomized controlled trial to evaluate a
hospital palliative care team. Br J Cancer. 2002;87:733–739.
Hann DM, Denniston M, Baker F. Measurement of fatigue in cancer patients: Further validation of
the fatigue symptom inventory. Qual Life Res. 2000;9:847-854.
Hannum Rose J, O’Toole EE, Dawson NV, et al. Perspectives, preferences, care practices, and
outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol.
2004;22(24):4907-4917.
Hansen NC, Evald T, Ibsen TB. Terbutaline inhalations by the turbuhaler as replacement for
domiciliary nebulizer therapy in severe chronic obstructive pulmonary disease. Resp Med.
1994;88(4):267-271.
Hanser S, Bauer-Wu S, Kubicek L, Healey M, Manola J, Hernandez M, Bunnell C. Effects of a music
therapy intervention on quality of life and distress in women with metastatic breast cancer. J Soc
Integr Oncol. 2006;4(3):116-124.
Hanser S. Music therapy in adult oncology: research issues. J Soc Integr Oncol. 2006;4(2):62-66.
Harcourt D, Rumsey N. Mastectomy patients’ decision-making for or against immediate breast
reconstruction. Psycho-Oncol. 2004;13:106–115.
Harding R, Epiphaniou E, Hamilton D, Bridger S, Robinson V, George R, Beynon T, Higginson IJ.
What are the perceived needs and challenges of informal caregivers in home cancer palliative care?
Qualitative data to construct a feasible psycho-educational intervention. Support Care Cancer.
2012;20(9):1975-1982.
Hardy J, Quinn S, Fazekas B, Plummer J, Eckerman S, Agar M, Spruyt O, Rowett D, Currow DC.
Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of
subcutaneous ketamine in the management of cancer pain. Journal of Clinical Oncology.
2012;30(29):3611-3617.
Harniss M, Amtmann D, Cook D, Johnson K. Considerations for Developing Interfaces for Collecting
Patient-Reported Outcomes That Allow the Inclusion of Individuals With Disabilities. Medical Care.
2007;45(5):S48-S54.
Harper P, Plunkett T, Khayat D. Editorial: Quality trials and quality of life in non-small-cell lung
cancer. J Clin Oncol. 2003;21(16):3007-3008.
Harper R, Brzier JE, Waterhourse JC, Walters SJ, Jones NM, Howard P. Comparison of outcome
measures for patients with Chronic Obstructive Pulmonary Disease (COPD) in an outpatient setting.
Thorax. 1997;52(10):879-87.
D:\478174570.doc
Harris AH, Osborne RH, Streeton CL, McNeil H. Quality of life and kaposi sarcoma: using preference
techniques to value the health gains from treatment. Support Care Cancer. 2002;10:486–493.
Harris EA, Kelly AW, Pockaj BA, Heppell J, Hentz JG, Kelly KA. Reoperation on the abdomen encased
in adhesions. J Surg. 2002;184:499-504.
Harris JT, Kumar KS, Rajagopal MR. Intravenous morphine for rapid control of severe cancer pain.
Palliative Medicine. 2003;17:248-256.
Harris K, Zhang L, Chow E. Reliability of the Brief Pain Inventory (BPI) in Patients with Bone
Metastases. Journal of Cancer Pain and Symptom Palliation. 2006;2(2):3-15.
Harris MB. Palliative care in children with cancer: which child and when? J Natl Cancer Inst Monogr.
2004;32:144-149.
Harrison A. Assessing patients’ pain: identifying reasons for error. J Adv Nurs. 1991;16:1018-1025.
Harrison LB, Zelefsky MJ, Pfister DG, et al. Detailed quality of life assessment in patients treated with
primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck. 1997;19:169175.
Harrison H. Journal Discussion: Coping mechanisms and quality of life (Virtual Mentor). Ethics
Journal of the American Medical Association. 2006;8(5):319-322.
Harrison SE, Watson EK, Ward AM, Khan NF, Turner D, Adams E, Forman D, Roche MF, Rose PW.
Primary health and supportive care needs of long-term cancer survivors: a questionnaire survey.
Journal of Clinical Oncology. 2011;29(15):2091-2098.
Hart SL, Latini DM, Cowan JE, Carroll PR, CaPSURETM Investigators. Fear of recurrence, treatment
satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer.
2008;16:161-169.
Hassan SJ, Weymuller EA Jr. Assessment of quality of life in head and neck cancer patients. Head
Neck. 1993;15(6):485-496.
Hassey Dow K, Ferrell BR, Haberman MR, Eaton L. The meaning of quality of life in cancer
survivorship. Oncol Nurs Forum. 1999.26(3):519-528.
Hauser K, Walsh D. Visual analogue scales and assessment of quality of life in cancer. J Support
Oncol. 2008 Jul-Aug;6(6):277-82.
Hauser CA, Stockler MR, Tattersall MHN. Prognostic factors in patients with recently diagnosed
incurable cancer: a systematic review. Support Care Cancer. 2006;14:999-1011.
Hauser K, Walsh D. Visual analogue scales and assessment of quality of life in cancer. J Support
Oncol. 2008;6:277-282.
Hawthorne G, Richardson J, Osborne R. The assessment of Quality of Life (AQOL) instrument: a
psychometric measure of health-related quality of life. Qual Life Res. 1999;8:209-224.
D:\478174570.doc
Haycox A. Optimizing decision making and resource allocation in palliative care. J Pain Symptom
Manage. 2009;38(1):45-53.
Hayden KA, Moinpour CM, Metch B, Feigl P, O’Bryan RM, Green S, Osborne CK. Pitfalls in quality-oflife assessment: lessons from a Southwest Oncology Group breast cancer clinical trial. Oncol Nurs
Forum. 1993;20(9):1415-1419.
Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of
life. New Engl J Med. 2003;348(19):1839-1854.
Hays JR. Trail making test norms for psychiatirc patients’. Perceptual and Motor Skills. 1995;80:187
–194.
Hays R, Cella D, Du H, et al. Item response throry analyses of physical functioning items in the
medical outcomes study. Medical Care. 2007;45(5):S32-S38.
Hays RD, Cunningham WE, Beck CK, Shapiro MF. Health-related quality of life in HIV disease.
Assessment. 1995;2(4):363-380.
Hays JT, Croghan IT, Baker CL, Cappelleri JC, Bushmakin AG. Changes in health-related quality of
life with smoking cessation treatment. The European Journal of Public Health. 2010:7 pages.
Hays RD, Cunningham WE, Sherbourne CD, et al. Health-related quality of life in patients with
human immunodeficiency virus infection in the United States: results from the HIV cose and services
utilization study. Am J Med. 2000;108:714-722.
Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the Kidney Disease Quality of
Life (KDQOL™) instrument. Qual Life Res. 1994;3:329-338.
Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, Greenfield S. The impact
of patient adherence on health outcomes for patients with chronic disease in the medical outcomes
study. J Behav Med. 1994;17(4):347-360.
Hays RD, Liu H, Spritzer K, Cella D. Item Response Theory Analyses of Physical Functioning Items in
the Medical Outcomes Study. Medical Care. 2007;45(5):S32-38.
Hays RD, Marshall GN, Wang EYI, Sherbourne CD. Four-year cross-lagged associations between
physical and medical outcomes study. J Consult Clin Psychol. 1994;62(3):441-449.
Hays RD, Morales LS. The RAND-36 Measure of Health-Related Quality of Life. Annals of Medicine.
2001;33(5) :350-357.
Hays RD, Morales LS, Reise SP. Item response theory and health outcomes measurement in the 21st
century. Med Care. 2000;38(9)(Suppl II):II28-II41.
Hays RD, Sherbourne CD, Mazel RM. The Rand 36-item health survey 1.0. Health Economics. 1993;
2:217-227.
D:\478174570.doc
Hays RD, Siu AL, Keeler M, Marshall GN, Kaplan rM, Simmons S, El Mouchi D, Schnelle JF. Long-term
care residents’ preferences for health states on the quality of well-being scale. Med Decis Making.
1996;16:254-261.
Hays RD, Stewart AL. The structure of self-reported health in chronic disease patients. J Consult Clin
Psychol. 1990;2(1):22-30.
Hays RD, Wells KB, Scherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of
patients with depression compared with chronic general medical illness. Arch Gen Psychiatry.
1995;52:11-59.
Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life
research. how meaningful is it? Pharmaoeconomics. 2000;419-423.
Hays RD. Next steps in use of IRT in the assessment of health outcomes. Summary Paper, Drug
Information Association June 23 – 25, 2004 Meeting.
Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med.
2001;33:350-357.
Head BA, Heitz L, Keeney C, Myers J, Appana SN, Studts JL, Bumpous J, Pfeifer M. The relationship
between weight loss and health-related quality of life in persons treated for head and neck cancer.
Supportive Care in Cancer. 2011;19(1):1511-1518.
Health Services Research Committee. Outcomes of cancer treatment for technology assessment and
cancer treatment guidelines. J Clin Oncol. 1996;14(2):671-679.
Hearn J, Higginson IJ. Do specialist palliative care teams improve outcomes for cancer patients? A
systematic literature review. Palliat Med. 1998;12:317–332.
Hearn J, Higginson IJ. Outcome measures in palliative care for advanced cancer patients: a review.
J Public Health Med. 1997;19:193–199.
Hebert RS, Jenckes MW, Ford DE, O’Connor DR, Cooper LA. Patient perspectives on spirituality and
the patient-physician relationship. J Gen Intern Med. 2001;16:685-692.
Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L. Compliance with consensus
recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer.
1999;85(5):1104-1113.
Hedenus M, Vansteenkiste J, Kotasek D, Austin M, Amado RG. Darbepoetin alfa for the treatment of
chemotherapy-induced anemia: disease progression and survival analysis from four randomized,
double-blind, placebo-controlled trials. J Clin Oncol. 2005;23:6941-6948.
Heffernan N, Cella D, Webster K, et al. Measuring health-related quality of life in patients with
hepatobiliary cancers: the Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire.
J Clin Oncol. 2002;20(0):2229-2239.
D:\478174570.doc
Heinonen H, Aro AR, Aalto AM, Uutela A. Is the evaluation of the global quality of life determined by
emotional status? Qual Life Res. 2004;13:1347–1356.
Heisler M. Actively engaging patients in treatment decision making and monitoring as a strategy to
improve hypertension outcomes in diabetes mellitus. Circulation. 2008;117:1355-1357.
Heller DA, Gold CH, Ahern FM, Pringle KE, Brown TV, Glessner MR. Changes in elderly women’s
health-related quality of life following discontinuation of hormone replacement therapy. BMC
Women’s Health. 2005;5:7.
Helwick C. Unique Study Identifies Gene Associated With Anxiety Phenotypes. Medscape Medical
News. 2011 March 29.
Henderson Brown J, Henteleff P, Barakat S, June Rowe C. Is it normal for terminally ill patients to
desire death? Am J Psychiatry. 1986;143(2):208-211.
Hendricks AM, Loggers ET, and Talcott JA. Costs of Home Versus Inpatient Treatment for Fever and
Neutropenia: Analysis of a Multicenter Randomized Trial. Journal of Clinical Oncology. October
2011;29(30):3984-89
Henry DH. The role of intravenous iron in cancer-related anemia. Oncology (Suppl). 2006;20(8):2124.
Hensing TA. Peterman AH, Schell MJ, Lee JH. Socinski MA.The impact of age on toxicity, response
rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung
carcinoma treated with carboplatin and paclitaxel. Cancer. 2003;98(4):779-788.
Hermann BP, Vickrey B, Hays RD, et al. A comparison of health-related quality of life in patients with
epilepsy, diabetes and multiple sclerosis. Epilepsy Res. 1996;25:113-118.
Hermann JF, Cella DF, Robinovitch A. Guidelines for support group programs. Cancer Practice;
1995;392):111-113.
Hermes GL, Delgado B, Tretiakova M, Cavigelli SA, Krausz T, Conzen SD, McClintock MK. Social
isolation dysregulates endocrine and behavioral stress while increasing malignant burden of
spontaneous mammary tumors. PNAS Early Edition. 2009;6 pages.
Hernandez L, Cella D. La calidad de vida relacionada a lasalad: Resultado importante de los
tratamientos para el cancer. Puerto Rico Health Science Journal. 1998;17(1):89-91 Spanish
Hernandez L, Chang CH, Cella D, Coronona M, et al. Development and validation of the Satisfaction
with Pharmacist Scale. Pharmacotherapy. 2000;20(7):837-843.
Herndon JE 2nd, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive
of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999;85(2):333-340.
Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic
prostate cancer who received or did not receive hormonal therapy. Cancer. 1993;71:1143-1150.
D:\478174570.doc
Herr HW, O’Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on
androgen deprivation therapy. J Urol. 2000;163:1743-1746.
Herr HW. Quality of life measurement in testicular cancer patients. Cancer. 1987;60(6):1412-1414.
Herr HW. Strategies for the management of recurrent and advanced urologic cancers: quality of life.
Cancer. 1987;60(Suppl):623-630.
Herrstedt J, Apornwirat W, Shaharyar A, Aziz Z, Roila F, Van Belle S, Russo MW, Levin J,
Ranganathan S, Guckert M, Grunberg SM. Phase III trial casopitant, a novel neurokinin-1 receptor
antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic
chemotherapy. Journal of Clinical Oncology. 2009;27(32):5363-5369.
Herzog TJ, Wright JD. The impact of cervical cancer on quality of life-the components and means for
management. Gynecol Oncol. 2007 Dec;107(3):572-7. Epub 2007 Oct 25. Review.
Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative
research with survivors, nurses, and physicians. J Clin Oncol 2007;25(16):2270-2273.
Hesketh PJ, Sanz-Altamira P, Bushey J, Hesketh AM. Prospective evaluation of the incidence of
delayed nausea and vomitting in patients with colorectal cancer receiving oxaliplatin-based
chemotherapy. Supportive Care in Cancer. 2012;20(5):1043-1048.
Hesketh PJ, Grunberg SM, Gralla RJ, et al. The oral neurokinin-1 antagonist aprepitant for the
prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, doubleblind, placebo-controlled trial in patients receiving high-dose cisplatin – the aprepitant protocol 052
study group. J Clin Oncol. 2003;21(22):4112–4119.
Hessig RE, Arcand LL, Frost MH. The effects of an educational intervention on oncology nurses’
attitude, perceived knowledge, and self-reported application of complementary therapies. Oncol Nurs
Forum. 2004;31(1):71–78.
Heyting A, Tolboom JTBM, Essers JGA. Statistical handling of dropouts in longitudinal clinical trials.
Stats Med. 1992;11:2043-2061.
Hickok JT, Morrow GR, McDonald S, Bell AJ. Frequency and correlates of fatigue in lung cancer
patients receiving radiation therapy:implications for management. J Pain Symptom Manage.
1996;11(6):370-377.
Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR. Nausea and emesis remain
significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetrics.
A University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program
Study of 360 Cancer Patients Treated in the Community. Cancer. 2003;97:2880–2886.
Hicks J, Bartholomew J, Ward-Smith P, Hutto CJ. Quality of life among childhood leukemia patients.
J Ped Oncol Nurs. 2003;20(4):192-200.
Hietanen PS. Measurement and practical aspects of quality of life in breast cancer. Acta Oncol.
1996;35(1):39-42.
D:\478174570.doc
Higgins SC, Montgomery GH, Bovbjerg DH. Distress before chemotherapy predicts delayed but not
acute nausea. Support Care Cancer. 2007;15:171-177.
Higginson IJ, Carr A. Measuring quality of life: using quality of life measures in the clinical setting.
BMJ. 2001;322:1297–1300.
Higginson IJ, Costantini M. Communication in end-of-life cancer care: a comparison of team
assessments in three European countries. J Clin Oncol. 2002;20(17):3674-3682.
Higginson IJ, Hart S, Burman R, Silber E, Saleem T, Edmonds P. Randomised controlled trial of a
new palliative care service: Compliance, recruitment and completeness of follow-up. BMC Palliative
Care. 2008;7(7):1-15.
Higginson IJ, Hearn J. A multicenter evaluation of cancer pain control by palliative care teams. J Pain
Symptom Manage. 1997;14:29-35.
Higginson IJ, Sen-Gupta GJA. Place of care in advanced cancer: a qualitative systematic literature
review of patient preferences. J Palliat Med. 2000;3:287–300.
Higginson IJ, Vivat B, Silber E, Saleem T, Burman R, Hart S, Edmonds P. Study Protocol: delayed
intervention randomized controlled trial within the Medical Research Council (MRC) Framework to
assess the effectiveness of a new palliative care service. BMC Palliative Care. 2006;5(7): 11 pages.
Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development
and psychometric properties. J Climacteris & Postmenopause. 1996;24:161-175.
Hilgers FJM, Aaronson NK, Ackerstaff AH, Schouwenburg PF, Van Zandwijk N. The influence of a
heat and moisture exchanger (HME) on the respiratory symptoms after total laryngectomy. Clin
Otolaryngol. 1991;16:152-156.
Hilgers FJM, Aaronson NK, Balm AJM, Van Zandwijk N. Improvements in respiratory and
psychosocial functining following total laryngectomy by the use of a heat and moisture exchanger.
Ann Otol Rhinol Laryngol. 1993;102:787-883.
Hilgers FJM, Ackerstaff AH, Aaronson NK, Schouwenburg PF, Van Zandwijk N. Physical and
psychosocial consequences of total laryngectomy. Clin Otolaryngol. 1990;15:421-425.
Hilgers FJM, Ackerstaff AH, Balm AJM, Tan IB, Aaronson NK, Persson JO. Development and clinical
evaluation of a second-generation voice prosthesis (Provox ®2), designed for anterograde and
retrograde insertion. Acta Otolaryngol. 1997;117:889-896.
Hill CD, Edwards MC, Thissen D, Langer MM, Wirth RJ, Burwinkle TM, Varni JW. Practical Issues in
the Application of Item Response Theory. A Demonstration Using Items From the Pediatric Quality of
Life Inventory (PedsQL) 4.0 Generic Core Scales. Medical Care. 2007;45(5):S39-S47.
Hinds PS, Gattuso JS, Fletcher A, et al. Quality of Life as conveyed by pediatric patients with cancer.
Qual Life Res. 2004;13:761–772.
D:\478174570.doc
Hinton J. Can home care maintain an acceptable quality of life for patients with terminal cancer and
their relatives? Palliat Med. 1994;8:183–196.
Hird A, Wong J, Zhang L, Tsao M, Barnes E, Danjoux C, Chow E. Exploration of symptoms clusters
within cancer patients with brain metastases using the Spitzer Quality of Life Index. Supportive Care
in Cancer. 2010;18(3):335-342.
Hjermstad MJ, Kaasa S. Quality of life in adult cancer patients treated with bone marrow
transplantation—a review of the literature. Euro J Cancer. 1995;31A(2):163-173.
Hlatky MA MD, Boothroyd D Ph.D, Vittinghoff E Ph.D, Sharp P EdD, Whooley MA MD. Quality of life
and depressive symptoms in postmenopausal women after receiving hormone therapy. JAMA.
2002;287(5):591-597.
Hlatky MA, Haney T, Barefoot JC, et al. Medical, psychological and social correlates of work disability
among men with coronary artery disease. Am J Cardiol. 1986;58L 911-915.
Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and Alternative Medicine among
advanced cancer patients enrolled in Phase I trials: a study of prognosis, quality of life, and
preferences for decision making. J Clin Oncol. 2007;25(5):548-554.
Hobday T, Sloan J, Goldberg R. What do global quality of life questions really measure? Insights
from Hobday et al and the “Do something” rule. J Clin Oncol. 2003;21(16):3179.
Hoekstra J, Binderls PJE, van Duijn NP, Schade E. The symptom monitor. A diary for monitoring
physical symptoms for cancer patients in palliative care: feasibility, reliability and compliance. J Pain
Symptom Manage. 2004;27(1):24-35.
Hofman A, Breteler MMB, van Duijn CM, Krestin GP, Pols HA, Stricker BHC, Tiemeier H, Uitterlinden
AG, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol 2007;22:819-829.
Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the
scale of the problem. Oncologist. 2007;12(Suppl 1):4-10.
Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of
mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and wellbeing in stage 0 and III breast cancer: a randomized, controlled trial. Journal of Clinical Oncology.
2012;30(12):1335-1342.
Hoffman KE, McCarthy EP, Recklitis C, Ng AK. Psychological distress in long-term survivors of adultonset cancer. Archives of Internal Medicine. 2009;169(14):1274-1281.
Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and
Afghanistan, mental health problems, and barriers to care. New Engl J Med. 2004;351(1):13–22.
Holford NHG, Sheiner LB. Understanding the dose-effect relationship: clinical application of
pharmacokinetic-pharmacodynamic models. Clin Pharmacokinetics. 1981;6:429-453.
D:\478174570.doc
Holland JC, Andersen B, Breitbart WS, Dudley MM, Fleishman S, Fulcher CD Greenberg DB, Greiner
CB, Handzo Rev. GF, Jacobsen PB, Knight SJ, Learson K, Levy MH, Manne S, McAllister-0Black R,
Peterman A, Riba MB, Slatkin NE, Valentine A, Wagner LI, Zevon MA. Distress Management.
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. V.1.2008
(slides).
Holland JC, Kash K, Passik SD, et al. A brief spiritual beliefs inventory for use in quality of life
research in life-threatening illness. Psycho-Oncol. 1998;7:460-469.
Holland JC, Kornblith AB, Zuckerman E. A centralized model for quality of life (QOL) data collection
by telephone interview in multicenter clinical trials. Proc Annu Meet Am Soc Clin Oncol.
1992;11:A1421.
Holland JC. Psychological care of patients: psycho-oncology’s contribution. ACS Award Lecture. J
Clin Oncol. 2003;21(23):Suppl 252–265.
Hollandsworth JG. Evaluating the impact of medical treatment on the quality of life: A five-year
update. Soc Sci Med. 1988;26:425-434.
Hollen PJ, Gralla RJ, Kris MG, McCoy S, Donaldson GW, Moinpour CM. A comparison of visual
analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): Does
format affect patient ratings of symptoms and quality of life? Quality of Life Research.
2005;14(3):837-847.
Hollen P, Gralla R, Kris M, Potanovich L. Quality of life assessment in individuals with lung cancer:
Testing the lung cancer symptom scale. Euro J Cancer. 1993;29(Supplement A):S51-S58.
Hollen PJ, Gralla RJ, Kris MG, Eberly SW, Cox C. Normative data and trends in quality of life from the
Lung Cancer Symptom Scale (LCSS). Support Care Cancer. 1999;7(3):140-148.
Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in
multicenter trials of new therapies. Cancer. 1994;73(8):2087-2098.
Hollen PJ, Gralla RJ. Comparison of instruments for measuring quality of life in patients with lung
cancer. Sem Oncol. 1996;23:31-40.
Hollen PJ, Gralla RJ, Stewart JA, Meharchand JM, Wierzbicki R, Leighl N. Can a computerized format
replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted
LCSS instrument (eLCSS-QL). Supportive Care in Cancer. 2013;21(1):165-172.
Hollen PJ, Gralla RJ, Jones RA, Thomas CY, Brenin DR, Weiss GR, Schroen AT, Petroni GR. A theorybased decision aid for patients with cancer: results of feasibility and acceptability testing of
DecisionKEYS for cancer. Supportive Care in Cancer. 2013;21(3):889-900.
Hollenberg NK, Williams GH, Anderson R, Akhras KS, Bittman RM, Krause SL. Symptoms and the
distress they cause: comparision of an aldosterone antagonist and a calcium channel blocking agent
in patients with systolic hypertension. Arch Intern Med. 2003;163:1543-1548.
Holley S. Cancer-related fatigue: suffering a different fatigue. Cancer Pract. 2000;8:87-95.
D:\478174570.doc
Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized
controlled trials. Br Med J. 1999;391:670-674.
Holman R, Math M, Glas CAW, de Haan RJ. Power analysis in randomized clinical trials based on item
response theory. Control Clin Trials. 2003;24:390-410.
Holman R. How does item selection procedure affect power and sample size when using an item
bank to measure health status? Quality of Life Newsletter Special Issue – Item Banking 9 – 11, Fall
2004.
Holmes MD, Chen WY, Feskanich, Kroenke CH, Colditz GA. Physical activity and survival after breast
cancer diagnosis. JAMA. 2005;293:2479-2486.
Holmes S, Dickerson J. The quality of life: design and evaluation of a self-assessment instrument for
use with cancer patients. Int J Nurs Stud. 1987;24:15-24.
Holmes S. Assessing the quality of life - reality or impossible dream? A discussion paper. Int J Nurs
Stud . 2005;42:493-501.
Holmes S. Use of a modified symptom distress scale in assessment of the cancer patients. Int J
Nurs Stud. 26:69-79, 1989.
Holzheimer A, McMillan SC, Weitzner M. Improving pain outcomes of hospice patients with cancer.
Oncol Nurs Forum. 1999;26:1499–1504.
Holzner B, Bode R, Hahn E, Cella D, Kopp M, Sperner-Unterweger B, Kemmler G. Equating EORTC
QLQ-C30 and FACT-G scores and its use in oncological research. European Journal of Cancer.
2006;42(18):3169-3177.
Holzner B, Kemmler G, Greil R, et al. The impact of hemoglobin levels on fatigue and quality of life in
cancer patients. Ann Oncol. 2002;13:965-973.
Holzner B, Kemmler G, Meraner V, et al. Fatigue in ovarian carcinoma patients. A neglected issue?
Cancer. 2003;97:1564–1572.
Homsi J, Walsh D, Nelson KA, LeGrand SB, Davis M, Khawam E, Nouneh C. The impact of a palliative
medicine consultation service in medical oncology. Support Care Cancer. 2002;10:337-342.
Homsi J, Walsh D, Rivera N, et al. Symptom evaluation in palliative medicine: patient report vs.
systematic assessment. Support Care Cancer. 2006;14:444-453.
Hoolen PJ, Gralla RJ, Rittenberg CN. Quality of life as a clinical trial endpoint: determining the
appropriate interval for repeated assessments in patients with advanced lung cancer. Support Care
Cancer. 2004;12:767-773.
Hopwood P, Harvey A, Davies J, et al. Survey of the administration of Quality of Life (QL)
Questionnaires in three multicentre randomized trials in cancer. Euro J Cancer. 1997;0(0):1-9.
D:\478174570.doc
Hopwood P, Harvey A, Stephens R. Guidelines for the collection of quality of life data. Medical
Research Council. (booklet).
Hopwood P, Stephens RJ, Machin D. Approaches to the analysis of quality of life data: experiences
gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual
Life Res. 1994;3(5):339-352.
Horigian VE, Robbins MS, Dominguez R, Ucha J, Rosa CL. Principles for defining adverse events in
behavioral intervention research: lessons from a family-focused adolescent drug abuse trial. Clinical
Trials. 2010;7(1):58-68.
Hormes JM, Lytle LA, Gross CR, Ahmed RL, Troxel AB, Schmitz KH. The body image and
relationships scale: Development and validation of a measure of body image in female breast cancer
survivors. J Clin Oncol. 2008;26(8):1269-1274.
Horn SD. Comments on "Is the spirit of capitalism undermining the ethics of health services
research?" Health Serv Res. 1994;28:678-683.
Hornberger J, Thom D, MaCurdy T. Effects of a self-administered previsit questionnaire to enhance
awareness of patients’ concerns in primary care. J Gen Intern Med. 1997;12:597-606.
Hornke LF, Habos M. Rule-based item bank construction and evaluation within the linear logistic
framework. Applied Psychology Measurement. 1986;10(4):369–380.
Hornquist JO. The concept of quality of life. Scand J Soc Med. 1982;10:57-61.
Horsley P, Bauer JD, Mazkowiack R, Gardner R, Bashford J. Palifermin improves severe mucositis,
swallowing problems, nutrition impact sysmptoms, and length of stay in patients undergoing
hematopoietic stem cell transplantation. Support Care Cancer. 2007;15:105-109.
Horsman J, Furlong w, Feeny D, Torrance G. Health Qual Life Outcomes 2003;1:54.
Horwitz AV, Videon TM, Schmitz MF, Davis D. Rethinking twins and environments: possible social
sources for assumed genetic influences in twin research. J Health Soc Behav. 2003;44(2):111-29.
Hoskin PJ, Robinson M, Slevin N, Morgan D, Harrington K, Gaffney C. Effect of epoetin alfa on
survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy
with curative intent for head and neck cancer. Journal of Clinical Oncology. 2009;27(34):5751-5756.
Hou WK. Intrapersonal and interpersonal dimensions of cancer perception: a confirmatory factor
analysis of the cancer experience and efficacy scale (CEES). Supportive Care in Cancer.
2010;18(5):561-572.
Houts AC, Fortner BV, Tauer KT, Veir AB, Wheeler BM, Schwartzberg LS, Okon TA. Reliability and
validity of the cancer care monitor. ASCO 2002 Poster Presentation.
Houts AC, Loh GA, Fortner BV, Kallich JD. Patient and caregiver time burden associated with
anaemia treatment in different patient populations. Support Care Cancer. 2006;14:1195-1204.
D:\478174570.doc
Houtzager BA, Grootenhuis MA, Caron HN, Last BF. Quality of Life and Psychological Adaptation in
Siblings of Paediatric Cancer Patients, 2 Years After Diagnosis. Psycho-Oncol. 2004;13:499–511.
Hoverman JR, If palliative car is the answer, what is the question? Journal of Oncology Practice.
2013;9(1):55-56.
Howell D, Mayo S, Currie S, Jones G, Boyle M, Hack T, Green E, Hoffman L, Collacutt V, McLeod D,
Simpson J. Psychosocial health care needs assessment of adult cancer patients: a consensus-based
guideline. Supportive Care in Cancer. 2012;20(12):3343-3354.
Howell D, Husain A, Seow H, Liu Y, Kustra R, Atzema C, Dudgeon D, Earle C, Sussman J, Barbera L.
Symptom clusters in a population-based ambulatory cancer cohort validated using bootstrap
methods. Eur J Cancer. 2012 Nov;48(16):3073-81.
Howell DM, Sussman J, Wiernikowski J, Pyette N, Bainbridge D, O’Brien M, Whelan T. A mixedmethod evaluation of nurse-led community-based supportive cancer care. Supportive Care in Cancer.
2008;16(12):1343-1352.
Howell WM, Turner SJ, Collins A, Bateman AC, Theaker JM. Influence of TNF and LT single
nucleotide polymorphisms on susceptiblity to and prognosis in cutaneous malignant melanoma in the
british population. J Immunogenetics. 2002;29:17–23.
Hoybye MT, Dalton SO, Christensen J, Ross L, Kuhn KG, Johansen C. Social and psychological
determinants of participation in internet-based cancer support groups. Supportive Care in Cancer.
2010;18(5):553-560.
Hrobjartsson A, Gotzche PC. Is the placebo powerless? An analysis of clinical trials comoparing
placebo with no treatment (erratum appears in New Engl J Med. 2001;345(4):304; Review New Engl
J Med. 2001;344(21):1594-1602.
Hsu C, Wang JD, Hwang JS, et al. Survival-weighted health profile for long-term survivors of acute
myelogenous leukemia. Qual Life Res. 2003;12:503-517.
Huang H, Brady M, Cella D, Fleming G. Validation and reduction of FACT/GOG-Ntx subscale for
platinum/paclitaxel induced neurological symptoms: A gynecologic oncology group (GOG) study.
International Journal of Gynecologiccal Cancer. 2007;17(2):387-393.
Huang YY, Oquendo MA, Friedman JM, et al. Substance abuse disorder and major depression are
associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism.
Neuropsychopharmacology. 2003;28(1):163-169.
Hubbard RE, O’Mahony MS, Woodhouse KW. Characterising frailty in the clinical setting - a
comparison of different approaches. Oxford Journals. 2008. pages 115-119.
Hudgens S, Cella D, Caprini C-A, Caprini J. Deep vein thrombosis: validation of a patient reported
leg symptom index. Health and Quality of Life Outcomes. 2003;76(1).
Hudson PL, Hayman-White K, Aranda S, Kristjanson LJ. Predicting family caregiver psychosocial
functioning in palliative care. Journal of Palliative Care. 2006 Autumn;22(3):133-140.
D:\478174570.doc
Hudson P, Quinn K, Kristjanson L, Thomas T, Braithwaite M, Fisher J, Cockayne M. Evaluation of a
psycho-educational group programme for family caregivers in home-based palliative care. Palliative
Medicine. 2008;22(3):270-280.
Hudy MJ. Student evaluations of overall teaching effectiveness: Can single-item measures be
justified? (Dissertation) Dissertation Abstracts International: Section B: the Sciences & Engineering
1998;58(10-B):5682.
Huff CA, Matsui W, Smith BD, Jones RJ. The paradox of response and survival in cancer
therapeutics. Blood First Edition Paper, prepublished online September 8, 2005.
Hughes SL, Cummings J, Weaver F, Manheim L, Braun B, Conrad K. A randomized trial of the cost
effectiveness of VA hospital-based home care for the terminally ill. Health Serv Res. 1992;26:801 –
817.
Hughes TAT, Wiles CM. Clinical measurment of swalllowing in health and in neurogenic dysphagia.
QJM. 1996;89(2):109-116.
Hui C, Triandis HC. Measurements in cross-cultural psychology: a review and comparison of
strategies. Cross Cultural Psychology. 1985;16:131-135.
Hui D, Arthur J, Dalal S, Bruera E. Quality of the supportive and palliative oncology literature: a
focused analysis on randomized controlled trials. Supportive Care in Cancer. 2012;20(8):1779-1785.
Humpel N, Iverson DC. Review and critique of the quality of exercise recommendations for cancer
patients and survivors. Support Care Cancer. 2005;13:493-502.
Hunt SM, Alonzo J, Bucquet D, Niero M, Wicklund I, McKenna S. Cross-cultural adaption of health
measures. European Group for Health Management and Quality of Life Assessment. Health Policy.
1991;19(1):33-44.
Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and
epidemiologists. J Royal Coll Gen Pract. 1985;35:185-188.
Huntington JL, Dueck A. Handling missing data. Curr Probl Cancer. 2005;29:317-325.
Hurny C, Berngard J. Problems in assessing quality of life (qol) of lung cancer patients in clinical
trials. Chest. 1989;96(1)(Suppl):102-S105.
Hurny C, Bernhard J, Coates A, et al. Timing of baseline quality of life assessment in an international
adjuvant breast cancer trial: Its effect on patient self-estimation. The International Breast Cancer
Study Group. Ann Oncol. 1994;5:65-74.
Hurny C, Bernhard J, Coates A, et al. Responsiveness of a single-item indicator versus a multi-item
scale: Assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care.
1996;34(3):234-248.
Hurny C, Bernhard J, Gelber RD, et al. Quality of life measures for patients receiving adjuvant
therapy for breast cancer: an international trial. Euro J Cancer. 1992;28(1):118-124.
D:\478174570.doc
Hurny C. Do patients with advanced cancer get appropriate information? Support Care Cancer.
2002;10:383-384.
Hurria A. Care of the older woman with early-stage breast cancer. Women’s Oncol Rev. 2002;2:253259.
Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS, Schmieder L, Ansari R, Tew WP,
Weckstein D, Kirshner J, Togawa K, Hansen K, Katheria V, Stone R, Galinsky I, Postiglione J, Cohen
HJ. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.
Journal of Clinical Oncology. 2011;29(10):1290-1296.
Hurst NP, Ruta DA, Kind P. Comparison of the MOS Short Form-12 (SF12) health status
questionnaire with the SF36 in patients with rheumatoid arthritis. Br J Rheum. 1998;37:862-869.
Huschka M, Mandrekar SJ, Schaefer PL, Jett JR, Sloan JA. A pooled analysis of quality of life
measures and adverse events data in North Central Cancer Treatment group lung cancer clinical
trials. Cancer. 2007;109:787-795.
Huskisson EC. Measurement of pain. Lancet. 1974;9:27-31.
Hutton JL, Baracos VE, Wismer WV. Chemosensory dysfunction is aprimary factor in the evolution of
declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom
Manage. 2007;3392):156-165.
Hwang C-L, Yu C-J, Shih J-Y, Yang P-C, Wu Y-T. Effects of exercise training on exercise capacity in
patients with non-smal lung cancer receiving targeted therapy. Supportive Care in Cancer.
2012;20(12):3169-3177.
Hwang SS, Chang VT, Alejandro Y, Osenenko P, Davis C, Cogswell J, Srinivas S, Kasimis B. Caregiver
unmet needs, burden, and satifaction in symptomatic advanced cancer patients at a Veterans Affairs
(VA) medical center. Palliat Support Care 2003;1(4):319-329.
Hwang SS, Chang VT, Rue M, Kasimis. Multidimensional independent predictors of cancer-related
fatigue. J Pain Symptom Manage. 2003;26:604–614.
Hwang SS, Scott C, Chang VT, Alejandro Y, Osenenko P, Cogswell J, Morales E, Davis C, Srinivas S,
Kasimis B. Prediction of survival for advanced cancer patients by recursive partitioning analysis.
ASCO Poster Presentation, 2002.
Hwang JP, Holmes HM, Kallen MA, Ensor Etchegaray J, Saab R, Abruckle RB, King KM, Escalante CP.
Accuracy of reporting current medications by cancer patients presenting to an emergency center.
Support Care Cancer. 2009 October [Epub ahead of print] 8 pages.
Hyland ME, Sodergren SC. Development of a new type of global quality of life scale, and comparison
of performance and preference for 12 global scales. Qual Life Res. 1996;5:469-480.
Hyland ME. A reformulation of quality of life for medical science. Qual Life Res. 1992;1:267-272.
D:\478174570.doc
Ichihara K, Sato K. Evidence-based laboratory interpretation system built on a large collection of
case records with well-defined diagnosis. Clin Chem Lab. 2001;39(11):1035-1044.
Iconomou G, Vagenakis AG, Kalofonos HP. The informational needs, satisfaction with
communication, and psychological status of primary caregivers of cancer patients receiving
chemotherapy. Support Care Cancer. 2001;9:591–596.
Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga
K, Sasako M, Mori M. Clinical significance of circulating tumor cells, including cancer stem-like cells,
in peripheral blood for recurrence and prognosis in patients with Dukes’ Stage B and C Colorectal
Cancer. Journal of Clinical Oncology. 2011;29(12):1547-1555.
Illman J, Corringham R, Robinson D, Davis H, Rossi J-F, Cella D, Trikha M. Are inflammatory
cytokines the common link between cancer-associated cachexia and depression? J Support Oncol
2005;3(1):37-50.
Imhof SL, Kaskie B, Wyatt MG. Finding the way to a better death: an evaluation of palliative care
referral tools. Journal of Gerontological Nursing. 2007 June;33(6):40-49.
Ingham J, Portenoy R. Symptom Assessment. Hem/oncol Clin N Am. 1996;10(1):21-39.
Ingram SS, Seo PH, Martell RE, et al. Comprehensive assessment of the elderly cancer patient: the
feasibility of self-report methodology. J Clin Oncol. 2002;20(3):770-775.
Inoue A, Yamada Y, Matsumura Y, et al. Randomized study of dexamethasone treatment for delayed
emesis, anorexia dn fatigue induced by irinotecan. Support Care Cancer. 2003;11:528-532.
Inoue S, Saeki T, Mantani T, Okamura H, Yamawaki S. Factors related to patient’s mental
adjustment to breast cancer: patient characteristics and family functioning. Support Care Cancer.
2003;11:178-184.
Institute of Medicine. Cancer care for the whole patients: meeting psychosocial health needs.
Report Brief. October 2007.
Ibrahim JG, Chu H, Chen M-H. Missing data in clinical studies: Issues and Methods. Journal of
Clinical Oncology. 2012;30(26):3297-3303.
Irvine D, Vincent L, Graydon JE, Bubel N, Thompson L. The prevalence and correlates of fatigue in
patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue
experienced by healthy individuals. Cancer Nurs. 1994;17(5):367-378.
Irvine DM, Vincent L, Bubela N, Thompson L, Graydon J. A critical appraisal of the research literature
investigating fatigue in the individual with cancer. Cancer Nurs. 1991;14(4):188-199.
Irwin MR, Olmstead R, Motivala SJ. Improving Sleep Quality in Older Adults with Moderate Sleep
Complaints: A Randomized Controlled Trial of Tai Chi Chih. SLEEP. 2008;31(7):1001-8.
Issaacs B, Kennie AT. The set test as an aid to the detection of dementia in old people. Brit J
Psychiat. 1973;123:467-470.
D:\478174570.doc
Italian Group for Antiemetic Research. Randomized, double-blind, dose-finding study of
dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or
cyclophosphamide. J Clin Oncol. 2004;22:725–729.
Jackowski D, Guyatt G. Part III. Outcomes analysis in orthopaedic surgery: a guide to health
measurement. Clin Orthopaedics Rel Res. 2003;413:80-89.
Jackson JL, Kroenke K. The effect of unmet expectations among adults presenting with physical
symptoms. Ann Intern Med. 2001;34(9 Pt 2):889-897.
Jackson JM, Rolnick SJ, Coughlin SS, Neslund-Dudas C, Hornbrook MC, Darbinian J, Bachman DJ,
Herrinton LJ. Social support among women who died of ovarian cancer. Support Care Cancer.
2007;15:547-556.
Jacobs C, Ross, RD, Walker IM, Stockdale FE. Behavior of cancer patients: a randomized study of the
effects of education and peer support groups. Am J Clin Oncol. 1983;6:347-350.
Jacobs M. Massage for the relief of pain: anatomical and physiological considerations. Phys Ther
Rev. 1959;(40)2:93–98.
Jacobsen PB, Davis K, Cella D. assessing quality of life in research and clinical practice. Oncology.
2003;16 9(Suppl. 10):133-139.
Jacobsen PB, Donovan KA, Trask PC, Fleishman SB, Zabora J, Baker F, Holland JC. Screening for
psychologic distress in ambulatory cancer patients: a multicenter evaluation of the distress
thermometer. Cancer. 2005;103:1494-1502.
Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH. Fatigue in women receiving
adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom
Manage. 1999;18(4):233-242.
Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J. Relation of family history of
prostate cancer to perceived vulnerability and screening behavior. Psycho-Oncol. 2004;13:80–85.
Jacobsen PB, Meade CD, Stein KD, Chirikos TN, Small BJ, Ruckdeschel JC. Efficacy and costs of two
forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol.
2002;20(12):2851-2862.
Jacobsen PB. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;32:93-97.
Jacobsen PB, Wells KJ, Meade CD, Quinn GP, Lee J-H, Fulp WJ, Gray JE, Baz RC, Springett GM,
Levine RM, Markham M-J, Schreiber FJ, Cartwright TH, Burke JM, Siegel RD, Malafa MP, Sullivan D.
Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients
with cancer regarding clinical trial participation: a multicenter randomized controlled trial. Journal of
Clinical Oncology. 2012;30(20):2516-2521.
Jaeschke R, Singer J, Guyatt GH. A comparison of seven-point and visual analogue scales. Data
from a randomized trial. Control Clin Trials. 1990;11:43-51.
D:\478174570.doc
Jaeschke R, Singer J, Guyatt GH. Measurements of health status: ascertaining the minimal clinically
imortant difference. Control Clin Trials. 1989;10:407-415.
Jahkola T. Self-preceptions of women after early breast cancer surgery. Eur J Surg Oncol.
1989;24:9-14.
Jahn P, Renz P, Stukenkemper J, Book K, Kuss O, Jordan K, Horn I, Thoke-Colberg A, Schmoll H J,
Landenberger M. Reduction of chemotherapy-induced anorexia, nausea, and emesis through a
structured nursing intervention: a cluster-randomized multicenter trial. Supportive Care in Cancer.
2009;17(12):1543-1552.
James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P. Measuring
response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst.
1999;1(6):523-528.
Janda M, Eakin EG, Bailey L, Walker D, Troy K. Supportive care needs of people with brain tumors
and their carers. Support Care Cancer. 2006;14:1094-1103.
Janda M, Obermair A, Cella D, Crandon J, Trimmel M. Vulvar cancer patients’ quality of life: a
qualitative assessment. International Journal of Gynecological Cancer. 2004;14(5):875-881.
Janda M, Obermair A, Cella D, Perrin L, Nicklin J, Ward B, Crandon A. The Functional Assessment of
Cancer-Vulva: Reliability and Validity. Gynecol Oncol 2005;97:568-575.
Jang RW, Le Maitre, Ding K, Winton T, Bezjak A, Seymour L, Shepherd FA, Leighl NB. Qualityadjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung
cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial.
Journal of Clinical Oncology. 2009;27(26):4268-4273.
Janiszewska J, Buss T, de Walden-Galuszko K, Majkowicz M, Lichodziejewska-Niemierko M, Modlinska
A. The religiousness as a way of coping with anxiety in women with breast cancer at different disease
stages. Supportive Care in Cancer. 2008;16(12):1361-1366.
Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J,
Courturier J, Peuchmaur M, Valent A, Plantaz D, Rubie H, Valteau-Couanet D, Thomas C, Combaret V,
Rousseau R, Eggert A, Michon J, Speleman F, Delattre O. Overall Genomic Pattern is a Predictor of
Outcome in Meuroblastoma. Journal of Clinical Oncology. 2009;27(7):1026-1033.
Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapyinduced cognitive changes in breast cancer patients. Supportive Care in Cancer. 2011;19(1):16471656.
Jansen J, Butow PN, van Weert JCM, van Dulmen S, Devine RJ, Heeren TJ, Bensing JM, Tattersall
MHN. Does Age Really Matter? Recall of Information Presented to Newly Referred Patients With
Cancer. Journal of Clinical Oncology. 2008;26(33):5450-5457.
Jansen L, Herrmann A, Stegmaier C, Singer S, Brenner h, Arndt V. Health-related quality of life
during the 10 years after diagnosis of colorectal cancer: a population-based study. Journal of Clinical
Oncology. 2011;29(24):3263-3269.
D:\478174570.doc
Jansen SJ, Kievit J, Nooij MA, et al. Patients’ preferences for adjuvant chemotherapy in early-stage
breast cancer: is treatment worthwhile? Br J Cancer. 2001;84:1577–1585.
Jansen ST, Stiggelbout AM, Nooij MA, Noordijk EM, Kievit J. Response shift in quality of life
measurement in early-stage breast cancer patients undergoing radiotherapy. Qual Life Res.
2000;9:603-615.
Janssen-Heijnen, MLG, Houterman S, Lemmens VEPP, Louwman MWJ, Maas HAAM, Coebergh JWW.
Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based
approach. Critical Reviews in Oncology Hematology. 2005;55:231-240
Janz NK, Wren PA, Copeland LA, Lowery JC, Goldfarb SL, Wilkins EG. Patient–physician concordance:
preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol.
2004;22(15):3091–3098.
Jarbrink K, Kreif N, Benedict A, Locklear J. Quality of life and drug costs associated with switching
antipsychotic medication to once-daily extended release quetiapine fumarate in patients with
schizophrenia. Current Medical Research and Opinion. 2009;25(3):709-716.
Jatoi A, Alberts SR, Foster N, et al. Is bortezomib, a proteasome inhibitor, effective in treating
cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group.
Support Care Cancer. 2005;13:381-386.
Jatoi A. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: a data-driven,
practical approach. Support Oncol. 2006;4(10):499-502.
Jatoi A, Dakhil SR, Sloan JA, Kugler JW, Rowland KM Jr, Schaefer PL, Novotny PJ, Wender DB, Gross
HM, Loprinzi CL. Prophylactic tetracycline does not diminish the severity of epidemial growth factor
receptor (EGFR) inhibitor-induces rash: results from the North Central Cancer Treatment Group
(Supplementary N03CB). Support Care Cancer. 2010 Sep 06. [Epub ahead of print].
Jatoi A, Thrower A, Sloan JA, Flynn PJ, Wentworth-Hartung NL, Dakhil SR, Mattar BI, Nikcevich DA,
Novotny P, Sekulic A, Loprinzi CL. Does sunscreen prevent epidermal growth factor receptor (EGFR)
inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment
Group (N05C4). Oncologist. 2010;15(9):1016-22. Epub 2010 Aug 26.
Jayashree M, Singhi SC, Malhi P. Follow up of survival and quality of life in children after intensive
care. Indian Pediatrics 2003;40:303-309.
Jemal A, Siegel R, Ward E, Murray Tt, Xu J, Thun MJ. Cancer Statistics, 2007. CA Cancer J Clin.
2007;57(1):43-66.
Jenkins CA, Schulz M, Hanson J, Bruera E. Demographic, symptom, and medication profiles of cancer
patients seen by a palliative care consult team in a tertiary referral hospital. J Pain Symptom
Manage. 2000;19(3):174–184.
Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Landridge C, Parlour L, Farewell V, Fallowfield
L. The attitudes of 1066 patients with cancer towards participation in randomized clinical trials.
British Journal of Cancer. 2010;103:1801-1807.
D:\478174570.doc
Jenkinson C, Layte R, Jenkinson D, Lawrence K, Petersen S, Paice C, Stradling J. A shorter form
health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? J Publ Hlth
Med. 1997;19(2):179-186.
Jenkinson C, Peto V, Jones G, Fitzpatrick R. Interpreting change scores on the Amyotrophic Lateral
Sclerosis Assessment Questionnaire (ALSAQ-40). Clin Rehab. 2003;17:380-385.
Jenkinson C. The SF-36 physical and mental health summary measures: an example of how to
interpret scores. J Hlth Serv Res Pol. 1998;3(2):92–96.
Jensen MP, McFarland CA. Increasing the reliability and validity of pain intensity measurement in
chronic pain patients. Pain. 1993;55:195-203.
Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain. 2003;4(1):221.
Jeon S, Given C, Sikorskii A, Given B. Do Interference-Based Cut-Points Differentiate Mild, Moderate,
and Severe Levels of 16 Cancer-Related Symptoms Over Time? Journal of Pain and Symptom
Management. (epub ahead of print on July 9, 2008).
Jim HSL, Phillips KM, Chait S, Faul LA, Popa MA, Lee Y-H, Hussin MG, Jacobsen PB, Small BJ. Metaanalysis of cognitive functioning in breast cancer survivors previously treated with standard-dose
chemotherapy. Journal of Clinical Oncology. 2012;30(29):3578-3587.
Jimenez-Gordo AM, Feliu J, Martinez B, de-Castro J, Rodriguez-Salas N, Sastre N, Vilches Y, Espinosa
E, Rodriguez-Aizcorbe JR, Gonzalez-Baron M. Supporting Care in Cancer. 2009;17(3):261-270.
Jin Y, Hayes DF, Li L, Robarge JD, Skaar TC, Philips S, Nguyen A, Schott A, Hayden J, Lemler S,
Storniolo AM, Flockhart DA, Stearns V. Estrogen Receptor Genotypes Influence Hot Flash Prevalence
and Composite Score Before and After Tamoxifen Therapy. Journal of Clinical Oncology.
2008;26(36):5849-5854.
Jocham HR, Dassen T, Widdershoven G, Halfens R. Quality of life in palliative care cancer patients: a
literature review. Journal of Clinical Nursing. 2006;15(9):1188-1195.
Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep.
1991;14(6):540-545.
Johnson CE, Girgis A, Paul CL, Currow DC. Cancer specialists’ palliative care referral practices and
perceptions: results of a national survey. Palliative Medicine. 2008;22(1):51-57.
Johnson DH, Horn L. Authorship and industry financial relationships: the tie that binds. Journal of
Clinical Oncology. 2010;28(8):1281-1283.
Johnson J. Cancer: A family disruption. Cancer Res. 1988;108:306-310.
Johnson JA, Coons SJ, Hays RD, Pickard AS. Health status and satisfaction with pharmacy services.
Am J Manage Care. 1999;5(2):163-170.
D:\478174570.doc
Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer
drugs. Cancer Treat Repts. 1985;69(10):1155-1157.
Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration
approval for oncology drugs. J Clin Oncol. 2003;21(7):1404-1411.
Johnson ME, Piderman KM, Sloan JA, Huschka M, Atherton PJ, Hanson JM, Brown PD, Rummans T.
Meausring spiritual quality of life in patients with cancer. J Support Oncol 2007;5(9):1-?
Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is
independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin
Oncol. 2006;24(22):3570-3575.
Johnson W, Krueger RF. Higher perceived life control decreases genetic variance in physical health:
evidence from a national twin study. Journal of Personality and Social Psychology. 2005;88(1):16573.
Johnston BC, Thorlund K, Schunemann HJ, Xie F, Murad MH, Montori VM, Guyatt GH. Improving the
interpretation of quality of life evidence in meta-analyses: the application of minimal important
difference units. Health Qual Life Outcomes. 2010;8:116. 5 pages.
Johnstone MJ. Quality versus quantity of life: who should decide? Aust J Adv Nurs. 1988;6(1):3137.
Johnstone PAS, Hawkins K, Hood S. Role of patient adherence in maintenance of results after
manipulative therapy for lymphedema. J Soc Integr Oncol. 2006;4(3):125-129.
Jokovic A, Locker D, Guyatt G. How well do parents know their children? Implication of proxy
reporting of child health-related quality of life. Qual Life Res. 2004;13:1297–1307.
Jolliet P, Health-Related Quality of Life Studies and French Advertising Control Committee. Healthrelated quality of life and patient-reported outcomes: scientific and useful outcome criteria. Comptes
rendus de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors:
Chassany O, Caulin C. October 2002.
Joly F, Espie M, Marty M, Heron J-F, Henry-Amar, M. Long-term quality of life in premenopausal
women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
Br J Cancer. 2000;83(5):577-582.
Jones CA, Feeny DH. Agreement between patient and proxy responses of health-related quality of
life after hip fracture. J Amer Geriatr Society 2005;53:1227-1233.
Jones JB, Snyder CF, Wu AW, for the “Website for Outpatient QOL Assessment” Research Network.
Issues in the design of internet-based systems for collecting patient-reported outcomes. 2010? 26
pages.
Jones CA, Feeny DH, Eng K. Test-retest reliability of health utitilies index scores: evidence from hip
fracture. Intl J Technol Assessment in Health Care 2005;21(3):393-398.
D:\478174570.doc
Jones G, Jenkinson C, Kennedy S. Evaluating the responsiveness of the endometriosis health profile
questionnaire: the EHP-30. Qual Life Res. 2004;13:705-713.
Jones G, Kennedy S, Barnard A, Wong J, Jenkinson C. Development of an endometriosis quality-oflife instrument: The Endometriosis Health Profile-30. Obstet Gynecol. 2001;98:258-264.
Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ, Mulgrew NC, Shepherd KE, et al.
The polycystic ovary syndrome health-related quality of life questionnaire (PCOSQ): a validation.
Human Reproduction. 2004;19(2):371-377.
Jones GL, Kennedy SH, Jenkinson C. Health-related quality of life measurement in women with
common benign gynecologic conditions: a systematic review. Am J Obstet Gynecol. 2002;187:501511.
Jones JB, Snyder CF, Wu AW. Issues in the design of internet-based systems for collecting patientreported outcomes. Manuscript. Pp 1-26.
Jones LW, Guill B, Keir ST, Carter K, Friedman HS, Bigner DD, Reardon DA. Exercise interest and
preferences among patients diagnosed with primary brain cancer. Support Care Cancer.
2007;15:47-55.
Jones M, Schenkel B, Just J, Fallowfield L. Epoetin alfa improves quality of life in patients with
cancer: results of metaanalysis. Cancer. 2004;101(8):1720:1732.
Jordhoy MS, Fayers P, Loge JH, Ahlner-Elmqvist M, Kaasa S. Quality of life in palliative cancer care:
results from a cluster randomized trial. J Clin Oncol. 2001;19:3884–3894.
Jordhoy MS, Fayers P, Salnes T, Ahlner-Elmqvist M, Jannert M, Kaasa S. A palliative care intervention
and death at home: a cluster randomized trial. Lancet. 2000;356:888–893.
Jordhoy MS, Kaasa S, Fayers P, Overness T, Underland G, Ahlner–Elmqvist M. Challenges in
palliative care research; recruitment, attrition and compliance: experience from a randomized
controlled trial. Palliat Med. 1999;13:299–310.
Jordon K, Hinke A, Grothey A, Joachim Schmoll H. Granisetron versus tropisetron for prophylaxis of
acute chemotherapy-induced emesis: a pooled anlaysis. Support Care Cancer. 2005;13:26-31.
Joseph RR. Viewpoints and concerns of a clinical trial participant. Cancer. 1994;74:2692-2693.
Juniper EF, Bousquet J, Abetz L, Bateman ED, The GOAL Committee. Identifying ‘well-controlled’ and
‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respiratory Medicine.
2006;100(4):616-621.
Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respair
Dis. 1993;147:832-838.
Juniper EF, Guyatt, GH, Willan A, Griffith LE. Determining a minimal important change in a diseasespecific quality of life questionnaire. J Clin Epidemiol. 1994;47(1):81-84.
D:\478174570.doc
Juniper EF, Langlands JM, Juniper BA. Patients may respond differently to paper and electronic
versions of the same questionnaires. Respiratory Medicine. 2009;103(6):932-934.
Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA. Sensitivity, specificity, reliability, and clinical
validity of provider-reported symptoms: a comparison with self-reported symptoms. J Acquir
Immune Defic Syndr. 1999;21:126-133.
Jylha M. What is self-rated health and why does it predict mortality? Towards a unified conceptual
model. Social Science and Medicine. 2009;69:307-316.
Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A. The EORTC core quality of
life Questionnaire (QLQ-C30): Validity and reliability when analysed with patients treated with
palliative radiotherapy. Euro J Cancer. 1995;31A(13/14):2260-2263.
Kaasa S, Loge JH, Fayers P, et al. Symptom Assessment in Palliative Care: A Need for International
Collaboration. Journal of Clinical Oncology. 2008;26(23):3867-3873.
Kaasa S, Mastekaasa A, Naess S. Quality of life of lung cancer patients in randomized clinical trial
evaluated by a psychosocial well-being questionnaire. Acta Oncol. 1988;27(4):335-342.
Kaasa S, Mastekaasa A, Stokke I, Naess S. Validation of a quality of life questionnaire for use in
clinical trials for treatment of patients with inoperable lung cancer. Eur J Cancer Clin Oncol.
1988;24(4):691-701.
Kaasa S, Mastekaasa A, Thorud E. Toxicity, physical function and everyday activity reported by
patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus
radiotherapy). Acta Oncol. 1988;27(4):343-349.
Kaasa S, Mastekaasa A. Psychosocial well-being of patients with inoperable non-small cell lung
cancer. Acta Oncol. 1988;27:829-835.
Kaasa S. Measurement of quality of life in clinical trials. Oncology. 1992;49(4):289-294.
Kaasa T, Loomis J, Gillis K, Bruera E, Hanson J. The Edmonton Functional Assessment Tool:
preliminary development and evaluation for use in palliative care. J Pain Symptom Manage.
1997;13(1):10-19.
Kagawa-Singer M. Improving the validity and generalizability of studies with underserved U.S.
populations expanding the research paradigm. Ann Epidemiol. 2000;10:S92-S103.
Kahn K L, Malin J L, Adams J, Ganz PA. Developing a reliable, valid, and feasible plan for quality-ofcare measurement for cancer: how should we measure? Med Care. 2002;40(6)(Supplement):III-73III-85.
Kahneman D, Krueger AB, Schkade DA, Schwarz N, Stone AA. A survey method for characterizing
daily life experience: the day reconstruction method. Science. 2004;306.
Kaiser HF. A second generation little jiffy. Psychometrika. 1970;35(4):401-415.
D:\478174570.doc
Kaizer L, Warr D, Hoskins P, et al. Effect of schedule and maintenance on the antiemetic efficacy of
ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients
receiving moderately emetogenic chemotherapy: A phase III trial by the National Cancer Institute. J
Clin Oncol. 1994;12:1050-1057.
Kallich J, McDermott A, Xu X, Fayers P, Cella D. The relationship between patient knowledge of
hemoglobin levels and health-related quality of life. Qual Life Res 2005;15:57-68.
Kalra L, Evans A, Perez I, Melbourn A, Patel A, Knapp M, Donaldson N. Training caretakers of stroke
patients: randomized controlled trial. BMJ. 2004;328:1-5.
Kane RL, Saleh KJ, Wilt TJ, Berhsadsky B. The functional outcomes of total knee arthroplasty. J
Bone Joint Surg Am. 2005;87:1719-1724.
Kang JH, Cook N, Manson J, Buring JE, Grodstein F. A randomized trial of vitamin E supplementation
and cognitive function in women. Arch Intern Med. 2006;166:2462-2468.
Kantarjian HM, Shan J, Smith T, Talpaz M, Kozuch P, Rios MB, Cortes J, Giles FJ, O’Brien S.
Response to therapy is independtly associated with survival prolongation in chronic myelogenous
leukemia in the blastic phase. Cancer. 2001;92:2501-2507.
Kao SC, Vardy J, Harvie R, Chatfield M, van Zandwijk N, Clarke S, Pavlakis N. Health-related quality
of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer.
2013;21(3):697-706.
Kaplan RM, Anderson JP, Patterson TL, McCutchan JA, Weinrich JD, Heaton RK, Atkinson JH, Thal L,
Chandler J, Grant I, and the HNRC Group. Validity of the quality of well-being scale for persons with
human immunodeficiency virus infection. Psychosomatic Med. 1995;57:138-147.
Kaplan RM, Anderson JP, Wu AW, et al. The Quality of Well-Being Scale: applications in AIDS, cystic
fibrosis, and arthritis. Med Care. 1989;27(suppl3):S27-S43.
Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well-being scale as an outcome measure in
chronic obstructive pulmonary disease. J Chronic Dis. 1984;37:85-95.
Kaplan RM, Bush JW, Berry CC. Health status index: category rating versus magnitude estimation for
measuring levels of well-being. Medical Care. 1979;17(5):501-525.
Kaplan RM, Ernst JA. Do category rating scales produce biased preference weights for a health
index? Medical Care. 1983;21(2):193-207.
Kaplan RM. Health-related quality of life in cardiovascular disease. J Cons Clin Psychol. 1988;3:382392.
Kaplar ME, Wachholtz AB, O’Brien H. The effect of religious and spiritual interventions on the
biological, psychologica, and spiritual outcomes of oncology patients: a meta-analytic review. J
Psychosoc Oncol. 2004;22(1):39-49.
D:\478174570.doc
Karlsen S, Addington-Hall JM. How do cancer patients who die at home differ from those who die
elsewhere? Palliat Med. 1998;12:279-286.
Karlsson M, Milberg A, Strang P. Dying with dignity according to Swedish medical students. Support
Care Cancer. 2006;14:334-339.
Karlsson S, Ruokonen E, Varpula T, Ala-Kokko TI, Pettila V, Finnsepsis Study Group. Long-term
outcome and quality-adjusted life years after severe sepsis. Crit Care Med. 2009 Apr;37(4):1268-74.
Karnofsky DA. Clinical evaluation of anticancer drugs. Gann Monograph on Cancer Research. 1967;
2:223-234.
Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA. Quality of life scores
predict survival among patients with head and neck cancer. J Clin Oncol. 2008;26(16):2754-2760.
Kashner TM, Trivedi MH, Wicker A, Fava M, Shores-Wilson K, Wisniewski SR, Rush AJ. Release bias
in accessing medical records in clinical trials: a STAR*D report. Int J Methods Psychiatr Res.
2009;18(3):147-158.
Kassam A, Skiadaresis J, Habib S, Alexander S, Wolfe J. Moving toward quality palliative cancer care:
parent and clinician perspectives on gaps between what matters and what is accessible. Journal of
Clinical Oncology. 2012 Nov 26 [epub ahead of print].
Kassam A, Skiadaresis J, Habib S, Alexander S, Wolfe J. Moving toward quality palliative cancer care:
parent and clinician perspectives on gaps between what matters and what is accessible. Journal of
Clinical Oncology. 2013;31(7):910-915.
Katsavdakis KA, Clifford PI, Evans RB, Graham P, Allen JG, Sargent JG, Lyle J, Frager DC. The how
are you? Scale: A quality-of-life outcomes measure for routine practice. Bulletin of the Menninger
Clinic. 1999;63(3):366-387.
Katz D, McHorney C. The relationship between insomnia and health-related quality of life in patients
with chronic illness. J Fam Pract. 2002;51(3.
Katz MR, Kopeck N, Waldron J, Devins GM. Screening for depression in head and neck cancer.
Psycho-Oncol. 2004;13:269–280.
Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientationmemory-concentratation test of cognitive impairment. Am J Psychiatry. 1983;140:734–739.
Kaufman J, Yang B-Z, Douglas-Palumeri H, Grasso D, Lipschitz D, Houshyar S, Krystal JH, Gelernter J.
Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of
depression in children. Biol Psychiatry 2006;59:673-680.
Kautio A-L, Haanpaa M, Kautiainen H, Kalso E, Saarto T. Burden of chemotherapy-induced
neuropathy—a cross-sectional study. Support Care Cancer. 2011;19(12):1991-96.
Kaye JM, Lawton MP, Gitlin LN, Kleban MH, Windsor LA, Kaye D. Older people’s performance on the
Profile of Mood States (POMS). Clin Gerontologist. 1988;7(3/4):35-56.
D:\478174570.doc
Kazak AE, Cant MC, Jensen MM, McSherry M, Rourke MT, Hwang WT, Alderfer MA, Beele D, et al.
Identifying psychosocial risk indicative of subsequent resource use In families of newly diagnosed
pediatric oncology patients. J Clin Oncol. 2003;21(17):3220-3225.
Kazis LE, Anderson JJ, Meenan RF. Health status information in clinical practice: the development
and testing of patient profile reports. J Rheum. 1988;15:338-344.
Kazis LE, Callahan LF, Meenan RF, Pincus T. Health status reports in the care of patients with
rheumatoid arthritis. J Clin Epidemiol. 1990;43(11):1243-1253.
Kazis LE, Miller DR, Clark J, Sinner K, Lee A, Rogers W, Spiro III A, Payne S, Fincke G, Selim A, Linzer
M. Arch Intern Med. 1998;158:626-632.
Kearney N, Kidd L, Miller M, Sage M, Khorrami J, McGee M, Cassidy J, Niven K, Gray P. Utilizing
handheld computers to monitor and support patients receving chemotherapy: results of a UK-based
feasibility study. Support Care Cancer. 2006;14(7):742-752.
Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, Sage M, Miller M, Maguire R.
Evaluation of a mobile phone-based, advanced symptom management system (ASyMS©) in the
management of chemotherapy-related toxicity. Supportive Care in Cancer. 2009;17(4):437-444.
Kearns AE, Northfelt DW, Dueck AC, Atherton PJ, Dakhil SR, Rowland Jr KM, Fuloria J, Flynn PJ,
Dentchev T, Loprinzi CL. Osteoporosis prevention in prostate cancer patients receiving androgen
ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
Supportive Care in Cancer. 2010;18(3):321-328.
Keating NL, Landrum MB, Arora NK, Malin JL, Ganz PA, van Ryn M, Weeks JC. Cancer patients’ roles
in treatment decisions: Do characteristics of the decision influence roles? Journal of Clinical Oncology.
2010;28(28):4364-4370.
Keating NL, Guadagnoli E, Landrum ME, Borbas C, Weeks JC. Treatment decision making in earlystage breast cancer: should surgeons match patients' desired level of involvment? J Clin Oncol.
2002;20(6):1473-1479.
Keats MR, Culos-Reed SN. A community-based physical activity program for adolescents with cancer
(project TREK): program feasibility and preliminary findings. J Pediatr Hematol Oncol. 2008
Apr;30(4):272-80.
Keefe DM, Peterson DE, Schubert MM. Developing evidence-based guidelines for management of
alimentary mucositis: process and pitfalls. Support Care Cancer. 2006;14(6):492-498.
Keefe DM. Mucositis guidelines: what have they achieved, and where to from here? Support Care
Cancer. 2006;14(6):489-491.
Keir ST, Guill AB, Carter KE, Boole LC, Gonzales L, Friedman HS. Differential levels of stress in
caregivers of brain tumor patients – ovservations from a pilot study. Support Care Cancer.
2006;14:1258-1261.
D:\478174570.doc
Keir St, Guill AB, Carter KE, Freidman HS. Stress and intervention preferences of patients with brain
tumors. Support Care Cancer. 2006;14:1213-1219.
Kelch RP. Maintaining the public trust in clinical research. N Eng J Med. 2002;346(4):285–287.
Keller SD, Ware JE Jr, Bentler PM, et al. Use of structural equation modeling to test the construct
validity of the SF-36 health survey in ten countries: results from the IQOLA project. J Clin Epidemiol.
1998;51(11):1179-1188.
Keller SD, Ware Jr JE, Gandek B, et al. Thesting the equivalence of translations of widely used
response choice labels: results from the IQOLA Project. J Clin Epidemiol. 1998;51(11):933–944.
Kelsen DP, Portenoy RK, Thaler HT, et al. Pain and depression in patients with newly diagnosed
pancreas cancer. J Clin Oncol. 1995;13(3):748-755.
Kemeny MM, Wellisch DK, Schain WS. Psychosocial outcome in a randomized surgical trial for
treatment of primary breast cancer. Cancer. 1988;62(6):1231-1237.
Kemmler G, Holzner B, Kopp M, et al. Comparison of two quality-of-life instruments for cancer
patients: the Functional Assessment of Cancer Therapy-general and the European Organization for
Research and Treatment of Cancer Quality of Life Questionnaire-C30. J Clin Oncol. 1999;17(9):29322940.
Kempen GI. The MOS short-form general health survey: Single item vs. multiple measures of
health-related quality of life: Some nuances. Psychol Rep. 1992;70(2):608-610.
Kendal WS. Dying with Cancer, The Influence of Age Comorbidity, and Cancer Site. Cancer
2008;112:1354-62.
Kendall M, Harris F, Boyd K, Sheikh A, Murray S, Brown D, Mallinson I, Kearney N, Worth A. Key
challendges and ways forward in researching the “good death”: qualitative in-depth interview and
focus group study. BMJ. 2007 (February);1-6.
Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a
serotonin transporter polymorphism in the prediction of episodes of major depression. Arch Gen
Psychiatry 2005;62:529-535.
Kennedy BJ. Aging and Cancer. Oncology (Huntington). 2000;14:1731-1733.
Kennett A, Hardy J, Shah S, A’Hern R. An open study of methotrimeprazine in the management of
nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2004;13:715-721.
Kenny PM, King MT, Viney RC, Boyer MJ, Pollicino CA, McLean JM, Fulham MJ, McCaughan BC.
Quality of life and survival in the 2 years after surgery for non-small cell lung cancer. J Clin Oncol.
2008;26(2):233-241.
Kerba M, Wu JSY, Duan Q, Hagen NA, Bennett MI. Neuropathic pain features in patients with bone
metastases referred for palliative radiotherapy. Journal of Clinical Oncology. 2010;28(33):48924897.
D:\478174570.doc
Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening
mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
JAMA. 1999;282(22):2156-2163.
Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry
supporting patient-reported outcomes research. Expert Rev. Pharmacoeconomics Outcomes Res.
2010;10(03):269-281.
Kerr JR, Burke B, Petty R, Gough J, Fear D, Mattey DL, Axford JS, Dalgleish AG, Nutt DJ. Seven
genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene
networks and clinical phenotypes. J. Clin. Pathol. 2008; 61:730-739.
Kessler L, Ramsey SD. The outcomes of The Cancer Outcomes Research Symposium: A
commentary. Med Care. 2002;40(6)(Supplement):III-104-III-108.
Kettis Lindblad A, Ring L, Glimelius B, Hansson MG. Focus on the individual: Quality of life
assessments in oncology. Acta Oncol. 2002;41(6):507-516.
Keung YK, Staton M, Kellum DZ, et al. Pilot study of quality of life (QOL) assessment in patients after
chemotherapy and bone marrow transplant. Proc Annu Meet Am Soc Clin Oncol. 1995;14:A1655.
Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O’Brien MER, Cunningham
D, Andreyev HJN. Symptoms and weight loss in patients with gastrointestinal and lung cancer at
presentation. Support Care Cancer. 2007;15:39-46.
Khoshknabi D, Davis MP. What are the mechanisms of cancer related fatigue. J Cancer Pain Sympt
Palliat. 2006;2(1):29-32.
Khoury MJ, McBride C, Schully SD, Ioannidis JPA, Feero WG, Janssens ACJW, Gwinn M, SimonsMorton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis
BR, Downing GJ, DuRoss A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P,
Gulcher JR, Hsu A, Hudson KL, Kardia SLR, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF,
Roberts HS Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J.
The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of
Health-Centers for Disease Control and Prevention Multidisciplinary Workshop. Genetics in Medicine.
2009;11(8):pages 1-9.
Kiebert G, Wait S, Bernhard J, et al. Practice and policy of measuring quality of life and health
economics in cancer clinical trials: a survey among co-operative trial groups. Qual Life Res.
2001;9:1073–1080.
Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral lowgrade gliomas of the adult: results of a randomized phase III trial on dose response (EORTC Trial
22844). E J Cancer. 1998;34(12):1902–1909.
Kiebert GM, Curran D, Aaronson NK. Quality of life as an endpoint in EORTC clinical trials. Stats
Med. 1998;17:561-569.
D:\478174570.doc
Kiebert GM, deHaes JCJM, van de Velde CJH. The impact of breast-conserving treatment and
mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol.
1991;9:1059-1070.
Kiessling A, Henriksson P. Perceived cognitive function is a major determination of health related
quality of life in a non-selected population of patients with coronary artery disease-a principal
components analysis. Qual Life Res. 2004;13:1621-1631.
Kilbourn KM, Anderson D, Costenaro A, Lusczakoski K, Borrayo E, Raben D. Feasibility of EASE: a
psychosocial program to improve symptom management in head and neck cancer patients.
Supportive Care in Cancer. 2013;21(1):191-200.
Kilbridge KL, Cole BF, Kirkwood JM, et al. Quality-of-life-adjusted survival analysis of high-dose
adjuvant interferon alfa-2b for high-risk melanoma patients using intergroup clinical trial data. J Clin
Oncol. 2002;20(5):1311-1318.
Kilbridge KL. Quality-adjusted life-years, comparative effectiveness in cancer care, and measuring
outcomes in the underserved. Oncology. 2010;24(6):530-537.
Kilgore WDS. The visual analogue mood scale: Can a single-item scale accurately classify depressive
mood state? Psycholog Repts. 1999;85(3):1238-1243.
Kim E, Jahan T, Aouizerat BE, Dodd MJ, Cooper BA, Paul SM, West C, Lee K. Swift PS, Wara W,
Miaskowski C. Changes in symptom clusters in patients undergoing radiation therapy. Supportive
Care in Cancer. 2009;17(11):1383-1392.
Kim SJ, Prasad GVR, Huang M, Nash MM, Famure O, Park J, Thenganatt MA, et al. A comparison of
the effects of C2-Cyclosporine and C0-Tacrolimus on renal function and cardiovascualr risk factors in
kidney transplant recipients. Transplantation. 2006;82:924-930.
Kim DH, Schwartz CE. The genetics of pain: implications for evaluation and treatment of spinal
disease. The Spine Journal. 2010;10:827-40.
Kim Y, Morrow GR. Changes in family relationships affect the development of chemotherapy-related
nausea symptoms. Support Care Cancer. 2003;11:171-177.
Kim Y, Roscoe JA, Morrow GR. The effects of information and negative effect on severity of side
effects from radiation therapy for prostate cancer. Support Care Cancer. 2002;10:416-421.
Kim H-J. Abraham IL. Statistical approaches to modeling symptom clusters in cancer patients.
Cancer Nursing. 2008;31(5):E1-E10.
Kimel M, Leidy NK, Mannix S, Dixon J. Does epoetin alfa improve health-related quality of life in
chronically III patients with anemia? Summary of Trials of Cancer, HIV/AIDS, and Chronic Kidney
Disease. International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
2008;11(1):57-75.
Kimmick GG, Peterson BL, Kornblith Ab, Mandelblatt J, Johnson JL, Wheeler J, Heinze R, Cohen HJ,
Muss HB. Improving accrual of older persons to cancer treatment trials: a randomized trial
D:\478174570.doc
comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol.
2005;23:2201-2207.
Kinahan KA, Sharp LK, Seidel K, Leisenring W. Didwania A, Lacouture ME, Stovall M, Haryani A,
Robison LL, Krull KR. Scarring, disfigurement, and quality of life in long-term survivors of childhood
cancer: a report from the childhood cancer survivor study. Journal of Clinical Oncology. 2012;24662474.
Kindler CH, Harms C, Amsler F, Ihde-Scholl T, Scheidegger D. The visual analog scale allows
effective measurement of preoperative anxiety and detection of patients’ anesthetic concerns.
Anesth. Analg. 2000;90:706-712.
King B. A review of research investigating pain and wound care. J Wound Care. 2003;12(6):219–
223.
King CR, Ferrell BR, Grant M, Sakurai C. Nurses’ perceptions of the meaning of quality of life for
bone marrow transplant survivors. Cancer Nurs. 1995;18(2):118-129.
King CR, Haberman M, Berry DL, Bush N, Butler L, Dow KH, Ferrell B, Grant M, Gue D, Hinds P,
Kreuer J, Padilla G, Underwood S. Quality of life and the cancer experience: The State-of-theKnowledge. Oncol Nurs Forum. 1997;24:27-41.
King MT, Dobson AJ, Harnett PR. A comparison of two quality-of-life questionnaires for cancer
clinical trials: the functional living index—cancer (FLIC) and the quality of life questionnaire core
module (QLQ-C30). J Clin Epidemiol. 1996;49(1):21-29.
King MT. A point of minimal important difference (MID): a critique of terminology and methods.
Expert Rev Pharmacoeconomics Outcomes Res. 2011;11(2):171-184.
King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual
Life Res. 1996;5:555-567.
King M. President’s message. ISOQOL Newsletter. 2006/2007;11(3).
King-Kallimanis BL, Oort FJ, Visser MRM, Sprangers MAG. Structural equation modeling of healthrelated quality-of-life data illustrates the measurement and conceptual perspectives on response
shift. Journal of Clinical Epidemiology. 2009;62:1157-1164.
Kirk P, Kirk K, Kristjanson LJ. What do patients receiving palliative care for cancer and their families
want to be told? A Canadian and Australian qualitative study. BMJ. 2004;June.
Kirkova J, Davis MP, Walsh D, et al. Cancer symptom assessment instruments: a systematic review.
J Clin Oncol. 2006;24:1459-1473.
Kirkova J, Walsh D. Cancer symptom clusters – a dynamic construct. Support Care Cancer
2007:15:1011-1013.
D:\478174570.doc
Kirou-Mauro A, Harris K, Sinclair E, Selby D, Chow E. Are Family Proxies a Calid Source of
Information About Cancer Patients’ Quality of Life at the End-of-Life? A Literature Review. Journal of
Cancer Pain & Symptom Palliation. 2006;2(2):23-33.
Kirsh KL, Passik S, Holtsclaw E, Donaghy K, Theobald D. I get tired for no reason: a single item
screening for cancer-related fatigue. J Pain Symptom Manage. 2001;22(5):931-937.
Kirsh KL, Walker R, Snider S, Weisenfluh S, Brown GM, Passik SD. Hospice staff members’ views on
conducting end-of-life research. Palliat Support Care. 2004;2:273-282.
Kirshner JJ, Heckler CE, Janelsins MC, Dakhil SR, Hopkins JO, Coles C, Morrow GR. Prevention of
pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial
of University of Rochester Cancer Center Clinical Community Oncology Program Research Base.
Journal of Clinical Oncology. 2012;30(16):1974-1979.
Kirsten DK, Wegner RE, Jorres RA, Magnussen H. Effects of theophylline withdrawal in severe
chronic obstructive pulmonary disease. Chest. 1993;104:1101-1107.
Kirsten L, Butow P, Price M, Hobbs K, Sundquist K. Who helps the leaders? Difficulties experienced
by cancer support group leaders. Support Care Cancer. 2006;14(7):770-778.
Kissane DW, Love A, Hatton A, et al. Effect of cognitive-existential group therapy on survival in
early-stage breast cancer. J Clin Oncol. 2004;22:4255–4260.
Kissane DW. Letting go of the hope that psychotherapy prolongs cancer survival. J Clin Oncol.
2007;25(36):5689-5690.
Kivimaki M, Vahtera J, Elovainio M, Helenius H, Singh-Manoux A, Pentti J. Optimism and pessimism
as predictors of change in health after death or onset of severe illness in family. Hlth Psych.
2005;24(4):413-431.
Kjerluff KH, Langenberg PW. A comparison of alternative ways of measuring fatigue among patients
having hysterectomy. Med Care. 1995;33(4 Suppl):156-163.
Klassen AF, Anthony SJ, Khan A, Sung L, Klaassen R. Identifying determinants of quality of life of
children with cancer and childhood cancer survivors: a systematic review. Supportive Care in Cancer.
2011;19(9):1275-1288.
Klassen A, Raina P, Reineking S, Dix D, Pritchard S, O’Donnell M. Developing a literature base to
understand the caregiving experience of parents of children with cancer: a systemic review of factors
related to parental health and well-being. Support Care Cancer. 2007;15:807-818.
Klassen AF, Klaassen R, Dix D, Pritchard S, Yanofsky R, O’Donnell M, Scott A, Sung L. Impact of
Caring for a Child With Cancer on Parents’ Health-Related Quality of Life. Journal of Clinical
Oncology. 2008;26(36):5877-5883.
Klassen AF, Strohm SJ, Maurice-Stam H, Grootenhuis MA. Quality of life questionnaires for children
with cancer and childhood cancer survivors: a review of the development of available measures.
Supportive Care in Cancer. 2010;18(9):1207-1218.
D:\478174570.doc
Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J,
Rapoport B, Rolston K, James Talcott for the Study Section on Infections of Multinational Association
for Support Care Cancer. The Multinational Association for Support Care Cancer risk index: A
multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol
2000;18:3038-3051.
Klastersky J, Paesmans M. Response to chemotherapy, quality of life benefits and survival in
advanced non-small lung cancer: review of literature results. Lung Cancer. 2001;(34)S95-S101.
Kleeberg UR, Tews JT, Ruprecht T, Hoing M, Kuhlmann A, Runge C. Patient satisfaction and quality
of life in cancer outpatients: results of the PASQOC study. Support Care Cancer. 2005;13:303-310.
Kleiman T, Zdanys K, Black B, Rightmer T, et al. Apolopoprotein E epsilon4 allele is unrelated to
cognitive or functional decline in Alzheimer’s Disease; retrospective and prospective analysis.
Dement Geriatr Cogn Disord. 2006;22(1):73-82.
Klein M, Taphoorn MJB, Heimans JJ, et al. Neurobehavorial status and health-related quality of life in
newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19:4037-4047.
Kleinman L, Kline Leidy N, Crawley J, Bonomi A, Schoenfeld P. A comparative trial of paper-andpencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD)
Questionnaire. Med Care. 2001;39:181-189.
Klepac RK, Dowling J, Rokke P, Dodge L, Schafer L. Interview vs. paper-and-pencil administration of
the McGill Pain Questionnaire. Pain. 1981;11:241-246.
Kligman L, Wong RKS, Johnston M, Laetsch MS, Members of the Supportive Care Guidelines Group of
Cancer Care Ontario’s Program in Evidence-based Care. The treatment of lymphedema related to
breast cancer: a systematic review and evidence summary. Support Care Cancer. 2004;12:421 –
431.
Klinkhammer-Schalke M, Koller M, Ehret C, Steinger B, Ernst B, Wyatt JC, Hofstadter F, Lorenz W,
Regensburg QOL Study Group. Implementing a system of quality-of-life diagnosis and therapy for
breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT. Br J
Cancer. 2008 Aug;99(3):415-22.
Kluthcovsky ACGC, Urbanetz AA, de Carvalho DS, Malus EMCP, Sylvestre GCS, Hatschbach SBB.
Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on healthrelated quality of life. Supportive Care in Cancer. 2012;20(8):1901-1909.
Knapp TR, Brown JK. Ten measurement commandments that often should be broken. Res Nurs
Health. 1995;18(5):465-469.
Knauper B, Turner PA. Measuring health: improving the validity of health assessments. Qual Life
Res. 2003;12(Suppl. 1):81–89.
Knaus WA, La Rosa JC, Marks RD, Bisbee Jr GE. The value of commercial funding in health services
research: the case of the APACHE III methodology. Health Serv Res. 1994;28:673-678.
D:\478174570.doc
Knight SJ, Chmiel JS, Kuzel T, Sharp L, Albers M, Fine R, Moran EM, Nadler RB, Sharifi R, Bennett CL.
Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and
criterion related validity of 3 measures. J Urol. 1998;160:1765-1769.
Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical evidence in cancer patients
during and after medical treatment: a systematic review of randomized and controlled clinical trials.
J Clin Oncol. 2005;23(16):3830-3842.
Knops KM, Srinivasan M, Meyers FJ. Patient desires: a model for assessment of patient preferences
for care of severe or terminal illness. Palliat Support Care. 2005;3:289-299.
Kobak KA, Greist JH, Jefferson JW, Mundt JC, Katzelnick DJ. computerized assessment of depression
and anxiety over the telephone using interactive voice response. MD Computing. May/June 1999.
Koch U, Muthny FA. Quality of life in patients with end-stage renal disease in relation to the method
of treatment. Psychother Psychosom. 1990;54:161-171.
Koczwara B, Clark MM. A couple with cancer: Wishes, joint decisions. J Clin Oncol. 2003;21(1):174176.
Kodlin D, Cohn Jr I. Simulation experiments of tumor measurement in clinical trials. Cancer
Treatment Reports. 1978;62(12):2077-2083.
Kodlin D. Survival time analysis for treatment evaluation in cancer therapy. Cancer Res. 1961;
21:1103-1107.
Koeberle D, Saletti P, Borner M, Gerber D, Dietrich D, et al. Patient-Reported Outcomes of Patients
With Advanced Biliary Tract Cancers Receiving Gemcitabine Plus Capecitabine: A Multicenter, Pahse II
Trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol. 2008;26(22):3695-3701.,
Koenig HG, George LK, Titus P, Meador KG. Religion, spirituality, and acute care hospitalization and
long-term care use by older patients. Arch Intern Med. 2004;164:1579-1585.
Koenig HG. Religion and medicine III: developing a theoretical model. Int J Psychiatry Med. 2001;
31(2):199-216.
Kogan ES, Kabacoff RI, Hersen M, Hasselt VB. Clinical cutoffs for the Beck Depression Inventory and
the Geriatric Depression Scale with Older adult psychiatric outpatients. J Psychopathol Behav Assess.
1994;16:233-242.
Kolden GG, Strauman TJ, Ward A, Kuta J, Woods TE, Schneider KL, Heerey E, Sanborn L, et al. A
pilot study of Group Exercise Training (GET) for women with primary breast cancer: feasibility and
health benefits. Psycho-Oncol. 2002;11:447-456.
Komp DM, Mahdi AE, Starling KA, Easley J, Vietti TJ, Berry DH, George SL. Quality of survival in
histiocytosis X: a Southwest Oncology Group Study. Med Pediatr Oncol. 1980;8:35-40.
D:\478174570.doc
Koo K, Zeng L, Chen E, Zhang L, Culleton S, Dennis K, Caissie A, Nguyen J, Holden L, Jon F, Tsao M,
Barnes E, Danjoux C, Sahgal A, Chow E. Do elderly patients with metastatic cancer have worse
quality of life scores? Support Care Cancer. 2012;20(9):2121-2127.
Kopec J, Land S, Cecchini R, Ganz P, et al. Validation of a self-reported neurotoxicity scale in
patients with operable colon cancer receiving oxaliplatin. Journal of Support Oncology.
2006;4(8):W1-W8.
Kopec JA, Yothers G, Ganz PA, Land sr, Cecchini RS, Wieand HS, Lembersky BC, et al. Quality of life
in operable colon cancer patients receiving oral compared with intravenous chemotherapy; results
from National Surgical Adjuvant Breast and bowel Project trial C-06. J Clin Oncol. 2007;25(4):424430.
Kopp I, Bauhofer A. Koller M. Understanding quality of life in patients with colorectal cancer:
comparison of data from a randomised controlled trial, a population based cohort study and the norm
reference population. Inflamm. 2004;53(supplement 2):S130-S135.
Korn EL. On estimating the distribution function for quality of life in cancer clinical trials. Biometrika.
1993;80:535-542.
Korn EL, Freidlin B, Abrams JS. Overall survival as the outcome for randomized clinical trials with
effective subsequent therapies. Journal of Clinical Oncology. 2011;29(17):2439-2442.
Kornblith A, Holland JC. Model for quality-of-life research from the Cancer and Leukemia Group B:
the telephone interview, conceptual approach to measurement, and theoretical framework. J Natl
Cancer Inst. Monogr. 1996;20:55-62.
Kornblith AB, Lan L, Archer L, Partridge A, Kimmick G, Hudis C, Winer E, Casey R, Bennett S, Cohen
HJ, Muss HB. Quality of life of older patients with early-stage breast cancer receiving adjuvant
chemotherapy: a companion study to cancer and leukemia Group B 49907. Journal of Clinical
Oncology. 2011;29(8):1022-1028.
Kornblith AB, Herndon JE, Silverman LR, Demakos EP, Odchimar-Reissig R, Holland JF, Powell BL,
DeCastro C, Ellerton J, Larson RA, Schiffer CA, Holland JC. Impact of azacytidine on the quality of life
patients with myelodysplastic syndrome treated in a randomized phase III trial: a cancer and
leukemia group B study. J Clin Oncol. 2002;20(10):2441-2452.
Kornblith AB, Huang HQ, Walker JL, Spirtos NM, Rotmensch J, Cella D. Quality of life of patients with
endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics
staging compared with laparatomy: a gynecologic oncology group study. Journal of Clinical
Oncology. 2009;27(32):5337-5342.
Kornblith AB, Kemeny M, Peterson BL, Wheeler J, Crawford J, Bartlett N, Fleming G, Graziano S, Muss
H, Cohen HJ. Survey of oncologists’ perceptions of barriers to accrual of older patients with breast
carcinoma to clinical trials. Cancer. 2002;95(5):989-996.
Kornblith AB. Editorial: Does Palliative Care Palliate? J Clin Oncol. 2001;19(8):2111–2113.
D:\478174570.doc
Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson ES, Weiss RB, Cooper
MR, Silver RT, Leone L, Canellos GP, Gottleib A, Holland JC. Quality of life assessment of Hodgkin’s
disease survivors: A model for cooperative clinical trials. Oncology. 1990;4(5):93-101.
Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson E, Weiss RB, Cooper
MR, Silver RT, Leone L, Canellos GP, Gottleib A, Holland JC. Hodgkin’s disease survivors at increased
risk for problems in psychosocial adaptation. Cancer. 1992;70:2214-2224.
Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson E, Canellos CP, Kosty
MP Cooper R, Weiss RB, Gottlieb A, Holland JC. Comparison of psychosocial adaptation and sexual
function of survivors of advanced Hodgkin’s disease treated by MOPP, ABVD, or MOPP alternating
with ABVD. Cancer. 1992;70:2508-2516.
Kornblith AB, Herndon JE, Zuckerman E, et al. Comparison of psychosocial adaptation of advanced
state Hodgkin’s disease and acute leukemia survivors. Annals of Oncology. 1998; 9:297-306.
Korolija D, Wood-Dauphinee S, Pointner R. Patient-Reported Outcomes. How important are they?
Surg Endosc. 2007;21:503-507.
Korolija D, Sauerland S, Wood-Dauphinee S, Abbou CC, Eypasch E, Caballero MG, Lumsden MA, Millat
B, Monson JR, Nilsson G, Pointner R, Schwenk W, Shamiyeh A, Szold A, Targarona E, Ure B,
Neugebauer E, European Association for Endoscopic Surgery. Surg Endosc. 2004 Jun;18(6):879-897.
Kosmidis P. Quality of life as a new end point. Chest. 1996;109(5 Suppl):110S-112S.
Kottschade LA, Sloan JA, Loprinzi CL. Response letter to the editor referencing manuscript the “Use
of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a
randomized phase III clinical trial” Support Care Cancer. 2011;19:727-728.
Kottschade LA, Sloan JA, Mazurczak MA, Johnson DB, Murphy BP, Rowland KM, Smith DA, Berg AR,
Stella PJ, Loprinzi CL. The use of vitamin E for the prevention of chemotherapy-induced peripheral
neuropathy: results of a randomized phase III clinical trial. Support Care Cancer. 2010 Oct 9. [epub
ahead of print] 9 pages.
Kouroukis CT, Meyer RM, Benger An, Macellus D, Foley R, Browman GP. An evaluation of age-related
differences in quality of life preferences in patients with non-hodgkin’s lymphoma. Leukemia &
Lymphoma. 2004;45(12):2471-2476.
Kowalski C, Pennell S, Vinokur A. Felicitometry: measuring the ’quality’ in quality of life. Bioethics.
2008 Jul;22(6):307-313.
Krahn M, Ritvo P, Irvine J, Tomlinson G, Bezjak A, Trachtenberg J, Naglie G. Construction of the
Patient Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system
for prostate cancer. J Clin Epid. 2000;53:920-930.
Kramer JA, Curran D, Piccart M, de Haes JCJM, Bruning P, Klijn J, Van Hoorebeeck I, Paridaens R.
Identification and interpretation of clinical and quality of life prognostic factors for survival and
response to treatment in first-line chemotherapy in advanced breast cancer. Euro J Cancer.
2000;36:1498-1506.
D:\478174570.doc
Krause NM, Jay GM. What do global self-rated health items measure? Med Care. 1994;32(9):
930–942.
Krause RS, Herrinton LJ, Grant M, Wendel CS, Green SB, Mohler MJ, Baldwin CM, McMullen CK, Rawl
SM, Matayoshi E, Coons SJ, Hornbrook MC. Health-related quality of life among long-term rectal
cancer survivors with an ostomy: manifestations by sex. Journal of Clinical Oncology.
2009;27(28):4664-4670.
Kravitz RL, Delafield JP, Hays RD, Drazin R, Conolly M. Bedside charting of pain levels in hospitalized
patients with cancer: a randomized controlled trial. J Pain Symptom Manage. 1996;11(2):81-87.
Kravitz RL. Measuring patients' expectations and requests. Ann Intern Med. 2001;134(9 Pt 2):881888.
Krebs MG, Sloane R, Priest L, Lancashire L, Hou J-M, Greystoke A, Ward TH, Ferraldeschi R, Hughes
A, Clack G, Ranson M, Dive C, Blackhall FH. Evaluation and prognostic significance of circulating
tumor cells in patients with non-small-cell lung cancer. Journal of Clinical Oncology.
2011l29(12):1556-1563.
Krech R, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage. 1991;6:360–367.
Kremer E, Atkinson JH, Ignelzi RJ. Measurement of pain: patient preference does not confound pain
measurement. Pain. 1981;10:241-248.
Kressin NR, Glickman ME, Peterson ED, Whittle J, Orner MB, Petersen LA. Functional status outcome
samong white and African-American cardiac patients in an equal access sytem. Am Heart J.
2007;153(3):418-425.
Kris JG, Hesketh PJ, Herrstedt J, et al. Consensus proposals for the prevention of acute and delayed
vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer. 2005;13;85-96.
Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW,
Chesney MJ, Gralla RJ, Grunberg SM. American Society of Clinical Oncology Guideline for Antiemetics
in Oncology: Update 2006. Journal of Clinical Oncology. 2006;24(18):2932-2947,5341-5342.
Kris M, Natale R, Herbst R, Lynch T, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth
factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer. Journal of
the American Medical Association. 2003;290(16):2149-2158.
Kristjanson LJ. Validity and reliability testing of the FAMCARE scale: measuring family satisfaction
with advanced cancer care. Soc Sci Med 1993;36(5):693-701.
Kristjanson L, Atwood J, Degner L. Validity and reliability of the Family Inventory of Needs (FIN):
measuring the care needs of families of advanced cancer patients. J Nurs Meas. 1995;3(2):104-126.
Kristjanson LJ. Validity and reliability testing of the Famcare Scale: measuring family satisfaction with
advanced cancer care. Soc Sci Med. 1993;36(5):693-701.
D:\478174570.doc
Kristjanson LJ, Leis A, Koop PM, Carrire KC, Mueller B. Family members’ care expectations, care
perceptions, and satisfaction with advanced cancer care: results of a multi-site pilot study. J Palliat
Care 1997;13(4):5-13.
Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social
support, and survival after breast cancer diagnosis. J Clin Oncol. 2006;24:1105-1111.
Kroenke K, Harris L. Symptoms research: a fertile field. Ann Intern Med. 2001;134(9 Pt 2):801-802.
Kroenke K. Studying symptoms: sampling and measurement issues. Ann Intern Med. 2001;134(9 Pt
2):844-853.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9 – Validity of a brief depression severity measure. J
Gen Intern Med. 2001;16:606-613.
Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS. Somatic symptoms in patients with
cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med.
2010;170:1686-1694.
Krohn M, Listing M, Tjahjono G, Reisshauer A, Peters E, Klapp BF, Rauchfuss M. Depression, mood,
stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage
therapy. Supportive Care in Cancer. 2011;19(9)1303-1312.
Kroll J, Egan E, Erickson P, Carey K, Johnson M. Moral conflict, religiosity, and neuroticism in an
outpatient sample. J Nerv Mental Dis. 2004;192:682-688.
Krongrad A, Granville LJ, Burke MA, Golden RM, Lai S, Cho L, Niederberger CS. Predictors of general
quality of life in patients with benign prostate hyperplasia or prostate cancer. J Urol. 1997;157: 534538.
Krongrad A, Litwin MS, Lai H, Lai S. Dimensions of quality of life in prostate cancer. J Urol.
1998;807-810.
Kropf ME, Blair J. Eliciting survey cooperation. Eval Review 2005;29(6):559-575.
Krouse RS, Easson AM, Angelos P. Ethical considerations and barriers to research in surgical
palliative care. J Am Coll Surg. 2003;196(3):469-474.
Krouse RS. Surgical management of malignant bowel obstruction. Surg Oncol Clin N Am.
2004;13:479-490.
Krucoff MW, Crater SW, Gallup D, et al. Music, imagery, touch, and prayer as adjuncts to
interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II
randomized study. Lancet. 2005;366:211-217.
Krueger JM, Majde JA, Obal Jr F. Sleep in host defense. Brain Behav Immun. 2003;17:S41–S47.
D:\478174570.doc
Krull K, Okcu MF, Potter B, Jain N, Dreyer Z, Kamdar K, Brouwers P. Screening for Neurocognitive
Impairment in Pediatric Cancer Long-Term Survivors. Journal of Clinical Oncology.
2008;26(25):4138-4143.
Krumins PE, Fihn SD, Kent DL. Symptom severity and patients' values in the decision to perform a
transurethral resection of the prostate. Med Decis Making. 1988;8:1-8.
Kudielka BM, Haneuth D, von Kanel R, Gander mL, Grande G, Fischer JE. Health-related quality of
life measured by the SF12 in working populations: associations with psychosocial work
characteristics. J Occup Health Psychol. 2005;10(4):429-40.
Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast
cancer patitnes – clinical assessment, significance for life quality and the impact of demographic,
oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275-286.
Kugaya A, Akechi T, Ikuyama T, et al. Prevalence, predictive factors, and screening for psychologic
distress in patients with newly diagnosed head and neck cancer. Cancer. 2000;88:2817–2823.
Kuhn CA, Hanke CW. Current status of melanoma vaccines. Dermatol Surg. 1997;23(8):649-654.
Kumar A, Soares H, Balducci L, Djulbegovic B. Treatment tolerance and efficacy in geriatric
oncology: a systematic review of phase III randomized trials conducted by five National Cancer
Institute-sponsored Cooperative Groups. J Clin Oncol. 2007;25(10):1272-1276.
Kun LE, Mulhern RK, Crisco JJ. Quality of life in children treated for brain tumors: intellectual,
emotional, and academic function. J Neurosurg. 1983;58:1-6.
Kunsebeck HW, Korber J, Freyberger H. Quality of life in patients with inflammatory bowel disease.
Psychother Psychosom. 1990;54:110-116.
Kurita GP, Sjogren P, Ekholm O, Kaasa S, Loge JH, Poviloniene I, Klepstad P. Prevalence and
predictors of cognitive dysfunction in opioid-treated patients with cancer: a multnational study.
Journal of Clinical Oncology. 2011;29(10):1297-1303.
Kuroi K, Shimozuma K, Ohashi Y, Hisamatsu K, Masuda N, Takeuchi A, Aranishi T, Morita S, Ohsumi
S, Hausheer FH. Prospective assessment of chemotherapy-induced peripheral neurapathy due to
weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study).
Supportive Care in Cancer. 2009;17(8):1071-80.
Kurtz JE, Dufour P. Strategies for improving quality of life in older patients with metastatic breast
cancer. Drugs Aging. 2002;19(8):605-622.
Kurtz ME, Kurtz JC, Stommel M, Given CW, Given B. Predictors of depressive symptomatology of
geriatric patients with colorectal cancer: a longitudinal view. Support Care Cancer. 2002;10:494–
501.
Kurtz ME, Kurtz JC, Stommel M, Given CW, Given B. The influence of symptoms, age, comorbidity
and cancer site on physical functioning and mental healthof geriatric women patients. Women Hlth.
1999;29(3)1-12.
D:\478174570.doc
Kushner JA, Lawrence HP, Kiss TL, Lee L, Tenenbaum HC. Development and validation of a PatientReported Oral Mucositis Symptom (PROMS) Scale. JCDA. 2008;74(1):59-59j.
Kutner NG, Zhang R, Barnhart H, Collins AJ. Health status and quality of life reported by incident
patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant. 2005;20:21592167.
Kuuppelomaki M, Lauri S. Cancer patients’ reported experience of suffering. Cancer Nurs.
1998;21(5):364–369.
Kuyken W, collaborating on behalf of the WHOQOL. The World Health Organization Quality of Life
Assessment (WHOQOL): Position paper from the world health organization. Soc Sci Med. 1995;
41(10):1403-1409.
Kvien TK, Heiberg T, Hagen KB. Minimal clinically important improvement/difference (MCII/MCID)
and patient acceptable symptom state (PASS): what do these concepts mean? Ann Rheum Dis. 2007
Nov;66 suppl 3:iii40-1.
Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotte IA. Chronic arm morbidity after
curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol.
2002;20:4242–4248.
La Puma J, Lawlor EF. Quality-adjusted life-years-ethical implications for physicians and
policymakers. JAMA. 1990;263:2917-2921.
Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory
rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996;348:1115-1119.
Lacouture ME, Maitland ML, Segaert S, Setser A, Baran R, Fox LP, Epstein JB, Barasch A, Einhorn L,
Wagner L, West DP, Rapoport BL, Kris MG, Basch E, Eaby B, Kurtin S, Olsen EA, Chen A, Dancey JE,
Trotti A. Supportive Care in Cancer. 2010;18(4):509-522.
Lacouture ME, Mitchell EP, Piperdi B, Pillai MV, Shearer H, Iannotti N, Xu F, Yassine M. Skin toxicity
evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating
the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients
with metastatic colorectal cancer. Journal of Clinical Oncology. 2010;28(8):1351-1357.
Ladewski LA, Belknap SM, Nebeker JR, et al. Dissemination of information on potentially fatal
adverse drug reactions for cancer drugs from 2000 to 2002: First results from the research on
adverse drug events and reports project. J Clin Oncol. 2003;21:3859-3866.
Lai JS, Cella D, Chang CH, Bode RK, Heinemann AW. Item banking to improve, shorten and
computerize self-reported fatigue: An illustration of steps to create a core item bank from the FACITFatigue Scale. Qual Life Res. 2003;12:485-501.
Lai JS, Cella D, Dineen K, Bode R, Von Roenn J, Gershon R. An item bank was created to improve
measurement of cancer-related fatigue. J Clin Epidemiol 2005;58:190-197.
Lai JS, Cella D, Peterman A, Barocas J, Goldman S. Anorexia/cachexia-related quality of life for
children with cancer. Cancer. 2005;104:1531-1539.
D:\478174570.doc
Lai JS, Cella D, Peterman A, Barocas J, Goldman S. Anorexia/cachexia-related QOL for children with
cancer: Testing the psychometric properties of the pediatric functional assessment of anorexia and
cachexi therapy (peds-FAACT). Cancer 2005;104(7):1531-1539.
Lai J-S, Cella D, Tomita T, Newmark M, Goldman S. Developing a health-related quality of life
instrument for childhood brain tumor survivors. Childs Nervous System. 2007;23:47-57.
Lai JS, Crane P, Cella D. Factor analysis techniques for assessing sufficient unidimensionality of
canceer related fatigue. Quality of Life Research. 2006;15(7):1179-1190.
Lai JS, Dineen K, Cella D, von Roenn J. An Item Response Theory based pain item bank can enhance
measurement precision. J Pain Sympt Mgmnt, 2005;30(3):278-288.
Lai JS, Kupst MJ, Cella D, Brown SR, Peterman A, Goldman S. Using Q-Methodology to Understand
Perceived Fatigue Reported by Adolescents with Cancer. Psycho-Oncology. 2007 ;16 :437-447.
Laird BJA, Walley J, Murray GD, Clausen E, Colvin LA, Fallon MT. Characterization of cancer-induced
bone pain : an exploratory study. Supportive Care in Cancer. 2011;19(9):1393-1402.
Laliberte N, Cella D, Masters G, et al. Real-time clinical application of quality of life (QOL)
assessment in lung cancer: a feasibility pilot (abstract). Qual Life Res. 2000;9:293, Abstract 1590.
Lam WWT, Au AHY, Wong JHF, Lehmann C, Koch U, Fielding R, Mehnert A. Unmet supportive care
needs: a cross-cultural comparison between Hong Kong Chinese and German Caucasion women with
breast cancer. Breast Cancer Res Treat. 2011 May. 11 pages.
Lambert HC, Gisel EG, Wood-Dauphinee S. The Functional Assessment of Dysphasia: psychometric
standards. Phys Occup Ther Geriatrics. 2001;19(3):1–14.
Lancee WJ, Vachon MLS, Ghadirian P, Adair W, Conway B, Dryer D. The impact of pain and the
impaired role performance on distress in persons with cancer. Can J Psychiatry. 1994;39:617-622.
Land SR, Kopec JA, Cecchini RS, Ganz PA, Wieand HS, Colangelo LH, Murphy K, Kuebler JP, Seay TE,
Needles BM, Bearden, III JD, Colman LK, Lanier KS, Pajon Jr ER, Cella D, Smith RE, O’Connell MJ,
Costantino JP, Wolmark N. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil
and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J
Clin Oncol. 2007;25(16):2205-2211.
Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, Christian NJ, Costantino JP,
Wolmark N, Ganz PA. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer
patients receiving sentinel-node biopsy or axillary dissection: National surgical adjuvant breast and
bowel project phase III protocol B-32. Journal of Clinical Oncology. 2010;28(25):3929-3936.
Landon BE, Wilson IB, Cleary PD. A conceptual model of the effects of health care organizations on
the quality of medical care. Special Communication. JAMA. 1998:279(17):1377–1382.
Langan-Fahey SM, Tormey DC, Jordan VC. Tamoxifen metabolites in patients on long-term adjuvant
therapy for breast cancer. Eur J Cancer. 1990;26:883-888.
D:\478174570.doc
Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans C, Aaronson NK, Slotman BJ. Impact
of late Treatment-Related Toxicity on quality of Life Among p[atients with head and Neck Cancer
Treated With Radiotherapy. J Clin Oncol. 2008;26(22):3770-3776.
Langendijk H, Aaronson NK, de Jong JMA, ten Velde GPM, Muller MJ, Lamer RJ, Slotman BJ, Wouters
EFM. Prospective study on quality of life before and after radical radiotherapy in non-small cell lung
cancer. J Clin Oncol. 2001;19:2123–2311.
Langendijk H, Aaronson NK, de Jong JMA, ten velde GPM, Muller MJ, Wouters M. The prognostic
impact of quality of life assessed with the EORTC QLQ_C30 in inoperable non-small cell lung
carcinoma treated with radiotherapy. Radiother Oncol. 2000;55:19-25.
Langer CJ, Hoffman JP, Ottery FD. Clinical significance of weight loss in cancer patients: rationale for
the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition. 2001;17(1)
Suppl:S1–S21.
Langeveld NE, Stam H, Grootenhuis MA, Last BF. Quality of life in young adult survivors of childhood
cancer. Support Care Cancer. 2002;10:579-600.
Langley GB, Sheppeard H. The visual analogue scale: Its use in pain measurement. Review.
Rheumatol Int. 1985;5:145-148.
Langley PC. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res
Opin. 2011;27(2):463-80.
Lansky LL, List MA, Lansky SB, Cohen ME, Sinks LF. Toward the development of a Play Performance
Scale for Children (PPSC). Cancer. 1985;56(Suppl):1837-1840.
Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in
childhood cancer patient. Cancer. 1987;60:1651-1656.
Lapid, MI, Rummans TA. Evaluation and management of geriatric depression in primary care. Mayo
Clin Proc. 2003;78:1423–1429.
Lapid MI, Rummans TA, Brown PD, Frost MH, Johnson ME, Huschka MM, Sloan JA, Richardson JW,
Hanson JM, Clark MM. Improving the quality of life of geriatric cancer patients with a structured
multidisciplinary intervention : a randomized controlled trial. Palliat Support Care 2007;5:107-114.
Lappalainen J, Long JC, Eggert M, et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B
receptor gene in 2 populations. Arch Gen Psychiatry. 1998;55:989-994.
Lara PN, Myers FJ. Treatment options in androgen-independent prostate cancer. Cancer Invest.
1999;17(2):137-144.
Lara-Munoz C, Feinstein AR. How should quality of life be measured? [Review] J Invest Med.
1999;47(1):17-24.
Larouche S, Edgar L. The measure of distress, a practical thermometer for outpatient screening.
Oncol Exch. 2004;3(3):34–39.
D:\478174570.doc
Larson JL, Covey MK, Berry JK, Wirtz S, Kim MJ. Reliability and validity of the Chronic Respiratory
Disease Questionnaire. Am Rev Resp Dis. 1993;147:A530.
Larue F, Colleau SM, Brasseur L, Cleeland CS. Multicentre study of cancer pain and its treatment in
France. BMJ. 1995;310;1034-1037.
Lasagna L, Frei E. The impact of regulations, tradition, and experiemental design on clinical cancer
trials: report and recommendations resulting from Washington Cancer Trials Conference. Am J Clin
Oncol. 1996;19:325-329.
Lasch K, Joish VN, Zhu Y, Rosa K, Qiu C, Crawford B. Validation of the sleep impact scale in patients
with major depressive disorder and insomnia. Curr Med Res Opin. 2009;25(7):1699-710.
Lasheen W, Russell M. Managerment of Cough in Cancer. Journal of Cancer Pain and Symptom
Palliation. 2006;2(2):39-43.
Lasheen W, Walsh D. The cancer anorexia-cachexia syndrome: myth or reality? Supportive Care in
Cancer. 2010;18(2):265-272.
Lau J. Methods of the evidence report. J Natl Cancer Inst Monogr. 2004;32:22.
Laugsand EA, Jakobsen G, Kaasa S, and Klepstad P. Inadequate symptom control in advanced
cancer patients across Europe. Support Care Cancer. 2011;19(12):2005-14.
Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the
consequences of treatment. N Engl J Med. 1998;318:1728-1733.
Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, Barnoud D, Bleichner G, Bruel C,
Choukroun G, et al. A communication strategy and brochure for relatives of patients dying in the
ICU. N Engl J Med. 2006;356:469-478.
Laviano A, De Luca S, Meguid MM, Fanelli FR. Cancer anorexia: a neglected issue in the optimal
management of cancer patients. J Cancer Pain Symptom Palliat. 2005;1(2):15-24.
Lavori PW, Dawson R, Shera D. A multiple imputation strategy for clinical trials with truncation of
patient data. Stats Med. 1995;14:1913-1925,.
Lawrence DP, Kupelnich B, Miller K, Devine D, Lau J. Evidence report on the occurrence,
assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;32:40-50.
Lazarus RS. Coping theory and research: past, present, and future. Psychosomatic Med. 1993;
5:234-247.
Le T, Leis A, Pahwa P, Wright K, Ali K, Reeder B. Quality of life issues in patients with ovarian cancer
and their caregivers: a review. cme review article. Obstetr Gyne Surv. 2003;58(11):749–758.
Le Tourneau C, Stathis A, Vidal L, Moore MJ, Siu LL. Choice of starting dose for molecularly targeted
agents evaluated in first-in-human phase I cancer clinical trials. Journal of Clinical Oncology.
2010;28(8):1401-1407.
D:\478174570.doc
Leandri P, Rossingnol G, Gautier J, Ramon J. Radical retropubic prostatectomy: morbidity and quality
of life. Experience with 620 consecutive cases. J Urol. 1992;147:883-887.
Lebovits AH, Zhukovsky DS. Cancer pain management: whose pain is it anyway? J Cancer Pain
Sympt Mgmt. 2005; 1(3):31-32.
Ledger SD. The duty of nurses to meet patients’ spiritual and/or religious needs. Br J Nurs.
2005;14(4):220-225.
Lee CW, Chi KN. The standard of reporting of health-related quality of life in clinical cancer trials. J
Clin Epidemiol. 2000; 53:451-458.
Lee H, Friedman ME, Cukor P, Ahern D. Interactive Voice Response System (IVRS) in health care
services. Nurs Outlook. 2003;51(6)277-283.
Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol.
2006;24,10:1633-1642.
Lee KA, Kieckhefer GM. Technical notes: measuring human responses using visual analogue scales.
Western J Nurs Res. 1989;11:128-132.
Lee L, Cheung WY, Atkinson E, Krzyzanowska MK. Impact of comorbidity on chemotherapy use and
outcomes in solid tumors: a systematic review. Journal of Clinical Oncology. 2011;29(1):106-117.
Lee MK, Park S, Lee ES, Ro J, Kang HS, Shin KH, Lee KS, Chung KW, Kim SW, Yun YH. Social
support and depressive mood 1 year after diagnosis of breast cancer compared with the general
female population : a prospective cohort study. Supportive Care in Cancer. 2011;19(9):1379-1392.
Lee MS, Pittler MH, Ernst E. Is tai chi an effective adjunct in cancer care? A systematic review of
controlled clinical trials. Support Care Cancer 2007;15:597-601.
Lee PP, Spritzer K, Hays RD. The impact of blurred vision on functioning and well-being. Ophthalm.
1997;104(3):390-396.
Lee SY, Song X-Y. Application of structural equation models to quality of life. Structural Equation
Modeling. 2005;12(3):435-453.
Lee V, Cohen SR, Edgar L, Laizner AM, Gagnon AJ. Clarifying “meaning” in the context of cancer
research: a systematic literature review. Palliat Support Care. 2004;2:291-303.
Lee YM. Lymphoedema care of breast cancer patients in a breast care clinick: a survey of knowledge
and health practice. Support Care Cancer. 2001;9:634–641.
Lee TS, Kilbreath SL, Refshauge KM, Pendlebury SC, Beith JM, Lee MJ. Quality of life of women
treated with radiotherapy for breast cancer. Support Care Cancer. 2008;16:399-405.
Lefante JJ, Harmon GN, Ashby KM, Barnard D, Webber LS. Use of the SF-8 to assess health-related
quality of life for a chronically ill, low-income population participating in the Central Louisana
Medication Access Program (CMAP). Qual Life Res. 2005;14(3):665-673.
D:\478174570.doc
Legault C, Maki PM, Resnick SM, Coker L, Hogan P, Bevers TB, Shumaker SA. Effects of Tamoxifen
and Raloxifene on memory and other cognitive abilities: cognition in the study of Tamoxifen and
Raloxifene. Journal of Clinical Oncology. 2009;27(31):5144-5152.
Legrand C, Efficace F. Implementing patient-reported health-related quality-of-life data in cancer
routine practice to improve accuracy of prognosis. Are we there yet? Expert Reviews
Pharmacoeconomics Outcomes Res. 2009;9(6):493-496.
Lehmacher W, Wassmer G, Reitmeir P. Procedures for two-sample comparisons with multiple
endpoints controlling the experiment wise error rate. Biometrics. 1991;47:511-521.
Lehto–Jarnstedt US, Ojanen M, Kellokumpu–Lehtinen P. Cancer-specific social support received by
newly diagnosed cancer patients: validating the new Structural–Functional Social Support Scale
(SFSS) Measurement Tool. Support Care Cancer. 2004;12:326–337.
Leidy NK, Chan K, Coughlin C. Is the Asthma Quality of Life Questionnaire (AQLQ) a useful indicator
of health-related quality of life in low-income samples? Am J Respir Crit Care Med. 1998;158:10821090.
Leidy NK, Coughlin C. Psychometric performance of the Asthma Quality of Life Questionnaire (AQLQ)
in a US Sample. Qual Life Res. 1998;7:127-134.
Leidy NK, Rentz A, Grace E. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic therapy. Epilepsia. 1998;39(9):965-977.
Leighl NB, Shepherd HL, Butow PN, Clarke SJ, McJannett M, Beale PJ, Wilcken NRC, Moore MJ, Chen
EX, Goldstein D, Horvath L, Knox JJ, Krzyzanowska M, Oza AM, Feld R, Hedley D, Xu W, Tattersall
MHN. Journal of Clinical Oncology. 2011;29(15):2077-2084.
Leitgeb C, Pecherstorfer M, Fritz E, Ludwig H. Quality of life in chronic anemia of cancer during
treatment with recombinant human erythropoietin. Cancer. 1994;73:2535-2542.
Lemieux J, Goodwin PJ, Bordeleau LJ, Lauzier S, Theberge V. Quality-of-Life measurement in
randomized clinical trials in breast cancer: an updated systematic review (2001-2009). JNCI.
2011;103(3):54 pages.
Lenderking WR, Gelber RD, Cotton DJ, et al. Evaluation of the quality of life associated with
zidovudine treatment in asymptomatic human immunodeficiency virus infection. New Engl J Med.
1994;330:738-743.
Lent L, Hahn E, Eremenco S, Webster K, Cella D. Using crosscultural input to adapt the Functional
Assessment of Chronic Illness Therapy (FACIT) scales. 1999;38(6):695-702.
Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middle-range theory of unpleasant symptoms:
an update. Advances in Nursing Science (ANS). 1997;19(3):14-27.
Leong KP, Yeak SCL, Sauragen ASM, et al. Why generic and disease-specific quality of life
instruments should be used together for the evaluation of patients with persistent allergic rhinitis.
Clin Exp Allergy. 2005;35:288-298.
D:\478174570.doc
Leopore SJ, Silver RC, Wortman CB, Wayment HA. A slightly different perspective is the social
constraint scale. J Personality Soc Psychol. 1996;70:271-282.
Leplege A, Hunt S. The problem of quality of life in medicine. JAMA. 1997;278(1):47-50.
Leplege AP, Berzon RA. Assessing HRQOL in early HIV disease: proceedings and recommendations
from and international gathering of social and medical scientists. (Introduction) Qual Life Res.
1997;6(6):469-470.
Lerner BH. Sins of omission: cancer research without informed consent. N Engl J Med. 2004;351:7.
Lerner DJ, Levine S, Malspeis S, D'Agostino RB. Job strain and health-related quality of life in a
national sample. Am J Publ Hlth. 1994;84:1580-1585.
Lette J. A simple and innovative device to measure arm volume at home for patients with
lymphedema after breast cancer. J Clin Oncol. 2006;24(34):5434-5440.
Leuenberger M, Kurmann S, Stanga Z. Nutritional screening tools in daily clinical practice: the focus
on cancer. Supportive Care in Cancer. 2010;18(Suppl 2):S17-S27.
Leung TF, Chu Y, Lee V, Cheng FW, Leung WK, Shing MM, Li CK. Long-term effects of pamidronate
in thalassemic patients with severe bone mineral density deficits. Hemoglobin. 2009;33:361-9.
Lev EL, Eller LS, Gejerman G, Kolassa J, Colella J, Pezzino J, Lane P, Munver R, Esposito M, Sheuch J,
Lanteri V, Sawczuk I. Quality of life of men treated for localized prostate cancer: outcomes at 6 and
12 months. Supportive Care in Cancer. 2009;17(5):509-518.
Leville SG, Ling S, Hochberg MC, et al. Widespread musculoskeletal pain and the progression of
disability in older disabled women. Ann Intern Med. 2001;135:1038–1046.
Levine C. The loneliness of the long-term care giver. New Engl J Med. 1999;340:1587-1590.
Levine EG, Aviv C, Yoo G, Ewing C, Au A. The benefits of prayer on mood and well-being of breast
cancer survivors. Supportive Care in Cancer. 2009;17(3):295-306.
Levine MH, Ganz PA. Beyond the development of quality of life instruments: where do we go from
here? J Clin Oncol. 2002;20(9):2215-2216.
Levine MH, Guyatt GH, Gent M, et al. Quality of life in stage II breast cancer: an instrument for
clinical trials. J Clin Oncol. 19988;6(12):1798-1810.
Levine MN. Conventional and complementary therapies: a tale of two research standards? Journal of
Clinical Oncology. 2010;28(12):1979-1981.
Levinson W, Kao A, Kuby A, Thisted RA. Not All Patients Want to Participate in Decision Making. J
Gen Intern Med. 2005;20:531-535.
D:\478174570.doc
Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge DR, Krischer J. Soy isoflavones in the
prevention of menopausal bone loss and menopausal symptoms. Arch Intern Med.
2011;171(15):1363-1369.
Levorato A, Stiefel F, Mazzocato C, Bruera E. Communication with terminal cancer patients in
palliative care: are there differences between nurses and physicians? Support Care Cancer.
2001;9:420-427.
Levy MF, Jennings L, Abouljoud MS, et al. Quality of life improvements at one, two, and five years
after liver transplantation. Transplantation. 1995;59(4):515-518.
Levy MH. Management of opioid-induced bowel dysfunction. JNCCN. 2003;1(Suppl3):S22–S26.
Lewis C, Pantell R, Kieckhefer G. Assessment of children’s health status: field test of new
approaches. Med Care. 1989;27(suppl):S54-S65.
Lewis C. Grappling with the quality of life: patients, FDA and drug companies struggle to link
therapies with well-being. FDA Consumer Magazine. 2001;1-5.
Lewis FM, Firsich SC, Parsell S. Clinical tool development for adult chemotherapy patients: process
and content. Cancer. 1979;2:99-108.
Lewis FM. Experienced personal control and quality of life in late-stage cancer patients. Nurs Res.
1982;31(2):113-119.
Lewis JA, Manne SL, DuHamel KN, et al. Social support, intrusive thoughts, and quality of life in
breast cancer survivors. J Behav Med. 2001;24(3):231-245.
Lewis JE, Nickell LA, Thompson LU, Szalai JP, Kiss A, Hilditch JR. A randomized controlled trial of the
effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause.
Menopause. 2006;13(4):631-642.
Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer
clinical trials. J Clin Oncol. 2003;21(7):1383-1389.
Lewis FM, Fletcher KA, Cochrane BB, Fann JR. Predictors of depressed mood in spouses of women
with breast cancer. J Clin Oncol. 2008;26(8):1289-1295.
Li J, Bentzen SRM, Renschler M, Mehta MP. Regression after whole-brain radiation therapy for brain
metastases correlates with survival and improved neurocognitive function. J Clin Oncol.
2007;25(10):1260-1266.
Li KK, Harris K, Hadi S, Chow E. What should be the optimal cut points for mild, moderate, and
severe pain? Journal of Palliative Medicine. 2007;10(6):1338-1346.
Li C, Friedman B, Conwell Y, Fiscella K. Validity of the patient health questionnaire 2 (PHQ-2) in
identifying major depression in older people. J Am Geriatri Soc. 2007;55:596-602.
D:\478174570.doc
Liakopoulou M, Panaretaki I, Papadakis V, Katsika A, Sarafidou J, Laskari H, Anastasopoulos I,
Vessalas G, Bouhoutsou D, Papaevangelou V, Polychronopoulou S, Haidas S. Burnout, staff support,
and coping in Pedicatric Oncology. Support Care Cancer. 2008;16:143-150.
Liang W, Burnett CB, Rowland JH, et al. Communication between physicians and older women with
localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol. 2002;
20(4):1008-1016.
Liao Y-C, Liao W-Y, Shun S-C, Yu C-J, Yang P-C, Lai Y-H. Symptoms psychological distress, and
supportive care needs in lung cancer patients. Supportive Care in Cancer. 2011;19(11):1743-1752.
Liavaag AH, Dorum A, Fossa SD, Trope C, Dahl AA. Controlled study of fatigue, quality of life, and
somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones? J
Clin Oncol. 2007;25(15):2049-2056.
Lichtman SM. How do we get more older patients into clinical trials? Oncology. 2007; 363.
Lichtman SM, Balducci L, Aapro M. Geriatric Oncology: a field coming of age. J Clin Oncol.
2007;25(14):1821-1823.
Lichtman SM, Wildiers H, Chatelut E, Steer C, Budman D, Morrison VA, et al. International society of
geriatric oncology chemotherapy taskforce: evaluation of chemotherapy in older patients – an
analysis of the medical literature. J Clin Oncol. 2007;25(14):1832-1843.
Lickley HA. Primary breast cancer in the elderly. Can J Surg. 1997;40(5):34-51.
Liebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade
gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC Trial 22844).
Euro J Cancer. 1998;34(12):1902-1909.
Lien K, Zeng L, Nguyen J, Cramarossa G, Culleton S, Caissie A, Lutz S, Chow E. Comparison of the
EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life patients with advanced
cancer. Expert Rev. Pharmacoeconomics Outcomes Res. 2011;11(5):541-547.
Lillimoe K, Lipford E III, Eggleston JC, Baker RR. Staging of bronchial carcinoma.
Surg Gynecol Obstet. 1984;158(6):566-568.
Lim J, Zebrack B. Social networks and quality of life for long-term survivors of leukemia and
lymphoma. Support Care Center. 2006;14:185-192.
Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley A. Patient decision aids for prostate cancer
treatment. A systematice review of the literature. A Cancer Journal for Clinicians. 2009;59(6):379390.
Lin L I-K. A concordance correlation coefficient to evaluate reproductivity. Biometrics. 1989;
45(1):255-268.
Lindemalm C, Strang P, Lekander M. Support group for cancer patients. Does it improve their
physical and psychological wellbeing? A pilot study. Support Care Cancer. 2005;13:652-657.
D:\478174570.doc
Lindemalm C, Mozaffari F, Choudhury A, Granstam-Bjorneklett H, Lekander M, Nilsson B, Ojutkangas
M-L, Osterborg A, Bergkvist L, Mellstedt H. Immunue response, depression and fatigue in relation to
support intervention in mammary cancer patients. Support Care Cancer. 2008;16:57-65.
Lingjun Z, Jing C, Jian L, Wee B, Jijun Z. Prediction of survival time in advanced cancer: a prognostic
scale for Chinese patients. J Pain Symptom Manage. 2009 Oct;38(4):578-86.
Lindley C. Quality of life measurements in oncology. Pharmacother. 1992;12(4):346-352.
Linn LS, Yager J. The effect of screening, sensitization, and feedback on notation of depression. J
Med Ed. 1980;55:942-949.
Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer patients. Cancer. 1982;
49(5):1048-1055.
Lipov EG, Joshi JR, Sanders S, Wilcox K, Lipov S, Xie H, Maganini R, Slavin K. Effects of stellateganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study.
Oncology. 2008:9:523-532.
Lipscomb J, Drummond M, Fryback D, Gold M, Revicki D. Retaining, and enhancing, the QALY.
Value in Health. 2009;12(supplement 1):S18-S26.
Lipscomb J, Drummond M, Fryback D, Gold M, Revicki D. Retaining, and enhancing, the QALY.
Value Lipscomb J, Donaldson MS, Arora NK, et al. J Natl Cancer Inst. Monogr. 2004;33:178–197.
Lipscomb J, Gotay CC, Snyder CF. Patient-Reported Outcomes in Cancer: A Review of Recent
Research and Policy Initiatives. CA Cancer J Clin. 2007;57:278-300.
Lipscomb J, Reeve BB, Clauser SB, Abrams JS, Bruner DW, Burke LB, Denicoff A, Ganz PA, Gondek K,
Minasian L, O’Mara A, Revicki DA, Rock EP, Rowland J, Sgambati M, Trimble E. Patient reported
outcomes assessment in cancer trials: Taking stock, moving forward. J Clin Oncol.
2007;25(32):5133-5140.
Lipscomb J, Donaldson MS, Hiatt RA. Cancer outcomes research and the arenas of application. J
Natl Cancer Inst. Monogr. 2004;33:1–7.
Lipscomb J, Snyder CF. The outcomes of cancer outcomes research: focusing on the national cancer
institute's quality-of-care initiative. Med Care. 2002;40(6)(Supplement):III-3-III-10.
Lipscomb J. Building, testing, and improving an item bank for chronic disease PROs: Keeping a
PROMIS. Summary Paper, Drug Info Assoc. June 23–25, 2004 Meeting.
Lis CG, Cambron JA, grutsch JF, Granick J, Gupta D. Self-reported quality of life in users and
nonusers of dietary supplements in cancer. Support Care Cancer. 2006;14:193-199.
Lis CG, Gupta D, Granick J, Grutsch JF. Can patient satisfaction with quality of life predict survival in
advanced colorectal cancer? Support Care Cancer. 2006;14:1104-1110.
D:\478174570.doc
Lis CG, Gupta D, Grutsch. The relationship between insomnia and patient satisfaction with quality of
life in cancer. Support Care Cancer. 2008;16:261-266.
Lis CG, Gupta D, Grutsch JF. Can anorexia predict patient satisfaction with quality of life in advanced
cancer? Supportive Care in Cancer. 2009;17(2):129-136.
List MA, D’Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. The Performance Status Scale
for Head and Neck Cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck
Scale. Cancer. 1996;77(11):2294-2301.
List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients.
Cancer. 1990;66:564-569.
List MA, Siston A, Haraf D, et al. Quality of life and performance in advanced head and neck cancer
patients on concomitant chemoradiotherapy: A prospective examination. J Clin Oncol.
1999;17:1020-1028.
Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996;
52:1324-1333.
Littlewood TJ, Bajetta E, Nortier JWR, Vercammen E, Rapoport B. Effects of epoetin alfa on
hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy:
results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19:2865–2874.
Littlewood TJ. Efficacy and quality of life outcomes of epoetin-alpha in a double-blind, placebocontrolled, multicentre study of cancer patients receiving non-platinum-containing chemotherapy.
Front Radiat Ther Oncol. 2002;37:34-37.
Littman GS, Walker BR, Schneider BE. Reassessment of verbal and visual analog ratings in analgesic
studies. Clin Pharmacol Ther. 1985;38(1):16-23.
Litwin MS, Fitzpatrick JM, Fossa SD, Newling DW. Defining an international research agenda for
quality of life in men with prostate cancer. Prostate. 1999;41(1):58-67.
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA prostate cancer indes:
development, reliability, and validity of a health-related quality of life measure. Med Care.
1998;36(7):1002-1012.
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality-of-life outcomes in men
treated for localized prostate cancer. Qual Life Outcomes. 1995;273:129-135.
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality of life outcomes in men
treated for localized prostate cancer. J Urol. 1994;152:1882-1887.
Litwin MS, McGuigan KA, Shpall AI, Dhanani N. Recovery of health related quality of life in the year
after radical prostatectomy: Early experience. J Urol. 1999;161:515-519.
Litwin MS. Measuring health-related quality of life in men with prostate cancer. J Urol.
1994;152:1882-1887.
D:\478174570.doc
Litwin MS. Improving the utility of quality-of-life data from men with prostate cancer. Journal of
Clinical Oncology. 2009;27(24):3877-3878.
Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R.
Development and cross-sectional validation of the Childhood Asthma Control Test. Journal of Allergy
and Clinical Immunology. 2007;119(4):817-825.
Liu C, Weber K, Robison E, Hu Z, Jacobson LP, Gange SJ. Assessing the effect of HAART on change
in quality of life among HIV-infected women. AIDS Res Therapy. 2006;3:6.
Liu L, Meers K, Capurso A, Engebretson TO, Glicksman AS. The impact of radiation therapy on
quality of life in patients with cancer. Cancer Pract. 1998;6(4):237-242.
Liu MC, Shields, PG, Warren RD, Cohen P, Wilkinson M, Ottaviano YL, Rao SB, Eng-Wong J, SeillierMoiseiwitsch, Noone A-M, Isaacs C. Circulating tumor cells: a useful predictor of treatment efficacy in
metastatic breast cancer. Journal of Clinical Oncology. 2009;27(31):5153-5159.
Llewellyn-Thomas H, Sutherland HJ, Tebshirani R, Ciampi A, Till JE, Boyd NF. The measurement of
patients' values in medicine. Med Decis Making. 1982;2(4):449-462.
Llobera J, Esteva M, Benito E, Terrasa J, Rifa J, Pons O, Maya A. Quality of life for oncology patients
during the terminal period. Validation of the HRCA-QL index. Support Care Cancer. 2003;11:294303.
Lloyd A, van Hanswijck de Jonge P, Doyle S, Cornes P. Health state utility scores for cancer-related
anemia through societal and patient valuations. Value in Health. 2008;11(7):1178-85.
Lloyd-Williams M, Dogra N. Caring for dying patients – what are the attitudes of medical students?
Support Care Cancer. 2003;11:696–699.
Lloyd-Williams M, Shiels c, Dowrick C. The development of the Brief Edinburgh Despression Scale
(BEDS) to screen for depression in patients with advanced cancer. J Affective Disorders.
2007;99:259-264.
Loan WB, Dundee JW. The clinical assessment of pain. Practitioner. 1967;198(188):759-768.
Lobchuk MM, Degner LF. Patients with cancer and next-of-kin response comparability on physical
and psychological symptom well-being: trends and measurement issues. Cancer Nurs.
2002;25(5):358-374.
Lobchuk MM. Symptoms as meaningful ‘family culture’ symbols in palliative care. J Palliat Care.
1999;15(4):24–31.
Loblaw DA, Bezjak A, Bunston T. Development and testing of a visit-specific patient satisfaction
questionnaire: the princess margaret hospital satisfaction with doctor questionnaire. J Clin Oncol.
1999;17(6):1931-1938.
Loblaw DA, Bezjak A, Singh PM, et al. Psychometric refinement of an outpatient, visit-specific
satisfaction with doctor questionnaire. Psycho-Oncol. 20034;13:223–234.
D:\478174570.doc
Locke DEC, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer
PL, Buckner JC. Validation of single-item linear analog scale assessment of quality of life in neurooncology patients. Journal of Pain and Symptom Management. 2007;34(6):628-638.
Locker D. Validity of single-item parental ratings of child oral health. International Journal of
Paediatric Dentistry. 2008;18(6):407-414.
Locock L, Smith L. Personal benefit, or benefiting others? Deciding whether to take part in clinical
trials. Clinical Trials. 2011;8(1):85-93.
Lofland JH, Schaffer M, Goldfarb N. Evaluating health-related quality-of-life: cost comparison of
computerized touch-screen technology and traditional paper systems. Pharmacother.
2000;20(11):1390-1395.
Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Reduced health-related quality of life among
Hodgkin;s disease survivors: a comparative study with general population norms. Ann Oncol.
1999;10(1):71-77.
Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality-of-life and health status instruments:
development of scientific review criteria. Clin Ther. 1996;18:979-992.
Lohr KN. Applications of health status assessment measures in clinical practice: overview of the
Third Conference on Advances in Health Status Assessment. Med Care. 1992;30(5):MS1-MS14.
Long HJ, Rayson S, Podratz KC, et al. Long-term survival of patients with advanced/recurrent
carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine,
doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
Am J Clin Oncol. 2002;25(6):547-551.
Longman AJ, Braden CJ, Mishel MH. Side-effects burden, psychological adjustment, and life quality
in women with breast cancer: pattern of association over time. ONCOL NURS FORUM.
1999;26(5):909-915.
Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer
treatment in Ontario, Canada. Support Care Cancer. 2006;14:1077-1085.
Loo R, Kells P. A caveat on using single-item measures. Employee Assistance Quarterly. 1998;
1998;14(2):75-80.
Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med. 1989;
28:299-308.
Loprinzi CL, Barton DL, Sloan JA. Whose opinion counts? J Clin Oncol. 2006;24(33):5183-5185.
Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J,
Christensen B, Pharm B. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a
20-year experience. Menopause. 2008;15(4):655-660.
D:\478174570.doc
Loprinzi CL, Goldberg RM, Su JQ, et al. Placebo-controlled trial of hydrazine sulfate in patients with
newly diagnosed non-small-cell lung cancer. J Clin Oncol. 1994;12:1126-1129.
Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark FA, Balcueva EP, Burger KN, et
al. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of
hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J
Clin Oncol. 2007;25(3):308-312.
Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland Jr KM, Camoriano
JK, Novotny PJ, Christensen BJ. Randomized comparison of megestrol acetate versus
dexamethasone versus fluoxymestrerone for the treatment of cancer anorexia/cachexia. Journal of
Clinical Oncology. 1999;17(10):3299-3306.
Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ,
Levitt R, Tschetter LK, Windschitl H. Lack of effect of coumarin in women with lymphedema after
treatment for breast cancer. N Engl J Med. 1999;340(5):346-50.
Loprinzi CL, Kuross SA, O’Fallon JR, et al. Randomized placebo-controlled evaluation of hydrazine
sulfate in patients with advanced colorectal cancer. J Clin Oncol. 1994;12(6):1121-1125.
Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A, Le-Lindqwister NA, Soori
GS, Jaslowski AJ, Novotny PJ, Lachance DH. Natural history of paclitaxel-associated acute pain
syndrome: prospective cohort study NCCTG N08C1. Journal of Clinical Oncology. 2011;29(11):14721478.
Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P,
Pandya K, Guttuso Jr. T, Barton D, Novotny P. Newer antidepressants and gabapentin for hot
flashes: an individual patient pooled analysis. Journal of Clinical Oncology. Published ahead of print
on March 30, 2009.
Loprinzi PD, Cardinal BJ, Si Q, Bennett JA, Winters-Stone KM. Theory-based predictors of follow-up
exercise behavior after a supervised exercise intervention in older breast cancer survivors.
Supportive Care in Cancer. 2012;20(10):2511-2521.
Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and healthrelated quality of life: findings from a national study of persons with HIV infection. Ann Intern Med.
2001;134(9 Pt 2):854-860.
Lorenzo-Hernandez J, Ouellette S. Ethnic identity, self-esteem, and values in Dominicans, Puerto
Ricans, and African Americans. Journal of Applied Social Psychology. 1998;28(21):2007-2024.
Louvet C, de Gramont A, Tournigand C, Artru P, Maindrault-Goebel F, Krulik M. Correlation between
progression free survival and response rate in patients with metastatic colorectal carcinoma. Cancer.
2001;91:2033-2038.
Lowe JB, Balanda KP, DelMar C, Hawes E. Psychologic distress in women with abnormal findings in
mass mammography screening. Cancer. 1999;85(5):1114-1118.
Lowry A, Bernhard J. Quantitative assessment of changes in patients’ constructs of quality of life: An
application of multilevel models. Qual Life Res. 2004;13:1177–1185.
D:\478174570.doc
Lu W, Hu D, Dean-Clower E, Doherty-Gilman A, Legedza ATR, Lee H, Matulonis U, Rosenthal DS.
Acupuncture for chemotherapy-induced leucopenia: exploratory meta-analysis of randomized
controlled trials. Journal of the Society for Integrative Oncology. 2007;5(1):1-10.
Lubeck DP, Litwin MS, Henning JM, Carroll PR. Measurement of health-related quality of life in men
with prostate cancer; the CaPSURE database. Qual Life Res. 1997;385-392.
Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR. Changes in health-related
quality of life in the first year after treatment for prostate cancer: Results from CaPSURE. Urology.
1999;53:180-186.
Lubeck DP. Health-related quality of life measurements and studies in rheumatoid arthritis. Am J
Manage Care. 2002;8(9):811-820.
Luciani A, Ascione G, Bertuzzi C, Marussi D, Codeca C, Di Maria G, Caldiera SE, Floriani I, Zonata S,
Ferrari D, Foa P. Detecting disabilities in older patients with cancer: comparison between
comprehensive geriatric assessment and vulnerable elders survey-13. Journal of Clinical Oncology.
2010;28(12):2046-2050.
Luckett T, Butow PN, King MT, Oguchi M, Heading G, Hackl NA, Rankin N, Price MA. A review and
recommendations for optimal outcome measures of anxiety, depression and general distress in
studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer
diagnoses. Support Care Cancer. 2010;18(10):1241-1262.
Luckett T, Britton B, Clover K, Rankin NM. Evidence for intervention to improve psychological
outcomes in people with head and neck cancer: a systematic review of the literature. Supportive
Care in Cancer. 2011;19(7):871-882.
Ludwig H, Crawford J, Osterborg A, Vansteenkiste J, Henry DH, Fleishman A, Bridges K, Glaspy JA.
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled
trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia. Journal of
Clinical Oncology. 2009;27(17):2838-2847.
Lund I, Lundeberg T, Sandberg L, Budh CN, Kowalski J, Svensson E. Lack of interchangeability
between visual analogue and verbal rating pain scales: a cross sectional description of pain etiology
groups. BMC Medical Research Methodology. 2005;5:31.
Lundh A, Gotzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of
bias in studies. BMC Medical Research Methodology. 2008;8:22.
Lunney JR. Resources for caregivers of terminally ill cancer patients. Cancer Pract. 2000;8:99-100.
Luo N, Johnson JA, Coons SJ. Using instrument-defined health state transitions to estimate minimally
important differences for four preference-based health-related quality of life instruments. Medical
Care. 2010;365-371.
Luo X, Cappelleri JC, Cella D, Li JZ, Charbonneau C, Kim ST, Chen I, Motzer RJ. Using the Rasch
model to validate and enhance the interpretation of the functional assessment of cancer therapykidney symptom index-disease-related symptoms scale. Value Health. 2009;12(4):580-586.
D:\478174570.doc
Luoma M, Hakamies-Blomqvist L, Sjostrom J, et a;. Physical performance, toxicity, and quality of life
as assessed by the physician and the patient. Acta Oncol. 2002;41(1):44-49.
Luoma ML, Hakamies-Blomqvist L. The meaning of quality of life in patients being treated for
advanced breast cancer: a qualitative study. Psycho-Oncol. 2004;13:729–739.
Lutgendorf SK, Sood AK, Anderson B, et al. J Clin Oncol. 2005;23:7105-7113.
Lyman GH, Glaspy J. Advanced in the management of chemotherapy-induced anemia and its
treatment. Oncology (Suppl). 2006;20(8):5-7.
Lyman GH. Benefits of early intervention with erythropoiesis-stimulating proteins in chemotherapyinduced anemia. Oncology (Suppl). 2006;20(8):16-20.
Lynch BM, Cerin E, Owen N, Hawkes AL, Aitken JF. Prospective Relationships of Physical Activity with
Quality of Life Among Colorectal Cancer Survivors. Journal of Clinical Oncology. 2008;26(27):44804487.
Lyon AW, Larsen ET, Edwards AL. The impact of new guidelines for glucose tolerance testing on
clinical practice and laboratory services. Can Med Assoc J. 2004;171:1067-1069.
Ma C, Jatoi A. Wine for appetite loss: “How do you know?” J Clin Oncol. 2007;25(10):1285-1287.
MacDonald JS. Vive la difference: sex and fluorouracil toxicity. J Clin Oncol. 2002;20(6):1439-1441.
Macdougall IC. Quality of life and anemia: The nephrology experience. Sem Oncol. 1998; 25(3)
(Suppl)7:39-42.
Mack JW, Cook EF, Wolfe j, Grier HE, Cleary PD, Weeks JC. Understanding of prognosis among
parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol.
2007;25(11):1257-1362.
Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal attainment,
and distress at the end of life: predictors and outcomes of receipt of care consistent with
preferences. Journal of Clinical Oncology. 2010;28(7):1203-1208.
Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC. Communication about prognosis between parents
and physicians of children with cancer: parent preferences and the impact of prognostic information.
J Clin Oncol. 2006;24(33)5265-5270.
Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC. Parents’ roles in decision making for
children with cancer in the first year of cancer treatment. Journal of Clinical Oncology.
2011;29(15):2085-2090.
Macquart-Moulin G, Viens P, Bouscary M-L, et al. Discordance between physicians’ estimations and
breast cancer patients’ self-assessment of side-effects of chemotherapy: an issue for quality of care.
Br J Cancer. 1997;76(12):1640-1645.
D:\478174570.doc
Macvean ML, White VM, Pratt S, Grogan S, Sanson-Fisher R. Reducing the unmet needs of patients
with colorectal cancer: a feasibility study of The Pathfinder Volunteer Program. Support Care Cancer.
2007;15:293-299.
Madalinska JB, Essink-Bot M-L, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Healthrelated quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected
or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001;19:1619-1628.
Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingooophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian
cancer. J Clin Oncol. 2005;23:6890-6898.
Madden J, Newton S. Why am I so tired all the time? Understanding cancer-related fatigue. Clin J
Oncol Nurs. 2006;10(5):659-661.
Maddigan SL, Feeny DH, Johnson JA for the DOVE Investigators. Construct validity of the RAND-12
and Health Utilities Index Mark 2 and 3 in type 2 diabetes. Qual Life Res. 2004;13:435-448.
Mader TJ, Blank FSJ, Smithline HA, Wolfe JM. How reliable are pain scores? A pilot study of 10
healthy volunteers. J Emerg Nurs. 2003;29(4):322–325.
Magder LS. Simple approaches to assess the possible impact of missing outcome information on
estimates of risk ratios, odds ratios, and risk differences. Control Clin Trials. 2003;24:411-421.
Magill L. Role of music therapy in integrative oncology. J Soc Integr Oncol. 2006;4(2):79-81.
Magruder-Habib K, Zung WWK, Feussner JR. Improving physicians’ recognition and treatment of
depression in general medical care. Med Care. 1990;28(3):239-250.
Maguire P, Selby P. Assessing quality of life in cancer patients. Br J Cancer. 1989;60:437-440.
Mahlungulu SN, Uys LR. Spirituality in nursing: an analysis of the concept. Curationis. 2004;
27(2):15-26.
Mahon SM, Cella DF, Donovan MI. Psychosocial adjustment to recurrent cancer. Oncology Nursing
Forum. 1990;17(3):47-52.
Mahood DJ, Dose AM, Loprinzi CL, et al. Inhibition of fluorouracil-induced stomatitis by oral
cryotherapy. J Clin Oncol. 1991;9(3):449-452.
Maitland ML, Ratain MJ, Cox NJ. Interpreting P Values in Pharmacogenetic Studies: A Call for Process
and Perspective. Journal of Clinical Oncology. 2007;25(29):4513-4515.
Maione P, Perrone F, Gallo C, et al. Pretreatment quality of life and functional status assessment
significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving
chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin
Oncol. 2005;23:6865–6872.
D:\478174570.doc
Malin JL, Ko C, Ayanian JZ, Harrington D, Nerenz DR, Kahn KL, Ganther-Urmie J, et al.
Understanding cancer patients’ experience and outcomes: Development and pilot study of the Cancer
Care Outcomes Research and Surveillance patient survey. 2006;14:837-848.
Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel, EJ, Kahn KL. Results of the national initiative
for cancer care quality: how can we improve the quality of cancer care in the united states? J Clin
Oncol. 2006;24:626-634.
Mallinson T, Cella D, Cashy J, Holzner B. Giving meaning to measure: linking self-reported fatigue
and function to performance of everyday activities. J Pain Symptom Manage. 2006;31(3):229-241.
Mallinson T, Cella D, Cashy J, Holzner B. Giving meaning to measure: Linking self-reported fatigue
and function to performance of everyday activities. J Pain Symptom Management 2006;31(3):229241.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a
comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;
140(4):672-676.
Malouff JM, Shutte NS, Ramerth W. Evaluation of a short form of the POMS-Depression Scale. J Clin
Psychol. 1985;41(3):389-391.
Mancuso CA, Peterson MG, Charlson ME. Effects of depressive symptoms on health-related quality of
life in asthma patients. J Gen Intern Med. 2000;15(5):301-310.
Mandelblatt J, Armetta C, Yabroff R, Liang W, Lawrence W. Descriptive review of the literature on
breast cancer outcomes: 1990 through 2000. J Natl Cancer Inst. Monogr. 2004;33:8–44.
Mandelblatt JS, Edge SB, Meropol NJ, et al. Sequelae of axillary lymph node dissection in older
women with stage 1 and 2 breast carcinoma. Cancer. 2002;95(12):2445-2454.
Mandelblatt JS, Cullen J, Lawrence WF, Stanton AL, Yi B, Kwan L, Ganz PA. Economic evaluation
alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship
among patients with breast cancer. J Clin Oncol. 2008;26(10):1684-1690.
Mandzuk LL, McMillan DE. A concept analysis of quality of life. J Orthopaedic Nurs. 2005;9:12-18.
Manegold C, Schwarz R. Quality of life and supportive care in the treatment of NSCLC. Chest.
1996;5:113S-114S.
Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the national
eye institute visual function questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496-1504.
Manne S, Babb J, Pinover W, Horwitz E, Ebbert J. psychoeducational group intervention for wives of
men with prostate cancer. Psycho-Oncol. 2004;13:37–46.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration.
Cancer Chemotherapy Reports. 1966;50(3):163-170.
D:\478174570.doc
Mantha S, Roizen MF, Fleisher LA, Thisted R, Foss J. Comparing methods of clincal measurement:
reporting standards for bland and altman analysis. Anesth Analg. 2000;90:593-602.
Mantovani G, Maccio A, Massa E, Madeddu C. Managing cancer-related anorexia/cachexia. Drugs.
2001;61:499–514.
Mantyh PW, Clohisy DR, Koltzenburh M, Hunt SP. Molecular mechanisms of cancer pain. Nature
Rev. 2002;2:201–209.
Mantyselka P, Kumpusalo E, Ahonen Riitta, Takala J. Patients’ versus general practitioners’
assessments of pain intensity in primary care patients with non-cancer pain. Br J Gen Pract. 2001;
51:995-997.
Marangolo M, De Giorgi U. Polychemotherapy in over seventy breast cancer patients. Tumori.
2002;88(1):S57-S58.
Marcus AC, Cella DF, Sedlacek S, Crawford ED, Crane LA, Garrett K, Quigel C, Gonin R. Psychosocial
counseling of cancer patients by telephone: A brief note on patient acceptance of an outcall
strategy. Psycho-Oncology. 1993;2:209-214.
Marcus AC, Garrett KM, Cella D, Wenzel LB, et al. Telephone counseling of breast cancer patients
after treatment: A description of a randomized clinical trial. Psycho-Oncology. 1998;7:470-482.
Mariani L, Marubini E. Design and analysis of phase II cancer trials: A review of statistical methods
and guidelines for medical researchers. International Statistical Review. 199;64:61-88.
Marijnen CAM, van de Velde CJH, Putter H, et al. Impact of short-term preoperative radiotherapy on
health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter
randomized trial. J Clin Oncol. 2005;23:1847-1858.
Marinakis HA, Zwemer FL. An inexpensive modification of the laboratory computer display changes
emergency physician’s work habits and perceptions. Ann Emerg Med. 2003;41:186-190.
Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Vercauteren J, Cleeland
CS, Flechtner H, Gotay C, Greimel E, Taphoorn MJ, Reeve BB, Koch JS-V, Weis J, Smit EF, van
Meerbeeck JP, Bottomley A, on behalf of the EORTC PROBE project and the Lung Cancer Group.
Minimal important differences for interpreting health-related quality of life scores from the EORTC
QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in
Cancer. 2011;19(11):1753-1760.
Markman M. Management of ovarian cancer: an impressive history of improvement in survival and
quality of life. Oncol. 2006;20(4):347-369.
Markou AL, Noyez L. Will cardiac surgery improve my quality of life?: Visual analogue score as a first
step in preoperative counseling. Neth Heart J. 2007;15(2):51-4.
Marquie L, Raufaste E, Lauque D, Marine C, Ecoiffier M, Sorum P. Pain rating by patients and
physicians: evidence of systematic pain miscalibration. Pain. 2003;102:289-296.
D:\478174570.doc
Marquis P. Development and validation of a questionnaire: state of the art and level of evidence
required. health-related quality of life and patient-reported outcomes: scientific and useful outcome
criteria. Comptes rendus de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris.
Main Authors: Chassany O, Caulin C. October 2002.
Marquis P, Arnould B, Acquadro C, Roberts WM. Patient-reported outcomes and health-related
quality of life in effectiveness studies: pros and cons. Drug Development Research. 2006;67(3):193201.
Marshall GN, Hays RD, Mazel R. Health status and satisfaction with health care: results from the
medical outcomes study. J Con Clin Psychol. 1996;64(2):380-390.
Marshall GN, Hays RD, Nicholas R. Evaluating agreement between clinical assessment methods. Intl
J Methods Psychiatr Res 1994;4:249-257.
Martenson JA, Halyard MY, Sloan JA, Prouix GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai THP,
Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, Double-Blind Study of Depot Octreotide Versus
Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy: Results of
North Central Cancer Treatment Group N00CA. Journal of Clinical Oncology. 2008;26(32):52485253.
Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, Atkins M, Fassbender K, Downing GM,
Baracos V. Prognostic factors in patients with advanced cancer: use of the patient-generated
subjective global assessment in survival prediction. Journal of Clinical Oncology. 2010;28(28):43764383.
Martin AR, Pearson JD, Cai B, Elmer M, Horgan K, Lindley C. Assessing the impact of chemotherapyinduced nausea and vomiting on patients’ daily lives: a modified version of the Functional Living
Index-Emesis (FLIE) with 5-day recall. Support Care Cancer. 2003;11:522-527.
Martin CG, Rubenstein EB, Elting LS, Kim YJ, Osoba D. Measuring chemotherapy-induced nausea and
emesis: pyshometric properties of a quality of life questionnaire. Cancer. 2003;98:645–655.
Martin CK, Church TS, Thompson AM, Earnest CP, Blair SN. Exercise dose and quality of life: a
randomized controlled trial. Arch Intern Med. 2009;169:269-278.
Martin LA, Hagen NA. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical
controversies. J Pain Symptom Manage. 1997;14(2):99-117.
Martin P. Seattle Symposium on Cancer Research Outcomes: Commentary on the papers by
Donaldson and Moinpour and by Osoba. Med Care. 2002;40(6) (Supplement):III-54-III-55.
Martin A, Rief W, Klaiberg A, Braehler E. Validity of the Brief Pain Patient Health Questionnaire Mood
Scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006;28:71-77.
Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C,
Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Schmucker-Von Koch, J, Shi Q,
Taphoorn MJ, Weis J, Bottomley A, on behalf of the European Organisation for Research and
Treatment of Cancer Clinical Groups. Expert Rev. Pharmacoeconomics Outcomes Res.
2011;11(5):587-599.
D:\478174570.doc
Martino M, Oliva E, Console G, et al. Administration of recombinant human erythropoietin alpha
before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma
patients. Support Care Cancer. 2005;13:182-187.
Maruta T, Colligan RC, Malinchoc M, Offord KP. Optimism-pessimism assessed in the 1960s and selfreported health status 30 years later. Mayo Clin Proc. 2002;77:748-753.
Marwick C. Acceptance of alternative therapies slowly growing in United Kingdom. J Natl Cancer
Inst. 2003;95(20):1503–1504.
Masera G, Spinetta JJ, Jankovic M, et al. Guidelines for assistance to terminally ill children with
cancer: A report of the SIOP working committee on psychosocial issues in pediatric oncology. Med
Pediatr Oncol. 1999;32:44-48.
Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr.
2004;32:57-71.
Masson AH. The value and limitation of subjective assessment of pain and analgesia. Proc Royal Soc
Med. 1966;59 Suppl:81-84.
Mast ME. Definition and measurement of quality of life in oncology nursing research: review and
theoretical implications. Oncol Nurs Forum. 1995; 22(6):957-964.
Mathers-Schmidt BA, Kurlinski M. Dysphagia evaluation practices: inconsistencies in clinical
assessment and instrumental examination decision-making. Dysphagia. 2003;18:114–125.
Mathew A, Peiffer LP, Rhoades K, McGarrity TJ. Improvement in quality of life measures in patients
with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and
ribavirin. Health and Quality of Life Outcomes. 2006;4:30 (8 pages).
Mathews WC, May S. EuroQol (EQ-5D) meausure of quality of life predicts mortality, emergency
department utilization, and hospital discharge rates in HIV-infected adults under care. Health Qual
Life Outcomes. 2007:5:5: 9 pages.
Mathias SD, Bates MM, Pasta DJ, Cisternas MG, Feeny D, Patrick DL. Use of the Health Utilities Index
with stroke patients and their caregivers. Stroke 1997;28:1888-1894.
Matsushita T, Mastsushima E, Maruyama M. Assessment of peri-operative quality of life in patients
undergoing surgery for gastrointestinal cancer. Support Care Cancer. 2004;12:319–325.
Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A
review of the perspective of those facing death from cancer. J Clin Oncol. 2006;24(21):3490-3496.
Mauer MEL, Taphoorn MJB, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, van der Rijt
CCD, Bernsen HJJA, Frenay M, Tijssen CC, Lacombe D, van den Bent MJ. Prognostic value of healthrelated quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from
a Phase III EORTC Brain Cancer Group Study. J Clin Oncol. 2007;25:5731-5737.
D:\478174570.doc
Maunsell E, Drolet M, Brisson J, Robert J, Deschenes L. Dietary change after breast cancer: extent,
predictors, and relation with psychological distress. J Clin Oncol. 2002;20(4):1017-1025.
Maunsell E, Pogany L, Barrera M, Shaw AK, Speechley KN. Quality of life among long-term
adolescent and adult survivors of childhood cancer. J Clin Oncol. 2006;24(16):2527-2535.
Mauskopf JA, Austin R, Dix LP, Berzon RA. Estimating the value of a generic quality-of-life measure.
Med Care. 1995;33(4):AS195-AS202.
May AM, Korstjens I, van Weert E, van den Borne B, Hoekstra-Weebers JEHM, van der Schans CP,
Mesters I, Passchier J, Grobbee DE, Ros WJG. Long-term effects on cancer survivors’ quality of life of
physical training versus physical training combined with cognitive-behavioral therapy: results from a
randomized trial. Supportive Care in Cancer. 2009;17(6):653-664.
Mayer DK, Travers D, Wyss A, Leak A, Waller A. Why do patients with cancer visit emergency
departments? Results of a 2008 population study in North America. Journal of Clinical Oncology.
2011;29(19):2683-2688.
Mayrbaurl B, Wintner LM, Giesinger JM, Himmelfreundpointner Th. Burgstaller S, Holzner B, Thaler J.
Chemotherapy line-associated differences in quality of life in patients with advanced cancer.
Supportive Care in Cancer. 2012;20(10):2399-2405.
Mayo NE, Scot SC, Dendukuri N, Ahmed S, Wood-Dauphinee S. Identifying response shift statistically
at the individual level. Quality of Life Research. 2008;17:627-639.
Mayou R, Bryant B. Quality of life in cardiovascular disease. Br Hlth J. 1993;69:460-466.
Mazumdar M, Smith A, Schwartz. A statistical simulation study finds discordance between WHO
Criteria and RECIST Guideline. J Clin Epidemiol. 2004;57:358-365.
Mazur DJ, Hickam DH. Interpretation of graphic data by patients in a general medicine clinic. J Gen
Intern Med. 1990;5:402-405.
Mazur DJ, Hickam DH. Patient’s Preferences for Risk Disclosure and Role in Decision Making for
Invasive Medical Procedures. J Gen Intern Med. 1997;12:114-117.
Mazzocato C, Sweeny C, Bruera E. Clinical research in palliative care: choice of trial design. Palliat
Med. 2001;15:261-264.
Mc Pherson CJ, Addington-Hall JM. Judging the quality fo care at the end of life: can proxies provide
reliable information? Soc Sci Med. 2003;56:95-109.
McAlister FA, Straus SE, Sackett DK, Altman DG. Analysis and reporting of factorial trials. JAMA.
2003;289(19):2545–2553.
McArdle CS, Calman KC, Cooper AF, Hughson AVM, Russell AR, Smith DC. The social, emotional and
financial implications of adjuvant chemotherapy in breast cancer. Br J Surg. 1981;68:261-164.
D:\478174570.doc
McCabe MS, Bhatia S, Oeffinger KC, Reaman GH, Tyne C, Wollins DS, Hudson MM. American Society
of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care. Journal of Clinical
Oncology. 2013;31(5):631-640.
McCain NL, Cella DF. Correlates of stress in HIV disease. Western Journal of Nursing Research.
1995;17(2):141-155.
McCain NL, Zeller J, Cella DF, Urbanski PA, Novak RM. The influence of stress management training
in HIV disease. Nursing Research. 1996;45(4):246-253.
McCarter H, Furlong W, Whitton AC, Feeny D, DePauw S, Willan AR, Barr RD. Health status
measurements at diagnosis as predictors of survival among adults with brain tumors. J Clin Oncol.
2006;24(22):3636-3643.
McCarthy DM. Quality of life: a critical assessment. Scand J Gastroenterol. 1995;30(Suppl
208):141-146.
McCarthy DO. Rethinking nutritional support for person with cancer cachexia. Biolog Res Nurs.
2003;5(1):3–17.
McCarthy EP, Burns RB, Davis RB, Phillips RS. Barriers to hospice care among older patients dying
with lung and colorectal cancer. J Clin Oncol. 2003;21(4):728-735.
McClain C, Rosenfeld B, Kosinksi A, Pessin H, Cimino JE, Breitbart W. Belief in an afterlife, spiritual
well-being and end-of-life despair in patients with advanced cancer. Gen Hosp Psychiatry.
2004;26:484-486.
McColl E, Han SW, Barton JR, Welfare MR. A comparison of the discriminatory power of the
Inflammatory Bowel Disease Quesionnaire and the SF-36 in peple with ulcerative colitis. Qual Life
Res. 2004;13:805-811.
McCorkle R, Benoliel JQ. Symptom distress, current concerns, and mood disturbances after diagnosis
of life threatening disease. Soc Sci Med. 1983;17:431-438.
McCorkle R, Pasacreta J, Tzuh Tang S. The silent killer. Psychological issues in ovarian cancer.
Holistic Nurs Pract. 2003;17(6):300-308.
McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978;1:373-378.
McCoubrie RC, Davies AN. Is there a correlation between spirituality and anxiety and depression in
patients with advanced cancer? Support Care Cancer. 2006;14:379-385.
McCreary ML, Slavin LA, Berry E. Predicting problem behavior and self-esteem among Afrian
American adolescents. Jornal of Adolescent Research 11(2):216-234, 1996.
McCusker J, Stoddard AM. Effects of an expanding home care program for terminally ill. Med Care.
1987;25:373-385.
D:\478174570.doc
McDermott MM, Greenland P, hahn EA, et al. The Effects of Continuing Medical Education Credits on
Physician Response Rates to a Mailed Questionnaire. Health Marketing Quarterly. 2003;20(4):27-42.
McDougall J, Tsonis M. Quality of life in survivors of childhood cancer: a systematic review of the
literature (2001-2008). Supportive Care in Cancer. 2009;17(10):1231-1246.
McGrath C, Bedi R. A national study of the importance of oral health to life quality to inform scales of
oral health related quality of life. Qual Life Res. 2004;13:813–818.
McGrath P, Moore A, McNaught M, Palmer G, Greene A, Atkinson D. Another form to fill in? Clients’
reflections on the hospice use of questionnaires. Support Care Cancer. 2005;13:691-701.
McGuire DB. Occurrence of cancer pain. J Natl Cancer Inst Monogr. 2004;32:51-56.
McHorney CA, Monahan PO. Postscript: applications of Rasch Analysis in health care. Editorial. Med
Care. 2004;42(Suppl 1):I-73–I-78.
McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status
surveys adequate? Qual Life Res. 1995;4:293-307.
McHorney CA, Ware JA, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II.
Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med
Care. 1993;31(3):247-263.
McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.
Med Care. 1994;32(1):40-66.
McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS
short- and long-form health status scales and Dartmouth COOP charts: Results from the medical
outcomes study. Med Care. 1992;30(5):253-265.
McHorney CA. Generic Health measurement: past accomplishments and a measurement paradigm
for the 21st century. Ann Intern Med. 1997;127:743-750.
McHorney CA. Health status assessment methods for adults: past accomplishments and future
challenges. Ann Rev Publ Hlth. 1999;20:309–335.
McHorney CA. The potential clinical value of quality-of-life information: response to Martin. Med
Care. 2002;40(6)(Supplement):III-56-III-62.
McHorney CA. The SWAL-QOL and SWAL-CARE Outcomes Tool for oropharyngeal dysphagia in
adults: III. Documentation of reliability and validity. Dysphagia. 2002;17:97–114.
McInnes JA, Knobf MT. Weight gain and quality of life in women treated with adjuvant
chemotherapy for early-stage breast cancer. Oncol Nurs Forum. 2001;28(4):675-684.
D:\478174570.doc
McJoynt TA, Hirzallah MA, Satele DV, Pitzen JH, Alberts SR, Rajkumar SV. Building a protocol
expressway: The Case of Mayo Clinic Cancer Center. Journal of Clinical Oncology.
2009;27(23):3855-3860.
McKenzie N, Marks I. Quick rating of depressed mood in patients with anxiety disorders. Br J
Psychiatry. 1999;174:266-269.
McLachlan SA, Allenby A, Matthews J, et al. Randomized trial of coordinated psychosocial
interventions based on patient self-assessments versus standard care to improve the psychosocial
functioning of patients with cancer. J Clin Oncol. 2001;19:4117–4125.
McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ.
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy
or Axillary Dissection: Patient Perceptions and Precautionary Behaviors. Journal of Clinical Oncology.
2008;26(32):5213-5219.
McLean LM, Walton T, Matthew A, Jones JM. Examination of couples’ attachment security in relation
to depression and hopelessness in martially distressed patients facing end-stage cancer and their
spouse caregivers: a buffer or facilitator of psychosocial distress? Supportive Care in Cancer.
2011;19(1):1539-1548.
McLeod HL. Genetic strategies to individualized supportive care. J Clin Oncol. 2002;20(12):27652767.
McMillan SC, Mahon M. A study of quality of life of hospice patients on admission and at week 3.
Cancer Nurs. 1994;17(1):52-60.
McMillan SC, Mahon M. Measuring quality of life in hospice patients using a newly developed Hospice
Quality-of-Life Index. Qual Life Res. 1994;3:437-447.
McMillan SC, Mahon M. The impact of hospice services on the quality of life of primary caregivers.
ONCOL NURS FORUM. 1994;21(7):1189-1195.
McMillan SC, Tittle M. A descriptive study of the management of pain and pain-related side effects in
a cancer center and a hospice. Hosp J. 1994;10:89–107.
McMillan SC, Weitzner M. Quality of life in cancer patients: use of a revised Hospice Index. Cancer
Pract. 1998;6:282–288.
McMillan SC. Pain and pain relief experienced by hospice patients with cancer. Cancer Nurs.
1996;19:298–307.
McMillan SC. Quality of life of primary caregivers of hospice patients with cancer. Cancer Pract.
1996;4:191-198.
McMillan SC. The quality of life of patients with cancer receiving hospice care. Oncol Nurs Forum.
1996;23(8):1221–1228.
D:\478174570.doc
McNair AGK, Brookes ST, Davis CR, Argyropoulos M, Blazeby JM. Communicating the results of
randomized clinical trials: do patients understand multidimensional patient-reported outcomes?
Journal of Clinical Oncology. 2010;28(%):738-743.
McNaughton-Collins M, Walker-Corkery E, Barry MJ. Health-related quality of life, satisfaction, and
economic outcome measures in studies of prostate cancer screening and treatment, 1990 – 2000. J
Natl Cancer Inst. Monogr. 2004;33:78–101.
McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J
Med. 1978;299(25):1397-1401.
McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity
of life in laryngeal cancer. N Engl J Med. 1981;305:982-987.
McQuay HJ, Jadad AR. Incident pain. Cancer Surveys. 1994;21:17-24.
McQuellon R, Thaler H, Cella D, Moore D. Quality of Life (QOL) outcomes from a randomized trial of
cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a gynecologic oncology group
study. Gynecologic Oncology. 2006;101:296-304.
McQuellon RP, Russell GB, Cella DF, et al. Quality of life measurement in bone marrow
transplantation: development of the Functional Assessment of Cancer Therapy -Bone Marrow
Transplant (FACT-BMT) scale. Bone Marrow Trans. 1997;19:357-368.
McWhinney IR, Bass MJ, Donner A. Evaluation of a palliative care service: Problems and pitfalls.
BMJ. 1994;309:1340-1342.
Meadows K, Steen N, McColl E, et al. The Diabetes Health Profile (DHP): A new instrument for
assessing the psychosocial profile of insulin requiring patients--Development and psychometric
evaluation. Qual Life Res. 1996;5:242-254.
Meads D, Doward L, McKenna S, Fisk J, Twiss J, Eckert B. The development and validation of the
unidimensional fatigue impact scale (U-FIS). Mult Scler. 2009;00:1-11.
Mear I. Difficulties of international clinical trials: cultural adaptation of quality of life questionnaires.
health-related quality of life and patient-reported outcomes: scientific and useful outcome criteria.
Comptes rendus de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main
Authors: Chassany O, Caulin C. October 2002.
Meek PM, Nail LM, Barsevick A, Schwartz AL, Stephen S, Whitmer K, Beck SL, et al. Psychometric
testing of fatigue instruments for use with cancer patients. Nurs Res. 2000;49(4):181-190.
Meers C, Hopman W, Singer MA, MacKenzie TA, Morton AR, McMurray M. A comparison of patient,
nurse, and physician assessment of health-related quality of life in end-stage renal disease. Dialysis
Trans. 1995;24:120-139.
Meeske KA, Siegel SE, Globe DR, Mack WJ, and Bernstein L. Prevalence and correlates of fatigue in
long-term survivors of childhood leukemia. J Clin Oncol. 2005;23:5501-5510.
D:\478174570.doc
Meeussen K, Van den Block L, Echteld MA, Boffin N, Bilsen J, Van Casteren V, Abarshi E, Donker G,
Onwuteaa-Philipsen B, and Deliens L. End-of-Life Care and Circumstances of Death in Patients Dying
As a Result of Cancer in Belgium and the Netherlands: A Retrospective Comparative Study. J Clin
Oncol. Nov 2011;29(32):4327-34
Meisler JG. Toward optimal health: the experts discuss chronic Pain. (An Interview with Russell K.
Portenoy and Christine Miaskowski). J Women’s Hlth Gender-Based Med. 2002;11(4):341–345.
Melchart D, Ihbe-Heffinger A, Leps B, von Schilling C, Linde K. Acupuncture and acupressure for the
prevention of chemotherapy-induced nausea – a randomized cross-over pilot study. 2006;14:878882.
Melia M, Moy C, Reynolds S, Hayman J, Murray T, Hovland K, Earle J, Kurinij N, et al. Quality of life
after iodine 125 brachytherapy vs enucleation for choroidal melanoma. Five year results from the
collaborative ocular melanoma study: COMS QOLS report No. 3. Arch Ophthalmol 2006;124:226-238.
Melink TJ, Clark GM, Von Hoff DD. The impact of phase I clinical trials on the quality of life of
patients with cancer. Anti-Cancer Drugs. 1992;3(6):571-576.
Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;
1:277-279.
Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191-197.
Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer
patients: use of the brief fatigue inventory. Cancer. 1999;85(5):1186-1196.
Mercadante S, Vitrano V, Catania V. Sexual issues in early late stage cancer: a review. Supportive
Care in Cancer. 2010;18(6):659-666.
Mercier M, Schraub S, Bourgeois P. Quality of life. Lancet. 1987;2(8551):161-162.
Mercier M, Schraub S, Bransfield DD, Fournier J. Patient acceptance and differential perceptions of
quality of life measures in a French oncology setting. Qual Life Res. 1992;1:53–61.
Merckaert I, Libert Y, Delvaux N, et al. Factors that influence physicians’ detection of distress in
patients with cancer. Cancer. 2005;104:411-421.
Meredith LS, Orlando M, Humphrey N, Camp P, Sherbourne CD. Are better ratings of the patientprovider relationship associated with higher quality care for depression? Med Care. 2001; 39(4):
349-360.
Merluzzi TV, Martinez Sanchez MA. Assessment of self-efficacy and coping with cancer:development
and validation of the cancer behavior inventory. Hlth Psychol. 1997;16(2):163-170.
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon Jr RM, Blum D, Ubel PA, Schnipper LE.
American Society of Clinical Oncology guidance statement: the cost of cancer care. Journal of Clinical
Oncology. 2009;27(23):3868-3874.
D:\478174570.doc
Merport A, Bober SL, Grose A, Recklitis CJ. Can the distress thermometer (DT) identify significant
psychological distress in long-term cancer survivors?: a comparison with the Brief Symptom
Inventory-18 (BSI-18). Supportive Care in Cancer. 2012;20(1):195-198.
Mertens WC, Higby DJ, Brown D, et al. Improving the care of patients with regard to chemotherapyinduced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic
prescribing guidelines. J Clin Oncol. 2003;21(7):1373-1378.
Mertz HR, Beck CK, Dixon W, Esquivel MA, Hays RD, Shapiro MF. Validation of a new measure of
diarrhea. Dig Dis Sci. 1995;40(9):1873-1882.
Mesa RA, Gotlib J, Gupta V, Catalano JV, Deininger MW, Shields AL, Miller CB, Silver RT, Talpaz M,
Winton EF, Harvey JH, Hare T, Erickson-Viitanen S, Sun W, Sandor V, Levy RS, Kantarjian HM,
Verstovsek S. Effect of Ruxolitinib therapy on myelofibrosis-related symptoms and other patientreported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. Journal of
Clinical Oncology. 2013;31(10):1285-1292.
Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, Pardanani AD, Steensma DP, Litzow
MR, Rivera CE, Camoriano J, Verstovsek S, Sloan J, Harrison C, Kantarjian H, Tefferi A. The
Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure
quality of life and symptomatic response to treatment in myelofibrosis. Leukemia Research.
2009;33:1199-1203.
Messing EM, Madeb R, Feng, C, Stephenson L, Gilchrist KW, Young T, Gee J. Grade and stage at
presentation do not predict mortality in patients with bladder cancer who survive their disease.
Journal of Clinical Oncology. 2009;27(15):2443-2449.
Metcalfe KA, Esplen MJ, Goel V, Narod SA. psychosocial functioning in women who have undergone
bilateral prophylactic mastectomy. Psycho-Oncol. 2004;13:14-25.
Mettlin C, Cookfair DL, Lane W, Pickren J. The quality of life in patients with cancer. NY State J Med.
1983;83(2):187-193.
Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain
treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity
and etiology. Pain. 2001;93:247–257.
Meyer, F, Fortin A, Gelinas M, Nabid A, Brochet F, Tetu B, Bairati I. Health-related quality of life as a
survival predictor for patients with localized head and neck cancer treated with radiation therapy.
Journal of Clinical Oncology. 2009;27(18):2977-2982
Meyer KB, Espindle DM, DeGiacomo JM, Jenuleson CS, Kurtin PS, Ross Davies A. Monitoring dialysis
patients’ health status. Am J Kidney Dis. 1994;24(2):267-279.
Meyerowitz BE, Sparks FC, Spears IK. Adjuvant chemotherapy for breast carcinoma: psychosocial
implications. Cancer. 1979;43(5):1613-1618.
Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients
with CNS tumors. J Clin Oncol. 2006;24(8):1305-1309.
D:\478174570.doc
Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain
metastases treated with whole brain radiation and motexafin gadolinum: results of a randomized
phase III trial. J Clin Oncol. 2004;22:157-165.
Meyers CA, Wefel JS. Editorial: The use of the mini-mental state examination to assess cognitive
functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol. 2003;21(19):3557-3558.
Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management
research. J Natl Cancer Inst Monogr. 2004;32:17-21.
Miaskowski C, Dodd M, West C, Schumacher K, Paul SM, Tripathy D, Koo P. Randomized clinical trial
of the effectiveness of a self-care intervention to improve cancer pain management. J Clin Oncol.
2004;22(9):1713–1720.
Miaskowski C, Kragness L, Dibble S, Wallhagen M. Differences in mood states, health status, and
caregiver strain between family caregivers of oncology outpatients with and without cancer-related
pain. J Pain Symptom Manage. 1997;13(3):138-147.
Miaskowski C, Mack KA, Dodd M, et al. Oncology outpatients with pain from bone metastasis require
more than around-the-clock dosing of analgesics to achieve adequate pain control. J Pain.
2002;3(1):12-20.
Miaskowski C. Gender differences in pain, fatigue, and depression in patients with cancer. J Natl
Cancer Inst Monogr. 2004;32:139-143.
Miaskowski C. The need to assess multiple symptoms. Editorial. Pain Manag Nurs. 2002;3(4):115.
Miaskowski C. Difference kinds of pain. Editorial. Pain Manag Nurs. 2001;2(4):119-120.
Michael M, Tannock F. Measuring health-related quality-of-life in clinical trials that evaluate the role
of chemotherapy in cancer treatment. Can Med Assoc J. 1998;158(13):1727-1734.
Michael YL, Berkman LF, Colditz GA, Holmes MD, Kawachi I. Social networks and health-related
quality of life in breast cancer survivors. J Psychosomatic Res. 2002;52:285-293.
Michel G, Rebholz CE, von der Weid NX, Bergstraesser E, Kuehni CE. Psychological distress in adult
survivors of childhoold cancer: the swiss childhood cancer survivor study. Journal of Clinical
Oncology. 2010;28(10):1740-1748.
Middeke M, Bauhofer A, Kopp I, Koller M. Computerized visulation of quality of life data of individual
cancer patients – the QoL-Profiler. Inflamm. Res. 2004;53(Supplement 2):S175-S178.
Midtgaard J, Rorth M, Stelter R, et al. The impact of a multidimensional exercise program on selfreported anxiety and depression in cancer patients undergoing chemotherapy: a phase II study.
Palliat Supportive Care. 2005;3:197-208.
Mikkelsen ME, Shull WH, Biester RC, Taichman DB, Lynch S, Demissie E, Hansen-Flaschen J, Christie
JD. Cognitive, mood and quality of life impairments in a select population of ARDS survivors.
Respirology. 2009;14(1):76-82.
D:\478174570.doc
Milberg A, Strang P, Jakobson M. Next of kin’s experience of powerlessness and helplessness in
palliative home care. Support Care Cancer. 2004;12:120–128.
Milberg A, Strang P. Met and unmet needs in hospital-based home care: qualitative evaluation
through open-ended questions. Palliat Med. 2000;14(6):533–534.
Miles BJ, Giesler B, Kattan MW. Recall and attitudes in patients with prostate cancer. Urology.
1999;53:169-174.
Mileshkin L, Stark R, Day B, Seymour JF, Zeldis JB, Prince HM. Development of neuropathy in
patients with myeloma treated with thalidomide: patterns of occurrence and the role of
electrophysiologic monitoring. J Clin Oncol. 2006;24(27):4507-4514.
Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost effectiveness
analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum. 2000;43(12):1695-1703.
Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer
survivors: health-related quality of life changes after radical prostatectomy, external radiation and
brachytherapy. J Clin Oncol. 2005;23:2772-2780.
Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B, Mass MK, Fisher E,
Simonian N. Factors that predict health-related quality of life in patients with relapsing-remitting
multiple sclerosis. Multiple Scerosis. 2003;9:1-5.
Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Clinical significance of the multiple sclerosis
functional composite. Arch Neurol. 2000;57:1319-1324.
Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in clinical research. JAMA.
1998;280:1449-1454.
Miller IW, Kabacoff RI, Epstein NB, Bishop DS, Keitner GI, Baldwin LM, van der Spuy HIJ. The
development of a clinical rating scale for the McMaster model of family functioning. Fam Proc. 1994;
33:53-69.
Miller JG, Hays RD. Literature review: adherence to combination antiretroviral therapy: synthesis of
the literature and clinical applications. AIDS Reader. 2000;10(3):177–185.
Miller JJ, Frost MH, Rummans TA, Husckha M, Atherton P, Brown P, Gamble G, Richardson J, Hanson
J, Sloan JA, Clark MM. Role of a medical social worker in improving quality of life for patients with
advanced cancer with a structured multidisciplinary intervention. Journal of Psychosocial Oncology.
2007;25(4):105-119.
Miller K, Ward-Smith P, Cox K, Jones EM, Portnoy JM. Development of an Asthma Disease
Management Program in a children’s hospital. Curr Allergy Asthma Reports. 2003;3:491-500.
Miller M, Mogun H, Azrael D, Hempstead K, Solomon DH. Cancer and the Risk of Suicide in Older
Americans. Journal of Clinical Oncology. 2008;26(29):4720-4724.
D:\478174570.doc
Miller MD, Ferris DG. Measurment of subjective phenomena in primary care research: the visual
analogue scale. Fam Pract Res J. 1993;13(1):15–24.
Miller SC, Kinzbrunner B, Pettit P, Williams JR. How Does the Timing of Hospice Referral Influence
Hospice Care in the Last Days of Life? American Geriatrics Society. 2003;51:798-803.
Miller WR, Thoresen CE. Spirituality, religion, and health. An emerging research field. Am Psychol.
2003;24-74.
Mills ME, Murray LJ, Johnston BT, Donnelly M. Feasibility of a standardized quality of life
questionnaire in a weekly diary format for inoperable lung cancer patients. European Journal of
Oncology Nursing. 2008:457-463.
Mills ME, Murray LJ, Johnston BT, Cardwell C, Donnelly M. Does a Patient-Held Quality-of-Life Diary
Benefit Patients With Inoperable Lung Cancer? Journal of Clinical Oncology. 2009;27(1):70-77.
Milne HM, Wallman KE, Gordon S, Courneya KS. Effects of a combined aerobic and resistance
exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat.
2008 Mar;108(2):279-88.
Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related
fatigue (CRF). Annals of Oncology. 2008 August.
Mishel MH, Belyea M, Germino BB, et al. Helping patients with localized prostate carcinoma manage
uncertainty and treatment side effects. nurse-delivered psychoeducational intervention over the
telephone. Cancer. 2002;94:1854–1866.
Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of Suicide in Persons With Cancer.
Journal of Clinical Oncology. 2008;26(29);4731-4738.
Mitchell AJ. Pooled analysis from 38 analyses of the accuracy of distress thermometer and other
ultra-short methods of detecting cancer-related mood disorders. Journal of Clinical Oncology.
2007;25(29):4670-4681.
Mitchell G, Del Mar C, ORourke P, Clavarino A. Do case conferences between general practitioners
and specialist palliative care services improve quality of life? A randomized controlled trial (ISRCTN
52269003). Palliative Medicine. 2008;22(8):904-912.
Mitchell GK. How well do general practitioners deliver palliative care? A systematic review. Palliative
Medicine. 2002 Nov;16(6):457-464.
Moadel AB, Shah C, Wylie-Rosett J, Harris MS, Patel SR, Hall CB, Sprarano JA. Randomized
controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of
life. J Clin Oncol. 2007 Oct 1;25(28):4387-95. Epub 2007 Sep 4.
Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr.
2004;32:112-118.
D:\478174570.doc
Modan B. Computing the length of survival in long-term disease: a methodological note with special
reference to polycythemia vera. JAMA. 1965;192:609-612.
Modi S, Panageas KS, Duck ET, et al. Prospective exploratory analysis of the association between
tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for
refractory metastatic breast cancer. J Clin Oncol. 2002l20(17):3665-3673.
Moertel CG, Hanley JA. The effect of measuring error on the results of therapeutic trials in advanced
cancer. Cancer. 1976;38(1):388-394.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of
meta-analyses of randomized controlled trials: The QUOROM statement. Lancet.
1999;354(9193):1834-1835.
Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving
the quality of reports of parallel-group randomized trials. Lancet. 2001;357:1191-1194.
Moinpour C. Quality of life assessment in cancer clinical trials. Presented at Cancer Prevention and
Control Colloquim (NCI) May 29, 2002.
Moinpour CM, Feigl P, Metch B, Hayden K, Meyskens FL, Crowley J. Quality of life end points in
cancer clinical trials: review and recommendations. J Natl Cancer Inst. 1989;81:485-495.
Moinpour CM, Lovato LC, Thompson IM, et al. Profile of men randomized to the prostate cancer
prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health
behaviors. J Clin Oncol. 2000;18:1942-1953.
Moinpour CM, Lyons B, Schmidt SP, Chansky K, Patchell RA. Substituting proxy ratings for patient
ratings in cancer clinical trials: An analysis based on a Southwest Oncology Group trial in patients
with brain metastases. Qual Life Res. 2000;9:219-231.
Moinpour CM, Savage MJ, Troxel A, et al. Quality of life in advanced prostate cancer: results of a
randomized therapeutic trial. J Natl Cancer Inst. 1998;90(20):1537-1544.
Moinpour CM. Costs of quality-of-life research in Southwest Oncology Group Trials. J Natl Cancer
Inst Monogr. 1996;20:11-16.
Moinpour CM, Polissar L. Factors affecting place of death of hospice and non-hospice patients. Am J
Publ Hlth. 1989;79:1549-1551.
Moinpour CM, Hayden KA, Unger JM, Thompson Jr IM, Redman MW, Canby-Hagino ED, Higgins BA,
Sullivan JW, Lemmon D, Breslin S, Crawford ED. Health-related quality of life results in pathologic
stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy
alone with radical prostatectomy plus radiation therapy. J Clin Oncol. 2008;26(1):112-120.
Moinpour CM, Vaught NL, Goldman B, Redman MW, Philip PA, Millwood B, Lippman SM, Seay TE,
Flynn PJ, O’Reilly EM, Rowland KM, Wong RP, Benedetti J, Blanke CD. Pain and emotional well-being
outcomes in southwest oncology group – directed intergroup trial S0205: a phase III study
D:\478174570.doc
comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with
advanced pancreas cancer. Journal of Clinical Oncology. 2010;28(22):3611-3616.
Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J, Ream E, Richardson A.
Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized
controlled trial. Journal of Clinical Oncology. 2012;30(36):4470-4476.
Molassiotis A, van den Akker OB, Milligan DW, et al. Quality of life in long-term survivors of marrow
transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone
Marrow Trans. 1996;17(2):249-258.
Molassiotis A, Yung HP, Yam BMC, Chan FYS, Mok TSK. The effectiveness of progressive muscle
relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer
patients: a randomised controlled trial. Support Care Cancer. 2002;10:237-246.
Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J,
Rittenberg C. A prospective observational study of chemotherapy-related nausea and vomiting in
routine practice in a UK cancer centre. Support Care Cancer. 2008;16:201-208.
Molassiotis A, Brearley S, Saunders M, Craven O”, Wardley A, Farrell C, Swindell R, Todd C, Luker K.
Effectiveness of a home care nursing program in the symptom management of patients with
colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. Journal of
Clinical Oncology. 2009;27(36):6191-6198.
Molassiotis A, Lowe M, Ellis J, Wagland R, Bailey C, Lloyd-Williams M, Tishelman C, and Smith J. The
experience of cough in patients diagnosed with lung cancer. Support Care Cancer.
2011;19(12):1997-2004.
Molenaar S, Sprangers MAG, Rutgers EJTh, et al. Decision support for patients with early-stage
breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and
quality of life. J Clin Oncol. 2001;19(6):1676-1687.
Monahan M. Quality of life of adults receiving chemotherapy: a comparison of instruments. Oncol
Nurs Forum. 1988;15(6):795-798.
Monk BJ, Huang H, Cella D, Long HJ. Quality of life outcomes from a randomized phase III trial of
Cisplatin with or without topotecan in advanced carcinoma of the cervix: A gynecologic oncology
group study. J Clin Oncol 2005;23(21):4617-4625.
Montazeri A, Milroy R, Gillis CR, McEwen J. Quality of life: perception of lung cancer patients. Eur J
Can. 1996;32A(13):2284-2289.
Montezari A. Quality of life data as prognostic indicators of survival in cancer patients: an overview
of the literature from 1982 to 2008. Health and Quality of Life Outcomes. 2009;7:102. 21 pages.
Monterosso L, Kristjanson LJ. Supportive and palliative care needs of families of children who die
from cancer: an Australian study. Palliative Medicine. 2008;22(1):59-69.
D:\478174570.doc
Monterosso L, Kristjanson LJ, Aoun S, Phillips MB. Supportive and palliative care needs of families of
children with life-threatening illnesses in Western Australia: evidence to guide the development of a
palliative care service. Palliative Medicine. 2007;21(8):689-696.
Montoya VP, Xie J, Williams D, Woodman RC, Wilhelm FE. An extended maintenance dosing regimen
of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy.
Support Care Center. 2007;15:1385-1392.
Moore A, Moore O, McQuay H, Gavaghan D. Deriving dicotomous outcome measures from
continuous data in randomized controlled trials of analgesics: use of pain intensity and visual
analogue scales. Pain. 1997;69(3):311-315.
Moore D, Blessing J, McQuellon R, Thaler H, et al. Phase III study of cisplatin with or without
paclitaxel in stae IVB, recurrent or persistent squamous cell carcinoma of the cervix. Journal of
Clinical Oncology. 2004;22(15):3113-3119.
Moore D, Donnelly J, McGuire W, Almadrones L, Cella D, Herzog T, Waggoner S. Limited access trial
using Amifostine for protection against Cisplatin and 3-Hour Paclitaxel-included Neurotoxicity: A
Phase II Study of the Gynecologic Oncology Group. Journal of Clinical Oncology. 2003;21(22):42074213.
Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale: an examination
of its reliability and validity in a research setting. Cancer. 1984;53:2002-2007.
Mor V. Cancer patients quality of life over the disease course: lessons from the real world. J Chron
Dis. 1987;40(6):535-544.
Morales LS. Assessing item and scale differential functioning using the DFIT Methodology. Summary
Paper, Drug Information Association June 23–25, 2004 Meeting.
Moran LA, Guyatte GH, et al. Establishing the minimal number of items for a responsive, valid,
health-related quality of life instrument. J Clin Epidemiol. 2001;543(6):571-579.
Morgan PA, Franks PJ, Moffatt CJ. Health-related quality of life with lymphoedema: a review of the
literature. Int Wound J. 2005;2:47-62.
Mori T, Yamazaki R, Aisa Y, et al. Brief oral cryotherapy for the prevention of high-dose melphalaninduced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Support Care Cancer.
2006;14:392-395.
Morita T, Akechi T, Ikenaga M, et al. Late referrals to specialized palliative care service in Japan. J
Clin Oncol. 2005;23:2637-2644.
Morita T, Kawa M, Honke Y, et al. Existential concerns of terminally ill cancer patients receiving
specialized palliative care in Japan. Support Care Cancer. 2004;12:137–140.
Moroi HH, Okimoto K, Terada Y. The effect of an oral prosthesis on the quality of life for head and
neck cancer patients. J Oral Rehab. 1999;26(4):265-273.
D:\478174570.doc
Morone JF, Mayer DK, Parsons SK. The transformation of a validated health-related quality of life
(HRQoL) instrument into a computer animated format : the Child Health Ratings Inventories
Transplant Module (CHRIs-HSCT). PRO Newsletter. 2006 ;37:5-8.
Morris J, Goddard M. Economic evaluation and quality of life assessments in cancer clinical trials: The
CHART trial. Euro J Cancer. 1993;29A:766-770.
Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual Life Res.
1998;7:85-91.
Morris JC, Heyman MD, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s
Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease.
Neurology. 1989;39:1159–1165.
Morris JN, Sherwood S. Quality of life of cancer patients at different stages in the disease trajectory.
J Chron Dis. 1987;40(6):545-553.
Morris MC, Evans DA, Hebert LE, Bienias JL. Commentary: methodological issues in the study of
cognitive decline. Am J Epidemiol. 1999;149:789–793.
Morrison RS, Meier DE. Palliative care. N Engl J Med. 2004;350(25):2582–2590.
Morrow GR. A patient report meausure for the quantification of chemotherapy induced nausea and
emesis: psychometric properties of the Morrow assessment of nausea and emesis (MANE). Br J
Cancer 1992;19:S72-4.
Morrow GR, Andrews PLR, Hickok JT, Roscoe JA, Matteson S. Fatigue associated with cancer and its
treatments. Support Care Cancer. 2002;10:389-398.
Morrow GR, Black JL. Measurement of quality of life in patients: psychometric analyses of the
Functional Living Index – Cancer (FLIC). Qual Life Res. 1992;1:287-296.
Morrow GR, Chiarello RJ, Derogaris LR. A new scale for assessing patients' psychosocial adjustment
to medical illness. Psychol Med. 1978;8:605-610.
Morrow GR, Feldstein M, Adler LM, et al. Development of brief measures of psychosocial adjustment
to medical illness applied to cancer patients. Gen Hosp Psychiatr. 1981;3:79-88.
Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression:
a randomized, double-blind trial from the University of Rochester Cancer Center community clinical
oncology program. J Clin Oncol. 2003;21:4635-4641.
Morrow GR, Roscoe JA, Hickok JT, Andrews PLR, Matteson S. Nausea and emesis: evidence for a
biobehavioral perspective. Support Care Cancer. 2002;10:96–105.
Morrow GR. The assessment of nausea and vomiting: past problems, current issues, and suggestions
for future research. Cancer. 1984;53(Suppl(10): 2267-2278.
D:\478174570.doc
Morton AR, Singer MS, Meers C, Lang J, McMurray M, Hopman WM, MacKenzie TA. Assessment of
health status in peritoneal dialysis patients: a potential outcome measure. Clin Nephrol.
1996;45(3):199-204.
Morton CC. Genetics, genomics and gene discovery in the auditory system. Hum Mol Genet.
2002;11(10):1229-1240.
Morton RP, Davies ADM, Baker J, Baker GA, Stell PM. Quality of life in treated head and neck cancer
patients: a preliminary report. Clin Otolaryngol. 1984;9:181-185.
Mosconi P, Apolone G, Barni S, Secondino S, Sbanotto A, Filiberti A. Quality of life in breast and
colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires.
Tumori. 2002;88:110-116.
Moser DK. Psychosocial factors and their association with clinical outcomes in patients with heart
failure: why clinicians do not seem to care. Eur J Cardiovasc Nurs. 2002;1:183-188.
Mosing MA, Zietsch BP, Shekar SN, Wright MJ, Martin NG. Genetic and environmental influences on
optimism and its relationship to mental and self-rated health: A twin study.
Mota DDCF, Pimenta CAM, Piper BF. Fatigue in Brazilian cancer patients, caregivers, and nursing
students: a psychometric validation study of the Piper Fatigue Scale-Revised. Supportive Care in
Cancer. 2009;17(6):645-654.
Motzer RJ, Murphy BA, Bacik J, Schwartz LH, Nanus DM, Mariani T, Loehrer P, Wilding G, et al.
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced
renal cell carcinoma. J Clin Oncol. 2000;18:2972-2980.
Movsas B. Quality of life in oncology trials: a clinical guide. Sem Radiol Oncol. 2003;13(3):235-247.
Movsas B, Moughan J, Sarna L, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M,
Wasserman T, Watkins Bruner D. Quality of life supersedes the classic prognositcators for long-term
survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Journal of Clinical
Oncology. 2009;27(34):5816-5822.
Moye LA. P-value interpretation and alpha allocation in clinical trials. Ann Epidemiol. 1998;
8(6):351-357.
Moye LA. Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.
Control Clin Trials. 2001;22:605-619.
Moynihan C. Men, Women, Gender, and Cancer. Eur J Cancer Care. 2002;11(3):166-172.
Mozley CG, Huxley P, Sutcliffe C, et al. Not knowing where I am doesn’t mean I don’t know what I
like: Cognitive impairment and quality of life responses in elderly people. Intl J Geriatr Psychiatr.
1999;14(9):776-783.
D:\478174570.doc
Mroczek DK, Spiro III A, Turiano NA. Do health behaviors explain the effect of neuroticism on
mortality? Longitudinal findings from the VA Normative Aging Study. Journal of Research Personality.
2009;43:653-659.
Mullen KH, Berry DL, Zierler BK. Computerized Symptom and Quality-of-Life Assessment for Patients
With Cancer Part II: Acceptability and Usability. Oncology Nursing Forum. 2004;31(5):E84-E89.
Mullens AB, McCaul KD, Erickson SC, Sandgren AK. Coping after cancer: risk perceptions, worry, and
health behaviors among colorectal cancer survivors. Psycho-Oncol. 2004;13:367–376.
Multani PS, Tobinai K, Kakizoe T, Armitage JO, Ohno R, Sugimura T. Report of the fifteenth
international symposium of the foundation for promotion of cancer research: new horizons in the
diagnosis and treatment of hematological malignancies based on molecular genetic features. Jpn J
Clin Oncol. 2002;32(9):371-85.
Mundt JC, Kobak KA, Taylor KVH, et al. Administration of the Hamilton Depression Rating Scale using
Interactive Voice Response Technology. MD Computing. 1998;15(1):31–39.
Munro AJ, Potter S. A quantitative approach to the distress caused by symptoms in patients treated
with radical radiotherapy. Br J Cancer. 1996;74:640-647.
Murata H. Spiritual pain and its care in patients with terminal cancer: construction of a conceptual
framework by philosophical approach. Palliat Support Care. 2003;1:15-21.
Murawski MM, Mychaskiw MA, Surdej J. Exploration of the relationship between health-related
quality of life and the price of pharmaceutical products. Drug Info J. 2003;37(2):221-231.
Murawski MM. Dimension change profile analysis: a systematic approach to health-related quality of
life instrument selection in novel applications. Drug Info J. 2003;37(2):165-175;2003.
Murray KJ, Nelson DF, Scott C, et al. Quality-adjusted survival analysis of malignant glioma. Patients
treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group
(RTOG) 83-02. Int J Radiat Oncol Biol Phys. 1995;3:453-459.
Muss HB, Tu D, Ingle JN, Martino S, Robert NJ, Pater JL, Whelan TJ, Palmer M, Piccart MJ, Shepherd
LE, Pritchard KI, He Z, Goss PE. Efficacy, toxicity, and quality of life in older women with early-stage
breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG Intergroup Trial
MA.17. J Clin Oncol. 2008;26(12):1956-1964.
Musso M, Scalone R, Bonanno V, Crescimanno A, Polizzi V, Porretto F, Bianchini C, Perrone T.
Paolonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and
vomiting in patients receiving multiple-day chemotherapy. Supportive Care in Cancer.
2009;17(2):205-210.
Mustacchi G, Cazzaniga ME, Pronzato P, De Matteis A, Di Costanzo F, Floriani I, et al. Breast cancer
in elderly women: A different reality? Results from the NORA study. Ann Oncol 2007;18:991-996
Mustian KM, Griggs JJ, Morrow GR, McTiernan A, Roscoe JA, Bole CW, Atkins JN, Issell BF. Exercise
and side effects among 749 patients during and after treatment for cancer: a University of Rochester
D:\478174570.doc
Cancer Center Community Clinical Oncology Program Study. Support Care Cancer. 2006;14(7):732741.
Mustian KM, Peppone L, Darling TV, Palesh O, Heckler CE, Morrow GR. A 4-week home-based
aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J
Support Oncol. 2009 Sep-Oct;7(5):158-67.
Muthny FA, Koch U, Stump S. Quality of life in oncology patients. Psychother Psychosom. 1990;
54:145-160.
Muzzatti B, Annuziata MA. Assessing the social impact of cancer: a review of available tools.
Supportive Care in Cancer. 2012;20(10):2249-2257.
Mykletun A, Dahl A, Fredrik Haaland C, et al. Side effects and cancer-related stress determine quality
of life in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:3061-3068.
Myung S-K, Ju W, McDonnelle DD, Lee YJ, Kazinets G, Cheng C-T, Moskowitz JM. Mobile phone use
and risk of tumors: a meta-analysis. Journal of Clinical Oncology. 2009;27(33):5565-5572.
Naeim A, Dy SM, Lorenz KA, Sanati H, Walling A, Asch S. Evedence-Based Recommendations for
Cancer Nausea and Vomiting. J Clin Oncol. 2008;26(23):3903-3910.
Nagaiah G, Hazard HW, Abraham J. Role of obesity and exercise in breast cancer survivors.
Oncology. 2010;24(4):342-350.
Nagel GC, Schmidt S, Strauss BM, Katenkamp D. Quality of life in breast cancer patients: a cluster
analytic approach. Breast Cancer Res Treat. 2001;68:75-87.
Nail LM. My get up and go got up and went: fatigue in people with cancer. J Natl Cancer Inst
Monogr. 2004;32:72-75.
Naqvi K, Garcia-Manero G, Sardesai S, Oh J, Vigil CE, Pierce S, Lei X, Shan J, Kantarjian HM, SuarezAlmazor ME. Association of Comorbidities with overall survival in Myelodysplastic Syndrome:
Development of a prognostic model. Journal of Clinical Oncology. 2011;29(16):2240-2246.
Narducci E, Grande R, Mentuccia L, Trapasso T, Sperduti I, Magnolfi E, Fariello AM, Gemma D,
Gamucci T. Symptom improvement as prognostic factor for survival in cancer patients undergoing
palliative care: a pilot study. Supportive Care in Cancer. 2012;20(6):1221-1226.
Natale R, Skarin A, Maddox A, et al. Improvement in symptoms and quality of life for advanced nonsmall-cell lung cancer patients receiving ZD1839 (‘IRESSA) in Ideal 2. ASCO 2002 Poster
Presentation.
National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-theScience Conference Statement: symptom management in cancer: pain, depression, and fatigue, July
15-17, 2003. J Natl Cancer Inst. 2003;05(15):1110-1117.
D:\478174570.doc
National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-theScience Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July
15-17, 2002. J Natl Cancer Inst. Monogr. 2004;32:9-16.
National Institutes of Health. Improving communication in the ICU about end-of-life care in the ICU
reduces symptoms of stress, anxiety, and depression in family members. National Institutes of
Health News. February 1, 2007. (Accessed online at: http://www.nih.gov/news/pr/feb2007/ninr01.htm)
Navari RM, Einhorn LH, Loehrer PJ, Passik SD, Vinson J, McClean J, Chowhan N, Hanna NH, Johnson
CS. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of
chemotherapy-induced nausea and vomiting: a Hoosier oncology group study. Support Care Cancer.
2007;15:1285-1291.
Navari RM, Brenner MC. Treatment of cancer-related anorexia with olanzapine and megestrol
acetate: a randomized trial. Supportive Care in Cancer. 2010;18(8):951-956.
Nayfield SG, Ganz PA, Moinpour CM, Cella DF, Hailey BJ. Report from a national cancer institute
workshop on quality of life assessment in cancer clinical trials. Qual Life Res. 1992;1:203-210.
Neben-Wittich MA, Atherton PJ, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Loprinzi CL,
Burger KN, Martenson JA, Miller RC. Comparison of provider-assessed and patient-reported outcome
measures of acute skin toxicity during a phase III trial of mometasone cream versus placebo during
breast radiotherapy: The North Central Cancer Treatment Group (N06C4). Int J Radiat Oncol Biol
Phys. 2010. [epub ahead of print] 6 pages.
Neerukonda S, Young RR, Bingham AD, Keville LR, Riggs MW. Adjuvant treatment of elderly breast
cancer patients. Abstract 652 Poster Session VI. Breast Cancer Res Treat. 2002;76(Suppl) S160.
Neidhart JA, Bell-Colakhasanoglu V. Quality of life as an end point in cancer treatment protocolstheoretical considerations. Cancer Bull. 1986;38(5):215-217.
Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson, Maguire TO. A comparison of
patient and proxy symptom assessments in advanced cancer patients. Palliat Med. 1999;13(4):
311–323.
Nekolaichuk CL, Bruera E. Assessing hope at the end of life: validation of an experience of hope
scale in advanced cancer patients. Palliat Support Care. 2004;2:243-253.
Nelson CJ, Rosenfeld B, Breitbart W, Galietta M. Spirituality, religion, and depression in the
terminally ill. Psychosomatics. 2002;43(3):213-220.
Nelson CJ, Cho C, Berk AR, Holland J, Roth AJ. Are gold standard depression measures appropriate
for use in geriatric cancer patients? A systematic evaluation of self-report depression instruments
used with geriatric, cancer, and geriatric cancer samples. Journal of Clinical Oncology.
2010;28(@):348-356.
Nelson EC, Greenfield S, Hays RD, Larson C, Leopold B, Batalden PB. Comparing outcomes and
charges for patients with acute myocardial infarction in three community hospitals: an approach for
assessing “value.” J Qual Hlth Care. 1995;7(20):95-108.
D:\478174570.doc
Nelson EC, Landgraf JM, Hays RD, Wasson JH, Kirk JW. The functional status of patients: how can it
be measured in physician's offices? Med Care. 1990;1111-1126.
Nelson EC, Hvitfeldt H, Reid R, Grossman D, Lindblad S, Mastanduno MP, Weiss LT, Fisher ES,
Weinstein JN. Using Patient-Reported Information to Improve Health Outcomes and Healthy Care
Value: Case studies from Dartmouth, Karolinska and Group Health. (Peer-Reviewed Technical
Report) 2012, 54 pages.
Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic
review and meta-analysis. JAMA. 2006;295(17):2057-2071.
Nelson KA, Walsh D, Sheehan FA. The Cancer Anorexia-Cachexia Syndrome. J Clin Oncol.
1994;12(1):213-225.
Nelson NJ. Trial data lacking for eldery patients with breast cancer. J Natl Cancer Inst.
2000;92(24):1968-1969.
Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for
cancer patients: overview and recommendations for future research. J Natl Cancer Inst.
2002;94:558–584.
Newlin ME, Reiling R, Nichols K. Necessity of axillary dissection in elderly women with early breast
cancer. World J Surg. 2002;26:1239-1242.
Newschaffer CJ, Bush TL, Penberthy LE, Bellantoni M, Helzlsour K, Diener-West M. Does comorbid
disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast
cancer patients. J Gerontology Med Sci. 1998;53A(5):M372-M378.
Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer
patients with administrative and medical records data. J Clin Epidemiol. 1997;50(6):725-733.
http://www.newswise.com/p/articles/view/526301/
Newswise – Better Understanding of Quality of
Life Assessments. Released Thursday, January 4, 2007. Source: Mayo Clinic.
Newton HB. Molecular neuro-oncology and development of targeted therapeutic strategies for brain
tumors. Expert Rev Anticancer Ther. 2004;4(1):105–128.
Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor
symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. Ann
Intern Med. 2006;145:869-879.
Ng K, von Gunten CF. Symptoms and attitudes of 100 consecutive patients admitted to an acute
hospice/palliative care unit. J Pain Symptom Manage. 1998;16:307-316.
Ng T-P, Niti M, Tan W-C, Cao Z, Ong K-C, Eng P. Depressive symptoms and chronic obstructive
pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and
quality of life. Arch Intern Med. 2007;167:60-67.
D:\478174570.doc
Nguyen LN, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomized
dose-response study: results of a self-assessment questionnaire. Urology. 1998; 991-997.
Nicholson B, Theodorescu D. Molecular therapeutics in prostate cancer. Histol Histopathol. 2003;
18(1):275-298.
Nickel JC, Payne CK, Forrest J, Parsons CL, Wan GJ, Xiao X. The relationship between symptoms,
sleep disturbances, and quality of life in patients with interstitial cystitis. J Urol. 2009;181:2555-61.
Nicolaou N, Moughan J, Sarna L, Langer C, Werner-Wasik M, Komaki R, Machtay M, Wasserman T, et
al. Quality of life (QOL) supercedes the classic predictors of survival in locally advanced non-small
cell lung cancer (NSCLC): an analysis of radiation therapy oncology group (RTOG) 9801. Int J Rad
Oncol Biol Phys 2007;69(3) Suppl 1:S58-S59.
Nicum S, Midgley R, Kerr DJ. Colorectal cancer. Acta Oncol. 2003;42(4):263–275.
Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA, Sprangers MA. Quality of life in
asymptomatic-and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. AIDS.
2000;14(2):181-187.
Nieuwkerk PT, Reijers MHE, Weigel HM, Lange JMA, Sprangers MAG. Quality of life in maintenance
vs prolonged induction therapy for HIV. JAMA. 2000;284(2):178-179.
Nijboer C, Triemstra M, Tempelaar R, Sandermann R, van den Bos GAM. determinants of caregiving
experiences and mental health of partners of cancer patients. Cancer. 1999;86(4):577–588.
Nijboer C, Triemstra M, Tempelaar R, Sandermann R, van den Bos, GAM. Measuring both negative
and positive reactions to giving care to cancer patients: psychometric qualities: of the caregiver
reaction assessment. Soc Sci Med. 1999;48:1259–1269.
Niraula S, Seruga B, Ocana A, Shao T, Goldstein R, Tannock IF, Amir E. The price we pay for
progress: a meta-analysis of harms of newly approved anticancer drugs. Journal of Clinical
Oncology. 2012;30(24):3012-3019.
Nissen SE. ADAPT: The wrong way to stop a clinical trial. PLoS Clin Trials. 2006;1(7):e35.
Noble M, Russell C, Kraemer L, Sharratt M. UW WELL-FIT: the impact of supervised exercise
programs on physical capacity and quality of life in individuals receiving treatment for cancer.
Supportive Care in Cancer. 2012;20(4):865-874.
Norcross JC, Guadagnoli E, Prochaska JO. Factor structure of the profile of mood states (POMS):
Two partial replications. J Clin Psychol. 1984;40(5):1270-1277.
Nordin K, Berglund G, Glimelius B, Sjoden PO. Predicting anxiety and depression among cancer
patients: a clinical model. Eur J Cancer. 2001;37:376-384.
Nordin K, Berglund G, Terje I, Glimelius B. The mental adjustment to cancer scale – a psychometric
analysis and the concept of coping. Psycho-Oncol. 1999;8:250-259.
D:\478174570.doc
Nordstrom CJ. The influence of spirituality on quality of life and pain in the terminally ill: an
exploratory study of the patient perspective to develop an empirical model. Qual Life Newsletter.
2004;33:17–20.
Norman GR, Sridhar FG, Guyatt GH, Walter SD. Relation of distribution and anchor-based
approaches in interpretation of changes in health-related quality of life. Med Care.
2001;39(10):1039-1047.
Norman GR, Stratford P. Methodological problems in the retrospective computation of
responsiveness to change: the lesson of Cronbach. J Clin Epidemiol. 1997;50(8):869-879.
Norman SA, Miller LT, Bernadette Erikson H, Norman MF, McCorkle. Development and validation of a
telephone questionnaire to characterize lymphedema in women treated for breast cancer. PhysTher.
2001;81(6):1192-1205.
Norquist JM, Fitzpatrick R, Jenkinson C. Health-related quality of life in amyotrophic lateral sclerosis:
Determining a meaningful deterioration. Qual Life Res. 2004;13:1409–1414.
Northouse LL, Mood D, Kershaw T, et al. Quality of life of women with recurrent breast cancer and
their family members. J Clin Oncol. 2002;20(19):4050-4064.
Northouse LL, Mood D, Monti JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, et al.
Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin
Oncol 2007;25(27):4171-4177.
Northouse LL, Katapodi MC, Song L, Zhang L, Mood DW. Interventions with family caregivers of
cancer patients: meta-analysis of randomized trials. A Cancer Journal for Clinicians. 2010;60(5):317339.
Northouse LL, Mood D, Templin T, Mellon S, George T. Couples’ patterns of adjustment to colon
cancer. Soc Sci Med. 2000;50:271–284.
Norton TR, Manne SL, Rubin S, et al. Prevelence and predictors of psychological distress among
women with ovarian cancer. J Clin Oncol. 2004;22(5):919-926.
Norum J, Grev A, Moen MA, Balteskard L, Holthe K. Information and communication technology
(ICT) in Oncology. Patients’ and relatives’ experiences and suggestions. Support Care Cancer.
2003;11:286-293.
Nosarti C, Roberts JV, Crayford T, McKenzie K, David AS. Early psychological adjustment in breast
cancer patients: a prospective study. J Psychosomatic Res 2003;53:1123-1130.
Nou E, Aberg T. Quality of survival in patients with surgically treated bronchial carcinoma. Thorax
35:255-263, 1980.
Nou E. Bronchial carcinoma III. Quantitative measurements of the quality of survival: a prospective
randomized study of the result of therapy in inoperable patients with localized disease. Scand J
Respir Dis. 1979;(suppl)104):107-130.
D:\478174570.doc
Nout RA, van de Poll-Franse LV, Lybeert MLM, Warlam-Rodenhuis CC, Jobsen JJ, Mens JWM, Lutgens
LCHW, Pras B, van Putten WLJ. Long-term outcome and quality of life of patients with endometrial
carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in
endometrial carcinoma 1 (PORTEC-1) trial. Journal of Clinical Oncology. 2011;29(13):1692-1700.
Novack M, Guest C. Application of a multidimensional caregiver burden inventory. Gerontologist.
1989;29:798-803.
Novotny P, Colligan RC, Szydlo DW, Clark MM, Rausch S, Wampfler J, Sloan JA, Yang P. A
pessimistic explanatory style in prognostic for poor lung cancer survival. Journal of Thoracic
Oncology. 2010;5(3):326-332.
Novotny PJ, Smith DJ, Guse L, Rummans TA, Hartmann L, Alberts S, Goldberg R, Gregory D, Johnson
M, Sloan JA. A pilot study assessing social support among cancer patients enrolled on clinical trials: a
comparison of younger versus older adults. Cancer Management and Research. 2010;2:133-142.
Nowak AK, Stockler MR, Byrne MJ. Assessing quality of life during chemotherapy for pleural
mesothelioma: feasibility, validity, and results of using the european organization for research and
treatment of cancer core quality of life questionnaire and lung cancer module. J Clin Oncol.
2004;22:3172–3180.
Noyes Jr, R, Kathol RG, Debelius-Enemark P, et al. Distress associated with cancer as measured by
the illness distress scale. Psychosomatics. 1990;31(3):321-330.
Nuamah IF, Cooley ME, Fawcett J, McCorkle R. Testing a theory for health-related quality of life in
cancer patients: a structural equation approach. Res Nurs Hlth. 1999;22(3):231-242.
Nyholm D, Kowalski J, Aquilonius S-M. Wireless real-time electronic data capture for self-assessment
of motor function and quality of life in Parkinson’s Disease. Movement Disorders. 2004;19(4):446451.
Oberhoff C. Speed of haemoglobin response in patients with cancer: a review of the erythropoietic
proteins. Support Care Cancer. 2007;15:603-611.
O’Brien ML, Hampilos JP. The feasibility of creating an item bank from a teacher-made test, using
the Rasch Model. Educ Psycholog Measure. 1988;48:201–213.
O’Brien P, Buxton MJ, Patterson DL. Relationship between functional status and health-related
quality-of-life after myocardial infarction. Med Care. 1993;31(10):950-955.
O’Brien P. Procedures for comparing samples with multiple endoints. Biometrics. 1984;40:10791087.
O’Callaghan C. Clinical issues: music therapy in an adult cancer inpatient treatment setting. J Soc
Integr Oncol. 2006;4(2):57-61.
O’Carroll RE, Cossar JA, Couston MC, Hayes PC. Sensitivity to change following liver transplantation:
a comparison of three instruments that measure quality of life. J Hlth Psychol. 2000;5(1):69-74.
D:\478174570.doc
O’Connor R. Issues in the measurement of health-related quality of life. measuring quality of life in
health. Working paper July 30, 1993. Elsevier/Churchill Livingstone, July 2004.
O’Dwyer PJ, Eckhardt SG, Haller DG, Tepper J, Ahnen D, Hamilton S, Benson AB III, Rothenberg M,
et al. Priorities in colorectal cancer research: recommendations from the gastrointestinal scientific
leadership council of the coalition of cancer cooperative groups. J Clin Oncol 2007;25(16):23132321.
O’Gorman P, McMillan DC, McArdle CS. Impact of weight loss, appetite, and the inflammatory
response on quality of life in gastrointestinal cancer patients. Nutr Cancer. 1998;32:76–80.
O’Gorman P, McMillan DC, McArdle CS. prognostic factors in advanced gastrointestinal cancer
patients with weight loss. Nutr Cancer. 2000;37:36–40.
O’Leary JF, Fairclough DL, Jankowski MK, Weeks JC. Comparison of time-tradeoff utilities and rating
scale values of cancer patients and their relatives: evidence for a possible plateau relationship. Med
Decis Making. 1995;15:132-137.
O’Leary M. The importance of standardisation and validation of symptom scores and quality of life:
the urologist’s point of view. Eur Urol. 1996;32:48-49.
O’Leary MP, Flowler FJ, Lenderking WR, et al. A brief male sexual function inventory for urology.
Urology. 1995;697-706.
O’Mara A. “Will I Suffer?” J Clin Oncol. 2007;25(13):1645-1646.
O’Mara A. Who’s taking care of the caregiver? J Clin Oncol. 2005;23:1-2.
O’Neill R, Scott J, Burke L. Critical issues for developing and maintaining item banks and cats: FDA
perspective. Summary Paper, Drug Information Association June 23 – 25, 2004 Meeting.
O’Quigley J, Pepe M, Fisher L. Continual reassessment method: a practical design for Phase I clinical
trials in cancer. Biometrics. 1990;46:33–48.
Oberhoff C. Speed of haemoglobin response in patients with cancer: a review of the erythropoietic
proteins. Support Care Cancer 2007;15:603-611.
Oberlin O. When quality of life is the major challenge? (Editorial) J Clin Oncol 2002;20(14):30513053.
Oberst MT, Thomas SE, Gass KA, Ward SE. Caregiving demands and appraisal of stress among
family caregivers. Cancer Nurs. 1989;12(4):209–215.
O'Boyle C. Making subjectivity scientific. Lancet. 1995;345(8949):602.
O'Boyle CA, McGee HM, Hickey A, O’Malley K, Joyce CR. Individual quality of life in patients
undergoing hip replacement. Lancet. 1992;339:1088-1091.
D:\478174570.doc
O’Brien MA, Whelan TJ, Villasis-Keever M, Gafni A, Charles C, Roberts R, Schiff S, Cai W. Are CancerRelated Decision Aids Effective? A Systematic Review and Meta-Analysis. Journal of Clinical
Oncology. 2009;27(6):974-985.
Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy:pathogensis and emerging
therapies. Support Care Cancer. 2004;12:619-625.
Ochs J, Mulhern R, Kun L. Quality of life assessment in cancer patients. Am J Clin. 1988;11(3):415421.
O’Donnell M, Hunskaar S. Preferences for involvement in treatment decision-making generally and in
hormone replacement and urinary incontinence treatment decision-making specifically. Patient
Education and Counseling. 2007 June;68:243-251.
O’Donnell M, Hunskaar S. Preferences for involvement in treatment decision-making among
Norwegian women with urinary incontinence. Acta Obstetricia et Gynecologica. 2007;86:1370-1376.
Office for Human Research Protections (OHRP). Guidance on Reviewing and Reporting Unanticipated
Problems Involving Risks to Subjects or Others and Adverse Events. January 15, 2007.
Ohrn K. The role of oral sequelae in health-related quality of life of cancer patients. Support Care
Cancer. 2002;10:656-658.
Ohrn KEO, Sjoden P-O, Wahlin Y-B, Elf M. Oral health and quality of life among patients with head
and neck cancer or haematological malignancies. Support Care Cancer. 2001;9:528-538.
Okusaka T, Okada S, Ishii H, Ikeda M, Kosakamoto H, Yoshimori M. Prognosis of advanced
pancreatic cancer patients with reference to calorie intake. Nutr Cancer. 1998.32:55–58.
Okuyama T, Akechi T, Kugaya A, et al. Factors correlated with fatigue in disease – free breast cancer
patients: application of the Cancer Fatigue Scale. Support Care Cancer. 2000;8:215–222.
Okuyama T, Tanaka K, Akechi T, et ak. Fatigue in Ambulatory Patients with Advanced Lung Cancer:
Prevalence, Correlated Factors, and Screening. J Pain Symptom Manage. 2001;22:554–564.
Oldervoll LM, Loge JH, Paltiel H, et al. Are palliative cancer patients willing and able to participate in
a physical exercise program? Palliat Support Care. 2005;3:281-287.
Oliva EN, D'Angelo A, Martino B, Nobile F. More concern about transfusion requirement when
evaluating quality of life in anemic patients. J Clin Oncol. 2002;20(14):3182-3184.
Oliver H, Blum MH, Roskin G. The psychiatrist as advocate for post surgical "quality of life."
Psychosomatics. 1976;17(3):157-159.
Olmi P. Limits to the radiation therapy due to age. Tumori. 2002;88(1)(Suppl 1):S95-S97.
Olschewski M, Schumacher M. Statistical analysis of quality of life data in cancer clinical trials. Stat
Med. 1990;9:749-763.
D:\478174570.doc
Olsen JA, Block DA, Block GJ. Controlling for occasion-specific effects when assessing the test-retest
reliability of self-report health questionnaires. Qual Life Res 2007.
Olson K, Turner AR, Courneya KS, Field C, Man G, Cree M, Hanson J. Possible links between
behavorial and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer.
Support Care Cancer. 2008;16:241-249.
Olson R, Tyldesley S, Carolan H, Parkinson M, Chhanabhai T, McKenzie M. Prospective comparison of
the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in
patients with brain metastases. Supportive Care in Cancer. 2011;19(11):1849-1856.
Olver IN. Prevention of Chemotherapy-Induced Nausea and Vomiting: Focus on Fosaprepitant.
Therapeutics and Clinical Risk Management. 2008;4(2):501-506.
Olver IN. Antiemetic study methodology: recommendations for future studies. Oncology. 1996;
53(Suppl 1):96–101.
Olweny CL, Clinch J, Schipper H, et al. Quality of life (QOL) in epidemic Kaposi’s sarcoma (EKS) in
Zimbabwe. Proc Annu Meet Am Soc Clin Oncol. 1995;14:A1674.
Omura K. Clinical implication of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based
chemotherapy: mutations in the DPD gene, and DPD inhibitory fluorpyrimidines. Int J Clin Oncol.
2003;8(3):132–138.
Onaitis MW, Noone RB, Fields R, et al. Complete response to neoadjuvant chemoradionato for rectal
cancer does not influence survival. Ann Surg Oncol. 2001;8(10):801-806.
O’Neal EL, Adams JR, McHugo GJ, Van Citters AD, Drake RE, Bartels SJ. Preferences of Older and
Younger Adults With Serious Mental Illness for Involvement in Decision-Making in Medical and
Psychiatric Settings. Am J Geriatr Psychiatry. 2008;16(10):826-833.
Oneschuk D, Balneaves L, Verhoef M, Boon H, Demmer C, Chiu L. The status of complementary
therapy services in Canadian palliative care settings. Support Care Cancer. 2007;15:939-947.
Ong KS, Seymour RA. Pain measurement in humans. Surg J Royal Coll Surg Edinburgh & Ireland.
2004;2(1):15-27.
Ong LML, Visser MRM, Lammes FB, van der Velden J, Kuenen BC, de Haes JCJM. Effect of providing
cancer patients with the audiotaped initial consultation on satisfaction, recall, and quality of life: A
randomized, double-blind study. J Clin Oncol. 2000;18:3052-3060.
Oort FJ. Using structural equation modeling to detect response shifts and true change. Quality of
Life Research. 2005;14:587-598.
Oort FJ, Visser MRM, Sprangers MAG. Formal definitions of measurment bias and explanation bias
clarify measurement and conceptual perspectives on response shift. Journal of Clinical Epidemiology.
2009;62:1126-1137
Oparil S. Antihypertensive therapy--efficacy and quality of life. N Engl J Med. 1993;328:959-961.
D:\478174570.doc
Opjordsmoen S, Fossa SD. Quality of life in patients treated for penile cancer: A follow-up study. Br
J Urol. 1994;74:652-657.
Order SE, Hellman S, Von Essen CF, Kligerman MM. Improvement in quality of survival following
whole-brain irradiation for brain metastasis. Radiol. 1968;91:149-153.
Ordovas JM. The quest for cardiovascular health in the genomic era: nutrigenetics and plasma
lipoproteins. Proc Nutr Soc. 2004;63(1):145–152.
Orlando M. Critical issues to address when applying Item Response Theory (IRT) Models. Summary
Paper, Drug Information Association June 23 – 25, 2004 Meeting
Osborne RH, Elsworth GR, Kissane DW, Burke SA, Hopper JL. The Mental Adjustment to Cancer
(MAC) Scale: replication and refinement in 632 breast cancer patients. Psychol Med. 1999;29:13351345.
Osborne RH, Elsworth GR, Sprangers MAG, Oort FJ, Hopper JL. The value of the Hospital Anxiety
and Depression Scale (HADS) for comparing women with early onset breast cancer with populationbased reference women. Qual Life Res. 2004;13:191–206.
Osborne RH, Sali A, Aaronson NK, Elsworth GR, Mdzewski B, Sinclair AJ. Immune function and
adjustment style: do they predict survival in breast cancer? Psycho-Oncol. 2004;13:199–210.
Osman LM, Godden DJ, Friend JAR, Legge JS, Douglas JG. Quality of life and hospital re-admission in
patients with chronic obstructuve pulmonary disease. Thorax. 1997;52:67-71.
Osoba D, Aaronson N, Muller M, et al. Effect of neurological dysfunction on health-related quality of
life in patients with high-grade glioma. J Neuro-Oncol. 1997;34:263–278.
Osoba D, Aaronson N, Zee B, Sprangers M, Velde A te. Modification of the EORTC QLQ-C30 (version
2.0) based on content validity and reliability testing in large samples of patients with cancer. Qual
Life Res. 1997;6:103-108.
Osoba D, Aaronson NK, Muller M, et al. The development and psychometric validation of a brain
cancer quality-of life questionnaire for use in combination with general cancer-specific questionnaires.
Qual Life Res. 1996;5:139-150.
Osoba D, Bezjak A, Brundage M, Zee B, Tu D, Pater J, for the Quality of Life Committee of the NCIC
CTG. Analsis and interpretation of health-related quality-of-life data from clinical trials: the basic
approach of the The National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer.
2005;41:280-287.
Osoba D, Brada M, Yung WKA, Prados M. Health-related quality of life in patients treated with
temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol.
2000;18:1481–1491.
Osoba D, Burchmore M. Health-related quality of life in women with metastatic breast cancer treated
with trastuzumab (Herceptin). Semin Oncol. 1999;26(suppl 12):84–88.
D:\478174570.doc
Osoba D, Dancey J, Zee B, Myles J, Pater J. Health-related quality of life studies of the National
Cancer Institute of Canada Clinical Trials Group. Natl Cancer Inst. 1996;20:107–111.
Osoba D, Murray N, Gelmon K, Karsai H, Knowling M, Shah A. Quality of life, appetite, and weight
change in patients receiving dose-intensive chemotherapy. Oncol. 1994;8(4):61–65.
Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in healthrelated quality-of-life scores. J Clin Oncol. 1998;16:139-144.
Osoba D, Slamon DJ, Burchmore M, Murphy M. Effects on quality of life of combined trastuzumab
and chemotherapy in women with metastatic breast cancer. J Clin Oncol. 2002;20(14):3106-3113.
Osoba D, Tannock IF, Ernst DS, Neville AJ. Health-related quality of life in men with metastic
prostate cancer treated with prednisone alone or mitoxantrone and prednisone. J Clin Oncol. 1999;
17:1654–1663.
Osoba D, Till JE, Pater JL, Young JR. Health-related quality of life: measurement and clinical
application. A workshop report. Can J Oncol. 1995;5(1):338-343.
Osoba D, Zee B, Pater J, Pater J, Warr D, Latreille J, Kaizer L. Determinants of postchemotherapy
nausea and vomiting in patients with cancer. J Clin Oncol. 1997;15:116–123.
Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of
the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast,ovarian and lung cancer.
Qual Life Res. 1994;3:353–364.
Osoba D, Zee B, Warr D, Kaizer L, Latreille J, Pater J. Quality of Life studies in chemotherapyinduced emesis. Oncol. 1996;53(suppl 1):92–95.
Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J. Effect of postchemotherapy nausea and
vomiting on health-related quality of life. Support Care Cancer. 1997;5:307–313.
Osoba D, Zee B. Completion rates in health-related quality of life assessment: approach of the
National Cancer Institute of Canada Clinical Trials Group. Stat Med. 1998;17:603–612.
Osoba D. Current applications of health-related quality of life assessment in oncology. Support Care
Cancer. 1997;5:100–104.
Osoba D. Health-related quality of life and predicting survival in cancer: not a simple matter.
Support Care Cancer. 2007;15:353-355.
Osoba D. Health-related quality-of-life assessment in clinical trials of supportive care in oncology.
Support Care Cancer. 2000;8:84-88.
Osoba D. How assessment of health-related quality of life can inform clinical practice. Network
News. 1997;Sept:12-13.
Osoba D. Interpreting the meaningfulness of changes in health-related quality of life scores: lessons
from studies in adults. Int J Cancer. 1999;Suppl 12:132–137.
D:\478174570.doc
Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol.
1994;12(3):608-616.
Osoba D. Measuring the effect of cancer on health related quality of life. PharmoEcon. 1995;7:
308–319.
Osoba D. Rationale for the timing of health-related quality-of-life (HQL) assessments in oncological
palliative therapy. Cancer Treat Rev. 1996;22(Suppl. A):69-73.
Osoba D. Self-rating symptom checklists: a simple method for recording and evaluating symptom
control in Oncology. Cancer Treat Rev. 1993;19(Suppl. A):43-51.
Osoba D. The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute
of Canada: organization and functions. Qual Life Res. 1992;1:211-218.
Osoba D. What has been learned from measuring health-related quality of life in clinical oncology.
Eur J Cancer. 1999;35(11):1565–1570.
Osoba DA. Taxonomy of the uses of health-related quality-of-life instruments in cancer care and the
clinical meaningfulness of the results. Med Care. 2002;40(6)(Supplement):III-31-III-38.
Ostendorf M, van Stel HF, Busken E, Schrijvers AJP, Martin LN, Verbout AJ, Dhert WJA. Patientreported outcome in total hip replacement: a comparison of five instruments of health status. J Bone
Joint Surg. 2004;86-b(6):801-808.
O'Toole BI, Battistutta D, Long A, Crouch K. A comparison of costs and data quality of three health
survey methods: mail, telephone and personal home interview. Am J Epid. 1986;124(2):317-328.
Ouwens M, Hermens R, Hulscher M, Vonk-Okhuijsen S, Tjan-Heijnen V, Termeer R, Marres H,
Wollersheim H, Grol R. Development of indicators for patient-centred cancer care. Supportive Care
in Cancer. 2010;18(1):121-130.
Owen JE, Klapow JC, Casebeer L. Evaluating the relationship between pain presentation and healthrelated quality of life in outpatients with metastatic or recurrent neoplastic disease. Qual Life Res.
2000;9:855-863.
Owen JE, Klapow JC, Roth DL, Nabell L, Tucker DC. Improving the effectiveness of adjuvant
psychological treatment for women with breast cancer: the feasbility of providing online support.
Psycho-Oncol. 2004;12:3281–292.
Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingam SS. Lung cancer in
elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol
2007;25(35):5570-5577.
Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, Guo P, Kris MG, Schwartz LH,
Riely GJ. Variability of lung tumor measurements on repeat computed tomography scans taken
within 15 minutes. Journal of Clinical Oncology. 2011;29(23):3114-3119.
O'Young J, McPeek B. Quality of life variables in surgical trials. J Chronic Dis. 1987;40:513-522.
D:\478174570.doc
Ozdogan M, Samur M, Sat Bozcuk HS, Coban E, Artac M, Savas B, et al. “Do not tell”: what factors
affect relatives’ attitudes to honest disclosure of diagnosis to cancer patients? Supportive Care
Cancer. 2004;12:497-502.
Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ, Eisenberg BL, Ganz PA, Kramer BS,
Kris MG, et al. Clinical Cancer Advances 2006: Major research advances in cancer treatments,
prevention, and screening – a report from the Amercian Society of Clinical Oncology. J Clin Oncol.
2007;25(1):146-162.
Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny, PJ, Sloan JA, Loprinzi CL,
Gostout BS. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
American Journal of Obstetrics and Gynecology. 2012;206:42.e1-7.
Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue,
insomnia, neuropathy, and pain. Journal of Clinical Oncology. 2012;30(30):3687-3696.
Packer RJ, Sposto R, Atkins TE, et ak. Quality of life in children with primitive neuroectodermal
tumors (medulloblastoma) of the posterior fossa. Pediatr Neurosci. 1987;13:169-175.
Padilla G, Grant MM. Quality of life as a cancer nursing outcome variable. Adv Nurse Sci. 1985;
8(1):45-60.
Padilla GV, Frank-Stromborg M. Single Instruments for measuring quality of life. Instr Assess Hlth
Funct. year/vol;114–134.
Padilla GV, Grant MM, Lipsett J, Anderson PR, Rhiner M, Bogen C. Health quality of life and colorectal
cancer. Cancer. 1992;70:1450-1456.
Padilla GV, Grant MM, Martin L. Rehabilitation and quality of life issues (Speech Rehabilitation
Following Laryngectomy Workshop). Head Neck Surg. 1988;10(Suppl. II):S156-S160.
Padilla GV, Grant MM. Psychosocial aspects of artificial feeding. Cancer. 1985;55(Suppl. 1):301304.
Paesmans M, Klastersky J. Do newer chemotherapeutic agents improve the quality of life of patients
with advanced non small cell lung cancer? Opinions on topics in supportive care in oncology.
Trimestrial 2, 2004. [newsletter]
Paise JA. Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr.
2004;32:98-102.
Pais-Ribeiro JL. Quality of life is a primary end-point in clinical settings. Clinic Nutr. 2004;23:121130.
Paiva CE, Paiva BSR. Prevalence, predictors, and prognostic impact of fatigue among Brazilian
outpatients with advanced cancers. Supportive Care in Cancer. 2013;21(4):1053-1060.
Palermo TM, Valenzuela D, Stork PP. A randomized trial of electronic versus paper pain diaries in
children: impact on compliance, accuracy, and acceptability. Pain. 2004;107(3):213-9.
D:\478174570.doc
Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins
MC, Morrow GR. Prevalence, demographics, and psychological associations of sleep disruption in
patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program.
Journal of Clinical Oncology. 2010;28(2):292-298.
Pallis AG, Wedding U, Lacombe D, Soubeyran P, Wildiers H. Questionnaires and instruments for a
multidimensional assessment of the older cancer patient: What clinicians need to know? Eur J.
Cancer. 2010;46:1019-25.
Palmblad M, Tiplady B. Electronic diaries and questionnaires: Designing user interfaces that are easy
for all patients to use. Qual Life Res. 2004;13:1199–1207.
Palmer BV, Walsh GA, McKinna JA, Greening WP. Adjuvant chemotherapy for breast cancer: side
effects and quality of life. BMJ. 1980;281:1594-1597.
Palmore E, Kivett V. Change in life satisfaction: A longitudinal study of persons aged 46-70. J
Gerontol. 1977;32(3):311-316.
Paltiel O, Avitzour M, Peretz T, et al. Determinants of the use of complementary therapies by
patients with cancer. J Clin Oncol. 2001;19: 2439–2448.
Paltiel O, Marzec-Boguslawska M, Soskolne V, et al. Use of tranquilizers and sleeping pills among
cancer patients is associated with a poorer quality of life. Qual Life Res. 2004;13:1699-1706.
Pandina GJ, Revicki DA, Kleinman L, Turkoz I, Wu JH, Kujawa MJ, Mahmoud R, Gharabawi GM.
Patient-rated troubling symptoms of depression instrument results correlate with traditional clinicianand patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled
trial. Journal of Affective Disorders. 2009 Mar 24[epub ahead of print] pages 8.
Panju AH, Danesh A, Minden MD, Kelvin DJ, Alibhai SMH. Associations between quality of life,
fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia. Supportive Care in
Cancer. 2009;17(5):539-546.
Panter AT, Reeve BB. Assessing tobacco beliefs among youth using item response theory models.
Drug Alcohol Dependence. 2002;68:S21-S39.
Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Nguyen Kreisl T,
Iwamoto FM, Sul J, Auh S, park GE, Fine HA, McL Black P. Scale to predict survival after surgery for
recurrent glioblastoma multiforme. Journal of Clinical Oncology. 2010;28(24):3838-3843.
Park SM, Park MH, Won JH, et al. EuroQol and survival prediction in terminal cancer patients: a
multicenter prospective study in hospice-palliative care units. Support Care Cancer. 2006;14:329333.
Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK, Rogatko A, Xu Z, Harris WB.
Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography.
J Clin Oncol. 2008;26(15):2464-2472.
D:\478174570.doc
Parker PA, Pettaway CA, Babaian RJ, Pisters LL, Miles B, Fortier A, Wei Q, Carr DD, Cohen L. The
effects of a presurgical stress management intervention for men with prostate cancer undergoing
radical prostatectomy. Journal of Clinical Oncology. Published ahead of print April 6, 2009.
Parkerson GR, Connis RT, Broadhead WE, Patrick DL, Taylor TR, Tse CJ. Disease-specific versus
generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med
Care. 1993;31:629-639.
Parkerson GR, Willke RJ, Hays RD. An international comparison of the reliability of the Duke health
profile for measuring health-related quality of life of patients treated with alprostadil for erectile
dysfunction. Med Care. 1999;37(1):56-67.
Parmer MKB, Ungerleider RS, Simon R. Assessing whether to perform a confirmatory randomized
clinical trial. J Natl Cancer Inst. 1996;88:1645–1651.
Parsons SK, Brown AP. Evaluation of quality of life of childhood cancer survivors: a methodological
conundrum. Med Pediatr Oncol. 1998;1:46-53.
Pascal Jean-Pierre, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, Peppone L, Hemstad A,
Esparaz BT, Hopkins JO. A Phase 3 randomized, placebo-controlled, double-blind, clinical trial of the
effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy. Cancer.
2010, 8 pages.
Pasero CL. Using the faces scale to assess pain. Am J Nurs. 1997; 97(7):19-20.
Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT. Outcomes of erythropoiesisstimulating agents in cancer patients with chemotherapy-induced anemia. Supportive Care in
Cancer. 2012;20(1):159-166.
Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis,
treatment, and impact: a review. Journal of Clinical Oncology. 2012;30(30):3726-3733.
Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. oncologists recognition
of depression in their patients with cancer. J Clin Oncol. 1998;16(4):1594-1600.
Passik SD, McDonald M. Psycho-social aspects of upper extremity lymphedema in women treated for
breast cancer. Cancer. 1998;83(10):1-4.
Passik SD, Whitcomb LA, Kirsh KL, Theobald DE. An unsuccessful attempt to develop a single-item
screen for insomnia in cancer patients. J Pain Symptom Manage. 2003;25:284–287.
Passik SD. Impediments and solutions to improving the management of cancer-related fatigue. J
Natl Cancer Inst Monogr. 2004;32:136.
Pasta DJ. Using propensity scores to adjust for group differences: examples comparing alternative
surgical methods. [paper]
Patel A, Knapp M, Evans A, Perez I, Kalra L. Training care givers of stroke patients: economic
evaluation. BMJ. 2004;328:1- 6.
D:\478174570.doc
Pater J, Osoba D, Zee B, et al. Effects of altering the time of administration and the time frame of
quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large antiemetic trial. Qual Life Res. 1998;7:273–278.
Pater JL, Zee B, Palmer M, Johnston D, Osoba D. Fatigue in patients with cancer: results with
National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30.
Support Care Cancer. 1997;5:410-413.
Paterson B, Canam C, Joachim G, Thorne S. Embedded assumptions in qualitative studies of fatigue.
West J Nurs Res. 2003;25(2):119-133.
Paterson B, Thorne S, Crawford J, Tarko M. Living with diabetes as a transformational experience.
Qual Hlth Res. 1999;9(6):786–802.
Paterson B, Thorne S. Developmental evolution of expertise in diabetes self-management. Clin Nurs
Res. 2000;9(4):402-419.
Paterson BL. The koala has claws: application of the shifting perspectives model in research of
chronic illness. Keynote address: 8th Qualitative Health Research Conferenence. Qual Hlth Res.
2003;13(7):987-994.
Paterson C. Seeking the patient’s perspective: A qualitative assessment of EuroQol, COOP-WONCA
charts and MYMOP. Qual Life Res. 2004;13:871–881.
Patrician PA. Single item graphic representational scale. Review. Nurs Res. 2004;53(5):347– 352.
Patrick D, Deyo R. Generic and disease-specific measures in assessing health status and quality of
life. Med Care. 1989;27:S217-S232.
Patrick D, Sittampalam Y, Somerville SM, Carter WB, Bergner M. A cross-cultural comparison of
health status values. Am J Publ Hlth. 1985;75(12):1402-1407.
Patrick D. Concept of health-related quality of life and of patient-reported outcomes. Health-related
quality of life and patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus
de la 4e Journee de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany
O, Caulin C. October 2002.
Patrick DL, Topolski TD, Edwards TC. Toward individualized measures of adolescent health and
quality of life. PRO Newsletter. 2006;37:2-4.
Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, and Levin B, et al. National Institutes of
Health State-of-the-Science Conference statement: symptom management in cancer: pain,
depression, and fatigue. J Natl Cancer Inst. 2003;95:1110-1117.
Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM.
Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors,
motives and costs. J Altern Compliment Med. 2002;8(4):477-485.
D:\478174570.doc
Patterson SG, Davis C, Schmitzer J, Foster E, Baglia J, Balducci L, Ellis C. Spiritual dimension of
cancer care. J Cancer Integr Med. 2004;2(2):85–93.
Paykel ES. The evolution of life events research in psychiatry. J Affect Dis. 2001;62:141-149.
Paykel ES. The interview for recent life events. Psychol Med. 1997;27:301-310.
Payne R, Mathias S, Pasta D, Wanke L, Williams R, Mahmoud R. Quality of life and cancer pain:
satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol.
1998;16:1588-1593.
Payne S, Smith P, Dean S. Identifying the concerns of informal carers in palliative care. Palliat Med.
1999;13:37–44.
Paz SH, Globe DR, Wu J, Azen SP, Varma R. Relationship between self-reported depression and selfreported visual function in Latinos. Arch Ophthalmol. 2003;121:1021-1027.
Pearce MJ, Coan AD, Herndon II JE, Koenig HG, Abernethy AP. Unmet spiritual care needs impact
emotional and spiritual well-being in advanced cancer patients. Supportive Care in Cancer.
2012;20(10):2269-2276.
Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A,
Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S,
Crucitta E, Apolloni F, Del Santo A, Siena S. Randomized trial of intravenous iron supplementation in
patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa. J
Clin Oncol. 2008;26(10):1619-1625.
Pemberger S, Jagsch R, Frey E, et al. Quality of life in long-term childhood cancer survivors and the
relation of late effects and subjective well-being. Support Care Cancer. 2005;13:49-56.
Penedo FJ, Dahn JR, Molton I, et al. Cognitive-behavioral stress management improves stressmanagement skills and quality of life in men recovering from treatment of prostate carcinoma.
Cancer. 2004;100:192–200.
Penedo FJ, Molton I, Dahn JR, et al. A randomized clinical trial of group-based cognitive-behavioral
stress management in localized prostate cancer: development of stress management skills improves
quality of life and benefit finding. Ann Behav Med. 2006:31(3):261-270.
Penninx BWJH, Guralnik JM, Pahor M, et al. Chronically depressed mood and cancer risk in older
persons. J Natl Cancer Inst. 1998;90:1888–1893.
Penson DF, Feng A, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate
cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol.
2003;21(6):1147-1154.
Penson R, Cella D, Wenzel L. Quality of Life in Ovarian Cancer. J Reprod Med 2005;50(6):407-416.
Penson R, Wenzel L, Vergote I, Cella D. Quality of life considerations in gynecologic cancer.
International Journal of Gynecology and Obstetrics. 2006;95(S1):S247-S257.
D:\478174570.doc
Peppercorn JM, Smith TJ, Helft PR, DeBono DJ, Berry SR, Wollins DS, Hayes DM, Von Roenn JH,
Schnipper LE. American Society of Clinical Oncology Statement: Toward Individualized Care for
Patients with Advanced Cancer. Journal of Clinical Oncology. 2011;29(6):755-760.
Pereira, J. Assessment and management of difficult symptoms in patients with advanced cancer.
Presented at ASCO Nov. 23, 1999.
Perez DG, Loprinzi CL, Barton DL, et al. Pilot evaluation of mirtazapine for the treatment of hot
flashes. J Support Oncol. 2004;2(1):50-56.
Perez DJ, Williams SM, Christensen EA, McGee RO, Campbell AV. A longitudinal study of healty
related quality of life and utility measures in patients with advanced breast cancer. Qual Life Res.
2001;10:587-593.
Perkins DO, Wyatt RJ, Bartko JJ. Penny-wise and pound-foolish: the impact of measurement error on
sample size requirements in clinical trials. Biol Psychiatry 2000;47:762-766.
Perneger TV, Leplege A, Etter J-F, Rougemont A. Validation of a french-language version of the MOS
36-item short form health survey (SF-36) in young healthy adults. J Clin Epidemiol. 1995;48:10511060.
Perrillo R, Rothstein KD, Rubin R, Alam, I, Imperial J, Harb G, Hu S, Klaskala W. Comparison of
quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the
combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis
C. Journal of Viral Hepatitis. 2004;11:157-165.
Perrin EB. Some thoughts on outcomes research, quality improvement, and performance
measurement. Med Care. 2002;40(6)(Suppl):III-89-III-91.
Perrine K, Hermann BP, Meador KJ, Vickrey BG, et al. The relationship of neuropsychological
functioning to quality of life in epilepsy. Arch Neurol. 1995;52:997-1003.
Perrone F, DeMaio E. Should adjuvant chemotherayp be used to treat breast cancer in elderly
patients (>70 years of age)? PRO. Tumori. 2002;88(1)(Suppl 1):S89-S90.
Perry DJ, Diehl LF. Changes in criteria for tumor response. J Clin Oncol. 1985;3(2):287.
Perry SW, Cella DF, Falkenberg J, Heidrich G, Goodwin C. Pain perception in burn patients with
stress disorders. Journal of Pain and Symptom Management. 1987;2(1):29-33.
Perry SW, Cella DF, Falkenberg J, Heidrich G, Goodwin C. Pain perception vs. pain response in burn
patients. American Journal of Nursing. 1987;87(5):698-699.
Perry SW, Cella DF, Klar H, Simring S, Oldham J, Tardiff K. Medical students selecting psychiatric
careers: A distinct breed. Journal of Psychiatric Education. 1988;1293):170-181.
Peruselli C, Camporesi E, Colombo AM. Quality-of-life assessment in a home care program for
advanced cancer patients: A study using the Symptom Distress Scale. J Pain Symptom Manage.
1993; 8:306-311.
D:\478174570.doc
Pessin H, Olden M, Jacobson C, Kosinski A. Clinical assessment of depression in terminally ill cancer
patients: a practical guide. Palliat Support Care. 2005;3:319-324.
Peterman A, Cella D. Quality of life and functional improvement issues in anemic HIV/AIDS patients
receiving home care. Home HealthCare Consultant, 1996; 3, 5(Suppl.):11-16. (Publication not available.)
Peterman AH, Cella D. Cancer-related fatigue: longitudinal relationship to mood, sleep disturbance,
and quality of life. Psychosomatic Medicine. 1998;61:86-87.
Peterman AH, Cella D, Glandon G, Dobrez D, Yount S. Mucositis in Head and Neck Cancer: Economic
and Quality-of-Life Outcomes. Journal of the National Cancer Institute. 2001;29:45-51.
Peterman AH, Cella D, Mo F, McCain N. Psychometric validation fo the revised Funtional Assessment
of Human immunodeficiency virus Infection (FAHI) quality of life instrument. Quality of life research.
1997;6(6):572-584.
Petersen MA, Groenvold M, Bjorner JB, Aaronson N, Conroy T, Cull A, Fayers P, Hjermstad M,
Sprangers M, Sullivan M; European Organisation for Research and Treatment of Cancer Quality of
Life Group. Use of differential item functioning analysis to assess the equivalence of translations of a
questionnaire. Qual Life Res. 2003;12(4):373-385.
Peterson DE, Keefe DM, Hutchins RD, Schubert MM. Alimentary tract mucositis in cancer patients:
impact of terminology and assessment on research and clinical practice. Support Care Cancer.
2006;14(6):499-504.
Petrisek AC, Laliberet LL, Allen SM, Mor V. The treatment decision-making process: age differences
in a sample of women recently diagnosed with nonrecurrent, early-stage breast cancer.
Gerontologist. 1997;37(5):598-608.
Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth
syndrome: short-term results of a pilot study. J Oral Pathol Med. 2004;33:111–114.
Pettit T, Livingston G, Manela M, Kitchen G, Katona C, Bowling A. Validation and normative data of
health status measures in older people: the Islington study. Int J Geriatr Psychiatry.
2001;16(11):1061-1070.
Petzke F, Radbruch L, Zech D, Loick G, Grond S. Temporal presentation of chronic cancer pain:
Transitory pains on admission to a multidisciplinary pain clinic. J Pain Symptom Manage.
1999;17:391-401.
Pfister DG, Cassileth BR, Deng GE, Yeung KS, Lee JS, Garrity D, Cronin A, Lee N, Kraus D, Shaha AR,
Shah J, Vickers AJ. Acupuncture for pain and dysfunction after nectk dissection: results of a
randomized controlled trial. Journal of Clinical Oncology. 2010;28(15):2565-2570.
Phelps AC, Lauderdale KE, Alcorn S, Dillinger J, Balboni MT, Van Wert M, VanderWeele TJ, Balboni
TA. Addressing spirituality within the care of patients at the end of life: perspectives of patients with
advanced cancer, oncologists, and oncology nurses. Journal of Clinical Oncology. 2012;30(20):25382544.
D:\478174570.doc
Philip J, Smith WB, Craft P, Lickiss N. Concurrent validity of the modified Edmonton Symptom
Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support
Care Cancer. 1998;6:539-541.
Phillips KA, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge
and research directions. J Natl Cancer Inst. 2003; 95(3):190-197.
Phillips KM, Pinilla-Ibarz J, Sotomayor E, Lee MR, Jim HSL, Small BJ, Sokol L, Lancet J, Tinsley S,
Sweet K, Komrokji R, Jacobsen PB. Supportive Care in Cancer. 2013;21(4):1097-1104.
Pickard AS, Johnson JA, Feeny DH. Responsiveness of generic health-related quality of life measures
in stroke. Qual Life Res 2005;14:207-219.
Pickard AS, Johnson JA, Feeny DH. Agreement between patient and proxy assessments of healthrelated quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke 2004;35:607612.
Pickard AS, Johnson JA, Lau F, Noseworthy T. Replicability of SF-36 summary scores by the SF-12 in
stroke patients. Stroke. 1999;30(6):1213-1217.
Pickard AS, Knight SJ. Proxy evaluation of health-related quality of life. A conceptual framework for
understanding multiple proxy perspectives. Med Care. 2005;43:493-499.
Pickard AS, Topfer L-A, Feeny DH. A structured review of studies on health-related quality of life and
economic evaluation in pediatric acute lymphoblastic leukemia. J Natl Cancer Inst. Monogr.
2004;33:102–125.
Pickard S, DeLeon M, Kohlmann R, Cella D, Rossenbloom R. Psychometric comparison of the
standard EQ_5D to a 5 level version in cancer patients. Medical Care. 2007;45(3):259-263.
Pickard-Holley S. Fatigue in cancer patients. Cancer Nurs. 1991;14(1):13-19.
Piette JD. Interactive Voice Response Systems in the diagnosis and management of chronic disease.
Am J Manag Care. 2000;6:817–827.
Pignata S, Ballatori E, Favalli G, Scambia G. Quality of life: gynecological cancers. Ann Oncol.
2001;12(Suppl)3:S37–42.
Pigott C, Pollard A, Thomson K, Aranda S. Unmet needs in cancer patients: development of a
supportive needs screening tool (SNST). Supportive Care in Cancer. 2009;17(1):33-46.
Pinquart M, Hoffken K, Silbereisen RK, Wedding U. Social support and survival in patients with acute
myeloid leukaemia. Support Care Cancer. 2006;15:81-87.
Pinto BM, Trunzo JJ, Reiss P, Shiu SY. Exercise participation after diagnosis of breast cancer: trends
and effects on mood and quality of life. Psycho-Oncol. 2002;11:389-400.
Pinto BM, Trunzo JJ. Body esteem and mood among sedentary and active breast cancer survivors.
Mayo Clin Proc. 2004;79:181–186.
D:\478174570.doc
Piredda M, Grazia De Marinis M, Rocci L, Gualandi R, Tartaglini D, Ream E. Meeting information
needs on cancer-related fatigue: an exploration of views held by Italian patients and nurses.
Support Care Cancer. 2007;15:1231-1241.
Pirl WF. Evidence reports on the occurrence, assessment, and treatment of depression in cancer
patients. J Natl Cancer Inst Monogr. 2004;32:32-39.
Pirl WF, Greer J, Temel JS, et al. Major depressive disorder in long-term cancer survivors: analysis of
the National Comorbidity Survey Replication. Journal of Clinical Oncology. 2009;27(25):4130-4134.
Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R. Nausea still the poor relation
in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of
nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.
Supportive Care in Cancer. 2013;21(3):735-748.
Pitceathly C, Maguire P. The psychological impact of cancer on patients’ partners and other key
relatives: a review. Eur J Cancer 2003;39:1517-1524.
Pitceathly C, Maguire P, Haddad P, Fletcher I. Prevalence of and markers for affective disorders
among cancer patients’ caregivers. J Psychosoc Oncol. 2004;22(3):45-68.
Pitorak EF, Armour MB, Sivec HD. Project safe conduct integrates palliative goals into comprehensive
cancer care. J Palliat Med. 2003;6(4):645-654.
Plante M, Corcos J, Gregoire I, Belanger MF, Brock G, Rossingol M. The international prostate
symptom score: physician versus self-administration in the quantification of symptomatology.
Urology. 1996;47(3):326–328.
Plaugher G, Haas M, Doble Jr. RW, Lopes MA, Cremata EE, Lantz C. The interexaminer reliability of a
galvanic skin resonse instrument. J Manipulative Physiol Ther. 1993;16:453-459.
Pluzhnikov A, Below JE, Konkashbaev A, Tikhomirov A, Kistner-Griffin E, Roe CA, Nicolae DL, Cox NJ.
Spoiling the whole bunch: quality control aimed at preserving the integrity of high-throughout
genotyping. The American Journal of Human Genetics. 2010;87:123-128.
Pocock SJ, Geller NL, Tsiatis A. The analysis of multitude endpoints in clinical trials. Biometrics.
1987;43:487-498.
Pohl G, Seemann H, Zojer N, Ochsner c, Luhan C, Schemper M, Ludwig H. “Laying on of hands”
improves well-being in patients with advanced cancer. Support Care Cancer. 2007;15:143-151.
Polley MJ, Seers HE, Cooke HJ, Hoffman C, Paterson C. How to summarise and report written
qualitative data from patients: a method for use in cancer support care. Support Care Cancer.
2007;15:963-971.
Polsky D, Eremina D, Hess G, Hill J, Hulnick S, Roumm A, Whyte JL, Kallich J. The importance of
clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for
the treatment of chemotherapy-induced anaemia. Pharmacoeconomics. 2009;27:755-65.
D:\478174570.doc
Polsky D, Keating NL, Weeks JC, Schulman KA. Patient choice of breast cancer treatment: impact on
health state preferences. Med Care. 2002;40(11):1068-1079.
Poole, C. Low P-Values or narrow confidence intervals: which are more durable? Epid. 2001;
12:291-294.
Poole H, Bramwell R, Murphy P. The utility of the Beck Depression Inventory Fast Screen (BDI-FS) in
a pain clinic population. European Journal of Pain. 2008.
Poon MA, O'Connell MJ, Moertel CG, et al. Biochemical modulation of fluorouracil: Evidence of
significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
J Clin Oncol. 1989;7(10):1407-1418.
Poon LW, Martin P, Bishop A, Cho J, da Rosa G, Deshpande N, Hensley R, MacDonald M, Margrett J,
Randall GK, Woodard JL, Miller S. Understanding Centenarians’ Psychosocial Dynamics and Their
Contributions to Healt and Quality of Life. Current Gerontology and Geriatrics Research. 2010;13
pages.
Poonacha TK, Go RS. Level of scientific evidence underlying recommendations arising from the
National Comprehensive Cancer Network Clinical Practice Guidelines. Journal of Clinical Oncology.
2011;29(2):186-191.
Porizo G, Aielli F, Narducci F, Cannita K, Piccolo D, Marchetti P. Pruritius in a patient with advanced
cancer successfully treated with continuous infuscion of granisetron. Support Care Cancer.
2004;12:208–209.
Portenoy RK, Kornblith AB, Wong G, et al. Pain in ovarian cancer patients: Prevalence,
characteristics, and associated symptoms. Cancer. 1994;74:907-915.
Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with
cancer pain. Pain 1999;81:129-134.
Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics and distress in a
cancer population. Qual Life Res. 1994;3(3):183-189.
Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, et al. The
Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevlance,
characteristics and distress. Eur J Cancer. 1994;30A(9):1326-1336.
Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain.
1990;41:273-281.
Porter AT, Blasko JC, Grimm PD, Reddy SM, Ragde H. Brachytherapy for prostate cancer. Cancer J
Clin. 1995;43:165-178.
Porzio G, Aielli F, Verna L, et al. Gabapentin in the treatment of severe sweating experienced by
advanced cancer patients. Support Care Cancer. 2006;14:389-391.
D:\478174570.doc
Postma TJ, Heimans JJ, Muller MJ, Ossenkoppele GJ, Vermorken JB, Aaronson NK. Pitfalls in grading
severity of chemotherapy-induced peripheral neuropathy. Ann Oncol. 1998;9:739-744.
Post-White J. Assessment of hope, sense of coherence, and spirituality in patients with cancer.
Oncol Nurs Forum. 1995;22(2):353.
Potosky AL, Knopf K, Clegg LX, et al. Quality-of-life outcomes after primary androgen deprivation
therapy: results from the prostate cancer outcomes study. J Clin Oncol. 2001;19:3750–3757.
Potosky AL, Reeve BB, Clegg LX, et al. Quality of life following localized prostate cancer treated
initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst. 2002;94(6):430-437.
Pouchot J. Health-related quality of life measures in rheumatology. Health-related quality of life and
patient-reported outcomes: scientific and useful outcome criteria. Comptes rendus de la 4e Journee
de therapeutique de I’UFR Lariboisiere Saint-Louis. Paris. Main Authors: Chassany O, Caulin C.
October 2002.
Poulsen B, Graversen HP, Beckmann J, Blichert-Toft M. A comparative study of post-operative
psychosocial function in women with primary operable breast cancer randomized to breast
conservation therapy of mastectomy. Eur J Surg Oncol. 1997;23:327-334.
Poulsen MJ. The art of oncology -- when the tumor is not the target: Not just tired. J Clin Oncol.
2001;19(21):4180–4181.
Power M, Bullinger M, Harper A. The World Health Organization Quality of Life Group. The World
Health Organization WHOQOL-100: tests of the universality of quality of life in 15 different cultural
groups worldwide. Hlth Psychol. 1999;18:495-505.
Prasad S, Saini S, Sumener JE, Hahn PF, Sahani D, Boland GW. Radiological measurement of breast
cancer metastases to lung and liver: comparison between WHO (Bidimensional) and RECIST
(Unidimensional) Guidelines. J Comp Assist Tomogr. 2003;27(3):389-384.
Pratheepawanit N, Salek MS, Finlay IG. The applicability of quality-of-life assessment in palliative
care: Comparing two quality-of-life measures. Palliat Med. 1999;13(4):352-334.
Preacher KJ, MacCallum RC. Repairing Tom Swift’s electric factor analysis machine. Understanding
Stats. 2003;2(1):13–43.
Priestman TJ, Baum M. Evaluation of quality of life in patients receiving treatment for advanced
breast cancer. Lancet. 1976;1:899-900.
Priestman TJ. Quality of life after cytotoxic chemotherapy: discussion paper. J R Soc Med.
1984;77(6):492-495.
Prieto JM, Atala J, Blanch J, et al. Role of depression as a predictor of mortality among cancer
patients after stem-cell transplantation. J Clin Oncol. 2005;23:6063-6071.
Prigerson HG. costs to society of family caregiving for patients with end-stage Alzheimer’s Disease.
N Eng J Med. 2003;349(20):1891–1892.
D:\478174570.doc
Prinsen H, Hopman MTE, Zwarts MJ, Leer JWH, Heerschap A, Bleijenberg G, van Laarhoven HWM.
Maximal exercise performance in patients with postcancer fatigue. Supportive Care in Cancer.
2013;21(2):439-448.
Procidano ME, Heller K. Measures of perceived social support from friends and from family: three
validation studies. Am J Community Psychol. 1983;11:1-24.
Provenzale D, Gary RN. Colorectal cancer screening and treatment: review of outcomes research. J
Natl Cancer Inst. Monogr. 2004;33:44–55.
Pruchno RA. The effects of help patterns on the mental health of spouse caregivers. Res Aging.
1990;12(1):57-71.
Ptacek JT, Ptacek JJ. Patients’ perceptions of receiving bad news about cancer. J Clin Oncol.
2001;19:4160–4164, 2001.
Pucciarelli S, Del Bianco P, Efficace F, Toppan P, Serpentini S, Friso ML, Lonardi S, De Salvo GL, Nitti
D. Health-related quality of life, faecal continence and bowel in rectal cancer patients after
chemoradiotherapy followed by radical surgery. Supportive Care in Cancer. 2010;18(5):601-608.
Puchalski CM, Kilpatrick SD, McCullough ME, Larson DB. A systematic review of spiritual and religious
variables in Palliative Medicine, American Journal of Hospice and Palliative Care, Hospice Journal,
Journal of Palliative Care, and Journal of Pain Symptom Management. Palliat Support Care.
2003;1:7-13.
Puntillo K, Neighbor M, O’Neil N. Nixon R. Accuracy of emergency nurses in assessment of patients’
pain. Pain Manag Nurs. 2003;4(4):171-175.
Purcell A, Fleming J, Bennett S, Burmeister B, Haines T. Determining the minimal clinically important
difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population.
Supportive Care in Cancer. 2010;18(3):307-316.
Purnell JQ, Palesh OG, Heckler CE, Adams MJ, Chin N, Mohile S, Peppone LJ, Atkins JN, Moore DF,
Spiegel D, Messing E, Morrow GR. Racial disparities in traumatic stress in prostate cancer patients:
secondary analysis of a National URCC CCOP Study of 317 men. Supportive Care in Cancer.
2011;19(7):899-908.
Pusic A, Thompson TA, Kerrigan CL, Sargeant R, Slezak S, Chang BW, Helzlsouer KJ, Manson PN.
Surgical options for early-stage breast cancer: plastic and reconstructive surgery. 1999;104(5):
1325-1333.
Puts MTE, Papoutsis A, Springall E, Tourangeau AE. A systematic review of unmet needs of newly
diagnosed older cancer patients undergoing active cancer treatment. Supportive Care in Cancer.
2012;20(7):1377-1394.
QOLID (Quality of Life Instruments Database). Mapi Research Institute. Brochure.
D:\478174570.doc
QualityMetric Incorporated and accredited by Tufts University School of Medicine, is provided to
ISOWOL members through an unrestricted grant from Pfizer. Understanding Health Outcomes, and
education series DISK I.
QualityMetric Incorporated and accredited by Tufts University School of Medicine, is provided to
ISOWOL members through an unrestricted grant from Pfizer. Understanding Health Outcomes, and
education series DISK II.
Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A,
EORTC Clinical Trials. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of
individual patient data from EORTC clinical trials. Lancet Oncol. 2009;10(9):865-71.
Raczek AE, Ware JE Jr, Bjorner JB, et al. Comparison of Rasch and summated rating scales
constructed from SF-36 physical functioning item in seven countries: results from the IQOLA project.
J Clin Epidemiol. 1998;51(11):1203-1214.
Radice D, Redaelli A. Breast cancer management: quality-of-life and cost considerations.
Pharmacoeconomics. 2003;21(6):383-396.
Radley SC, Jones GL. Measuring quality of life in urogynaecology. BJOG. 2004;111(1):33-36.
Radloff LS. The CES-D scale: A self-report depression scale for research in the general population.
Appl Psycholog Measure. 1977;1(3):385-401.
Raghavan D. Disparities in cancer care: challenges and solutions. Oncology. 2007; 493.
Rainbird KJ, Perkins JJ, Sanson-Fisher RW. The needs assessment for advanced cancer patients (NAACP): a measure of the perceived needs of patients with advanced, incurable cancer. A study of
validity, reliability and acceptability. Psycho-Oncology 2005;14:297-306.
Rait DS, Ostroff JS, Smith K, Cella DF, Tan C, Lesko LM. Lives in a balance: Perceived family
functioning and the psychosocial adjustment of adolescent cancer survivors. Family Process.
1992;31:383-397.
Raju NS, Laffitte LJ, Byrne BM. Measurement equivalence: a comparison of methods based on
confirmatory factor analysis and item response theory. Journal of Applied Psychology. 2002;87:517529.
Ramaswamy S. Translating cancer genomics into clinical oncology. New Engl J Med. 2004;
350:18:1814-1816.
Ramsey S. What is cancer outcomes research? a diversity of perspectives for an emerging field.
Med Care. 2002;40(6)(Suppl):III-1-III-2.
Rand EH, Badger LW, Coggins DR. Toward a resolution of contradictions: utility feedback from the
GHQ. Gen Hosp Psych. 1988;10:189-196.
Rapoport BL, Jordan K, Boice JA, Taylor A, Brown C, Hardwick JS, Carides A, Webb T, Schmoll H-J.
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad
D:\478174570.doc
range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.
Supportive Care in Cancer. 2010;18(4):423-432.
Rapp S, Shumaker S, Smith T, Gibson P, Berzon R, Hoffman R. Adaptation and evaluation of the
Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients.
Qual Life Res. 1998;7:353–363.
Rat A-C, Pouchot J, Guillemin F, Baumann M, Retel-Rude N, Spitz E, Coste J. Content of quality-oflife instruments is affected by item-generation methods. International Journal for Quality in Health
Care. 2007;19(6):390-398.
Ratain MJ. Flushing Oral Oncology Drugs Down the Toilet. Journal of Clinical Oncology. Oct
2011;29(30):3958-59.
Ratka A, Miller V, Brown K, Raut A, Cipher D, Meczekalski B, Simpkins JW. Menopausal Vasomotor
Symptoms (MVS) survery for assessment of hot flashes. J Women’s Health. 2006;15(1):77-89.
Rauch P, Miny J, Conroy T, Neyton L, Guillemin F. Quality of life among disease – free survivors of
rectal cancer. J Clin Oncol. 2004;22:354–360.
Rausch SM, Clark MM, Patten C, Liu H, Felten S, Li Y, Sloan J, Yang P. Relationship between cytokine
gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer
survivors. Cancer. 2010;116(17):4103-4113.
Rauscher M. Yoga Gives Immune Boost to Breast Cancer Survivors. Reuters 2007.
Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Cancer: Disease and nutrition are key
determinants of patients’ quality of life. Support Care Cancer. 2004;12:246–252.
Rayson D, Reyno L. Exercise and cancer: no pain, some gain? (Editorial) J Clin Oncol.
2003;21(9)1651-1652.
Razavi D, Merckaert I, Marchal S, et al. How to optimize physicians’ communication skills in cancer
care: Results of a randomized study assessing the usefulness of posttraining consolidation
workshops. J Clin Oncol. 2003;21(16):3141-3149.
Razis DV. Clinical trials in cancer research-philosphical and methodological considerations: discussion
paper. J R Soc Med. 1987;80:94-96.
Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR. Double-blind,
placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa
in children with cancer receiving myelosuppressive chemotherapy. J Clin Oncol. 2006;24(22):35833589.
Rebollo P, Castejon I, Cuervo J, Villa G, Garcia-Cueto E, Diaz-Cuervo H, Zardain PC, Muniz J, Alonso
J; the Spanish CAT-Health Research Group. Validation of a computer-adaptive test to evaluate
generic health-related quality of life. Health Qual Life Outcomes. 2010;8:147.
D:\478174570.doc
Recklitis CJ, Lockwood RA, Rothwell MA, Diller LR. Suicidal ideation and attempts in adult survivors
of childhood cancer. J Clin Oncol. 2006;24(24):3852-2857.
Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL. Short- and long-term effects of acute
myeloid leukemia on patient health-related quality of life. Cancer Treatment Rev. 2004;30:103-117.
Redd WH, Montgomery GH, DuHamel KN. Behavioral intervention for cancer treatment side effects.
JNCI. 2001;93(11):810-823.
Reddick BK, Nanda JP, Campbell L, Ryman DG, Gaston-Johansson F. Examining the influence of
coping with pain on depression, anxiety, and fatigue among women with breast cancer. J
Pscyhosocial Oncol. 2005;23(2/3):137-157.
Reddy S, Bruera E, Pace E, Zhang K, Reyes-Gibby CC. Clinically important improvement in the
intensity of fatigue in patients with advanced cancer. J Palliat Medicine 2007;10(5):1068-?
Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important different in symptoms: A
comparison of two techniques. J Clin Epidemiol. 1996;49:1215-1219.
Rees JR, Blazeby JM, Fayers P, Friend EA, Welsh FKS, John TG, Rees M. Patient-reported outcomes
after hepatic resection of colorectal cancer metastases. Journal of Clinical Oncology.
2012;30(12):1364-1370.
Reese E, Hardy J, Ling J, Broadley K, A’Hern R. The use of the Edmonton Symptom Assessment
Scale (ESAS) within a palliative care unit in the UK. Palliat Med. 1998;12(2):75–82.
Reese JB, Shelby RA, Keefe FJ, Porter LS, Abernethy AP. Sexual concerns in cancer patients: a
comparison of GI and breast cancer patients. Support Care Cancer. 2010;18:1179-1189.
Reeve B, Hays R, Bjorner J, et al. Psychometric evaluation and calibration of health-related quality of
life items bankd: Plans for the patient-reported Outcome Measurement Information System
(PROMIS). Medical Care. 2007;45(5):S22-S31.
Reeve B. Application of Item Response Theory (IRT) modeling for building and evaluating
questionnaires measuring patient-reported outcomes. Summary Paper, Drug Information Association
June 23 – 25, 2004 Meeting.
Reeve BB. Item and scale analysis of clinical and non-clinical sample responses to the MMPI-2
Depression Scales employing Item Response Theory. Dissertation Abstracts International: Section B:
Sci Eng. 2000;61(4-B):2267.
Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, Thissen D, Revicki DA, Weiss DJ,
Hambleton RK, Liu H, Gershon R, Reise SP, Lai JS, Cella D. Psychometric Evaluation and Calibration
of Health-Related Quality of Life Item Banks. Plans for the Patient-Reported Outcomes Measurement
Information System (PROMIS). Medical Care. 2007;45(%):S22-31.
Regan M, Ristevski E, Jones R, Breen S, Hartney A. Examining the introduction of a supportive care
screening and referral process for cancer patients: how does practice comparewith protocols?
Supportive Care in Cancer. 2012;20(1):119-126
D:\478174570.doc
Regine WF, Schmitt FA, Scott CB, Dearth c, Patchell RA, Nichols C Jr, Gore EM, Franklin RL III, et al.
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multiinstitutional cooperative group setting: results of radiation therapy oncology group trial BR-0018. Int
J Rad Oncol Phys 2004;58(5):1246-1352.
Reifler DR, Kessler HS, Bernhard EJ, Leon AC, Martin GJ. Impact of screening for mental health
concerns on health service utilization and functional status in primary care patients. Arch Intern Med.
1996;15622):2593-2599.
Reindl TK, Geilen W, Hartmann R, et al. Acupuncture against chemotherapy-induced nausea and
vomiting in pediatric oncology: interim results of a multicenter crossover study. Support Care
Cancer. 2006;14:172-176.
Reise SP, Widaman KF, Pugh RH. Confirmatory factor analysis and item response theory: two
approaches for exploring measurement. Psychological Bulletin. 1993;114:552-566.
Reitan RM. The relation of the trail making test to organic brain damage . J Cons Psychol.
1955;19(5):393–394.
Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Perceptual and
Motor Skills. 1958;8:271-276.
Ren XS, Qian S, Selim A, Wang XS, Kazis L. Assessment of health-related quality of life among
patients with various types of cancers in the US. Qual Life Newsletter. 2004;27–29.
Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient
assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper
gastrointestinal disorders. Qual Life Res. 2004;13:1737-1749.
Repetto L, Costantini M, Campora E, Amoroso D, Gianni A, Vecchio C, Simoni C, Marigliano V, Rosso
R, Santi L. A retrospective comparison of detection and treatment of breast cancer in young and
elderly patients. Breast Cancer Res Treat. 1997;43:27-31.
Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to
Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group
for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494-502.
Repetto L, Venturinon A, Vercelli M, et al. Performance status and comorbidity in elderly cancer
patients compared with young patients with neoplasia and elderly patients without neoplastic
conditions. Cancer. 1998;82(4):760-765.
Rettig RA, Sadler JH, Meyer KB, Wasson JH, Parkerson GR, Kantz B, Hays RD, Patrick DL. Assessing
health qual life outcomes in dialysis: a report on an institute of medicine workshop. Am J Kidney Dis.
1997;30(1):140-155.
Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as a predictor of
mortality: results of a prospective study. Am J Med. 1992;93:663-669.
D:\478174570.doc
Reuben DB, Valle LA, Hays RD, Siu AL. Measuring physical function in community-dwelling older
persons: a comparison of self-administered, interviewer-administered, and performance-based
measures. J Am Geriatric Soc. 1995;43:17-23.
Revicki DA, Brandenburg N, Matza L, Hornbrook MC, Feeny D. Health-related quality of life and
utilities in primary-care patients with generalized anxiety disorder. Quality of life Research.
2008;17:1285-1294.
Revicki D, Cella D, Sloan J, Lenderking W, Aaronson N. Responsiveness and minimal important
differences for patient reported outcomes. Health and Quality of Life Outcomes. 2006;4(70). Health
and Quality of Life Outcomes | Full text | Responsiveness and minimal important differences for
patient reported outcomes
Revicki D, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman, M. Recommendations
on health-related quality of life research to support labeling and promotional claims in the United
States. Qual Life Res. 2000;9:887–900.
Revicki DA, Cella DF. Health status assessment for the twenty-first century: item response theory,
item banking, and computer adaptive testing. Qual Life Res. 1997;6:595-600.
Revicki DA, Ehreth JL. Health-related quality of life assessment and planning for the pharmaceutical
industry. Clin Ther. 1997;19:1101-1115.
Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the
measurement of health-related quality of life. Qual Life Res. 1993;2:477-487.
Revicki DA, Sorenson S, Wu AW. Reliabilty and validity of physical and mental health summary
scores from the MOS HIV Health Survey. Med Care. 1998;36:126-137.
Revicki DA, Swartz C, Gold K, Kallich J, Woolley M. Imputing health status scores missing due to
morality: comparison of multiple techniques. Qual Life Res. 1997; 6:708.
Revicki DA. Feasability and barriers for a national item bank: if we build it will they come? Summary
Paper, Drug Information Association June 23 – 25, 2004 Meeting.
Revicki DA, Sloan J. Practical and philosophical issues surrounding a national item bank: if we build
it will they come? Qual Life Res. 2007;16:167-174.
Reyes-Gibby CC, Mendoza TR, Wang S, Anderson KO, Cleeland CS. Pain and fatigue in communitydwelling adults. Pain Med. 2003;4(3):231–237.
Reynolds MW, Shibata A, Zhao S, Jones N, Fahrbach K, Goodnough LT. Impact of clinical trial design
and execution-related factors on incidence of thromboembolic events in cancer patients: A
systematic review and meta-analysis. Current Medical Research and Opinion. 2008;24(2):497-505.
Rhee YS, Yun YH, Park S, Shin DO, Lee KM, Yoo HJ, Kim JH, Kim SO, Lee R, Lee YO, Kim NS.
Depression in Family Caregivers of Cancer Patients: The Feeling of Burden As a Predictor of
Depression. Journal of Clinical Oncology. 2008;26(36):5890-5895.
D:\478174570.doc
Rhoades HM, Grabowski J, Elk R, Cowan K. Factor stationarity and invariance of the POMS in cocaine
patients. Psychopharmacol Bull. 1993;29(2):263-267.
Rhoads CP. Survival of patients with cancer as a function of research. Transactions of the Association
of Life Insurance Medical Directors of America. 1950;33:44-56.
Rhodes VA, McDaniel RW, Matthews CA. Hospice patients’ and nurses’ perceptions of self-care
deficits based on symptom experience. Cancer Nurs. 1998;21:312–319.
Rhondali W, Perceau E, Berthiller J, Saltel P, Trillet-Lenoir V, Tredan O, Coulon J-P, Bruera E, Filbet
M. Frequency of depression among oncology outpatients and association with other symptoms.
Support Care Cancer. 2012;20(11):2795-2802.
Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, Leslie WT. Re-validation
and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
Qual Life Res. 2001;9:1137–1146.
Richardson LC, Wang W, Hartzema AG, Wagner S. The role of health-related quality of life in early
discontinuation of chemotherapy for breast cancer. Breast 2007;13(6):581-587.
Richardson MT, Leon AS, Jacobs DR Jr, Ainsworth BE, Serfass RC. Comprehensive evaluation of
Minnesota Leisure Time Physical Activity Questionnaire. J Clin Epidemiol. 1994;47:271-281.
Richardson A, Plant H, Moore S, Medina J, Cornwall A, Ream E. Developing supportive care for
family members of people with lung cancer: a feasibility study. Support Care Cancer.
2007;15:1259-1269.
Richy F, Deceulaer F, Ethgen O, Bruyere O, Reginster J-Y. Development and Validation of the
ORACLE score to predict risk of osteoporosis. Mayo Clinic Proc. 2004;79(11):1402–1408.
Riess H, Kelley JM, Bailey RW, Dunn EJ, Phillips M. Empathy training for resident physicians: a
randomized controlled trial of a neuroscience-informed curriculum. J Gen Intern Med. 2012 May; 9
pages.
Rijsdijk FV, Sneider H, Ormel J, Sham P, Goldberg DP, Spector TD. Genetic and environmental
influences on psychological distress in the population: general health questionnaire analyses in UK
twins. Psychol Med. 2003;33(5):793–801.
Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment
patterns among older women with breast cancer. An HMO and fee-for-service comparison. JAMA.
1999;281(8):720-726.
Rinaldi M, Selvaggi G, Marelli O, et al. Quality of Life analysis of three platinum-based doublets for
advanced non-small cell lung cancer (NSCLC). ASCO 2002 Poster Presentation.
Rincck G, van den Bos GAM, Kleijen JCVM, de Haes HJ, Schade E, Veenhof CH. Methodological
issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol.
1997;15:1697–1707.
D:\478174570.doc
Ring A, Sestak I, Baum M, Howell A, Buzdar A, Dowsett M, Forbes JF, and Cuzick J. Influence of
Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the
Arimidex, Tamoxifen Alone or in Combination Trial. J. Clin. Oncol. Nov 2011;29(30):4266-73
Ringash J, Bezjak A, O’Sullivan B, Redelmeier DA. Interpreting differences in quality of life: The
FACT-H & N in laryngeal cancer patients. Qual Life Res. 2004;13:725–733.
Ringash J, Redelmeier DA, O’Sullivan B, Bezjak A. Quality of life and utility in irradiated laryngeal
cancer patients. Int J Rad Oncol Biol Phys. 2000;47:875-881.
Ringdal GI, Jordhoy MS, Kaasa S. Measuing quality of palliative care: psychometric properties of the
FAMCARE scale. Qual Life Res 2003;12:167-176.
Ringdal GI, Ringdal K. A follow-up study of the quality of life in cancer patients with different
prognoses. Qual Life Res. 2000;9:65-73.
Ripamonti C, Bruera E. Dyspnea: pathophysiology and assessment. [Review] [94 refs] J Pain
Symptom Manage. 1997;13(4):220-232.
Ripamonti CI, Brunelli C. Comparison between numerical rating scale and six-level verbal rating scale
in cancer patients with pain: a preliminary report. Supportive Care in Cancer. 2009;17(11):14331434.
Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium.
Drugs. 2001;61:955–977.
Ripamonti C, Mercadante S. How to use octreotide for malignant bowel obstruction. J Support
Oncol. 2004;2(4):1-8.
Ripamonti C, Twycross R, Baines M, et al. Clinical-practice recommendations for the management of
bowel obstruction in patients with end-stage cancer. Support Care Cancer. 2001;9:223-233.
Ripamonti C, Fagnoni E, Campa T, Giardina V, Brunelli C, Pigni A, De Conno F. Decreases in pain at
rest and movement-related pain during zoledronic acid treatment in patients with bone metastases
due to breast or prostate cancer: a pilot study. Support Care Cancer. 2007;15:1177-1184.
Rippentrop AE, Altmaier EM, Chen JJ, Found EM, Keffala VJ. The relationship between
religion/spirituality and physical health, mental health, and pain in a chronic pain population. Pain.
2005;116:311-321.
Risch N, Herrell R, Lehner T, Liang K-Y, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Ries Merikangas K.
Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of
depression. JAMA. 2009;301(23):2462-71.
Risberg T, Jacobsen BK. The association between mental distress and the use of alternative
medicine among cancer patients in North Norway. Qual Life Res. 2003;12:539-544.
Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: Relationships to
sleep quality. Qual Life Res. 2004;13:783–791.
D:\478174570.doc
Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B,
Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Use of epoetin and darbepoetin in
patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology
Clinical Practice Guideline Update. J Clin Oncol. 2008;26(1):132-149.
Roach MJ, Connors AF, Dawson NV, et al. Depressed mood and survival in seriously ill hospitalized
adults. Arch Intern Med. 1998;158:397–404.
Roberts CS, Baker F, Hann D, Runfola J, Witt C, McDonald J, Livingston ML, Ruiterman J, Ampela R,
et al. Patient-physician communication regarding use of complementary therapies during cancer
treatment. J Psychosocial Oncol. 2005;23(4):35-60.
Roberts JA. Care near the end of life: Palliative care in the community acute care hospital.
Presented at ASCO, 1999.
Roberts LJ, Neal DJ, Kivlahan DR, Baer JS, Marlatt GA. Individual drinking changes following a brief
intervention among college students: clinical significance in an indicated preventive context. J
Consult Clin Psychol. 2000;68:500-505.
Roberts LW, Warner TD, Rogers M, Horwitz R, Redgrave G. Medical student illness and impairment:
a vignette-based survey study involving 955 students at 9 medical schools. Compr Psychiatr. 2005;
46:229-237.
Roberts R, Hemingway H, Marmot M. Psychometric and clinical validity of the SF-36 General Health
Survey in the Whitehall II Study. Br J Hlth Psychol. 1997;2:285-300.
Roberts RE, Vernon SW, Rhoades HM. Effects of language and ethnic status on reliability and validity
of the center for epidemiologic studies-depression scale with psychiatric patients. J Nerv Mental Dis.
1989;177(10):581-592.
Robertson C, Langston A, McColl E, Fayers PM, Campbell MK, for the PRISM Trial Group. An
investigation into people’s perceptions of ‘quality of life’ when completing health-related quality of life
questionnaires. Patient Reported Outcomes Newsletter #34, Spring Issue, 2005.
Robertson G. Individuals’ perception of their quality of life following a liver transplant: an
exploratory study. J Adv Nurs. 1999;30(2):497-505.
Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in
patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol.
2004;22(7):1268-1275.
Robinson BC. Validation of a caregiver strain index. J Gerontology. 1983;38(3):344–348.
Robinson GE, Fernald RD, Clayton DF. Genes and Social Behavior. Science. 2008;322:896-900.
Robinson JD, Hoover DR, Venetis MK, Kearney TJ, Street Jr RL. Consultations between patients with
breast cancer and surgeons: a pathway from patient-centered communication to reduced
hopelessness. Journal of Clinical Oncology. 2013;31(3):351-358.
D:\478174570.doc
Rocha Lima GM, Green MR, Rotche R, et al. Irinotecan plus gemcitabine results in no survival
advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic
pancreatic cancer despite increased tumor response rate. J Clin Oncol. 2004;22(18):3776-3783.
Roche K, Paul N, Smuck B, et al. Factors affecting workload of cancer clinical trials: results of a
multicenter study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol.
2002;20(2):545-556.
Roche KJ, Chang MW, Lazarus H. Cutaneous anthrax infection. New Engl J Med.
2001;345(22):1611.
Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review
of the evidence. J Clin Oncol. 2002;20(15):3302-3316.
Rockwood K. The measuring, meaning and importance of activities of daily living (ADLs) as an
outcome. International Psychogeriatric. 2007;19(3):467-482.
Rocque GB, Barnett AE, Illig LC, Eickhoff JC, Bailey GG, Campbell TC, Stewart JA, Cleary JF.
Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?
Journal of Oncology Practice. 2013;9(1):51-54.
Rodgers GM. Guidelines for the use of erythropoietic growth factors inpatients with chemotherapyinduced anemia. Oncology (Suppl). 2006;20(8):12-15.
Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RKS, Supportive Care Guidelines Group of
Cancer Care Ontario Program in Evidence-Based Care. The treatment of depression in cancer
patients; a systematic review. Support Care Cancer. 2007;15:123-136.
Rodin G, Walsh A, Zimmerman C, et al. The contribution of attachment security and social support to
depressive symptoms in patients with metastatic cancer. Psycho-Oncology. 2007;16(12):1080-1091.
Rodin G, Mackay JA, Zimmermann C, Mayer C, Howell D, Katz M, Sussman J, Brouwers M. Clinicianpatient communications: a systematic review. Supportive Care in Cancer. 2009;17(6):627-644.
Roger LQ, Courneya KS, Robbins KT, Malone J, Seiz A, Koch L, Rao K, Nagarkar M. Physical activity
and quality of life in head and neck cancer survivors. Support Care Cancer. 2006;14:1012-1019.
Rogers MP, Orav J, Black PM. The use of a simple Likert scale to measure quality of life in brain
tumor patients. J Neurooncol. 2001;55(2):121-131.
Rogers SN, Fisher SE, Woolgar JA. A review of quality of life assessment in oral cancer. [Review] J
Oral Maxillofacial Surg. 1999;28(2):99-117.
Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller Jr EA. The addition of mood and
anxiety domains to the University of Washington Quality of Life Scale. Head & Neck. 2002;4:523529.
Rogers SN, Humphris G, Lowe D, Brown JS, Vaughan ED. The impact of surgery for oral cancer on
quality of life as measured by the Medical Outcomes Short Form 36. Oral Oncol. 1998;34;171-179.
D:\478174570.doc
Roh J-L, Kim A-Y, June Cho M. Xerostomia following radiotherapy of the head and neck affects vocal
function. J Clin Oncol. 2005;23:3016-3023.
Rohrer JE, Herman DC, Merry SP, Naessens JM, Houston MS. Validity of overall self-rated health as
an outcome measure in small samples: a pilot study involving a case series. Journal of Evaluation in
Clinical Practice. 2009;15:366-369.
Roila F, Cortesi E. Quality of life as a primary end point in Oncology. Ann Oncol. 2001;12(Suppl
3):S3-S6.
Rokach A. Caring for those who care for the dying: coping with the demands on palliative care
workers. Palliat Support Care. 2005;3:325-332.
Romeis JC, Scherrer JF, Xian H, et al. Heritability of self-reported health. Hlth Serv Res. 2000;35(5
Pt. 1):995–1010.
Romito F, Montanaro R, corvasce C, Di Bisceglie M, mattioli V. Is cancer0related fatigue more
strongly correlated to haematological or to psychological factors in cancer patients? Supportive Care
in Cancer. 2008;16(8):943-946.
Ronaldson S, Devery K. The experience of transition to palliative care services: perspectives of
patients and nurses. International Journal of Palliative Nursing. 2001 April;7(4):171-177.
Ronen GM, Rosenbaum MP, Streiner DL. Outcome measures in pediatric neurology: why do we need
them? J Child Neurol. 2000;15(12):775-780.
Ronson A, Body JJ. Psychosocial rehabilitation of cancer patients after curative therapy. Support
Cancer Care. 2002;10:281-291.
Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling, Carson A, and Grant R. Frequency,
Clinical Associations, and Longitudinal Course of Major Depressive Disorder in Adults With Cerebral
Glioma. J. Clin. Oncology. Nov 2011;29(32);4308-12.
Roscoe JA, Morrow GR, Hickok JT, et al. Temporal interrelationships among fatigue, circadian rhythm
and depression in breast cancer patients undergoing chemotherapy treatment. Support Cancer Care.
2002;10:329-336.
Roscoe JA, Morrow GR, Colagiuri B, Heckler CE, Pudlo BD, Colman L, Hoelzer K, Jacobs A. Insight in
the prediction of chemotherapy-induced nausea. Supportive Care in Cancer. 2010;18(7):869-876.
Roscoe JA, Heckler CE, Morrow GR, Mohile SG, Dakhil SR, Wade JL, Kuebler JP. Journal of Clinical
Oncology. 2012;30(27):3389-3395
Rose K, Tullo A. Measuring quality of life is important (letter). BMJ. 1996;313(7063):1006-1007.
Rose JS, Dierker LC. An item response theory analysis of nicotine dependence symptoms in recent
onset adolescent smokers. Drug Alcohol Depend. 2010 Mar 15. [Epub ahead of print].
D:\478174570.doc
Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, Cesano A, Gayko U, Chen MG, Clarke S.
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated
with fluorouracil-based chemotherapy. J Clin Oncol. 2006;24(33):5194-5200.
Rosen RC, Cappelleri, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5item version of the International Index of Erecticle Function (IIEF-5) as a diagnostic tool for erectile
dysfunction. Intl J Impotence Res. 1996;11:319–329.
Rosenbaum E, Gautier H, Fobair P, et al. Cancer Supportive Care, Improving the Quality of Life for
Cancer Patients. A Program Evaluation Report. Support Care Cancer. 2004;12:293–301.
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal
effects. Biometrika. 1983;70(1):41-55.
Rosendahl I, Kiebert GM, Curran D, et al. Quality-adjusted survival (Q-TwiST) analysis of EORTC trial
30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with
metastatic prostate cancer. Prostate. 1999;38:100-109.
Rosenquist A, Bergman K, Strang P. Optimizing hospital-based home care for dying cancer patients.
A population-based study. Palliat Med. 1999;13(5):393–397.
Rosenstock J. Clozapine therapy during cancer treatment. Am J Psychiatr. 2004;161(1):175.
Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kles MS, Weber RS, Lewin JS, Garden
AS, Ang KK, Wang XS, Cleeland CS. Measuring head and neck cancer symptom burden: the
development and validation of the M.D. Anderson symptom inventory, head and neck module. Head
and Neck. 2007 Oct. :923-931.
Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy
for head and neck cancers: the patient’s perspective. Cancer Nurs. 2002;25(6):461-467.
Rosmolen WD, Boer KR, de Leeuw RJR, Gamel CJ, van Berge Henegouwen MI, Bergman JJGHM,
Sprangers MAG. Quality of life and fear of cancer recurrence after endoscopic and surgical treatment
for early neoplasia in Barrett’s esophagus. Endoscopy. 2010;42(7):525-531.
Ross MM, Rideout EM, Carson MM. The use of the diary as a data collection technique. West J Nurs
Res. 1994;16(4):414-425.
Ross S, Mosher CE, Ronis-Tobin V, Hermele S. Ostroff JS. Psychosocial adjustment of family
caregivers of head and neck cancer survivors. Supportive Care in Cancer. 2010;18(2):171-178.
Rosser R. The history of health related quality of life in 10 1/2 paragraphs. J R Soc Med. 1993;
86:315-318.
Rossi EL. Psychosocial Genomics: Gene expression, neurogenesis, and human experience in mindbody medicine. Adv Mind Body Med. 2002;18(2):22–30.
Rothman M, Hedrick S, Bulcroft KA, Hickam DH, Rubenstein LZ. The validity of proxy-generated
scores as measures of patient health status. Med Care. 1991;29:115-124.
D:\478174570.doc
Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am
Geriatr Soc. 2008;56(12):13 pages.
Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: a new challenge in delivering quality cancer
care. J Clin Oncol. 2006;24(32):5101-5104.
Rowland JH, Varricchio CG, Trimble EL, Gore-Langton RE. Investigator-Initiated Health-Related
Quality-of-Life-Research. Oncol. 2001;15(10):1–6.
Rowland JH, Yancik R. Cancer Survivorship: The Interface of Aging, Comorbidity, and Quality Care.
J Natl Cancer Inst. 2006;98,8:504-505.
Roychowdhury D. Editorial: Phase I trials: physician and patient perceptions. J Clin Oncol.
2003;99(227):4658–4650.
Rubenstein LV, McCoy JM, Cope DW, Barrett PA, Hirsch SH, Messer KS, Young RT. Improving patient
quality of life with feedback to physicians about functional status. J Gen Intern Med. 1995;10:607614.
Rubin DB. Using multivariate matched sampling and regression adjustment to control bias in
observational studies. J Am Stat Assoc. 1979;74(366):318-328.
Ruden E, Reardon DA, Coan AD, Herndon II JE, Hornsby WE, West M, Fels DR, Desjardins A,
Vredenburgh JJ, Waner E, Friedman AH, Friedman HS, Peters KB, Jones LW. Exercise behavior,
functional capacity, and survival in adults with malignant recurrent glioma. Journal of Clinical
Oncology. 2011;29(21):2918-2923.
Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D,
Simonian A. Use of the multiple sclerosis functional composite to predict disability in relapsing MS.
Neurology. 2001;56:1324-1330.
Rummans TA, Clark MM, Sloan JA, et al. Impacting quality of life for patients with advanced cancer
with a structured multidisciplinary intervention: a randomized controlled trial. 2006;24:635-642.
Rummans TA, Frost M, Suman VJ, et al. Quality of life and pain in patients with recurrent breast and
gynecologic cancer. Psychosomatics. 1998;39:437-445.
Russell CK. Passion and heretics: meaning in life and quality of persons with dementia. JAGS.
1996;44:1400-1402.
Rusthoven JJ, Osoba D, Butts CA, Yelle L, Findlay H, Grenville A. The impact of postchemotherapy
nausea and vomiting on quality of life after moderately emetogenic chemotherapy. Support Care
Cancer. 1998;6:389-395.
Rustin GJS. Can we now agree to use the same definition measure response according to CA-125. J
Clin Oncol. 2004;22(20):4035–4036.
Rustoen T, Moum T, Wiklund I, Hanestad BR. Quality of life in newly diagnosed cancer patients. J
Adv Nurs. 1999;29(2):490-498.
D:\478174570.doc
Rustoen T, Wiklund I. Hope in newly diagnosed patients with cancer. Cancer Nurs. 2000;23:214219.
Ryan JL, Heckler CE, Roscoe JA, DAkhil SR, Kirshner J, Flynn PJ, Hickok JT, Morrow GR. Ginger
(Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576
patients. Supportive Care in Cancer. 2012;20(7):1479-1490.
Saad F, Adachi JD, Brown JP, Canning LA, Gelmon KA, Josse RG, Pritchard KI. Cancer TreatmentInduced Bone Loss in Breast and Prostate Cancer. Journal of Clinical Oncology. 2008;26(33):54655476.
Sackett DL. Bias in Analytic Research. pp. 51–63.
Sadura A, Pater J, Osoba D, Levine M, Palmer M, Bennett K. Quality-of-life assessment: Patient
compliance with questionnaire completion. J Natl Cancer Inst. 1992;84(13):1023-1026.
Sagnier PP. Health-related quality of life: outcome criterion? perspective from a pharmaceutical
representative. health-related quality of life and patient-reported outcomes: scientific and useful
outcome criteria. Comptes rendus de la 4e Journee de therapeutique de I’UFR Lariboisiere SaintLouis. Paris. Main Authors: Chassany O, Caulin C. October 2002.
Sahlberg–Blom E, Ternestedt BM, Johansson JE. The last month of life: continuity, care site and
place of death. Palliat Med. 1998;12:287–296.
Sahm S, Will R, Hommel G. What are cancer patients’ preferences about treatment at the end of life,
and who should start talking about it? A comparison with healthy people and medical staff. Support
Care Cancer. 2005;13:206-214.
Saini S. Radiologic measurement of tumor size in clinical trials: past, present, and future. AJR.
2001;176:333-334.
Sales E. Psychosocial impact of the phase of cancer on the family: an updated review. J Psychosoc
Oncol. 1991;9:1-18.
Saliba D, Orlando M, Wenger NS, Hays RD, Rubenstein LZ. Identifying a short functional disability
screen for older persons. Journal of Gerontology: Medical Sciences. 2000;55A(12):M750-M756.
Saligan LN, Kim HA. A systematic review of the association between immunogenomic markers and
cancer-related fatigue. Brain Behav Immun. 2012;26(6):830-848.
Salisbury C, Bosanquet N, Wilkinson EK, et al. The impact of different models of specialist palliative
care on patients’ quality of life: systematic literature review. Palliat Med. 1999;13(1):3-17.
Salminen E, Vire J, Poussa T, Knifsund S. Unmet needs in information flow between breast cancer
patients, their spouses, and physicians. Support Care Cancer. 2004;12:663–668.
Salo JC. Surgery for Esophageal Cancer: Quality of Life Matters. Ann Surg Oncol. 2010;17(1):1213.
D:\478174570.doc
Salsman JM, Yost KJ, West DW, Cella D. Spiritual well-being and health-related quality of life in
colorectal cancer: a multi-site examination of the role of personal meaning. Supportive Care in
Cancer. 2011;19(6):757-764.
Sammarco A. Perceived social support, uncertainty, and quality of life of younger breast cancer
survivors. Cancer Nurs. 2001;24(3):212–219.
Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically
important differences in health status measures. Pharmacoeconomics. 1999;2:142-155.
Sanchez MM, Binkowitz BS. Guidelines for measurement validation in clinical trial design. J Biopharm
Stat. 1999;9(3):417-438.
Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised
controlled trials: bibliographic study. Br Med J. 1998;317:1191-1194.
Sanders T, Skevington S. Participation as an expression of patient uncertainty: an exploration of
bowel cancer consultants. Psycho-Oncol. 2004;13:675–688.
Sanderson K, Andrews G, Corry J, Lapsley H. Using the effect size to model change in preference
values from descriptive health status. Qual Life Res. 2004;13:1255–1264.
Sandhaus LM, Meyer P. How useful are CBC and reticulocyte reports to clinicians? Am J Clin Path.
2002;118(5):787-793.
Sandison AJP, Gold DM, Wright P, Jones PA. Breast conservation or mastectomy: treatment choice of
women aged 70 years and older. Br J Surg. 1996;83:994-996.
Sandoval DA, Matt KS. Gender differences in the endocrine and metabolic responses to hypoxic
exercise. J Appl Physiology. 2002;92:504-512.
Sanoff HK, Sargent DJ, Green EM, et al. Racial differences in advanced colorectal cancer outcomes
and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. Journal of Clinical
Oncology. 2009;27(25):4116-4123.
Santanello NC, Baker D, Cappelleri JC, et al. Regulatory issues for health-related quality of lifePhRMA health outcomes committee workshop, 1999. Value in Health. 2002;5(1):14-25.
Santin O, Mills M, Treanor C, Donnelly M. A comparative analysis of the health and well-being of
cancer survivors to the general population. Supportive Care in Cancer. 2012;20(10):2545-2552.
Sargent DJ. A general framework for random effects survival analysis in the cox proportional hazards
setting. Biometrics. 1998;54:1486-1497.
Sarna L, Evangelista L, Tashkin D, Padilla G, Holmes C, Brecht ML, Grannis F. Impact of respiratory
symptoms and pulmonary function on quality-of-life of long-term survivors of non-small cell lung
cancer. Chest. 2004;125(2):439-445.
Sarna L, McCorkle R. Burden of care and lung cancer. Cancer Pract. 1996;4(5):245-251.
D:\478174570.doc
Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life long-term survivors
of non-small cell lung cancer. J Clin Oncol. 2002;20(13):2920-2929.
Sarna L. Women with lung cancer: impact on quality of life. Qual Life Res. 1993;2(1):13-22.
Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary
breast cancer. Ann Intern Med 1994;120:104-110.
Sato K, Miyashita M, Morita T, Sanjo M, Shima Y, Uchitomi Y. Quality of end-of-life treatment for
cancer patients in general wards and the palliative care unit at a regional cancer center in Japan: a
retrospective chart review. Support Care Cancer. 2008;16:113-122.
Savard Josee, Simard S, Ivers H, and Morin CM. Randomized study on the efficacy of cognitivebehavorial therapy for insomnia secondary to breast cancer, Part I: Sleep and psychological effects.
J Clin Oncol. 2005;23:6083-6096.
Savelieva I, Paquette M, Dorian P, Luderitz B, Camm J. Quality of life in patients with silent atrial
fibrillation. Heart. 2001;85:216-217.
Sawada NO, de Paula JM, Sonobe HM, Fontao Zago MM, Guerrero GP, Nicolussi AC. Depression,
fatigue, and health-related quality of life in head and neck cancer patients: a prospective pilot study.
Support Care Cancer. 2012;20(11):2705-2711.
Say R, Murtagh M, Thomson R. Patients’ preference for involvement in medical decision making: A
narrative review. Patient Education and Counseling. 2006;60:102-114.
Schaafsma J, Osoba D. The Karnofsky performance status scale re-examined: a cross-validation
with the EORTC-C30. Qual Life Res. 1994;3:413-424.
Schag CA, Ganz PA, Wing DS, Sim MS, Lee JJ. Quality of life in adult survivors of lung, colon and
prostate cancer. Qual Life Res. 1994;3(2):127-141.
Schag CC, Heinrich RL, Ganz PA. Karnofsky Performance Status revisited: reliability, validity, and
guidelines. J Clin Oncol. 1984;2(3):187-193.
Schagen SB, van Dam, FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PT. Cognitive deficits
after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85:640–650.
Scharf O, Colevas AD. Adverse event reporting in publications compared with sponsor database for
cancer clinical trials. J Clin Oncol. 2006;24(24):3933-3938.
Scheier MF, Helgeson VS, Schulz R, et al. Interventions to enhance physical and psychological
functioning among younger women who are ending nonhormonal adjuvant treatment for early-stage
breast cancer. J Clin Oncol. 2005;23(19): 4298-4311.
Schiessl C, Sittl R, Griessinger N, Lutter N, Schuettler J. Intravenous morphine consumption in
outpatients with canceer during their last week of life – an analysis based on patient-controlled
analgesia data. Supportive Care in Cancer. 2008;16(8):917-924.
D:\478174570.doc
Schiller JH, Adak S, Cella D, DeVore III RF, Johnson DH. Topotecan versus oberservation after
cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-A Phase III Trial of the
Eastern Cooperative Oncology Group. J Clin Oncol. 2001;19(8):2114–2122.
Schilsky RL. Personalizing cancer care: American Society of Clinical Oncology Presidential Address
2009. Journal of Clinical Oncology. 2009;27(23):3725-3730.
Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the
Functional Living Index--Cancer: development and validation. J Clin Oncol. 1984;2(5):472-483.
Schipper H, Levitt M. Measuring quality of life: risks and benefits. Cancer Treat Rep. 1985;
69(10):1115-1123.
Schipper H. Editorial: Why measure quality of life? Can Med Assoc J. 1983;128:1367–1369.
Schmale AH, Morrow GR, Schmitt MH, Adler LM, Enelow A, Murawski BJ, Gates C. Well-being of
cancer survivors. Psychosomatic Med. 1983;45(2):163-169.
Schneider BP, Zhao F, Wang M, Stearns V, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge
Jr GW, Wood WC, Davidson NE, Sparano JA. Neuropathy is not associated with clinical outcomes in
patients receiving adjuvant taxane-containing therapy for operable breast cancer. Journal of Clinical
Oncology. 2012;30(25):3051-3057.
Schnelle JF, Keeler E, Hays RD, Simmons S, Ouslander JG, Siu AL. A cost and value analysis of two
interventions with incontinent nursing home residents. J Am Geriatrics Soc. 1995;43:1112-1117.
Schnoll RA, Harlow LL, Stolbach LL, Brandt U. A structural model of the relationships among stage of
disease, age, coping, and psychological adjustment in women with breast cancer. Psycho-Oncol.
1998;7:69-77.
Schofield P. Pain assessment: how far have we come in listening to our patients? Prof Nurs. 2003;
18(5):276–279.
Scholten C, Weinlander G, Krainer M, Frischenschlager O, Zielinski CC. Difference in patient’s
acceptance of early versus late initiation of psychosocial support in breast cancer. Support Care
Cancer. 2001;9:459-464.
Schor EL, Lerner DJ, Malspeis SSM. Physicians’ assessment of functional health status and wellbeing: the patient’s perspective. Arch Intern Med. 1995;155(3):309-314.
Schriesheim CA, Hinkin TR, Podsakoff PM. Can ipsative and single-item measures produce erroneous
results in field studies of French and Raven’s (1959) five bases of power? An empirical investigation.
J Appl Psychol. 1991;76(1):106-114.
Schron EB, Shumaker SA. The integration of health quality of life in clinical research: expereriences
from cardiovascular clinical trials. Progr Cardiovasc Nurs. 1992;7(2):21-28.
D:\478174570.doc
Schubert MM, Williams BE, Lloyd ME, Donaldson G, Chapko MK. Clinical assessment scale for the
rating of oral mucosal changes associated with bone marrow transplantation: development of an oral
mucositis index. Cancer. 1992;69:2469–2477.
Schubert MM, Eduardo FP, Guthrie KA, Franquin J-C, Bensadoun R-JJ, Migliorati CA, Lloid CME,
Eduardo CP, Walter N-F, Marques MM, Hamdi M. A phase III randomized double-blind placebocontrolled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral
mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer.
2007;15:1145-1154.
Schulman-Green D, McCorkle R, Curry L, Cherlin E, Johnson-Hurzeler R, Bradley E. At the
crossroads: Making the transition to hospice. Palliat Support Care. 2004;2:351-360.
Schulz R, Beach SR, Lind B, et al. Involvement in caregiving and adjustment to death of a spouse.
JAMA. 2001;285:3123–3129.
Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study.
JAMA. 1999;23:282.
Schulz R, Mendelsohn AB, Haley WE, et al. End-of-life care and the effects of bereavement on family
caregivers of persons with dementia. N Engl J Med. 2003;349(20):1936–1942.
Schumacher M, Olschewski M, Schulgen G. Assessment of quality of life in clinical trials. Stat Med.
1991;10:1915-1930.
Schunemann HJ, Akl EA, Guyatt GH. Interpreting the results of patient reported outcome measures
in clinical trials: The clinicians’ perspective. Health and Quality of Life Outcomes. 2006;4:8 pages.
Schwappach DLB, Wernli M. Chemotherapy patients’ perceptions of drug administration safety.
Journal of Clinical Oncology. 2010;28(17):2896-2901.
Schwartz AL, Mori M, Gao R, Nail LM, King ME. Exercise reduces daily fatigue in women with breast
cancer receiving chemotherapy. Med Sci Sports Exercise. 2001;718-723.
Schwartz C, Bell Meisenhelder J, Ma Y, Reed G. Altruistic social interest behaviors are associated with
better mental health. Psychosom Med. 2003;65:778–785.
Schwartz C, Lennes I, Hammes B, Lapham C, Bottner W, Ma Y. Honing advance care planning
intervention using qualitative analysis: the living well interview. J Palliat Med. 2003;6(4):593-603.
Schwartz C, Sendor R. Helping others helps oneself: response shift effects in peer support. Soc Sci
Med. 1999;48:1563-1575.
Schwartz CE, Cole BF, Gelber RD. Measuring patient-centered outcomes in neurologic disease. Arch
Neurol. 1995;52:754-762.
Schwartz CE, Cole BF, Vickrey BG, Gelber RD. The Q-TWIST approach to assessing health-related
quality of life in epilepsy. Qual Life Res. 1995;4(2):135-141.
D:\478174570.doc
Schwartz CE, Merriman MP, Reed G, Byock I. Evaluation of the Missoula-VITAS quality of life index –
revised: Research tool or clinical tool? J Palliat Med. 2005;8(1):121.
Schwartz CE, Sprangers MAG. Introduction to symposium on the challenge of response shift in social
science and medicine. Soc Sci Med. (Editorial) 1999;48:1505-1506.
Schwartz CE, Sprangers MAG. Methodological approaches for assessing response shift in longitudinal
health-related quality-of-life research. Soc Sci Med. 1999;48(11):1531-1548.
Schwartz, C.E., Sprangers MAG. An introduction to quality of life assessment in oncology: the value
of measuring patient-reported outcomes. Am J Manag Care. 2002;8:S55-S559.
Schwartz MD, Lerman C, Audrain J, Cella D, et al. The impact of a brief problem solving intervention
for relatives of recently diagnosed breast cancer patients. Annals of Behavioral Medicine.
1998;20(1):7-12.
Schwartzberg LS. Chemotherapy-induced Nausea and vomiting: Which antiemetic for which therapy?
Oncology. 2007; 21(8).
Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to
clinical trials: a review. Control Clin Trials. 2002;23:662-674.
Scrimin S, Axia G, Tremolada M, Pillon M, Capello F, Zanesco L. Conversational strategies with
parents of newly diagnosed children: an analysis of 4880 conversational turns. Support Care Cancer.
2005;13:287-294.
Seale C. A comparison of hospice and conventional care. Soc Sci Med. 1991;32:147–152.
Sebille V, Hardouin JB, Le Neel T, Kubis G, Boyer F, Guillemin F, Falissard B. Methodological issues
regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for
the comparison of patient-reported outcomes in two groups of patients – a simulation study. BMC
Med Res Methodol. 2010 Mar 25;10(1):24.
Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving Androgen deprivation
therapy for prostate cancer. J Clin Oncol. 2003;21(9):1653-1659.
Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud’Homme DG, Malone SC, Wells GA, Scott
CG, Slovinec D’Angelo ME. J Clin Oncol. 2009 Jan 20;27(3):344-51. Epub 2008 Dec 8.
Sekeres, et al. The impact of a physician awareness group and the first year of training on
hematology-oncology fellows. J Clin Oncol. 2003;21:3676-3682.
Sela RA, Watanabe S, Nekolaichuk CL. Sleep disturbances in palliative cancer patients attending a
pain and symptom control clinic. Palliat Support Care. 2005;3:23-31.
Selai C, Trimble MR. Assessing quality of life in dementia. Aging Ment Hlth. 1999;3(2):101-111.
Selby P. Measurement of the quality of life after cancer treatment. Br J Hosp Med. 1985;33:266271.
D:\478174570.doc
Selby D, Chakraborty A, Myers J, Saskin R, Mazzotta P, Gill A. High scores on the Edmonton
Symptom Assessment Scale identify patients with self-defined high symptom burden. J Palliat Med.
2011 Dec;14(12):1309-16.
Selby PJ, Chapman JAW, Etazadi-Amoli J, Dalley D, Boyd NF. The development of a method for
assessing the quality of life of cancer patients. Br J Cancer. 1984;50:13-22.
Semple CJ, Dunwoody L, Kernohan WG, McCaughan E. Development and evaluation of a problemfocused psychosocial intervention for patients with head nd neck cancer. Supportive Care in Cancer.
2009;17(4):379-388.
Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, Liu Y, Husain A, Sussman J, Earle
C. Trajectory of performance status and symptom scores for patients with cancer during the last six
months of life. Journal of Clinical Oncology. 2011;29(9):1151-1158.
Seow H-Y, Whelan P, Levine MN, Cowan K, Lysakowski B, Kowaleski B, Snider A, Xu RY, Arnold A.
Funding oncology clinical trials: are cooperative group trials sustainable? Journal of Clinical Oncology.
2012;30(13):1456-1461.
Sepucha KR, Belkora JK, Mutchnick S, Esserman LJ. Consultation planning to help breast cancer
patients prepare for medical consultations: effect on communication and satisfaction for patients and
physicians. J Clin Oncol. 2002;20(11):2695-2700.
Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate
or severe? Grading pain severity by its interference with function. Pain. 1995;61:277-284.
Seruga B, Sterling L, Wang L,Tannock IF. Reporting of serious adverse drug reactions of targeted
anticancer agents in pivotal phase III clinical trials. Journal of Clinical Oncology. 2011;29(2):174185.
Setoguchi S, Earle CC, Glynn R, Stedman M, Polinski JM. Comparison of Prospective and
Retrospective Indicators of the Quality of End-of-Life Cancer Care. Journal of Clinical Oncology.
2008;26(35):5671-5678.
Shacham S, Dar R, Cleeland CS. The relationship of mood state to the severity of clinical pain. Pain.
1984;18:187-197.
Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of survival among patients with
advanced cancer. J Clin Oncol. 2002;20(10):2514-2519.
Shah S, Doyle K, Ethan L, Shen P, Pennell T, Ferree C, Levine E, Perrier N. Breast cancer recurrences
in elderly patients after lumpectomy. Am Surg. 2002;68(8):735–739.
Shah SN, Doyle K, Lange EM, Shen P, Pennell T, Ferree C, Levine EA, Perrier ND. Breast cancer
recurrences in elderly patients after lumpectomy. Am Surg . 2002;68(8):735-739.
Shah SN, Sesti AM, Copley-Merriman K, Planti M. Quality of life terminology included in package
inserts for US approved medications. Qual Life Res. 2003;12:1107–1117.
D:\478174570.doc
Shaiova L, Lapin J, Manco LS, Shasha D, Hu K, Harrison L, Portenoy RK. Tolerability and effects of
two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiationinduced oral mucositis. Support Care Cancer. 2004;12:268–273.
Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Improving interperetation of clinical studies by use
of confindence levels, clinical significance curves, and risk-benefit contours. Lancet. 2001;357:13491353.
Shanafelt T, Adjei A, Meyskens FL. When your favorite patient relapses: physician grief and wellbeing in the practice of Oncology. J Clin Oncol. 2003;21(13):2616–2619.
Shapiro MF. Is the spirit of capitalism undermining the ethics of health services research? Hlth Serv
Res. 1994;28:661-672.
Shapiro SL, Lopez AM, Schwartz GE, et al. Quality of life and breast cancer: relationship to
psychosocial variables. J Clin Psychol. 2001;57(4):501-519.
Shasha D, George MJ, Harrison LB. Once-weekly dosing of Epoetin increases hemoglobin and
improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or
swquentially with chemotherapy. Cancer. 2003;98:1072-1079.
Shaw EG, Rosdhal R, D’Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, Rapp SR. Phase II study
of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life.
J Clin Oncol. 2006;24:1415-1420.
Sheikh JI, Yesavage JA. 9/Geriatric Depression Scale (GDS) recent evidence and development of a
shorter version. Clin Gerontolgist. 1986;5(1/2):165–173.
Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St. John’s Wort in major depression: a
randomized controlled trial. JAMA. 2001;285(15):1978-1986.
Shen L, Pulkstenis E, Hoseyni M. Estimation of mean quality adjusted survival time. Stats Med.
1999;18:1541-1554.
Shepherd HL, Tattersall MHN, Butow PN. Physician-identified factors affecting patient participation in
reaching treatment decisions. J Clin Oncol. 2008;26(10):1724-1731.
Sher TG, Cella D, Sarafian B, Leslie W. An old procedure with a new population: The use of the
Communication Box in a medical setting. The Behavior Therapist. 1993; 248-259.
Sher TG, Cella D, Leslie WT, Bonomi P, Taylor SG (IV), Sarafian, B. Communication differences
between physicians and their patients in an oncology setting. Journal of Clinical Psychology in Medical
Settings. 1997;4(3):281-293.
Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related
quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248-254.
D:\478174570.doc
Sherbourne CD, Hays RD, Wells KB. Personal and psychosocial risk factors for physical and mental
health outcomes and course of depression among depressed patients. J Consult Clin Psychol.
1995;63(3):345-355.
Sherbourne CD, Hays RD. Marital status, social support, and health transitions in chronic disease
patients. J Hlth Soc Behav. 31:328-343, 1990.
Sherbourne CD, Wells KB, Hays RD, Rogers WH, Burnam MA, Judd, LL. Subthreshold depression and
depressive disorder: clinical characteristics of general medical and mental health specialty
outpatients. Am J Psychiatry. 1994;151(2):1777-1784.
Sherliker L, Steptoe A. Coping with new treatments for cancer: a feasibility study of daily diary
measures. Patient Educ Couns. 2000;40(1)12-19.
Sherman AC, Coleman EA, Griffith K, et al. Use of a supportive care team for screening and
preemptive intervention among multiple myeloma patients receiving stem cell transplantation.
Support Care Cancer. 2003;11:568-574.
Sherman AC, Plante TG, Simonton S, Adams DC, Harbison C, Burris SK. A multidimensional measure
of religious involvement for cancer patients: the Duke Religious Index. Support Care Cancer.
2000;8:102-109.
Sherwood PR, Given BA, Given CW, Sikorskii A, You M, Prince J. The impact of a problem-solving
intervention on increasing caregiver assistance and improving caregiver health. Support Care Cancer.
2012; 20(9):1937-1947.
Shi Y, Warner DO. Surgery as a teachable moment for smoking cessation. Anesthesiology.
2010;112(1):102-107.
Shields CG, Morrow GR, Griggs J, Mallinger J, Roscoe J, Wade JL, Dakhil SR, Fitch TR. DecisionMaking Role Preferences of Patients Receiving Adjuvant Cancer Treatment: A University of Rochester
Cancer Center Community Clinical Oncology Program. Supportive Cancer Therapy. 2004;1(2):119126.
Shih YC, Wang XS, Cantor SB, Cleeland CS. The association between symptom burdens and utility in
Chinese cancer patients. Qual Life Res. 2006;15(8):1427-38.
Shim EJ, Mehnert A, Koyama A, Cho SJ, Inui H, Paik NS, Koch U. Health-related quality of life in
breast cancer: a cross-cultural survey of German, Japanese, and South Korean patients. Breast
Cancer Res Treat. 2006;99(3):341-350.
Shimozuma K, Ganz PA, Petersen L, Hirji K. Quality of life in the first year after breast cancer
surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat. 1999;56:45-57.
Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Mukai H,
Katsumata N, Sunada Y, Watanabe T, Hausheer FH. Feasibility and validity of the patient
neurotoxicity questionnaire during taxane chemotherapy in a phase III randomized trial in patients
with breast cancer: N-SAS BC 02. Supportive Care in Cancer. 2009;17(12):1483-1492.
D:\478174570.doc
Shun SC, Chiou JF, lai YH, Yu PJ, Wei LL, Tsai JR, Kao CY, Hsiao YL. Changes in quality of life and its
related facrots in liveer cancer patients receiving sterotactic radiation therapy. Supp Care in Cancer.
2008;16(9):1059-1066.
Shun SC, Lai YH, Jing TT, Jeng C, Lee FY, Hu LS, Cheng SY. Fatigue patterns and correlated in male
liver cancer patients receiving transcatheter hepatic arterial chemoembolization. Support Care
Cancer. 2005;13:311-317.
Siddiqui F, Pajak TJ, Bruner DW, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, et al.
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a
radiation therapy oncology group analysis. Intl J Rad Oncol Biol Phys 2007;x:1-8.
Siegrist J, Junge A. Background material for the workshop on QALYs: conceptual and methodological
problems in research on the quality of life in clinical medicine. Soc Sci Med. 1989;29(3):463-468.
Siena S, Peeters M, Van Cutsem E, Humblet Y, conte P, Bajetta E, Comandini D, Bodoky G, et al.
Association of progression-free survival with patient-reported outcomes and survival: results from a
randomized Phase III trial of panitumumab. Brit J Cancer 2007;97:1469-1474.
Sigle J, Porzsolt F. Practical aspects of quality-of-life measurement: design and feasibility study of
the quality-of-life recorder and the standardized measurement of quality of life in an outpatient clinic.
Cancer Treat Rev. 1996;22(Suppl A):75-89.
Sigurdardottir V, Bolund C, Nilson B. Quality of life and ethics: opinions about chemotherapy among
patients with advanced melanoma, next of kin and care-providers. Psycho-Oncol. 1995;4(4):287300.
Sigurdardottir V, Bolund C, Sullivan M. Quality of life evaluation by the EORTC questionnaire
technique in patients with generalized malignant melanoma on chemotherapy. Acta Oncol.
1996;35(2):149-158.
Sigurdardottir V, Brandberg Y, Sullivan M. Criterion-based validation of the EORTC QLQ-C36 in
melanoma: the CIPS questionnaire and proxy raters. Qual Life Res. 1996;(3):375-386.
Sikora K. Commentary of Carlson and Bultz Review. Is psychosocial care worth the money? PsychoOncol. 2004;13:855-856.
Sikorskii A, Given CW, Given B, Jeon S, You M. Differential symptom reporting by mode of
administration of the assessment. Medical Care. 2009;47(8):866-874.
Silvestri GA, Knittig S, Zoller JS, Nietert PJ. Importance of faith on medical decisions regarding
cancer care. J Clin Oncol. 2003;21(7):1379-1382.
Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a
multidimensional measure of fear of cancer recurrence. Supportive Care in Cancer. 2009;17(3):241252.
Simeit R, Deck R, Contra-Marx B. Sleep management training for cancer patients with insomnia.
Support Care Cancer. 2004;12:176–183.
D:\478174570.doc
Simes RJ, Coates AS. Patient preferences for adjuvant chemotherapy of early breast cancer: how
much benefit is needed? J Natl Cancer Inst Monogr. 2001;30:146-152.
Simmonds MA. Management of breakthrough pain due to cancer. Oncology. 1999;13(8):11031108.
Simon GE, Revicki DA, Grothaus L, Vonkorff M. SF-36 summary scores: are physical and mental
health truly distinct? Med Care. 1998;36:567-572.
Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation
between somatic symptoms and depression. N Engl J Med. 1999;341:1329–1335.
Simon R, Wittes RE, Ellenberg SS. Randomized Phase II Clinical Trials. Cancer Treat Rep.
1985;69(12):1375-81.
Simons JPFHA, Aaronson NK, Vansteenkiste JF, et al. Effects of medroxyprogesterone acetate on
appetite, wieght, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebocontrolled multicenter study. J Clin Oncol. 1996;14(4):1077-1084.
Simons JPFHA, Schols AMWJ, Buurman WA, Wouters EFM. Weight loss and low body cell mass in
males with lung cancer: relationship with systemic inflammation, acute-phase response, resting
energy expenditure, and catabolic and anabolic hormones. Clin Sci. 1999;97:215–223.
Simons JPFHA, Schols AMWJ, Hoefnagels JMJ, Westerterp KR, ten Velde GPM, Wouters EFM. Effects
of medroxyprogesterone acetate on food intake, body composition, and resing expenditure in
patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
Cancer. 1998;82:553–560.
Singer AJ, Gulla J. Parents and practitioners are poor judges of young children’s pain and severity.
Acad Emerg Med. 2002;9(6):609-612.
Singer PA, Martin DK, Kelner M. Quality-of-life care: patients’ perspectives. J Am Med Assoc.
1999;281(2):163-168.
Singh R, Kolvraa S, Bross P, Gregersen N, Andersen Nexo B, Frederiksen H, Christensen K, Rattan K,
Rattan SI. Association between low self-rated health and heterozygosity for -110A> C polymorphism
in the promoter of HSP70-I in aged Danish twins. Biogerontology. 2004;5(3):169-176.
Singh R, Kolvraa S, Rattan SI. Genetics of human longevity with emphasis on the relevance of
HSP70 as candidate genes. Froniers in Bioscience. 2007;12:4504-13.
Singh J, Sloan JA, Johanson NA. Challenges with health-related quality of life assessment in
arthroplasty patients: problems and solutions. Journal of the American Academy of Orthopaedic
Surgeons. 2010;18(2):72-82.
Singh JA, Sloan JA, Atherton PJ, Smith T, Hack TF, Huschka MM, Rummans TA, Clark MM, Diekmann
B, Degner LF. Preferred roles in treatment decision making among patients with cancer: a pooled
analysis of studies using the Control Preferences Scale. Am J Manag Care 2010 Sep;16(9):688-96.
D:\478174570.doc
Singh M, Alexander K, Roger VL, Rihal CS, Whitson HE, Lerman A, Jahangir A, Nair KS. Frailty and its
potential relevance to cardiovascular care. Mayo Clinic Proc. 2008;83(10):1146-1153.
Sirilla J, Overcash J. Quality of Life (QOL), supportive care, and spirituality in hematopoietic stem cell
transplant. Supportive Care in Cancer. 2013;21(4):1137-1144.
Sitzia J, Dikken C, Hughes J. Psychometric evaluation of a questionnaire to document side-effects of
chemotherapy. J Adv Nursing. 1997;25:999-1007.
Siu AL, Hays RD, Ouslander JG, Osterwell D, Valdez RB, Krynski M, Gross A. Measuring functioning
and health in the very old. J Gerontology Med Sci. 1993;48(1):M10-M14.
Siu AL, Ouslander JG, Osterweil D, Reuben DB, Hays RD. Change in self-reported functioning in older
persons entering a residential care facility. J Clin Epidemiol. 1993;46(10)1093-1101.
Siu AL, Reuben DB, Hays RD. Hierarchical measures of physical function in ambulatory geriatrics. J
Am Geriatric Soc. 1990;38:1113-1119.
Sivesind D. Baile WF.The psychologic distress in patients with cancer. Nurs Clin N Am. 2001;36(4):
809-825.
Sjovall K, Attner B, Lithman T, Noreen D, Gunnars B, Thome B, Olsson H. Influence on the health of
the partner affected by tumor disease in the wife or husband based on a population-based register
study of cancer in Sweden. Journal of Clinical Oncology. 2009;27(28):4781-4786.
Skeel RT. Quality of life assessment in cancer clinical trials-its time to catch up. J Natl Cancer Inst.
1989;81(7):472-473.
Skeel RT. Quality of life dimensions that are most important to cancer patients. Oncology.
1993;7:55-61.
Skerman HM, Yates PM, Battistutta D. Cancer-related symptom clusters for symptom management in
outpatientsafter commencing adjuvant chemotherapy, at 6 months, and 12 months. Supportive Care
in Cancer. 2012;20(1):95-106.
Skerman HM, Yates PM, Battistutta D. Multivariate methods to identify cancer-related symptom
clusters. Research in Nursing and Health. 2009;32:345-360.
Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R,
Portenoy R, Stambler N, Israel R. Methylnaltrexone for treatment of opioid-induced constipation in
advanced illness patients. J Support Oncol. 2009;7(1):39-46.
Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the
doctor or the patient? Br J Cancer. 1988;57:109-112.
Sloan JA, Zhao X, Novotny PJ, Wampfler J, Garces Y, Clark MM. Relationship between deficits in
overall quality of life and non-small-cell lung cancer survival. Journal of Clinical Oncology.
2012;30(13):1498-1504.
D:\478174570.doc
Sloan JA, de Andrade M, Decker P, Wampfler J, Oswold C, Clark M, Yang P. Genetic variations and
patient-reported quality of life among patients with lung cancer. Journal of Clinical Oncology.
2012;30(14):1699-1704.
Sloan JA. Metrics to assess quality of life after management of early-stage lung cancer. The Cancer
Journal. 2011;17(1):63-67.
Sloan JA, Berk L, Roscoe J, Fisch MJ, Shaw EG, Wyatt g, Morrow GR, Dueck AC. Integrating patientreported outcomes into cancer symptom management clinical trials supported by the National Cancer
Institute-sponsored clinical trials network. J Clin Oncol 2007;25(32):5070-5077.
Sloan JA, Dueck AC, Erickson PA, Guess H, Revicki DA, Santanello NC, Mayo/FDA Patient-Reported
Outcomes Consensus Meeting Group. Analysis and interpretation of results based on patientreported outcomes. Value Health 2007 Nov-Dec; 10 Suppl 2:S106-15.
Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML. The Mayo Clinic manuscript
series relative to the discussion, dissemination, and operationalization of the Food and Drug
Administration guidance on patient-reported outcomes. Value Health 2007 Nov-Dec; 10(Suppl
2):S59-63.
Sloan JA, Frost MH, Berzon R. Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D,
Clinical Significance Consensus Meeting Group. The clinical significance of quality of life assessments
in oncology: a summary for clinicians. Supportive Care in Cancer. 2006;14:988-998.
Sloan JA, Sargent DJ, Lindman J, Allmer C, et al. A new graphic for quality adjusted life years (QTWiST) survival analysis: The Q-TWiST plot. Qual Life Res. 2002;11:37-45.
Sloan PA, Donnelly MB, Schwartz RW, Sloan DA. Cancer pain assessment and management by
housestaff. Pain. 1996;67:475-481.
Small W, Carrara R, Danford L, Logemann JA, Cella D. Quality of Life and nutrition in the patient
with cancer. Oncology issues: Oncology Economivs & Program Management. 2002;17(2):13-14.
Smart CR, McLaughlin GW. Reward structures of academic disciplines. Res Higher Ed. 1978;8:3955.
Smart CR, Yates JW. Quality of life. Cancer. 1987;60(Suppl 1):620-622.
Smets EM, Garssen B, Banks B, DeHaes JC. The Multidimensional Fatigue Inventory (MFI)
psychometric qualities of an instrument to assess fatigue. J Psychosom. 1995;39(3):316-325.
Smets EM, Garssen B, Cull A, de Haes JC. Application of the multidimensional fatigue inventory (MFI20) in cancer patients receiving radiotherapy. Br J Cancer. 1996;73(2):241-245.
Smets EMA. Measuring change in fatigue: the effects of response shift.
Smith AB, Lynch P, Wright P, Velikova G, Shelby PJ. Agreement between quality-of-life instruments:
The EORTC QLQ-C30 and FACT-G. ICRF Cancer Medicine Research Unit, St. James’ University
Hospital, Leeds, England.
D:\478174570.doc
Smith D, Reaney M, Speight J. Conducting literature reviews to support the use of patient-reported
outcomes (PRO) measures in clinical trials – The benefits of a systematic search strategy. ISPOR
Connections. 2009;15(4):4-6.
Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational
challenge: systematic review of randomised controlled trials. BMJ. 2003;327(7429):1459–1461.
Smith JC. The inadequacy of survival rates in the evaluation of cancer therapy. Surg Gyne Obst.
1956;103(3):307-312.
Smith ND. Quality of life studies from the perspective of an FDA reviewing statistician. Drug Info J.
1993;27:617-623.
Smith SK, Mayer DK, Zimmerman S, Williams CS, Benecha H, Ganz PA, Edwards LJ, Abernethy AP.
Quality of life among long-term survivors of Non-Hodgkin Lymphona: A follow-up study. Journal of
Clinical Oncology. 2013;31(2):272-279.
Smith T. Adding hospice and palliative care services to the cancer center menu. J Palliat Med.
2003;6(4):641-644.
Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of
recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080-1082.
Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE,
Paice JA, Peppercorn JM, Somerfield M, Stovall E, Von Roenn JH. American Society of Clinical
Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.
Journal of Clinical Oncology. 2012;30(8):880-887.
Smith Jr RE, Aapro MA, Ludwig H, Pinter T, Smakal M, Ciuleanu TE, Chen L, Lillie T, Glaspy JA.
Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving
chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind,
placebo-controlled study. J Clin Oncol. 2008;26(7):1040-1050.
Smneek FWJM, Van Haastregt JCM, De Witte LP, Crebolder FJM. Effectiveness of home care
programmes for patient with incurable cancer on their quality of life: a systematic review: BMJ.
1998;316:1939–1943.
Sneeuw K, Aaronson NK, Osoba D, et al. The use significant others as proxy raters of the quality of
life of patients with brain cancer. Med Care. 1997;35(5):490-506.
Sneeuw KCA, Aaronson NK, de Haan RJ, Limburg M. Assessing quality of life after stroke. The value
and limitations of proxy ratings. Stroke. 1997;28(8):1541-1549.
Sneeuw KCA, Aaronson NK, Sprangers MAG, Detmar SB, Wever LDV, Schornagel JH. Evaluating the
quality of life of cancer patients: assessments by patients, significant others, physicians and nurses.
Br J Cancer. 1999;81(1):87-94.
D:\478174570.doc
Sneeuw KCA, Aaronson NK, Sprangers MAG, Detmar SB, Wever LDV, Schornagel JH. Comparison of
patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin
Epidemiol. 1998;51(7):617-631.
Sneeuw KCA, Aaronson NK, Sprangers MAG, Detmar SB, Wever LDV, Schornagel JH. Value of
caregiver ratings in evaluating the quality of life in patients with cancer. J Clin Oncol.
1997;15(3):1206-1217.
Sneeuw KCA, Aaronson NK, Yarnold JR, et al. Cosmetic and functional outcomes of breast
conserving treatment for early-stage breast cancer. 2. Relationship with psychosocial functioning.
Radiother Oncol. 1992;25:160-166.
Sneeuw KCA, Albertsen PC, Aaronson NK. Comparison of patient and spouse assessments of health
related quality of life in men with metastatic prostate cancer. J Urol. 2001;165:478-482.
Sneeuw KCA, Sprangers MAG, Aaronson NK. The role of health care providers and significant others
in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol. 2002;55:1130–
1143.
Sneeuw KCA. Quality of life assessment by proxy. J Clin Epidemiol. 2002;55:1130-1143.
Snyder RE, Cunningham W, Nakazoneo TT, Hays R. Access to medical care reported by Asians and
Pacific Islanders in a West Coast Physician Group Association. Med Care Res. 2000;57(2):196–215.
Snyder CF, Blackford AL, Brahmer JR, Carducci MA, Pili R, Stearns V, Wolff AC, Dy SM, Wu AW.
Needs assessments can identify scores on HRQOL questionnaires that represent problems for
patients: an illustration with the supportive care needs survey and the QLQ-C30. Qual Life Res.
2010;19:837-845.
Snyder CF, Blackford AL, Aaronson NK, Detmar SB, Carducci MA, Brundage MD, Wu AW. Can patientreported outcome measures identify cancer patients’ most bothersome issues? Journal of Clinical
Oncology. 2011;29(9):1216-1220.
Snyder CF, Jensen RE, Geller G, Carducci MA, Wu AW. Relevant content for a patient-reported
outcomes questionnaire for use in oncology clinical practice: putting doctors and patients on the
same page. Qual Life Res. 2010;19:1045-1055.
Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Wolff AC, Carducci MA, Earle CC. Quality
of Care for Comorbid Conditions During the Transition to Survivorship: Differences Between Cancer
Survivors and Noncancer Controls. Journal of Clinical Oncology. 2013;31(9):1140-1148.
Sochocki MP, Verity S, Atherton PJ, Huntington JL, Sloan JA, Embil JM, Trepman E. Foot and Ankle
Surgery. 2008;14:11-15.
Sola CL, Bostwick JM. Inplantable cardioverter-defibrillators, induced anxiety, and quality of life.
Mayo Clin Proc. 2005;80(2):232-237.
Solberg Nes L, Roach AR, Segerstrom SC. Executive functions, self-regulation, and chronic pain: a
review. Ann Behav Med. 2009;37:173-183.
D:\478174570.doc
Soledad Cepeda M, Africano JM, Polo R, Alcala R, Carr DB. Agreement between percentage pain
reductions calculated from numeric rating scores of pain intensity and those reported by patients with
acute or cancer pain. Pain. 2003;106:439-442.
Sollner W, Maislinger S, Konig A, Devries A, Lukas P. Providing psychosocial support for breast
cancer patients based on screening for distress within a consultation-liaison service. Psycho-Oncol.
2004;13:893-897.
Somerfield M, Curbow B. Methodological issues and research strategies in the study of coping with
cancer. Soc Sci Med. 1992;34(11):1203-1216.
Song JI, Shin DW, Choi JY, Kang J, Baik YJ, Mo H, Park MH, Choi SE, Kwak JH, Kim EJ. Quality of life
and mental health in family caregivers of patients with terminal cancer. Supportive Care in Cancer.
2011;19(10):1519-1526.
Soni MK, Cella D, Masters GA, Burch SP, Heyes, Silberman. The validity and clinical utility of
symptom monitoring in advanced lung cancer: a literature review. Clin Lung Cancer. 2002;4(3):153160.
Soni MK, Cella D. Quality of life and symptom measures in oncology: an overview. Am J Manage
Care. 2002;8(18)Suppl:S560–S573.
Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer.
2004;100(9 Suppl):1995-2025.
Soothill K, Morris SM, Harman J, Francis B, Thomas C, McIllmurray. The significant unmet needs of
cancer patients: probing psychosocial concerns. Support Care Cancer. 2001;9:597–605.
Souery D, Oswald P, Linkowski P, Mendlewicz J. Molecular genetics in the analysis of suicide. Ann
Med. 2003;35(3):191–196.
Sousa KH. Description of a health-related quality of life conceptual model. Outcomes Manage Nurs
Pract. 1999;3(2):78-82.
Spagnola S, Zabora J, Brintzenhofeszoc K, Hooker c, Cohen G, Baker F. The Satisfaction with Life
Domains Scale for Breast Cancer (SLDS-BC). Breast J. 2003;9(6):463-471.
Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG, Barg FK. Scope of symptoms
and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer
patients. Supportive Care in Cancer. 2012;20(10):2433-2439.
Spector WD, Katz S, Murphy JB, Fulton JP. The hierarchical relationship between activities of daily
living and instrumental activities of daily living. J Chron Dis. 1987;40(6):481-489.
Speechley KN, Barrera M, Shaw AK, Morrison HI, Maunsell E. Health-related quality of life among
child and adolescent survivors of childhood cancer. J Clin Oncol. 2006;24(16):2536-2543.
D:\478174570.doc
Speer DC, Greenbaum PE. Five methods for computing significant individual client change and
improvement rates: support for an individual growth curve approach. J Consult Clin Psychol.
1995;63:1044-1048.
Spiegel D. Mind matters in cancer survival. JAMA. 2011;305(2):502-3.
Speigel D, Giese-Davis J. Depression and cancer: mechanism and disease progression. Biol
Psychiatr. 2003;54:269–282.
Spertus JA, Jones P, McDonell M, Fan V, Fihn SD. health status predicts long-term outcome in
outpatients with coronary disease. Circulation. 2002;106:43–49.
Spiegelhalter DJ, Gore SM, Fitzpatrick R, Fletcher AD, Jones DR, Cox DR. Quality of life measures in
health care. III: resource allocation. BMJ. 1992;305(6863):1205-1209.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the
PGQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.
Journal of the American Medical Association. 1999;282(18):1737-1744.
Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QLIndex for use by physicians. J Chron Dis. 1981;34:585-597.
Spitzer WO. State of science 1986: quality of life and functional status as target variables for
research. J Chron Dis. 1987;40(6):465-471.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the
PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.
JAMA. 1999;282:1737-1744.
Sprangers M, Hoogstraten J. On delay and reassessment of retrospective preratings. J Exper Educ.
1988;56:148-153.
Sprangers M, Hoogstraten J. Response-style effects, response-shift bias and bogus-pipeline: A
replication. Psychol Rep. 1988;62:11-16.
Sprangers M, Hoogstraten J. Response-style effects, response-shift bias and bogus-pipeline. Psychol
Rep. 1987;61:579-585.
Sprangers M, Hoogstraten J. Subject bias in three self-report measures of change. Methodika.
1991;V:1-13.
Sprangers M, Van Den Brink W, Van Herden J, Hoogstraten J. A constructive replication of White’s
alleged refutation of Nisbett and Wilson and of Bem: limitations on verbal reports of internal events.
J Exper Soc Psychol. 1987;23:302-310.
Sprangers M. Response shift and the retrospective pretest. On the usefulness of retrospective
pretest-posttest designs in detecting training related response shifts. (Doctoral Dissertation) Den
Haag: SVO, 1988.
D:\478174570.doc
Sprangers M. Response-shift bias in program evaluation. Impact Assess Bull. 1989;7:153-166.
Sprangers M. Subject bias and the retrospective pretest in retrospect. Bull Psychonomic Soc. 1989;
27(1):11-14.
Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European Organization for
Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing
questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res. 1993;(4):287-295.
Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal
cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research
and Treatment of Cancer Study Group on Quality of Life. Euro J Cancer. 1999;35(2):238-247.
Sprangers MA. Quality of life assessment in oncology. Achievements and challenges. Acta Oncol.
2002;41(3):229-237.
Sprangers M. Disregarding clinical trial-based patient-reported outcomes is unwarranted: five
advances to substantiate the scientific stringency of quality-of-life measurement. Acta Oncologica.
2009.
Sprangers MAG, Bartels M, Veenhoven R, Baas F, Martin NG, Mosing M, Movsas B, Ropka ME,
Shinozaki G, Swaab D, The GeneQOL Consortium. Qual Life Res. Published online April 24, 2010.
Sprangers MAG. Disregarding clinical trial-based patient-reported outcomes is unwarranted: five
advances to substantiate the scientific stringency of quality-of-life measurement. Acta Oncologica.
2010;49:155-163.
Sprangers MAG, Aaronson NK. The current status of quality-of-life assessment in surgical
investigations. Theoretical Surg. 1991;6:158-165.
Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating
the quality of life of patients with chronic disease: a review. J Clin Epidemiol. 1992;45(7):743-760.
Sprangers MAG, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European Organization
for Research and Treatment of Cancer approach to developing questionnaire modules: an update and
overview. Qual Life Res. 1998;7:291-300.
Sprangers MAG, Groenvold M, Arraras JI, et al. Quality-of-life assessments in colorectal cancer
patients: evaluation of cancer therapies. Sem Oncol. 1999;26(6):691-696.
Sprangers MAG, Groenvold M, Arraras JI, et al. The European Organization for Research and
Treatment of Cancer Breast Cancer– Specific Quality-of-Life Questionnaire Module: first results from a
three-country field study. J Clin Oncol. 1996;14:2756-2768.
Sprangers MAG, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA. Assessing meaningful changes
in quality of life over time: a user’s guide for clinicians. Mayo Clin Proc. 2002;77:561-571.
Sprangers MAG, Schwartz CE. Editorial: The challenge of response shift for quality-of-life-based
clinical oncology research. Ann Oncol. 1999;10:747-749.
D:\478174570.doc
Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a
theoretical model. Soc Sci Med. 1999 ;48(11):1507-1515.
Sprangers MAG, Sneeuw KCA. Are healthcare providers adequate raters of patients’ quality of lifeperhaps more than we think? Acta Oncol. 2000;39:5-8.
Sprangers MAG, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer. stoma vs
nonstoma patients. Dis Colon Rectum. 1995;38:361-369.
Sprangers MAG, te Velde A, Aaronson NK, Taal BG. Quality of life following surgery for colorectal
cancer: a literature review. Psycho-Oncol. 1993;2:247-259.
Sprangers MAG, Van Dam FSAM, Broersen J, et al. Revealing response shift in longitudinal research
on fatigue. Acta Oncol. 1999;38:709-718.
Sprangers MAG. Response-shift bias: a challenge to the assessment of patients’ quality of life in
cancer clinical trials. Cancer Treat Rev. 1996;22(suppA):55-62.
Spratt KF. Patient-level minimal clinically important difference based on clinical judgment and
minimally detectable measurement difference: a rationale for the SF-36 physical function scale in the
SPORT intervertebral disc hermiation cohort. Spine. (Phila Pa 1976); 2009 Jul 15:34(16):1722-31.
Spunberg JJ, Chang CH, Goldman M, Auricchio E, Bell JJ. Quality of long-term survival following
irradiation for intracranial tumors in children under the age of two. Int J Radiat Oncol Biol Phys.
1981;7(6):727-736.
Sredl D. Myths and facts about pain in neonates. Neonatal Network. 2003;22(6):69–71.
Sridhara R, Chen G, Chi GYH, Griebel DJ. evaluation of health-related quality of life measures in
oncology drug product applications: issues and concerns. J Biopharm Stat. 2004;14(1):23-30.
Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G. Studies with different types of
visual analog scales for measurement of pain. Clin Pharmacol Ther. 1983;34(2):234-239.
Staats HF, Bradney CP, Gwinn WM, et al. Cytokine requirements for induction of systemic and
mucosal CTL after nasal immunization. J Immunol. 2001;167(9):5386-5394.
Staff I, Salner A, Bohannon R, Panatieri P, Maljanian R. Disease-specific symptoms and general
quality of life of patients with prostate carcinoma before and after primary three-dimensional
conformal radiotherapy. Cancer. 2003;98:2335-2343.
Stafford L, Judd F. Long-term quality of life in Australian women previously diagnosed with
gynaecologic cancer. Support Care Cancer. 2011;19(12):2047-56
Stahl SM. The psychopharmacology of painful physical symptoms in depression. J Clin Psychiatry.
2002;63(5):382–383.
Stancliffe RJ. Proxy respondents and the reliability of the quality of life questionnaire empowerment
factor. J Intellectual Disability Res. 1999;43(3):185-193.
D:\478174570.doc
Stanton AL, Danoff-Burg S, Cameron CL, et al. Emotionally expressive coping predicts psychological
and physical adjustment to breast cancer. J Consult Clin Psychol. 2000;68(5):875-882.
Stanton AL, Danoff-Burg S, Sworowski LA, et al. Randomized, controlled trial of written emotional
expression and benefit finding in breast cancer patients. J Clin Oncol. 2002;20(20):4160-4168.
Stanton AL, Ganz PA, Kwan L, et al. Outcomes from the moving beyond cancer psychoeducational,
randomized, controlled trial with breast cancer patients. J Clin Oncol. 2005;23:6009-6018.
Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol.
2006;24(32):5132-5137.
Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life
assessments in clinical trials. Qual Life Res. 1996;5:496-502.
Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their
nature, associations, and relation to quality of Life. J Clin Oncol. 2002;20(14):3137-3148.
Di Stasi F, Blasi F, Conti S, Mantovani LG, Merlino L, Cesana G. PRS17-Cost of chronic obstructive
pulmonary disease: an health care administrative databases analysis. ISPOR 13th Annual European
Congress. 2010 (poster).
Stauder MC, Romero Y, Kabat B, Atherton PJ, Geno D, Deschamps C, Jatoi A, Sloan JA, Botros M,
Jung KW, Arora AS, Miller RC, for the EABE Registry Consortium. Overall survival and self-reported
fatigue in patients with esophageal cancer. Supportive Care in Cancer. 2013;21(2):511-520.
Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine reduced the frequency and severity of hot
flashes in some postmenopausal women. JAMA. 2003;289:2827-2834.
Stearns V, Hayes DF. Cooling off hot flashes. J Clin Oncol. 2002;20(6):1436-1438.
Stearns V, Johnson MD, Rae JM, et al. Active tamoxifen metaoblite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer
Inst. 2003;95:1758-1764.
Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a
prospective randomized clinical trial. J Clin Oncol. 2005;23:6919-6930.
Steel J, Baum A, Carr B. Quality of life in patients diagnozed with primary hepatocelluar carcinoma:
hepatic arterial infusion of cisplatin versus 90-yttrium microspheres (Therasphere). Psycho-Oncol.
2004;13:73–79.
Steel J, Eton D, Cella D, Olek M, Carr B. Clinically meaningful changes in health related quality of life
in patients diagnosed with hepatobiliary carcinoma. Ann Oncol 2006;17:304-312.
Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. Depression, immunity, and survival in patients
with hepatobiliary carcinoma. J Clin Oncol 2007;25(17):2397-2405.
D:\478174570.doc
Steensma DP, Loprinzi CL. Epoetin alfa and darbepoetin alfa go head to head. J Clin Oncol.
2006;24(15):2233-2236.
Steensma DP, Molina R, Sloan JA, et al. Phase III study of two different dosing schedules of
erythropoietin in anemic patients with cancer. J Clin Oncol. 2006;24:1079-1089.
Steensma DP, Hepinstall KV, Johnson VM, Novotny PJ, Sloan JA, Camoriano JK, Niblack JM, Mesa RA.
Common troublesome symptoms in their impacts on quality of life in patients with myelodyslpastic
syndromes (MDS): Results of a large internet-based survey. Science Direct. 2008; 32.
Steensma DP, Sloan JA, Dakhil SR, Dalton R, Kahanic SP, Prager DJ, Stella PJ, Rowland Jr KM,
Novotny PJ, Loprinzi CL. Phase III, randomized study of the effects of parentral iron, oral iron, or no
iron supplementation on the erythropoietic response to darbepoetin alfa for patients with
chemotherapy-associated anemia. Journal of Clinical Oncology. 2011;29(1):97-105.
Steer CB, Marx GM, Galani E, Harper PG, Khayat D. Quality of life: it’s never too late. J Clin Oncol.
2002;20(13):2915-2917.
Stefanek ME, Derogatis LP, Shaw A. Psychological distress among oncology patients: prevalence and
severity as measured with the Brief Symptom Inventory. Psychosomatics. 1987;28(10):530-539.
Stein KD, Denniston M, Baker F, Dent M, Hann DM, Bushhouse S, West M. Validation of a modified
Rotterdam Symptom Checklist for use with cancer patients in the United States. J Pain Symptom
Manage. 2003;26(5):975-989.
Steinbach S, Hummel T, Bohner C, Berktold S, Hundt W, Kriner M, Heinrich P, Sommer H, Hanusch C,
Prechtl A, Schmidt B, Bauerfeind I, Seck K, Jacobs VR, Schmalfeldt B, Harbeck N. Qualitative and
quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast
cancer or gynecologic malignancies. Journal of Clinical Oncology. 2009;27(11):1899-1905.
Steinberg T, Roseman M, Kasymjanova G, Dobson S, Lajeunesse L, Dajczman E, Kreisman H,
MacDonald N, Agulnik J, Cohen V, Rosberger Z, Chasen M, Small D. Prevalence of emotional distress
in newly diagnosed lung cancer patients. Supportive Care in Cancer. 2009;17(12):1493-1498.
Steinbrook R. Protecting research subjects – the crisis at Johns Hopkins. N Engl J Med.
2002;346(9):716-720.
Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, Holmberg L. Quality of
life after radical prostatectomy or watchful waiting. New Engl J Med. 2002;347(11):790-796.
Steinhauser KE, Clipp EC, Bosworth HB, et al. Measuring quality of life at the end of life: validation of
the QUAL-E. Palliat Support Care. 2004;2:3-14.
Steinhauser KE, Clipp EC, McNeilly M, Christakis NA, McIntyre LM, Tulsky JA. In search of a good
death: observations of patients, families, and providers. Ann Intern Med. 2000;132:825-832.
Stepanski EJ, Walker MS, Schwartzberg LS, Blakely LJ, Fu D, Fortner BV. Prevalence of insomnia and
associated symptoms in patients with cancer. Poster presented at ASCO. 2007;#9098.
D:\478174570.doc
Stephens R. The analysis, interpretation, and presentation of quality of life data. J Biopharm Stat.
2004;14(1):53-71.
Stephens RJ, Hopwood P, Girling DJ, Machin D. Randomized trials with quality of life endpoints: are
doctors’ rating of patients’ physical symptoms interchangeable with patients’ self ratings? Qual Life
Res. 1997; 6:225–236.
Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea
and vomiting in patients with advanced cancer. Support Care Cancer. 2006;14:348-353.
Stephenson N, Herman J. Pain measurement: a comparison using horizontal and vertical visual
analogue scales. Appl Nurs Res. 2000;13(3):157-158.
Stepp L, Pakis TS. Anorexia and cachexia in advanced cancer. Nurs Clin N Am. 2001;36:735–744.
Sterba KR, Swartz RJ, Basen-Engquist K, Black PC, Pettaway CA. Long-term quality of life after
radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial.
Supportive Care in Cancer. 2011;19(8):1117-1124.
Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple
imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ.
2009;339:157-160.
Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic
conditions. JAMA. 1989;262(7):907-913.
Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in
a patient population. Med Care. 1988;26(7):724-732.
Stewart AL, Hays RD, Wells KB, Rogers WH, Spritzer KL, Greenfield S. Long-term functioning and
well-being outcomes associated with physical activity and exercise in patients with chronic conditions
in the medical outcomes study. J Clin Epidemiol. 1994;47(7):719-730.
Stewart AL, Sherbourne CD, Wells KB, Burnam MA, Rogers WH, Hays RD, Ware JE, Jr. Do depressed
patients in different treatment settings have different levels of well-being and functioning? J Consult
Clin Psychol. 1993;61(5):849-857.
Stewart AL, Teno J, Patrick DL, Lynn J. The concept of quality of life of dying persons in the context
of health care. J Pain Symptom Manage. 1999;17(2):93-108.
Stewart AL. Conceptual and methodologic issues in defining quality of life: state of the art. Prog
Cardiovasc Nurs. 1992;7(1):3-11.
Stewart DE, Wong F, Cheung AM, et al. Information needs and decisional preferences among
women with ovarian cancer. Gynecologic Oncol. 2000;77:357-361.
Stiefel F, Die Trill M, Berney A, Olarte JMN, Razavi D. Depression in palliative care: a pragmatic
report from the Expert Working Group of the European Association for Palliative Care. Support Care
Cancer. 2001;9:477-488.
D:\478174570.doc
Stiefel F. Psychosocial aspects of cancer pain. Support Care Cancer. 1993;1:130-134.
Stiel S, Bertram L, Neuhaus S, Nauck F, Ostgathe C, Elsner F, Radbruch L. Evaluation and
comparison of two prognostic scores and the physician’s estimate of survival in terminally ill patients.
Supportive Care in Cancer. 2010;18(1):43-50.
Stiel S, Pastrana T, Balzer C, Elsner F, Ostgathe C, Radbruch L. Outcome assessment instruments in
palliative and hospice care – a review of the literature. Support Care Cancer. 2012;20(11):28792893.
Stiff PJ, Emmanouilides C, Bensinger WI, Gentile T, Blazar B, Shea TC, et al. Palifermin reduces
patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic
stem-cell transplantation setting. J Clin Oncol. 2006;24(33):5186-5193.
Stiff PJ, Shpall EJ, Liu PY, et al. Randomized Phase II trial of two high-dose chemotherapy regimens
with stell cell transplantation for the treatment of advanced ovarian cancer in first remission or
chemosensitive relapse: a Southwest Oncology Group study. Gynecol Oncol. 2004;64:98–106.
Stiggelbout AM, de Haes JCJM. Patient preference for cancer therapy: An overview of measurement
approaches. J Clin Oncol. 2001;19:220-230.
Stiggelbout AM, Kiebert GM, Kievit J, Leer JWH, Habbema JDF, DeHaes JCJM. The “utility” of the
time trade-off method in cancer patients: feasibility and proportional trade-off. J Clinic Epidemiol.
1995;48:1207-1214.
Stockler M, Osaba D, Goodwin P, Corey P, Tannock I. Responsiveness to change in health-related
quality of life in a randomized clinical trial: a comparison of the Prostrate Cancer Specific Quality of
Life instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific
module. Epidemiol. 1998;51(2):137-145.
Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IF. Convergent discriminitive, and predictive
validity of the prostate cancer specific quality of life instrument (PROSQOLI) assessment and
comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European
Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. J Clin
Epidemiol. 1999;52(7):653-666.
Stockler MR, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in
people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind,
placebo-controlled cross-over trial. J Clin Oncol. 2004;22:3389–3394.
Stocker MR, Wilcken NRC. Why is management of cancer pain still a problem? Journal of Clinical
Oncology. 2012;30(16):1907-1908.
Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, Isenberg DA. Consistency and validity
of patient administered assessment of quality of life by the MOS SF-36; Its association with disease
activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 1997;24:16081614.
D:\478174570.doc
Stone P, Richards M, A’Hern R, Hardy J. A study to investigate the prevalence, severity and
correlates of fatigue among patients with cancer in comparison with a control group of volunteers
without cancer. Ann Oncol. 2000;11:561-567.
Stone PC, Murphy RF, Matar HE, Almerie MQ. Quality of life in patients with prostate cancer:
development and application of a hybrid assessment method. Prostate Cancer Prostatic Dis.
2009;12(1):72-77.
Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper
diaries. BMJ. 2002;324(7347):1193-4.
Strahan R, Gerbasi KC. Short, homogeneous versions of the Marlow-Crowne social desirability scale.
J Clin Psychol. 1972;28:191-193.
Strandberg A, Strandberg TE, Salomaa VV, Pitkala K, Happola O, Miettinen TA. J Clin Epidemiol.
2004;57:415-421.
Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS
patients (review). Anti-Cancer Res. 1997;17:657–662.
Strang S, Strang P, Ternestedt, BM. Existential support in brain tumor patients and their spouses.
Support Care Cancer. 2001;9:625-633.
Strasser F, Fisch M, Bodurka DC, Sivesind D, Bruera E. E-motions: Email for written emotional
expression. J Clin Oncol. 2002;20(15):3352-3355.
Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, et al. Comparison of orally
administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancerrelated anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebocontrolled clinical trial from the Cannabis-in-Cachexia-Study-Group. J Clin Oncol. 2006;24(21):33943400.
Strasser F, Sweeney C, Willey J, Solley G, Palmer JL, Bruera E. Impact of a half-day multidisciplinary
symptom control and palliative care clinic in a cancer center on recommendations, symptom intensity,
and patient satisfaction. ASCO 2002 Poster Presentation.
Strasser F. The silent symptom early satiety: a forerunner of distinct phenotypes of
anorexia/cachexia syndromes. Support Care Cancer. 2006;14(7):689-692.
Straus DJ. Management of anemia in patients with hematologic malignancies. Oncology (Suppl).
2006;20(8):8-11.
Strauss N, Simon R. Investigating a sequence of randomized phase II trials to discover promising
treatments. Stat Med. 1995;14(13):1479-89.
Street RL, Gold WR, McDowell T. Using health status surveys in medical consultations. Med Care.
1994;32(7):732-744.
D:\478174570.doc
Street RL, Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality
of life. Med Decis Making. 1997;17(3):298-306.
Stricker KH, Cavegn R, Takala J, Rothen HU. Does ICU length of stay influence quality of life? Acta
Anaesthesiol Scand. 2005 Aug;49(7):975-83.
Strohscheer I, Verebes J, Samonigg H. Implementation of a palliative care team in an Austrian
university hospital. Support Care Cancer. 2006;14:795-801.
Strom S, Baldwin BJ, Sigurdson AJ, Schusterman MA. Cosmetic saline breast implants: a survey of
satisfaction, breast-feeding experience, cancer screening, and health. Plastic and Reconstructive
Surgery. 1997;100(6):1553-1557.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA,
Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA.
2000;283(15):2008-2012.
Stuart GW, Laraia MT, Ornstein SM, Nietert PJ. An Interactive Voice Response System to enhance
antidepressant medication compliance. Top Health Inform Manage. 2003;24(1):15–20.
Stull DE, Leidy NK, Jones PW, Stahl E. Measuring functional performance in patients with COPD: A
discussion of patient-reported outcome measures. Current Medical Research and Opinion.
2007;23(11):2655-2665.
Stull DE. Analyzing growth and change: latent variable growth curve modeling with an application to
clinical trials. Quality of Life Research. 2008;17:47-59.
Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal periods for patient-reported outcomes:
challenges and potential solutions. Current Medical Research and Opinion. 2009;25(4):929-42.
Stylianou M, Follmann DA. The accelerated biased coin up-and-down design in phase I trials. J
Biopharm Stat. 2004;14(1):249-260.
Subramanian U, Fihn SD, Weinberger M, et al. A controlled trial of including symptom data in
computer-based care suggestions for managing patients with chronic heart failure. Am J Med.
2004;116:375-384.
Sugar CA, Sturm R, Lee TT, Sherbourne CD, Olshen RA, Wells KB, Lenert LA. Empirically defined
health states for depression from the SF-12. Hlth Serv Res. 1998;33:911-928.
Sugarbaker PH, Barofsky I, Rosenberg SA, Gianola FJ. Quality of life assessment of patients in
extremity sarcoma clinical trials. Surg. 1982;91(1):17-23.
Sugawara Y, Akechi T, Shima Y, Ikuyama T, Akizuki N, Nakano T. Efficacy of methylphenidate for
fatigue in advanced cancer patients: a preliminary study. Palliat Med. 2002;16:261–263.
Sulmasy DP, McIlvane JM, Pasley PM, Rahn M. A scale fore measuring patient perceptions of the
quality of end-of-life care and satisfaction with treatment: the reliability and validity of QUEST. J Pain
Symptom Manage 2002;23(6):458-470.
D:\478174570.doc
Sun CC, Bodurka DC, Weaver CB, et al. Rankings and symptom assessments of side effects from
chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer.
2005;13:219–227.
Sun Y, Ren Y, Fang Z, Li C, Fang R, Gao B, Han X, Tian W, Pao W, Chen H, Ji H. Lung
Adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic
mutant kinases. Journal of Clinical Oncology. 2010;28(30):4616-4620.
Sun Z, Aubry M-C, Deschamps C, Marks RS, Okuno SH, Williams BA, Sugimara H, Pankratz S, Yang P.
Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an
analysis of 5018 hospital- and 712 population-based cases. The Journal of Thoracic and
Cardiovascular Surgery. 2006;131(5):1014-1020.
Sundaram M, Smith MJ, Revicki DA, Elswick B, Miller LA. Rasch analysis informed the development of
a classification system for a diabetes-specific preference-based measure of health. Journal of Clinical
Epidemiology. 2009;62:845-56.
Sutherland HJ Dunn V, Boyd NF. Measurement of values for states of health with linear analog
scales. Med Decis Making. 1983;3(4):477-487.
Sutherland HJ, Llewellyn-Thomas H, Boyd NF, Till JE. Attitudes toward quality of survival: the
concept of "maximum endurable time." Med Decis Making. 1982;2(3):299-309.
Sutherland HJ, Llewellyn-Thomas H, Lockwood GA, Tritchler DL, Till JE. Cancer patients: their desire
for information and participation in treatment decisions. J Roy Soc Med. 1989;82:260-263.
Sutherland HJ, Lockwood GA, Cunningham AJ. A simple, rapid method for assessing psychological
distress in cancer patients: Evidence of validity for linear analog scales. J Psychosoc Oncol.
1989;7:31-43.
Sutherland HJ, Walker P, Till JE. The development of a method for determining oncology patients’
emotional distress using linear analogue scales. Cancer Nurs. 1988;11(5):303-308.
Sutherland JE, Wesley RM, Cole PM, Nesvacil LJ, Daly ML, Gepner GJ. differences and similarities
between patient and physician perceptions fo patient pain. Fam Med. 1988;20(5):343-346.
Suzuki S, Akechi T, Kobayashi M, Taniguchi K, Goto K, Sasaki S, Tsugane S, Nishiwaki Y, Miyaoka H,
Uchitomi Y. Daily omega-3 fatty acid intake and depression in Japanese patients with newly
diagnosed lung cancer. Br J Cancer. 2004;90(4):787-793.
Svanberg A, Birgegard G, Ohrn K. Oral cryotherapy reduces mucositis and opioid use after
myeloablative therapy – a randomized controlled trial. Support Care Cancer. 2007;15:1155-1161.
Sweeney C, Schmitz, KH, Lazovich D, Virnig BA, Wallace RB, Folsom AR. functional limitation in
elderly female cancer survivors. J Natl Cancer Inst. 2006;98,8:521-529.
Swenson KK, Nissen MJ, Ceronsky C, Swenson, L, Lee MW, Tuttle TM. Comparison of side effects
between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surgical
Oncol. 2002;9(8):745-753.
D:\478174570.doc
Swoboda SM, Lipsett PA. Impact of a prolonged surgical critical illness on patient’s families. Am J Crit
Care. 2002;11(5):459(8).
Sydes MR, Spiegelhalter DJ, Altman DG, Babiker AB, Parmar MKB and the DAMOCLES Group.
Systematic qualitative review of the literature on data monitoring committees for randomized
controlled trials. Clin Trials. 2004;1:60–79.
Sylvester J, Blaski JC, Grimm P, Ragde H. Interstitial implatation techniques in prostate cancer. J
Surg Oncol. 1997;66:65-75.
Symonds T, Berzon R, Marquis P, et al. The clinical significance of quality of life results: practical
considerations for specific audiences. Mayo Clin Proc. 2002; 77:572-583.
Sze J, Marisette S, Williams D, Nyhof-Young J, Crooks D, Husain A, Bezjak A, Wong RKS. Decision
making in palliative radiation therapy: reframing hope in caregivers and patients with brain
metastases. Support Care Cancer. 2006;14:1055-1063.
Szeinbach SL, Baran RW, Bratten J, Jones MP. Psychometric development and validation of the
chronic constipation treatment satisfaction questionnaire (CTSAT-Q). Value in Health.
2009;12(6):1004-1010.
Szmukler GI, Burgess P, Herrman H, Benson A, Colusa S, Bloch S. Caring for relatives with serious
mental illness: the development of the experience of caregiving inventory. Psychiatry Psychiatr
Epidemiol. 1996;31:137-148.
Tack J, Von Roenn JH. A randomized, double-blind, placebo-controlled study to assess the efficacy
and safety of NKTR-118 in relieving opioid-induced constipation (OIC) in patients with cancer-related
pain. (Protocol Synopsis.) 6 pages
Taenzer P, Bultz BD, Carlson LE, Speca M, DeGagne T, Olson K, Doll R, Roseberger Z. Impact of
computerized quality of life screening on physician behavior and patient satisfaction in lung cancer
outpatients. Psycho-Oncology. 2000(3):203-213.
Taenzer PA, Speca M, Atkinson MJ, Bultz BD, Page S, Harasym P, Davis JL. Computerized quality-oflife screening in an oncology clinic. Cancer Pract. 1997;5(3):168-175.
Taft LB, Looker PA, Cella D. Osteoporosis: A disease management opportunity. Journal of
Orthopaedic Nursing. 2000;19(2): 67-76.
Takeuchi EE, Keding A, Awad N, Hofmann U, Campbell LJ, Selby PJ, Brown JM, Velikova G. Impact
of patient-reported outcomes in Oncology: a longitudinal analysis of patient-physician
communication. Journal of Clinical Oncology. 2011;29(21):2910-2917.
Talcott JA. Prostate cancer quality of life: beyond initial treatments –- and the patient. J Clin Oncol
2007;25(27):4155-4156.
Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate
cancer therapy. J Clin Oncol. 2003;21(21):3979–3986.
D:\478174570.doc
Tamburini M, Brunelli C, Rosso S, Ventafridda V. Prognostic value of quality of life scores in terminal
cancer patients. J Pain Symptom Manage. 1996;11(1):32-41.
Tan BHL, Deans DAC, Skipworth RJE, Ross JA, Fearon KCH. Biomarkers for cancer cachexia: is there
also a genetic component to cachexia? Support Care Cancer. 2008;16:229-234.
Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Development and validation of the Cancer
Dyspnea Scale: a multidimensional, brief, self-rating scale. Br J Cancer. 2000;82(4):800-805.
Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Impact of dyspnea, pain, and fatigue on
daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage.
2002;23(5):417–423.
Tang M-F, Liou T-H, Lin C-C. Improving sleep quality for cancer patients: benefits of a home-based
exercise intervention. Support Care Cancer. 2010;18(10):1329-1339.
Tangalos EG, Smith GE, Ivnik RJ, et al. The Mini-Mental State Examination in general medical
practice: clinical utility and acceptance. Mayo Clin Proc. 1996;71(9):829-837.
Tang H, Foster NR, Grothey A, Ansell SM, Goldberg RM, Sargent DJ. Comparison of error rates in
single-arm versus randomized phase II cancer clinical trials. Journal of Clinical Oncology.
2010;28(15):1936-1941.
Tangen CM, Goldman BH, Swanson GP, Thompson IM. Biased hormonal therapy duration analysis
makes results uninterpretable. Journal of Clinical Oncology. 2009;27(33):e203.
Taniguchi K, Akechi T, Suzuki S, Mihara M, Uchitomi Y. Lack of marital support and poor
psychological responses in male cancer patients. Support Care Cancer. 2003;11:604-610.
Tannock I, Gospodarowicz M, Meakin W, Panzarella T, Stewart L, Rider W. Treatment of metastatic
prostatic cancer with low-dose presnisone: evaluation of pain and quality of life as pragmatic indices
of response. J Clin Oncol. 1989;7:590-597.
Tannock I, Osoba D, Stockler MR, et al. Chemotherapy with mitoxantrone plus prednisone or
prednisone alone for symptomatic hormone-resistant prostate cancer: a canadian randomized trial
with palliative end points. J Clin Oncol. 1996;14:1756-1764.
Tannock I. Treating the patient, not just the cancer. N Engl J Med. 3(17):1534-1535, 1987.
Tannock I. When is a cancer treatment worthwhile? New Eng J Med. 1990;323(14):989-990.
Tannock IF, Ahles TA, Ganz PA, van Dam FS. Cognitive impairment associated with chemotherapy
for cancer: report of a workshop. J Clin Oncol. 2004;22:2233–2239.
Tao ML, Ganz PA. Looking beyond survival: assessment of quality-of-life in breast cancer patients.
Diseases of the Breast Updates. 1998;2(4):1-7.
Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with
low-grade gliomas: The impact of radiotherapy. Ann Neurol. 1994;36:48-54.
D:\478174570.doc
Taphoorn MJ, van den Bent MJ, Mauer MEL, Coens C, Delattre JY, Brandes AA, Sillevis Smitt PAE,
bernsen HJJA, et al. Health-related quality of life in patients treated for anaplastic oligodendroglioma
with adjuvant chemotherapy: results of a European Organization for Research and Treatment of
Cancer randomized clinical trial. J Clin Oncol. 2007;25(36):5723-5730.
Tardiff K, Cella D, Sieferth C, Perry S. Selection and change of specialties by medical school
graduates. Journal of Medical Education. 1986;61:790-796.
Targ EF, Levine EG. The efficacy of a mind-body-spirit group for women with breast cancer: a
randomized controlled trial. Gen Hosp Psychiatry. 2002 ;24:238-248.
Targum SD, Engelhardt N, Busner. Using IT tools to increase in-study ratings reliability. Evidence
Matters 2007; 13 (3)
Taskila T, Lindbohm M, Martikainen R, Lehto U, Hakanen J, Hietanen P. Cancer survivors’ received
and needed social support from their work place and the occupational health services. Support Care
Cancer. 2006;14:427-435.
Tassinari D, Maltoni M, Sartori S, Fantini M, Poggi B, Ravaioli A. Outcome research in palliative care:
could it represent a new dimension of clinical research or clinical practice? Support Care Cancer.
2005;13:176-181.
Tassinari D, Panzini I, Sartori S, Ravaioli A. Surrogate outcomes in quality-of-life research: Where
will we end up? Correspondence (Editorial) 1894, 2003.
Tassinari D, Montanari L, Maltoni M, Ballardini M, Piancastelli A, Musi M, Porzio G, Minotti V, Caraceni
A, Poggi B, Stella A, Aielli F, Scarpi E. The palliative prognostic score and survival in patients with
advanced solid tumors receiving chemotherapy. Support Care Cancer. 2008;16:359-370.
Tataryn D, Chochinov HM. Predicting the trajectory of will to live in terminally ill patients.
Psychosomatics. 2002;43(5):370-377.
Tattersall MHN, Gattellari M, Voight K, Vutow PN. When the treatment goal is not cure: are patients
informed adequately? Support Cancer Care. 2002;10:314-321.
Taussky D, Schneider U, Rousson V, Pescia R. Patient-reported toxicity correlated to dose-volume
histograms of the rectum in radiotherapy of the prostate. Am J Clin Oncol. 2003;26(5):144-149.
Taylor BV, Buckner JC, Cascino TL, et al. Effects of radiation and chemotherapy on cognitive function
in patients with high-grade glioma. J Clin Oncol. 1998;16:2195-2201.
Taylor KM, Bezjak A, Macdonald K, DePetrillo AD. MD-QOL: Predicting oncologist use of quality of life
information. Proc Annu Meet Am Soc Clin Oncol. 1995;14:A1665.
Tchekmedyian NS, Kallich J, McDermott A, Fayers P, Erder MH. The relationship between psychologic
distress and cancer-related fatigue. Cancer. 2003;98(1):198-203.
Tchekmedyian NS, Cella DF. Clinical usefulness of quality of life evaluations: The case of anorexia.
Contemporary Oncology. 1995;30-33. (Publication not available.)
D:\478174570.doc
Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in
women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 2003;21:4175-4183.
Tcheurekdjian H, Palermo T, Hostoffer R. Quality of life in common variable immunodeficiency
requiring intravenous immunoglobulin therapy. Ann Allergy Asthma Immun. 2004;93;160-165.
Tefferi A. Pharmaceutical Erythropoietin use in patients with cancer: Is it time to abandon ship or
just drop anchor? Mayo Clin Proc. 2007;82(11):1316-1318.
te Velde A, Sprangers MAG, Aaronson NK. Feasibility, psychometric, and stability across modes of
administration of the CARES-SF. Ann Oncol. 1996;7:381-390.
Temel JS, Pirl WF, Recklitis CJ, Cashavelly B, Lynch TJ. Feasibility and validity of a one-item fatigue
screen in a thoracic oncology clinic. J Thor Oncol. 2006;1(5):454-459.
Tempelaar R, de Haes JCJM, de Ruiter JH, Bakker D, van den Heuvel WJA, van Nieuwenhuijzen MG.
The social experiences of cancer patients under treatment: a comparative study. Soc Sci Med. 1989;
29(5):635-642.
Temple RJ. Implications of effects in placebo groups. Editorial: J Nat Cancer Inst. 2003;95(1):2-3.
Teno JM, Byock I, Field MJ. Research agenda for developing measures to examine quality of care
and quality of life of patients diagnosed with life-limiting illness. J Pain Symptom Manage.
1999;17(2):75-81.
Teno JM, Connor SR. Referring a patient and family to high-quality palliative care at the close of the
life: “We met a new personality…with this level of compassion and empathy.” JAMA.
2009;301(6):651-659.
Teno JM, Shu JE, Casarett D, Spence C, Rhodes R, Connor S. Timing of Referral to Hospice and
Quality of Care: Length of Stay and Bereaved Family Members’ Perceptions of the Timing of Hospice
Referral. Journal of Pain and Symptom Management. 2007;34(2):120-125.
Teno JM, Lima JC, Doyle Lyons K. Cancer patient assessment and reports of excellence: reliability
and validity of advanced cancer patient perceptions of the quality of care. Journal of Clinical
Oncology. 2009;27(10):1621-1626.
Ter Riet G, de Craen AJ, De Boer A, Kessels AG. Is placebo analgesia mediated by endogenous
opioid? A systematic review. Pain. 1998;76:273-275.
Terakado A, Watanabe T. Creation of a questionnaire to measure stress among nurses engaged in
palliatve care on general wards. Supportive Care in Cancer. 2012;20(10):2537-2544.
Tercyak KP, Peshkin BN, Brogan BM, DeMarco T, Pennanen MF, Willey SC, Magnatn CM, Rogers S,
Isaacs C, Schwartz MD. Quality of life after contralateral prophylactic mastectomy in newly
diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol.
2007;25(3):285-291.
D:\478174570.doc
Teresi D. Differential item functioning and health assessment. Summary Paper, Drug Information
Association, Advances in Health Outcomes Measurement, June 23–25, 2004 Meeting.
Teresi JA. Statistical methods for examination of differential item functioning (DIF) with applications
to cross-cultural measurement of functional, physical and mental health. Journal of Mental Health
and Aging. 2001;7(1):31-40.
Terraciano A, Lockenhoff CE, Zonderman AB, Ferrucci L, Costa PT. Personality Predictors of
Longevity: Activity, Emotional Stability, and Conscientiousness. Psychosomatic Medicine.
2008;70(6):621-627.
Terrell JE, Fisher SG, Wolf GT. Long-term quality of life after treatment of laryngeal cancer, Arch
Otolaryngol. Head Neck Surg. 1998;124;964-971.
Terry PC, Lane AM, Lane HJ, Keohane L. Development and validation of a mood measure for
adolescents. J Sports Med. 1999;17:861-872.
Terry PC, Lane AM. Normative values for hte profile of mood states for use with athletic samples.
Journal of Applied Sport Psychology. 2000;12:93-109.
Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific
quality of life questionnaire for patients with Graves’ opthalmopathy: the GO-QOL. Br J Ophthalmol.
1998;82:773-779.
Teschendorf B, Schwartz C, Ferrans CE, O’Mara A, Novotny P, Sloan JA. Caregiver role stress: when
families become providers. Cancer Control. 2007;14(2):183-189.
Testa MA Simonson DC. Assessment of quality-of-life outcomes. New Engl J Med. 1996;334(13):
835-840.
Testa MA, Anderson TB, Nackley JF, Hollenberg MK. Quality of life and antihypertensive therapy in
men: A comparison of captopril with enalapril. N Engl J Med. 1993;328:907-913.
Testa MA, Hollenburg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and
spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic
system. Am J Hypertens. 1991;4:363-373.
Testa MA, Nackley JF. Methods for quality of life studies. Ann Rev Publ Hlth. 1994;15:535-559.
Testa MA, Simonson DC. Assessment of quality of life (letter). N Engl J Med. 1996;335:521-522.
Teunissen JJM, Kwekkeboom DJ, Krenning EP. Quality of life in patients with gastroenteropancreatic
tumors with [177Lu-DOTA0,Tyr3] octreotate. J Clin Oncol. 2004;22:2724–2729.
Teutsch SM. A framework for outcomes research in cancer: response to Carolyn Clancy. Med Care.
2002;40(6) (Supplement):III-101-III-103.
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment
in solid tumors. J Nat Cancer Inst. 2000;92:205-216.
D:\478174570.doc
Therneau TM. How many stratification factors are “too many” to use in randomization plan? Control
Clin Trials. 1993;14:98-108.
Thiesse P, Ollivier L, Di Stefano-Louineau D, Negrier S, Savary J, Pignard K, Lasset C, Escudier B.
Response rate accuracy in oncology trials: reasons for interobserver variability. J Clin Oncol.
1997;15(12):3507-3514.
Thissen D. Developing Tailored Instruments: Item Banking and Computerized Adaptive Assessment.
Summary Paper, Drug Information Association, Advances in Health Outcomes Measurement,
June 23–25, 2004 Meeting.
Thomas BC, Pandey M, Ramdas K, et al. Identifying and predicting behaviour outcomes in cancer
patients undergoing curative treatment. Psycho-Oncol. 2004;13:490–493.
Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel
RJ. Methylnaltrexone for opioid-induced constipation in advanced illness. The New England Journal
of Medicine. 2008;358:2332-43.
Thombs BD, Bassel M, McGuire L, Smith MT, Hudson M, Haythornthwaite JA. A systematic
comparison of fatigue levels in systematic sclerosis with general population, cancer and rheumatic
disease samples. Rheumatology. 2008;47:1559-1563.
Thome B, Dykes A-K, Hallberg IR. Quality of life in old people with and without cancer. Qual Life
Res. 2004;13:1067–1080.
Thompson E, Sola I, Subirana M. Non-invasive interventions for improving well-being and quality of
life in patients with lung cancer – A systematic review of the evidence. Lung Cancer. 2005;50:163176.
Thompson GN, Chochinov HM, Wilson KG, McPherson CJ, Chary S, O’Shea FM, Kuhl DR, Fainsinger
RL, Gagnon PR, Macmillan KA. Prognostic acceptance and the well-being of patients receiving
palliative care for cancer. Journal of Clinical Oncology. 2009;27(34):5757-5762.
Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi
CL. Levetiracetam for the treatment of hot flashes: a Phase II study. Support Care Cancer
2008;16:75-82.
Thongprasert S, Sanguanmitra P, Umsa-wasdi T. Relationship between quality of life and clinical
outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus
chemotherapy. Proc Annu Meet Am Soc Clin Oncol. 1995;14:A1093.
Thongprasert S. Lung cancer and quality-of-life. Aust N Z J Med. 1998;28(3):397-399.
Thorsen L, Skovlund E, Stromme SB, Hornslien K, Dahl AA, Fossa SD. Effectiveness of physical
activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer
patients shortly after chemotherapy. J Clin Oncol. 2005;23:2378-2388.
Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. Discovering statistically significant
pathways in expression profiling studies. PNAS. 2005;102(38):13544-13549.
D:\478174570.doc
Tidhar D, Katz-Leurer M. Aqua lympohatic therapy in women who suffer from breast cancer
treatment-related lymphedema: a randomized controlled study. Support Care Cancer. 2010
Mar;18(3):383-92. Epub 2009 Jun 3. Erratum in: Support Care Cancer. 2010 Mar;18(3):393.
Tieman J, Sladek R, Currow D. Changes in the Quantity and Level of Evidence of Palliative and
Hospice Care Literature: The Last Century. Journal of Clinical Oncology. 2008;26(35):5679-5683.
Tierney WM, McKinley ED. When the physician-researcher gets cancer: understanding cancer, its
treatment, and quality of life from the patient's perspective. Med Care. 2002;40(6) (Supplement):
III-20-III-27.
Tiffany R. Quality of life for patients receiving chemotherapy and hormonal therapy. Recent Results
Cancer Res. 1988;108:316-318.
Till JE, Osoba D, Pater JL, Young JR. Research on health-related quality of life: dissemination into
practical applications. Qual Life Res. 1994;3:279-283.
Till JE. Measuring quality of life: apparent benefits, potential concerns. Can J Oncol. 1994;
4(1):243-248.
Tilson H, Spilker B. Guest Editorial-Bibliography. Med Care. 1990;28(12):DS1–DS29.
Tisdale MJ. Cachexia in cancer patients. Nature Reviews. 2002;2:862–870.
Tishelman C, Taube A, Sachs L. Self-reported symptom distress in cancer patients: Reflections of
disease, illness or sickness? Soc Sci Med. 1991;33:1229-1240.
Tishelman C, Petersson L-M, Degner LF, Sprangers MAG. Symptom prevalence, intensity, and
distress in patients with inoperable lung cancer in relation to time of death. J Clin Oncol.
2007;25(34):5381-5389.
Tishelman C, Lovgren M, Broberger E, Hamberg K, Sprangers MAG. Are the most distressing
concerns of patients with inoperable lung cancer adequately assessed? A mixed-methods analysis.
Journal of Clinical Oncology. 2010;28(15):1942-1949.
Tombaugh TN. Trail making test a and b: normative data stratified by age and education. Arch Clin
Neuropsychol. 2004;19:203–214.
Tomich PL, Helgeson VS. Five years later: a cross-sectional comparision of breast cancer survivors
with healthy women. Psycho-Oncol. 2002;11:154-169.
Tomlinson D, Hinds PS, Bartels U, Hendershot E, Sung L. Parent reports of quality of life for pediatric
patients with cancer with no realistic chance for cure. Journal of Clinical Oncology. 2011;29(6):639645.
Tonkin K, Tritchler D, Tannock I. Criteria of tumor response used in clinical trials of chemotherapy. J
Clin Oncol. 1985;3(6):870-875.
D:\478174570.doc
Torrance GW, Feeny D. Utilities and quality-adjusted life years. Intl J Technol Assess Hlth Care.
1989;5:559-575.
Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions: Health Utilities
Index. Pharmacoeconom. 1995;7:503-520.
Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis. 1987;
40(6):593-600.
Torri V, Simon R, Russek-Cohen E, Midthune D, Friedman M. Statistical model to determine the
relationship of response and survival in patients with advanced ovarian cancer treated with
chemotherapy. J Natl Cancer Inst. 1992;84:376-378.
Townsely CA, Selby R, LSiu LL. Systematic review of barriers to the recruitment of older patients with
cancer onto clinical trials. J Clin Oncol. 2005;23:3112-3124.
Townsley CA, Naidoo K, Pond GR, Melnick W, Straus SE, Siu LL. Are older cancer patients being
referred to oncologists? a mail questionnaire of Ontario primary care practitioners to evaluate their
referral patterns. J Clin Oncol. 2003;21:4627–4634.
Townsley CA, Pond GR, Peloza B, et al. Analysis of treatment practices for elderly cancer patients in
Ontario, Canada. J Clin Oncol. 2005;23(16):3802-3810.
Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SC. Symptoms tell it all: a systematic review
of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol
Hematol. 2012;84(1):130-148. doi: 10.1016/j.critrevonc.2012.02.011.
Trask PC, Paterson AG, Esper P, Pau J, Redman B. Longitudinal course of depression, fatigue, and
quality of life in patients with high risk melanoma receiving adjuvant interferon . Psycho-Oncol.
2004;13:526–536.
Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;32:80-92.
Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME,
Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van
Leeuwen FE, Williams JP, Nichols CR, Einhorn LH, Fossa SD. Testicular cancer survivorship: research
strategies and recommendations. JNCI. 2010;102(15):pages 1-17.
Treish I, Shord S, Valgus J, Harvey D, Nagy J, Stegal J, Lindley C. Randomized double-blind study of
the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly
emetogenic chemotherapy. Support Care Cancer. 2003;11:516-521.
Tremblay A, Sheeran L, Aranda SK. Psychoeducational interventions to alleviate hot flashes: a
systematic review. Menopause. 2008;15(1):193-202.
Trice Loggers E, Maciejewski PK, Paulk E, DeSanto-Madeya S, Nilsson M, Viswanath K, Wright AA,
Balboni TA, Temel J, Stieglitz H, Block S, Prigerson HG. Racial differences in predictors of intensive
end-of-life care in patients with advanced cancer. Journal of Clinical Oncology. 2009;27(33):55595564.
D:\478174570.doc
Trillet-Lenoir V, Freyer G, Kaemmerlen P, et al. Assessment of tumour response to chemotherapy for
metastatic colorectal cancer: accuracy of the RECIST criteria. Br J Radiol. 2002;75(899):903-908.
Trimble EL, Rowland J, Varricchio C, Gore-Langton RE. Health-related quality of life in cancer clinical
trials. Oncol. 2001;15(4):456-466.
Trippa L, Lee EQ, Wen PY, Batchelor TT, Cloughesy T, Parmigiani G, Alexander BM. Bayesian
adaptive randomized trial design for patients with recurrent glioblastoma. Journal of Clinical
Oncology. 2012;30(26):3258-3263.
Troidl H, Kusche J, Vestweber KH, Eypasch E, Koeppen L, Bouillen B. Quality of life: an important
endpoint both in surgical practice and research. J Chronic Dis. 1987;40:523-528.
Tross S, Herndon J, Korzun A, Kornblith AB, Cella DF, Holland JF, Raich P, Johnson A, Kiang DT,
Perloff M, Norton L, Wood W, Holland JC. Psychological symptoms and disease-free and overall
survival in women with stage II breast cancer. Journal of the National Cancer Institute.
1996;88(10):661-667.
Trotti A, Bentzen S. the need for adverse effects reporting standards in oncology clinical trials. J Clin
Oncol. 2004;22(1):19–22.
Trotti A, Byhardt R, Stetz J, et al. Common Toxicity Criteria: Version 2.0. An improved reference for
grading the acute effects of cancer treatment: impact on radiotherapy. Int J Rad Oncol Biol Phys.
2000; 47(1):13-47.
Trotti A, Dimitrios Colevas A, Setser A, et al. CTCAE v3.0: development of a comprehensive grading
system for the adverse effects of cancer treatment. Sem Rad Oncol. 2003;13(3):176-181.
Trotti A. The evolution of toxicity criteria and reporting standards. Sem Rad Onc. 2002;12(1, Suppl
1):1-3.
Trotti A. Toxicity in head and neck cancer: a review of trends and issues. [Review] Intl J Rad Oncol,
Biol Phys. 2000;47(1):1-12.
Troup JD. Some problems of measurment in clinical trials of physiotherapy, with particular reference
to the assessment of pain. Physiotherapy. 1970;56(11):491-496.
Troxel AB, Esserman DA. Frailty models for quality of life in oncology. J Biopharm Stat.
2004;14(1):145-154.
Troxel AB, Fairclough DL, Curran D, Hahn EA. Statistical analysis of quality of life with missing data
in cancer clinical trials. Stat Med. 1998;17:653–666.
Truong PT, Bernstein V, Wai E, Chua B, Speers C, Olivotto IA. Age-related variations in the use of
axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int Rad Oncol Bio
Phys. 2002;54(3)794-803.
Tsai AC, Morton SC, Mangione CM, Keeler EB. A meta-analysis of interventions to improve care for
chronic illnesses. Am J Manage Care 2005;11:478-488.
D:\478174570.doc
Tsai SC, Liu LN, Tang ST, Chen JC, Chen ML. Cancer pain as the presenting problem in emergency
departments: incidence and related factors. Supportive Care in Cancer. 2010;18(1):57-66.
Tseng T-H, Cleeland CS, Wang XS, Lin C-C. Assessing cancer symptoms in adolescents with cancer
using the Taiwanese version of the M.D. Anderson Symptom Inventory. Cancer Nursing.
2008;31(3):E9-E16.
Tsianakas V, Robert G, Maben J, Richardson A, Dale C, Wiseman T. Implementing patient-centered
cancer care: using experience-based co-design to improve patient experience in breast and lung
cancer services. Support Care Cancer. 2012;20(11):2639-2647.
Tubach F, Wells GA, Ravaud P, Dougados M. Minimal clinically important difference, low disease
activity state, and patient acceptable symptom state: methodological issues. J Rheumatol. 2005
Oct;32(10):2025-9.
Tuinman MA, Hoekstra HJ, Sleijfer DT, Fleer J, Vidrine DJ, Gritz ER, Hoekstra-Weebers JEHM.
Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in
couples before and after chemotherapy. Support Care Cancer. 2007;15:279-286.
Tukey JW. One Degree of Freedom for Non-Additivity. Biometrics. 1949;5(3):232-242.
Tullis De, Guyatt GH. Quality of life in cystic fibrosis. Pharmacoeconomics. 1995;8(1):23–33.
Turini M, Redaelli A, Gramegna P, Radice D. Quality of life and economic considerations in the
management of prostrate cancer. Pharmacoeconomics. 2003;21(8):527-541.
Turk D. Statistical significance and clinical significance are not synonyms. Editorial: Clin J Pain.
2000;16:185-187.
Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT,
et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain.
2003;106:337-345.
Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, et al. Core outcome
domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2006;125:208-215.
Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, Cleeland CS, Cowan P, Farrar JT,
Hertz S, Max MB, Rappaport BA. Identifying important outcome domains for chronic pain clinical
trials: An IMMPACT Survey of People with Pain. Pain, in press, 2008.
Turner-Bowker DM, Bayliss MS, Ware JE, Kosinski M. Usefulness of the SF-8 Health Survey for
comparing the impact of migraine and other conditions. Qual Life Res. 2003;12:1003–1012.
Turner-Cobb JM, Sephton SE, Koopman C, Blake-Mortimer J, Spiegel D. Social support and salivary
cortisol in women with metastatic breast cancer. Psychosomatic Med. 2000;62:337-345.
Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, et al. Etanercept
and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled
randomised phase III trial . Lancet 2006;367(9504):29-35.
D:\478174570.doc
Tyson PD, Pongruenphant R, Aggarwal B. Coping with organizational stress among hospital nurses in
Southern Ontario. Int J Nurs Stud. 2002;39:453-459.
Tzuh Tang S, McCorkle R. Use of family proxies in quality of life research for cancer patients at the
end of life: a literature review. Cancer Investigation. 2002;20(7&8):1086-1104.
Ubel PA, Smith DM, Zikmund-Fisher BJ, Derry HA, McClure J, Stark A, Wiese C, Greene S, Jankovic A,
Fagerlin A. Testing whether decision aids introduce cognitive biases: results of a randomized trial.
Patient Education and Counseling. 2009 December [Epub ahead of print] 6 pages.
Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical
practice. Sem Dialysis. 2005;18(2):82-90.
Urban N. Developing measures of mammography performance. Med Care.
2002;40(6)(Supplement): III-86-III-88.
Vacek PM, Winstead-Fry P, Secker-Walker RH, Hooper GJ. Factors influencing quality of life in breast
cancer survivors. Qual Life Res. 2003;12:527-537.
Vainio A, Auvinen A. Prevalence of symptoms among patients with advanced cancer: An international
collaborative study. J Pain Symptom Manage. 1996;12:3-10.
Valderas JM, Alonso J, Prieto L, Espallargues M, Castells X. Content-based interpretation aids for
health-related quality of life measures in clinical practice. an example for the Visual Function Index
(VF-14). Qual Life Res. 2004;13:35–44.
Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, Revicki DA, Symonds T,
Parada A, Alonso J. The impact of measuring patient-reported outcomes in clinical practice: a
systematic review of the literature. Qual Life Res. 2008;17(2):179-193.
Valentine AD, Meyers CA. Copgnitive and mood disturbance as causes and symptoms of fatigue in
cancer patients. Cancer. 2001;92(6 Suppl):1694-1698.
Vallance JK, Lavallee CM, Culos-Reed NS, Trudeau MG. Physical activity is associated with clinically
important differences in health-related quality of life among rural and small-town breast cancer
survivors. Supportive Care in Cancer. 2012;20(5):1079-1087.
Vallance JKH, Courneya KS, Plotnikoff RC, Yasui Y, Mackey JR. Randomized controlled trial of the
effects of print materials and step pedometers on physical activity and quality of life in breast cancer
survivors. J Clin Oncol 2007;25(17):2352-2359.
van Belle S, Paridaens R, Evers G, et al. Comparison of proposed diagnostic criteria with FACT-F and
VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer. 2005;13:
246-254.
van Cutsem E, Peeters M, Siena S, Humblet Y, Hendlisz A, Neyns B, Canon J, et al. Open-label phase
II trial of panitumumab plus best supportive care compared with best supportive care alone in
patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol. 2007;25(13):16581664.
D:\478174570.doc
van Dam CJ, Becker KM, Ndowa F, Islam MQ. Syndromic approach to STD Case Management:
Where do we go from here? Sex Transm Infect. 1998;74 Suppl 1:S175–178.
van de Poll-Franse LV, Sadetsky N, Kwan L, Litwin S. Severity of cardiovascular disease and healthrelated quality of life in men with prostate cancer: a longitudinal analysis from CaPSURE. Quality of
Life Research. 2008;17:845-855.
Van den Berg JP, Kalmijn S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in
patients with ALS. American Academy of Neurology. 2010;1264-1267.
van den Brink M, van den Hout WB, Stiggelbout AM, et al. Cost-utility analysis of preoperative
radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch
Colorectal Cancer Group. J Clin Oncol. 2004;22:244–253.
van der Zee J, Review: Heating the patient: a promising approach? Ann Oncol. 2002;13:1173–
1184.
van Dijik S, van Roosmalen MS, Otten W, Stalmeier PFM. Decision making regarding prophylactic
mastectomy: Stability of preferences and the impact of anticipated feelings of regret. J Clin Oncol.
2008;26(14):2358-2363.
van Exel NJA, Scholte op Reimer WJM, Brouwer WBF, et al. Instruments for assessing the burden of
informal caregiving for stroke patients in clinical practice: a comparison of CSI, CRA, SCQ, and SelfRated Burden. Clinical Rehab. 2004;18:203–214.
van Gossum A, Kurian R, Whitwell J, Jeejeebhoy KN. Decrease in lipid peroxidation measured by
breath pentane output in normals after oral supplementation with vitamin E. Clin Nutrition. 1988;7:
53-57.
van Heijl M, Sprangers MA, de Boer AG, Lagarde SM, Reitsma HB, Busch OR, Tilanus HW, van
Lanschot JJ, van Berge Henegouwen MI. Preoperative and early postoperative quality of life predict
survival in potentially curable patients with esophageal cancer. Ann Surg Oncol. 2009; October 15
online.
van Holten-Verzantvoort ATM, Zwinderman AH, Aaronson NK, et al. The effect of supportive
pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J
Cancer. 1991;27(5):544-549.
van Oostrom I, Meijers-Heijboer H, Lodder LN, et al. J Clin Oncol. 2003;21:3867-3874.
van Roosmalen MS, Stalmeier PFM, Verhoef LCG, et al. Randomized trial of a shared decision-making
intervention consisting of trade-offs and individualized treatment information for BRCA1/2 Mutation
Carriers. J Clin Oncol. 2004;22(16);3293–3301.
van Rossum LGM, Laheij RJF, Vlemmix F, Jansen JBMJ, Vergeugt FWA. Health-related quality of life
in patients with cardiovascular disease--the effect of upper gastrointestinal symptom treatment.
Ailment Pharmacol Ther. 2004;19:1099-1104.
D:\478174570.doc
van Tulder MW, Aaronson NK, Bruning PF. The quality of life of long-term survivors of Hodgkin's
disease. Ann Oncol. 1994;5:153-158.
van Weert E, Hoekstra-Weebers J, Otter R, Postema K, Sanderman R, van der Schans C. Cancerrelated fatigue: predictors and effects of rehabilitation. Oncologist. 2006;11:184-196.
Vanderwerker LC, Laff RE, Kadan-Lottick NS, McColl S, Prigerson HG. Psychiatric disorders and
mental health service use among caregivers of advanced cancer patients. J Clin Oncol.
2005;23:6899-6907.
Vandyk AD, Harrison MB, Macartney G, Ross-White A, Stacey D. Emergency department visits for
symptoms experienced by oncology patients: a systematic review. Supportive Care in Cancer.
2012;20(8):1589-1599.
Vansteenkiste J, Pirker R, Massute B, et al. Double-blind, placebo-controlled, randomized phase III
trial of Darbepoetin Alpha in lung cancer patients receiving cheotherapy. J Nat Cancer. 2002;94
(6):1211-1220.
Vansteenkiste J, Tomita D, Rossi G, Pirker R. Darbepoetin alfa in lung cancer patients on
chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-tosevere anaemia at baseline. Support Care Cancer. 2004;12:253–262.
Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a
review of published studies and recommendations for future research. J Clin Oncol
2007;25(17):2455-2463.
Vardy J, Wong K, Yi Q, Park A, Maruff P, Wagner L, Tannock IF. Assessing cognitive function in
cancer patients. Support Care Cancer. 2006;14:1111-1118.
Vargo J, Howard K, Petrillo J, Scott J, Revicki DA. Development and validation of the patient and
clinician sedation satisfaction index for colonscopy and upper endoscopy. Clin Gastroenterol Hepatol.
2009;7(2):156-162.
Varni JW, Seid M, Rode CA. The PedsQLTM: measurement model for the pediatric quality of life
inventory. Med Care. 1999;37:126-139.
Varni JW, Limbers CA, Newman DA. Using factor analysis to confirm the validity of children’s selfreported health-related quality of life across different modes of administration. Journal of the Society
for Clinical Trials. 2009;6(2):185-195.
Veit CT, Ware JE Jr. The structure of psychological distress and well-being in general populations. J
Consult Clin Psychol. 1983;51:730-742.
Velanovich V, Gabel M, Walker EM, et al. Causes for the undertreatment of elderly breast cancer
patients: tailoring treatments to individual patients. J Am Coll Surg. 2002;194(1):8-13.
Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg.
1999;177(3):184-187.
D:\478174570.doc
Velanovich V. Experience with a generic quality of life instrument in a general surgical practice. Intl
J Surgical Investigation 1999;1(5):447-452.
Velanovich V. The quality of quality of life studies in general surgical journals. J Am Coll Surg.
2001;193:288-296.
Velikova G. Patient benefits from psychosocial care: screening for distress and models of care.
Journal of Clinical Oncology. 2010;28(33):4871-4873.
Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves
communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22:714724.
Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves
communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–
724.
Velikova G, Brown JM, Smith AB, Selby PJ. Computer-based quality of life questionnaires may
contribute to doctor-patient interactions in oncology. Br J Cancer. 2002;86(1):51-59.
Velikova G, Keding A, Harley C, Cocks K, Booth L, Smith AB, Wright P, Selby PJ, Brown JM. Patients
report improvements in continuity of care when quality of life assessments are used routinely in
oncology practice: Secondary outcomes of a randomized controlled trial. European Journal of
Cancer. 2010;46:2381-2388.
Velikova G, Wright EP, Smith AB, et al. Automated collection of quality-of-life data: A comparison of
paper and computer touch-screen questionnaires. J Clin Oncol. 1999;17:998-1007.
Velikova G, Wright P, Smith AB, et al. Self-reported quality of life if individual cancer patients:
concordance of resutls with disease course and medical records. J Clin Oncol. 2001;19(7):20642073.
Vella-Brodrick DA, Allen FC. Development and psychometric validation of the mental, physical, and
spiritual well-being scale. Psychol Rep. 1995;77(2):659-674.
Vera-Llonch, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic
hematopoietic stem-cell transplationin patients with hematologic malignancies. Support Care Cancer.
2007;15(5):491-496.
Verstovsek S, Kantarjian H, Mesa RA, Pardanani AD, Cortest-Franco J, Thomas DA, Estrov Z, Fridman
JS, Bradley EC, Erickson-Viitanen S, Vaddi K, Levy R, Tefferi A. Safety and efficacy of INCB018424, a
JAK1 and JAK2 inhibitor, in myelofibrosis. NEJM. 2010;363:1117-27.
Ververs JMMA, Roumen RMH, Vingerhoets AJJM, et al. Risk, severity and predictors of physical and
psychological morbidity after axillary lymph node dissection for breast cancer. Euro J Cancer.
2001;37:991-999.
Vickers AJ. Prediction models: revolutionary in principle, but do they do more good than harm?
Journal of Clinical Oncology. 2011;29(22):2951-2.
D:\478174570.doc
Vickers AJ. The use of percentage change from baseline as an outcome in a controlled trial is
statistically inefficient: a simulation study. BMC Medical Research Methodology. 2001;1:6.
Vickers AJ, Phil D, McCarney R, Phil M. Use of a single global assessment to reduce missing data in a
clinical trial with follow-up at one year. Contol Clin Trials. 2003;24:731–735.
Vickers AJ, Straus D, Fearon B, Cassileth BR. Acupuncture for postchemotherapy fatigue: a phase II
study. J Clin Oncol. 2004;22(9):1731–1735.
Vickers AJ. Multiple assessment in quality-of-life trials: how many questionnaires? How often should
they be given? J Soc Integr Oncol. 2006;4(3):135-138.
Vickers AJ. Statistical considerations for use of composite health-related quality-of-life scores in
randomized trials. Qual Life Res. 2004;13:717–723.
Vickers AJ. How to improve accrual to clinical trials of symptom control 1: Recruitment strategies.
Journal of the Society for Integrative Oncology. 2007;5(1):38-42.
Vickrey BG, Hays RD, Engel J Jr, et al. Outcome assessment for epilepsy surgery: the impact of
measuring health-related quality of life. Ann Neurol. 1995;37(2):159-166.
Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW. Comparison of a generic to diseasetargeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol.
1997;50(5):557-569.
Vickrey BG, Hays RD, Graber J, Rausch R, Engel J Jr, Brook RH. A health-related quality of life
instrument for patients evaluated for epilepsy surgery. Med Care. 1992;30(4):299-319.
Vickrey BG, Hays RD, Rausch R, et al. Outcomes in 248 patients who had diagostic evaluations for
epilepsy surgery. Lancet. 1995;346:1445-1449.
Vickrey BG, Hays RD, Rausch R, Sutherling WW, Engel J Jr, Brook RH. Quality of life of epilepsy
surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or
depressive symptoms. Epilepsia. 1994;35(3):597-607.
Victorson D, Soni M, Cella D. Meta-analysis of the relationship between tumor response and patientreported outcomes. Cancer 2006;106(3):494-504.
Videtic GMM, Reddy CA, Sorenson L. A prospective study of quality of life including fatigue and
pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung
cancer. Supportive Care in Cancer. 2013;21(1):211-218.
Vietti TJ. Evaluation of toxicity: clinical issues. Cancer Treat Rep. 1980;64(2-3):457-61.
Villalon An, Chan V. Multicenter, randomized trial of ramosetron plus dexamethasone versus
ramosetron alone in controlling cisplatin-induced emesis. Support Care Cancer. 2004;12:58–63.
D:\478174570.doc
Villareal DT, Fontana L, Weiss EP, Racette SB, Steger-May K, Schechtman KB, Klein S, Holloszy JO.
Bone mineral density response to caloric restriction-induced with loss or exercise-induced weight loss:
a randomized controlled trial. Arch Intern Med. 2006;166:2502-2510.
Vincent C. Understanding and responding to adverse events. New Engl J Med. 2003;348(11):10511056.
Vincent M, Dranitsaris G, Verma S, Lau C, Gascon P, Van Belle S, Ludwig H. The development and
validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall
cell lung cancer receiving palliative chemotherapy. Support Care Cancer. 2007;15:265-272.
Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RKS, Supportive Care Guidelines Group of
the Cancer Care Ontario Program in Evidence-Based Care. The management of dyspnea in cancer
patients: a systematic review. Support Care Cancer. 2008;16:329-337.
Visser MRM, Oort FJ, Sprangers MAG. Methods to detect response shift in quality of life data: a
convergent validity study. Quality of Life Research. 2005;14:629-639.
Visser A, Van Andel G. Education and counseling in cancer: the neglected case of the prostate
cancer patients. Patient Educ Couns. 2000;40(3):197-199.
Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye
symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose,
multicenter trial. Arch Int Med. 1999;159(2):174-181.
Vlastos G, Mirza NO, Meric F, et al. Breast conservation therapy as a treatment option for the elderly.
Cancer. 2001;92(5):1092-1100.
Vodermaier A, Millman R. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool
in cancer patients: a systematic review and meta-analysis. Supportive Care in Cancer. 2011;19(12);
1899-1908.
Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver and oncologist perceptions of cancerrelated fatigue: Results of a tripat assessment survey. Seminars in Hematology. 1997;34(3):4-12.
Vohra JU, Brazil K, Szala-Meneok K. The Last Word: Family Members’ descriptions of end-of-life care
in long term care facilities. Journal of Palliative Care. 2006;22:33-39.
Voltz R, Galushko M, Walisko J, Karbach U, Ernstmann N, Pfaff H, Nauck F, Radbruch L, Ostgathe C.
Issues of “life” and “death” for patients receiving palliative care - comments when confronted with a
research tool. Supportive Care in Cancer. 2011;19(6):771-778.
Voogt E, van der Heide A, van Leeuwen AF, Visser AP, Cleiren MP, Passchier J, van der Maas PJ.
Positive and negative affect after diagnosis of advanced cancer. Psychooncology. 2005;14(4):26273.
Vora VA, Ahmedzai SH. Pulse oximetry in supportive and palliative care. Supportive Care Cancer.
2004;12:758-61.
D:\478174570.doc
Vroege JA, Aaronson NK. Type A behavior and social support among employed women. Behav Med.
1994;19:169-173.
Waber DP, Turek J, Catgania L, Stevenson K, Robaey P, Romero I, Adams H, Alyman c, JandetBrunet C, Neuberg DS, Sallan SE, Silverman LB. Neuropsychological outcomes from a randomized
trial of triple intrathercal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in
acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol
95-01. J Clin Oncol 2007;25(31):4914-4921.
Wacholder S, Carroll RJ, Pee D, Gail MH. The partial questionnaire design for case-control studies.
Stats Med. 1994;13(5-7):623-634.
Wachtel T, Peitte J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human
immunodeficiency virus infection: Measurement by the medical outcomes study instrument. Ann
Intern Med. 1992;116:129-137.
Wadler S, Brain C, Catalano P, Einzig AI, Cella D, Benson AB. Randomized phase II trial of either
fluorouracil, parenteral hydroxyurea, interferon-alpha-2a, and filgrastism or doxorubicin/docetaxel in
patients with advanced gastric cancer with quality-of-life assessment: eastern cooperative oncology
group study E6296. Cancer J. 2002;8(3):282-286.
Wadler S, Ryan L, Rothenberg ML, Cleeland C, Cella D, Giguere JK, Stucky-Marshall L, Benson III AB.
Randomized trial of standard-dose octreotide acetate for chemotherapy-induced diarrhea (E1295): An
intergroup study of the Eastern Cooperative Oncology Group. Advances in Oncology. 2002:227-234.
Wagner AK, Ehrenberg BL, Tran TA, Bungay KM, Cynn DJ, Rogers WH. Patient-based health status
measurement in clinical practice: a study of its impact on epilepsy patients’ care. Qual Life Res.
1997;6:329-341.
Wagner AK, Gandek B, Aaronson NK, et al. Cross-cultutal comparisons of the content of SF-36
translations across 10 countries: results from the IQOLA project. J Clin Epidemiol. 1998;51(11):925932.
Wagner L, Cella D. Fatigue and cancer: Causes, prevalence and treatment approaches. British
Journal of Cancer. 2004;91:822-828.
Wagner L, Cella D. The Lipman/Lawrence Article Reviewed (fatigue). Oncology. 2004;18(12):15361538.
Wagner LI, Lacouture ME. Dermatologic toxicities associated with EGFR inhibitors: The clinical
psychologist’s perspective. Oncology 2007; 21(11).
Wagner TH, Patrick DL, Galer BS, Berzon RD. A new instrument to assess the long-term quality of
life effects from migraine: Development and psychometric testing of the MSQOL. Headache.
36:484-492, 1996.
Wagner LI, Beaumont JL, Ding B, Malin J, Peterman A, Calhoun E, Cella D. Measuring health-related
quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy:
validation of the Functional Assessment of Cancer Therapy – Neutropenia (FACT-N). Support Care
Cancer. 2008;16:47-56.
D:\478174570.doc
Wakefield JA. Relationship between two expressions of reliability: percentage agreement and phi.
Educational and Psychological Measurement. 1980;40(3):593-597.
Wakelee HA, Change ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, et al.
Lunc cancer incidence in never smokers. J Clin Oncol. 2007;25(5):472-478.
Walco GA. Commentary: psychologists in pediatric oncology: kudos, criticism, and courses for the
future. J Ped Psychol. 2005;30(1):115-118.
Waljee JE, Halwey S, Alderman AK, Morrow M, Katz SJ. Patient satisfaction with treatment of breast
cancer: Does surgeon specialization matter? J Clin Oncol 2007;25(24):3694-3698.
Waljee JE, Hu ES, Ubel PA, Smith DM, Newman LA, Alderman AK. Effect of Esthetic outcome after
breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol.
2008;26(20):3331-3337.
Walker J, Sofaer B. Predictors of psychological distress in chronic pain patients. J Adv Nurs.
1998;27(2):320-326.
Walker J, Waters RA, Murray G, Swanson H, Hibberd CJ, Rush RW, Storey DJ, Strong VA, Fallon MT,
Wall LR, Sharpe M. Better Off Dead: Suicidal Thoughts in Cancer Patients. Journal of Clinical
Oncology. 2008;26(29):4725-4730.
Walker SN, Sechrist KR, Pender NJ. The health-promoting lifestyle profile: development and
psychometric characteristics. Nurs Res. 1987;36(2):76-81.
Wallace LM, Priestman SG, Dunn JA, Priestman TJ. The quality of life of early breast cancer patients
treated by two different radiotherapy regimens. Clin Oncol (R Coll Radiol). 1993;5:228-233.
Waller A, Garland SN, Bultz BD. Using screening for distress, the sixth vital sign, to advance patient
care with assessment and targeted interventions. Support Care Cancer. 2012;20(9):2241-2246.
Wallston KA, Kaplan GD, Maides SA. Development and validation of the health locus of control (HLC)
scale. J Consult Clin Psychol. 1976;44:580-585.
Walsh D, Rybicki L, Nelson KA, Donnelly S. Symptoms and prognosis in advanced cancer. Support
Care Cancer. 2002;10:385-388.
Walsh D, Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer. 2006;14:831836.
Wan GJ, Counte MA, Cella DF. The influence of personal expectations on cancer patients’ reports of
health-related quality of life. Psycho-Oncol. 1997;6:1-11.
Wan GJ, Counte MA, Cella D. A framework for organizing health-related quality of life research.
Journal of Rehabilitation Outcomes Measurement . 1997; 1 (2): 1-12
D:\478174570.doc
Wan GJ, Counte MA, Cella D, Hernandez L, et al. The impact of socio-cultural and clinical factors on
health-related quality of life reports among Hispanic and African-American cancer patients. Journal of
Outcome Measurement. 1999;3(3):200-215.
Wan GJ, Counte MA, Cella D, Hernandez L, et al. An analysis of the impact of demographic, clinical
and social factors on health-related quality of life. Value in Health. 1999;2(4):308-318.
Wang H, Huang E, Dale W, et al. Self-assessed health-related quality of life in men who have
completed radiotherapy for prostate cancer: Instrument validation and its relation to patient-assessed
bother of symptoms. Int J Cancer. 2000;90:163-172.
Wang L. In clinical trials and in the clinic, what is the placebo’s effect? J Nat Cancer Inst.
2993l95(1)6-7.
Wang L. Researchers push for sharing of trial results with participants. J Natl Cancer Inst.
2002;94(14):1049-1050.
Wang M, Rosen A, Kazis L, Loveland S, Anderson J, Berlowitz D. Correlation of risk adjustment
measures based on diagnoses and patient self-reported health status. Hlth Serv Outcomes Res
Methodol. 2000;1(3-4):351-365.
Wang W, Chen s, Brune KA, Hruban RH, Parmigiani G, Klein AP. PanPRO: Risk assessment for
individuals with a family history of pancreatic cancer. J Clin Oncol. 2007;25(11):1417-1422.
Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS. Longitudinal Study of
the Relationship Between Chemoradiation Therapy for Non-Small-Cell Lung Cancer and Patient
Symptoms. Journal of Clinical Oncology. 2006 ;24(27) :4485-4491.
Wang XS, Laudico AV, Guo H, Mendoza TR, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS.
Filipino version of the M.D. Anderson Symptom Inventory : Validation and Multisymptom
Measurement in Cancer Patients. Journal of Pain and Symptom Management. 2006;31(6):542-552.
Wang XS, Giralt SA, Mendoza TR, et al. Clinical factors associated with cancer-related fatigue in
patients being treated for leukemia and non-hodgkin's lymphoma. J Clin Oncol. 2002;20;5;13191328.
Wang XS, Williams LA, Krishnan S, Liao Z, Liu P, Mao L, Shi Q, Mobley GM, Woodruff JF, Cleeland CS.
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer
undergoing chemoradiation therapy. Brain Behav Immun. 2012;26(5):699-705.
Wapnir IL, Cody RP, Greco RS. Subtle differences in quality of life after breast cancer surgery. Ann
Surg Oncol. 1999;6(4):359-366.
Ward MM. Are patient self-report measures of arthritis activity confounded by mood? A longitudinal
study of patients with rheumatoid arthritis. Journal of Rheumatology. 1994;21(6):1046-1050.
Ward PCJ. The CBC at the turn of the millennium: an overview. Clin Chem. 2000;(46)8(B):12151220.
D:\478174570.doc
Ward W, Hahn E, Mo F, Hernandez L, Tulsky D, Cella D. Reliability and Validity of the functional
Assessment of Cancer Therapy-Colorectal (FACT-C) Quality of Life Instrument. Quality of Life
Research. 1999;8(3):181-195.
Ward-Smith P, Kapitan D. Quality of life among men treated with radiation therapy for prostate
cancer. Urol Nurs. 2005;25(4):263-272.
Ward-Smith P, Wittkopp D, Sheldon JM. Quality of life among men treated with brachytherapy for
prostate cancer. Urol Nurs. 2004;24(2):95-99.
Ward-Smith P. Brachytherapy for prostate cancer: the patient’s perspective. Urol Nurs.
2003;23(3):213-217.
Ware JE Jr, Gandek B, and the IQOLA Project Group. The SF-36 health survey: development and use
in mental health research and the IQOLA project. Int J Ment Hlth. 1994;23(2):49-73.
Ware JE Jr, Gandek V, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated
using standard and country-specific algorithms in 10 countries: results from the IQOLA project. J Clin
Epidemiol. 1998;51(11):1167-1170.
Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for
the scoring and statistical analysis of SF-36 health profile and summary measures: summary of
results from the Medical Outcomes Study. Med Care. 1995;33(4-Suppl):AS264-279.
Ware JE Jr, Kosinski M, Bjorner JB. Item banking and the improvement of health status measures.
Quality of Life Newsletter Special Issue – Item Banking 2 – 5, Fall 2004.
Ware JE Jr, Kosinski M, Gandek B, et al. The factor structure of the SF-36 Health Survey in 10
countries; results from the IQOLA Project. International Quality of Life Assessment. J Clin
Epidemiol. 1998;51(11):1159-1165.
Ware JE Jr, Kosinski M, Keller SD. A 12-Item short-form health survey. Med Care. 1996;34:220-233.
Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual
framework and item selection. Med Care. 1992;30(6):473-483.
Ware JE Jr. Standards for validating health measures: Definition and content. J Chron Dis.
1987;40(6):473-480.
Ware JE Jr. Conceptualization and measurement of health-related quality of life: comments on an
evolving field. Arch Phys Med Rehab. 2003;84(Supp 2):S43–S51.
Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med.
2003;348(21):2136-2137.
Ware JH. Linear Models for the analysis of longitudinal studies. Am Stat. 1992;39:95-101.
D:\478174570.doc
Ware LJ, Epps CD, Herr K, Packard A. Evalution of the Revised Faces Pain Scale, Verbal Descriptor
Scale, Numeric Rating Scale, and Iowa Pain Thermometer in older minority adults. Pain Manage
Nurs. 2006;7(3):117-125.
Warr D, McKinney, Tannock I. Influence of measurement error on assessment of response to
anticancer chemotherapy: proposal for new criteria of tumor response. J Clin Oncol. 1984;2(9):10401046.
Warr D, Wilan A, Venner P, et al. A randomised, double-bllind comparison of granisetron with highdose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. Eur J
Cancer. 1993;29A(1):33-36.
Warr DG, Hesketh PJ, Gralla RJ, Muss HB, Herrstedt J, Eisenberg PD, Raftopoulos H, Grunberg SM,
Gabrie M, Rodgers A, Bohidar N, Klinger G, Hustad CM, Horgan KJ, Skobieranda F. Efficacy and
Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in
Patients With Breast Cancer After Moderately Emetogenic Chemotherapy. Journal of Clinical
Oncology. 2005;23(12):2822-2830.
Warren JL, Brown ML, Fay MP, Schussler N, Potosky AL, Riley GF. Costs of treatment for elderly
women with early-stage breast cancer in fee-for-service settings. J Clin Oncol. 2002;20(1):307-316.
Wasson J, Hays R, Rubenstein L, Nelson E, Leaning J, Johnson D, Keller A, Landgraf J, Rosenkrans C.
The short-term effect of patient health status assessment in a health maintenance organization. Qual
Life Res. 1992;1:99-106.
Wasson J, Keller A, Rubenstein L, Hays RD, Nelson E, Johnson D. Benefits and obstacles of health
status assessment in ambulatory settings: the clinician’s point of view. Med Care. 1992;30(5):MS42MS49.
Wasson JH, Stukel TA, Weiss JE, Hays RD, Jette AM, Nelson EC. A randomized trial of the use of
patient self-assessment data to improve community practices. Effective Clin Pract. 1999;2(1):1-10.
Waterman C, Victor TW, Jensen MP, Gould EM, Gammaitoni AR, Galer BS. The assessment of pain
quality: an item response theory analysis. J Pain. 2010 Mar;11(3):273-9.
Watkins CL, Lightbody CE, Sutton CJ, Holcroft L, Jack CIA, Dickinson HA, van den Broek MD, Leathley
MJ. Evaluation of a single-item screening tool for depression after stroke: a cohort study. Clinical
Rehabilitation. 2007;21:846-852.
Watkins-Bruner D, Scott C, Lawton C, DelRowe J, Rotman M, Buswell L, Beard C, Cella D. RTOG”s
first quality of life study – RTOG 90-20: A phase II trial of external beam radiation with etanidazole
for locally advanced prostate cancer. International Journal of Radiation Oncology, Biology, and
Physics. 1995;33:901-906.
Watson D, Clark LA. Measurement and mismeasurement of mood: recurrent and emergent issues. J
Personality Assess. 1997;68:267-296.
Watson M, Greer S, young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire
measure of adjustment to cancer: the MAC scale. Psychol Med. 1988;18:203-209.
D:\478174570.doc
Watson M, Law M, dos Santos MD, Greer S, Baruch J, Bliss J. The Mini-MAC: further development of
the mental adjustment to cancer scale. J Psychosoc Oncol. 1994;12(3):33-46.
Watson WL. Ten-year survival in lung cancer. A study of 56 cases. Cancer. 1965;18:133-135.
Weber BA, Roberts BL, Resnick M, et al. The effect of dyadic intervention on self-efficacy, social
support, and depression for men with prostate cancer. Psycho-Oncol. 2004;13:47–60.
Weber M, Huber C. Documentation of severe pain, opioid doses, and opioid-related side effects in
outpatients with cancer: a retrospective study. J of Pain and Symptom Manage. 1999;17(1):49-54.
Webster K, Cella D. Quality of life in low-grade non-Hodgkin’s lymphoma. Oncol. 1998;12(5):697717.
Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT)
measurement system: Properties applications, and interpretation. Health and Quality of Life
Outcomes. 2003;1(1):79-85.
Wedding U, Pientka L, Hoffken K. Quality-of-life in elderly patients with cancer: A short review. Eur
J Cancer 2007;43:2203-2210.
Wedding U, Rohrig B, Klippstein A, Brix C, Pientka L, Hoffken K. Comorbidity and functional deficits
independently contribute to quality of life before chemotherapy in elderly cancer patients. Support
Care Cancer 2007;15:1097-1104.
Weeks JC, Nelson H, Gelber S, Sargent DD, Schroeder G, for the Clinical Outcomes of Surgical
Therapy (COST) Study Group. Short-term quality of life outcomes following laparoscopic-assisted
colectomy vs open colectomy of colon cancer. JAMA. 2002;287:321-328.
Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health--related quality of life
after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20(2):557-566.
Wei LJ, Johnson WE. Combining dependent tests with incomplete, repeated measurements.
Biometrika. 1985;72:359-364.
Weijer C, Freedman B, Shapiro S, Fuks A, Skrutkowska M, Sigurjonsdottir M. Assessing the
interpretation of criteria for clinical trial eligibility: a survey of oncology investigators. Clin Invest
Med. 1998;21(1)17-26.
Weiler K, Christ AM, Woodworth GG, Weiler RL, Weiler JM. Quality of patient-reported outcome data
captured using paper and interactive voice response diaries in an allergic rhinitis study: is electronic
data capture really better? Ann Allergy Asthma Immunol. 2004;92:335-339.
Weinberger M, Oddone EZ, Samsa GP, Landsman PB. Are health-related quality-of-life measures
affected by the mode of administration? J Clin Epidemiol. 1996;49(2):135-140.
Weiner BJ, McKinney MM, Carpenter WR. Adapting clinical trials networks to promote cancer
prevention and control research. Cancer. 2006;106(1):180-187.
D:\478174570.doc
Weiner JS, Cole SA. ACare: A communication training program for shared decision making along a
life-limiting illness. Palliat Support Care. 2005;2:231-241.
Weis J. Support Groups for Cancer Patients. Support Care Cancer. 2003;11:763–768.
Weissman MM, Olfson M, Gameroff MJ, Feder A, Fuentes M. A comparison of three scales for
assessing social functioning in primary care. Am J Psychiatr. 2001;158(3):460-466.
Weissman, MM. Assessing depressive symptoms in five psychiatric populations: a validation study.
Am J Epidemiol. 1977; 106:203-214.
Weitzner M, McMillan S, Jacobsen P. Family caregiver quality of life: differences between curative
and palliative cancer treatment setting. J Pain Symptom Manage. 1999;17(6):418-428.
Weitzner M, Meyers C, Steinbruecker S, Saleeba A. Family caregiver quality of life (QOL): a
preliminary report comparing patients’ vs. caregivers’ views. Proc Annu Meet Am Soc Clin Oncol.
1995;14:A1642.
Weitzner MA, Jacobsen PB, Wagner Jr, H, Friedland J, Cox C. The Caregiver Quality of Life IndexCancer (CQOLC) scale: development and validation of an instrument to measure quality of life of the
family caregiver of patients with cancer. Qual Life Res. 1999;8:55-63.
Weitzner MA, McMillan SC. The caregiver quality of life index-Cancer (CQOLC) scale: revalidation in a
home hospice setting. J Palliat Care. 1999;15(2)13-20.
Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of
Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general
version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75(5):1151-1161.
Weitzner MA, Moody LN, McMillan SC. Symptom management issues in hospice care. Am J Hosp
Palliat Care. 1997;14:190–195.
Weitzner MA. Meyers CA, Byrne K. Psychosocial functioning and quality of life in patients with
primary brain tumors. J Neurosurg. 1996;84(1):29-34.
Welch HG, Fisher ES. Diagnostic testing following screening mammography in the elderly. J Natl
Cancer Inst. 1998;90(18):1389-1392.
Wells KB, Burnam MA, Rogers W, Hays RD, Camp P. The course of depression in adult outpatients:
results from the medical outcomes study. Arch Gen Psychiatry. 1992;49:788-794.
Wells KB, Hays RD, Burnam MA, Rogers W, Greenfield S, Ware JE. Detection of drepressive disorder
for patients receiving prepaid or fee-for-service care: results from the medical outcomes study.
JAMA. 1989;262(23):2398-3302.
Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results
from the medical outcomes study. JAMA. 1989;262(7):914-919.
D:\478174570.doc
Wells N, McDowell MR, Hendricks P, Dietrich MS, Murphy B. Cancer pain management in ambulatory
care: can we link assessment and action to outcomes. Supportive Care in Cancer.
2011;19(11):1865-1872.
Welshman A. Palliative care: some organizational considerations. Minerva Anesthesiol. 2005;
2005;71:439-43.
Wen J, Ren Y, Wang L, Li Y, Liu Y, Zhou M, Liu P, Ye L, Li Y, Tian W. The reporting quality of metaanalyses improves: a random sampling study. Journal of Clinical Epidemiology. 2008;61(8):770-775.
Weng, CSW. Where is health-related quality-of-life assessment in oncology clinical study heading? J
Biopharm Stat. 2004;14(1):1-3.
Wengstrom Y, Haggmark C, Strander H, Forsberg C. Effects of a nursing intervention on subjective
distress, side effects and quality of life of breast cancer patients receiving curative radiation therapy:
A randomized study. Acta Oncol. 1999;38:763-770.
Wenrich MD, Curtis JR, Shannon SE, Carline JD, Ambrozy DM, Ramsey PG. Communicating with
dying patients within the spectrum of medical care from terminal diagnosis to death. Arch Intern
Med. 2001;161:868-874.
Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein D, Bernstein M, Kluhsman B, Osann K, et
al. Defining and measuring reproductive concerns of female cancer survivors . J Natl Inst Monogr
2005;34:94-98.
Wenzel L, Fairclough D, Brady M, Cella D, Garrett K, Kluhsman B, Marcus A. Age-related differences
in the quality of life of breast carcinoma patients after treatment. Cancer. 1999;86(9):1768-1774.
Wenzel L, Huang H, Monk B, Rose P, Cella D. Quality of life comparisons in a randomized trial of
secondary cytoreduction in advanced ovarian carcinoma: A Gynecologic Oncology Group Study. J
Clin Oncol 2005;23(24):5605-5612.
Wenzel L, Huang HQ, Monk BJ, Rose PG, and Cella D. Quality-of-life comparisons in a randomized
trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecological Oncology
Group Study. J Clin Oncol. 2005;23:5605-5612.
Wenzel L, Vergote I, Cella D. Quality of Life in patients with receiving treatment for Gynecologic
malignancies: Special considerations for patient care. International Journal of Gynecologic
Obstetrics. 2003;290(16):2149-2158.
Wenzel LB, Donnelly JP, Fowler JM, Habbal R, Taylor TH, Aziz N, Cella D. Resilience, reflection, and
residual stress in ovarian cancer survivorship: A Gynecologic Oncology Group study. PsychoOncology. 2002;11:142-153.
Wenzel LB, Huang HQ, Armstrong DK, Walker JL, Cella D. Health-related quality of life during and
after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer; a
gynecologic oncology group study. J Clin Oncol. 2007;25(4):437-443.
D:\478174570.doc
Westerman MJ, Hak T, Sprangers MAG, Groen HJM, van der Wal G, The A-M. Listen to their
answers! Response behaviour in the measurement of physical and role functioning. Quality of Life
Research. 2008;17:549-558.
Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical
phenomena. Res Nurs Hlth. 1990;13:227-236.
Weymuller EA, Yueh B, Deleyiannis FW, Kuntz AL, Alsarraf R, Coltrerea MD. Quality of life in head
and neck cancer. (Articles) Laryngoscope. 2000;110(3, Part 3)(Suppl 94):4-7.
Whalen GF, Ferrans CE. Quality of life as an outcome in clinical trials and cancer care: a primer for
surgeons. (Review) J Surg Oncol. 2001;77(4):270-276.
Whedon M, Stearns D, Mills LE. Quality of life of long-term adult supervisors of autologous Bone
Marrow Transplantation. Oncol Nurs Forum. 1995;22(10):1527-1535: discussion 1535-1537.
Whelan T, Goss PE, Ingle JN, et al. Assessment of quality of life in MA.17: a randomized, placebocontrolled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol.
2005;23:6931-6940.
Whelan T, Levine M, Julian J, Kirkbride P, Skingley P. The effects of radiation therapy on quality of
life of women with breast cancer: results of a randomized trial. Cancer. 1999;88:2260-2266.
White C, Gilshenan K, Hardy J. A survey of the views of palliative care healthcare professionals
towards referring cancer patients to participate in randomized controlled trials in palliative care.
Supportive Care in Cancer. 2008;16(12):1397-1405.
White C, Hardy J. What do palliative care patients and their relatives think about research in
palliative care? – a systematic review. Supportive Care in Cancer. 2010;18(8):905-912.
White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Chronic widespread muskoskeletal pain with
or without fibromyalgia: psychosocial distress in a representative community adult sample. J
Rheumatol. 2002;29:588-594.
White VM, Hopper JL, Wearing AJ, Hill DJ. The role of genes in tobacco smoking during adolescence
and young adulthood: a multivariate behaviour genetic investigation. Addiction. 2003;98(8):1087100.
Whitehead J. On being a statistician on a data and safety monitoring board. Stats Med.
1999;18:3425-3434.
Whitehead J. Designing phase II studies in the context of a programme of clinical research.
Biometrics. 1985;41(2):373-83.
Whiteneck GG, Charlifue SW, Frankel HL, Fraser MH, Gardner BP, Gerhart KA, Krishnan KR, Menter
RR, Nuseibeh I, Short DJ, Silver JR. Mortality, morbidity, and psychosocial outcomes of persons spinal
cord injured more than 20 years ago. Paraplegia. 1992;30:617-630.
D:\478174570.doc
Whitlatch CJ, Zarit SH, von Eye A. Efficacy of interventions with caregivers: a re-analysis. Gerontol
Soc Am. 1991;31:9-14.
Whitman M. The starving patient: supportive care for people with cancer. Clin J Oncol Nurs.
2000;4:121–125.
Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression: two
questions are as good as many. J Gen Intern Med. 1997;12:439-445.
Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and
intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an
age-matched control population. Cancer. 1994;74:2520-2532.
Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on
weight loss in patients with pancreatic cancer. Nutr Cancer. 2000;36:177–184.
Wijkstra PH, Tenvergert EM, VanAltena R, et al. Reliability and validity of the Chronic Respiratory
Questionnaire (CRQ). Thorax. 1994;49:465-457.
Wijkstra PJ, Van Altena R, Draan J, Otten V, Postma DS, Koeter GH. Quality of life in patients with
chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J.
1994;7:269-273.
Wikblad K, Leksell J, Wibell L. Health-related quality of life in relation to metabolic control and late
complications in patients with insulin dependent diabetes mellitus. Qual Life Res. 1996;5:123-130.
Wiklund I, Aquardro C, Chassany O, on behalf of the European Regulatory Issues on Quality of Life
Assessment (ERIQA) Group. Patient-reported outcomes in a regulatory environment: there is a need
for guidance. health-related quality of life and patient-reported outcomes: scientific and useful
outcome criteria. Comptes rendus de la 4e Journee de therapeutique de I’UFR Lariboisiere SaintLouis. Paris. Main Authors: Chassany O, Caulin C. October 2002.
Wiklund I, Chassany O, Gnanasakthy A. Symptom assessment – differences and similarities in how
to meet regulatory requirements in international trials. ISPOR Connections. 2011l17(1):4-7.
Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials. Control Clin Trials. 1991;12:204S216S.
Wiklund I. Aspects of Quality of life in gastrointestinal disease: some methodological issues. Scand J
Gastroenterol. 1995;30(Suppl. 208):129-132.
Wilcox RA, Djulbegovic B, Guyatt GH, Montori VM. Randomized trials in oncology stopped early for
benefit. J Clin Oncol. 2008;26(1):18-19.
Wild D, Eremenco S, Mear I, Martin M, Houchin C, Gawlicki M, Hareendran A, Wiklund I, Chong LY,
von Maltzahn R, Cohen L, Molsen E. Multinational Trials – Recommendations on the translations
required, approaches to using the same language in different countries, and the approaches to
support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation
good research practices task force report. Value in Health. 2009;12(4):430-440.
D:\478174570.doc
Wilders H, Kunkler I, Biganzoli, L. Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M,
Girre V, Brain E, Audisio RA, Bartelink H, Barton M, Giordano SH, Muss H, and Aapro M. Management
of breast cancer in elderly individuals: recommendations of the International Society of Geriatric
Oncology. Lancelot Oncol. 2007;8:1101-15.
Wilkinson SM, Love SB, Westcombe AM, Gambles MA, Burgess CC, Cargill A, Young T, et al.
Effectiveness of aromatherapy massage in the management of anxiety of depression in patients with
cancer; a multicenter randomized controlled trial. J Clin Oncol. 2007;25(5):532-539.
Williams ES, Manwell LB, Konrad TR, Linzer M. The relationship of organizational culture, stress,
satisfaction, and burnout with physician-reported error and suboptimal patient care: results from the
MEMO study. Health Care Manage Rev 2007;32(3):203-212.
Williams AM, Dawson S, Kristjanson LJ. Exploring the relationship between personal control and the
hospital environment. Journal of Clinical Nursing. 2008;17:1601-1609.
Williams G, Pazdur R, Temple R. assessing tumor-related signs and symptoms to support cancer
drug approval. J Biopharm Stat. 2004;14(1):5-21.
Williams J, Chen Y, Rugin P, Finkelstein J, Okunieff P. The biological basis of a comprehensive
grading system ofr the adverse effects of cancer treatment. Sem Rad Oncol. 2003;13(3):182-188.
Williams NS, Johnston D. The quality of life after rectal excision for low rectal cancer. Br J Surg.
1983;70:460-462.
Williamson HA. The BDI: Normative data and problems with generalizability. Fam Med. 1989;21:5860.
Willis G, Zahnd E. Questionnaire design from a cross-cultural perspective: An empirical investigation
of Koreans and Non-Koreans. Journal of Health Care for the Poor and Underserved. 2007;18:197217.
Wilson CB, Crafts D, Levin V. Brain tumors: criteria of response and definition of recurrence. Natl
Cancer Inst Monogr. 1977;46:197-203.
Wilson D, Parsons J, Wakefield M. The health-related quality-of-life of never smokers, ex-smokers,
and light, moderate, and heavy smokers. Prev Med. 1999;29(3):139-144.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. JAMA. 1995;273:
59-64.
Wilson IB. clinical understanding and clinical implications of response shift. Soc Sci Med. 1999;
48:1577-1588.
Wilson KA, Dowling AJ, Abdolell M, Tannock IF. Perception of quality of life by patients, partners and
treating physicians. Qual Life Res. 2000;9:1041-1052.
Wilson KG, Chochinov HM, McPherson CJ, LeMay K, Allard P, Chary S, Gagnon PR, Macmillan K, et al.
Suffering with advanced cancer. J Clin Oncol. 2007;15(13):1691-1697.
D:\478174570.doc
Wilson KG, Chochinov HM, Skirko MG, Allard P, Chary S, Gagnon PR, Macmikllan K, et al. Depression
and anxiety disorders in palliatve cancer care. J Pain Symptom Manage. 2007;33(2):118-129.
Wilson M, Allen D, Li JC. Improving the measurement in behavorial sciences using item response
models: Part I – Introducing item response models. August 2005.
Wilson M, Allen D, Li JC. Improving the measurement in behavorial sciences using item response
Models: Part II – Comparison with the classical test theory approach. August 2005.
Wincent A, Liden Y, Arner S. Pain questionnaires in the analysis of long lasting (chronic) pain
conditions. Eur J Pain. 2003;7(4):311-321.
Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz P, Kramer B, Kris M,
Markman M, Mayer R, Pfister D, Raghavan D, Ramsey S, Reaman G, Sandler H, Sawaya R, Schuchter
L, Sweetenham J, Vahdat L, Schilsky R, Blayney D, Lichter A. Clinical Cancer Advances 2008: Major
Research Advances in Cancer Treatment, Prevention, and Screening – A Report From the American
Society of Clinical Oncology. Journal of Clinical Oncology. 2009;27(5):812-826.
Winer EP, Sutton LM. Quality-of-life after bone marrow transplantation. Cancer. 1994;8:19-26.
Winer EP. Quality-of-life research in patients with breast cancer. Cancer. 1994;74:410-415.
Winther D, Saunte DM, Knap M, Haahr V, Jensen AB. Nail changes due to docetaxel – a neglected
side effect and nuisance for the patient. Support Care Cancer. 2007;15:1191-1197.
Wirz S, Wartenberg HC, Nadstawek J. Less nausea, emesis, and constipation comparing
hydromorphone and morphine? A prospective open-labeled investigation on cancer pain. Supp Care
in Cancer. 2008;16(9):999-1010.
Wish JB, Coyne DW. Use of Erythropoiesis-stimulating agents in patients with anemia of chronic
kidney disease: Overcoming the pharmacological and pharmacoeconomic limitations of existing
therapies. Mayo Clin Proc. 2007;82(11):1371-1380.
Witkowski A, Carlsson ME. Support group programme for relatives of terminally ill cancer patients.
Support Care Cancer. 2004;12:168–175.
Wolberg WH, Romsaas EP, Tanner MA, Malec JF. Psychosexual adaptation to breast cancer surgery.
Cancer. 1989;63:1645-1655.
Wolf SL, Barton DL, Qin R, Wus EJ, Sloan JA, Liu H, Aaronson NK, Satele DV, Mattar BI, Green NB,
Loprinzi CL. The relationship between numbness, tingling, and shooting/burning pain in patients with
chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20
instrument, N06CA. Supportive Care in Cancer. 2012;20(3):625-632.
Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog
scales and longer fatigue questionnaires in 7760 patients. The Journal of Rheumatology.
2004;31(10):1896-1902.
D:\478174570.doc
Woloshin S, Schwartz LM, Byram S, Fischhoff B, Welch HG. A new scale for assessing perceptions of
chance: a validation study. Med Decis Making. 2000;20:298-307.
Wong RKS, Franssen E, Szumachjer E, et al. What do patients living with advanced cancer and their
carers want to know? A needs assessment. Support Care Cancer. 2002;10:408-415.
Wong RKS, Paul N, Ding K, Whitehead, M, Brundage M, Fyles A, et al. 5-Hydroxytryptamine-3
Receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation
induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada
Clinical Trials Group (SC19). J Clin Oncol. 2006;24(21):3458-3464.
Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatric Nursing.
1988;14(1):9-17.
Wood AJJ. A proprosal for radical changes in the drug-approval process. N Engl J Med.
2006;355(6):618-623.
Wood AM, White IR, Thompson SG. Are missing outcome data adequately handled? A review of
published randomized controlled trials in major medical journals. Clin Trials. 2004;1:368–376.
Wood-Dauphinee S, Williams JI. Reintegration to normal living as a proxy to quality of life. J Chron
Dis. 1987;40(6):491-499.
Woods S, Beaver K, Luker K. Users’ views of palliative care services: ethical implication. Nurs Ethics.
2000;7(4):314–326.
Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG. Place of death:
correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental
health. Journal of Clinical Oncology. 2010;28(29):4457-4464.
Wright EP, Selby PJ, Crawford M, et al. Feasibility and compliance of automated measurement of
quality of life in Oncology practice. J Clin Oncol. 2003;21(2):374-382.
Wright JD, Burke WM, Wilde ET, Lewin SN, Charles AS, Kim JH, Goldman N, Neugut AI, Herzog TJ,
Hershman DL. Comparative effectiveness of robotic versus laparoscopic hysterectomy for
endometrial cancer. Journal of Clinical Oncology. 2012;30(8):783-791.
Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol.
1997;50(3):239-246.
Wright JP, Whelan TJ, Schiff S, et al. Why cancer patients enter randomized clinical trials: exploring
the factors that influence their decision. J Clin Oncol. 2004;22(21):4312–4318.
Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the medical outcomes study healthrelated quality of life measures in HIV/AIDS. Qual Life Res. 1997;6:531-554.
Wu AW, Jacobsen DL, Berzon RA, et al. The effect of mode of administration on medical outcomes
study health rating and EuroQol scores in AIDS. Qual Life Res. 1997;6:3-10.
D:\478174570.doc
Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the
medical outcomes study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481-493.
Wu AW, Rudin HR, Mathews WC, et al. A health status questionnaire using 30 items from the
Medical Outcomes Study: preliminary validation in persons with early HIV infection. Med Care.
1991;29:786-798.
Wu HS, McSweeney M. Assessing fatigue in persons with cancer: an instrument development and
testing study. Cancer. 2004;101:1685-1695.
Wu HS, Wyrich KW, McSweeney M. Assessing fatigue in persons with cancer: further validation of
the Wu Cancer Fatigue Scale. J Pain Symptom Manage. 2006;32(3):255-265.
Wu HW, McSweeney M. Cancer-related fatigue: “It’s so much more than just being tired.” Eur J
Oncol Nurs. 2007;11:117-125.
Wujcik D. Current research in side effects of high-dose chemotherapy. Semin Oncol Nurs.
1992;8(2):102-112.
Wyrich KW, Tierney WM, Wolinsky FD. Using the standard error of measurement to identify
important changes on the Asthma Quality of Life Questionnaire. Qual Life Res. 2002;11;1-7.
Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical
significance in evaluating intra-individual changes in health-related quality of life. Med Care.
1999;37(5):469-478.
Wyrwich KW, Tierney WM, Babu AN, Krinke K, Wolinsky FD. A comparison of clinically important
differences in health-related quality of life for patients with chronic lung disease, asthma, or heart
disease. Hlth Serv Res. 2005;40(2):577-591 or 593-597.
Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for
identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol.
1999;52:861-873.
Wyrwich KW, Wolinsky FD. Identifying meaningful intra-individual change standards for healthrelated quality of life measures. J Eval Clin Pract. 2000;6:39-49.
Wyrwich KW. Minimal important difference thresholds and the standard error of measurement: is
there a connection? J Biopharm Stat. 2004;14(1):97-110.
Xiao H, Lichtman SM. Management of colorectal cancer in older patients. Oncology. 2006;
20(7):741-750.
Xing D, Hambleton RK. Impact of test design, item quality, and item bank size on the psychometric
properties of computer-based credentialing examinations. Educ Psychol Measure. 2004;64(1):5-21.
Xu JM, Song ST, Feng FY, et al. Cobrotoxin-containing analgesic for chronic pain. Oncol Rep.
2006;16(5):1077-1084.
D:\478174570.doc
Yamashita H, Okuma K, Seto Y, Mori K, Kobayashi S, Wakui R, Ohtomo K, Nakagawa K. A
retrospective comparison of clinical outcomes and quality of life measures between definitive
chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. Journal of
Surgical Oncology. 2009;100(6):435-441.
Yan LL, Liu K, Matthews KA, Daviglus ML, Ferguson TF, Kiefe CL. Pyschosocial factors and risk of
hypertension: the coronary artery risk development in yound adults (CARDIA) study. JAMA.
2003;290(16):2138-2148.
Yan, TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized
and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for
early-stage non-small-cell lung cancer. Journal of Clinical Oncology. 2009;27(15):2553-2562.
Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in
postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885-892.
Yancik R, Yates J. Quality of life assessment of cancer patients: Conceptual and methodological
challenges and constraints. Cancer Bull. 1986;38(5):217-222.
Yanez B, Edmondson D, Stanton AL, Park CL, Kwan L, Ganz PA, Blank TO. Facets of spirituality as
predictors of adjustment of cancer: Relative contributions of having faith and finding meaning.
Journal of Consulting and Clinical Psychology. 2009;77(4):730-741.
Yano F, Sherif AE, Turaga K, Stadlhuber RJ, Tsuboi K, Ramaswamy S, Mittal SK. Gastrointestinal
quality of life in patients after anti reflux surgery. Diseases of the Esophagus. 2009;22(2):177-184.
Yao M, Karnell LH, Funk GF, Lu H, Dornfeld K, Buatti JM. Health-related quality-of-life outcomes
following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J
Rad Oncol Biol Phys 2007;69(5):1354-1360.
Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the
Karnofsky Performance Status. Cancer. 1980;45:2220-2224.
Yates P, Aranda S, Hargraves M, et al. Randomized controlled trial of an educational intervention for
managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin
Oncol. 2005;23:6027-6036.
Yavas C, Zorlu F, Ozyigit G, Gurkaynak M, Yavas G, Yuce D, Cengiz M, Yildiz F, Akyol F. Healthrelated quality of life in high-grade glioma patients: a prospective single-center study. Supportive
Care in Cancer. 2012;20(10):2315-2325.
Yavas C, Zorlu F, Ozyigit G, Gurkaynak M, Yavas G, Yuce D, Cengiz M, Yildiz F, Akyol F. Prospective
assessment of health-related quality of life in patients with low-grade glioma. Supportive Care in
Cancer. 2012;20(8):1859-1868.
Yellen SB, Cella DF. Social well being and decision-making in oncology. Topics on Supportive Care in
Oncology, 1996; 19:7-8
D:\478174570.doc
Yellen SB, Cella DF, Bonomi A. Quality of life in people with Hodgkin’s Disease. Oncol. 1993;7(8):
41–45.
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemiarelated symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System.
J Pain Symptom Manage. 1997;13(2):63-74.
Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. Journal of the
National Cancer Institute. 1994;86:1766-1770.
Yellen SB, Cella DF. Someone to live for: Social well-being parenthood status, and decision-making
in oncology. Journal of Clinical Oncology. 1995;13(5):1255-1264.
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of
a geriatric depression screening scale: a preliminary report. J Psychiat Res. 1983;17(1):37-49.
Yesavage JA. Geriatric Depression Scale. Psychopharmacol. 1988;24:709-711.
Yoshida T, Sawa T, Ishiguro T, Horiba A, Minatoguchi S, Fujiwara H. The Efficacy of prophylactic
Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination
chemotherapy for non-small cell lung cancer. Supportive Care in Cancer. 2009;17(3):315-320.
Yost K, Cella D. Health-related quality of life and colorectal cancer. Colorectal Cancer Index &
Reviews. 2003;4(4):4-7.
Yost K, Sorenson M, Hahn E, Glendenning A, Gnanasakthy A, Cella D. Using multiple anchor-and
distribution based estimates to evaluate clinically meaningful change on the Functional Assessment of
Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument. Val Health, 2005;8(2):117127.
Yost K, Yount S, Eton D, Silberman C, Broughton-Heyes; Cella D. Validation of the Functional
Assessment of Cancer Therapy-Breast Symptom Index (FBSI). Breast Cancer Res Treatment,
2005;90:295-298.
Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ, West DW. Minimally important
differences were estimated for the Functional Assessment of Canter Therapy-Colorectal (FACT-C)
instrument using a combination of distribution and anghor-based approaches. Journal of Clinical
Epidemiology. 2005;58(12):1241-1251.
Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ, West DW. Estimating minimally
important differences in the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) scale. J
Clin Epidemiol 2005;58:1241-1251.
Yost KJ, Eton DT. Combining distribution and anchor-based approaches to determine minimally
important differences: the FACIT experience. Eval Health Prof. 2005;28(2):172-91.
Yost KJ, Sorensen MV, Hahn EA, Glendenning GA, Gnanasakthy A, Cella D. Using multiple anchorand distribution-based estimates to evaluate clinically meaningful change on the Functional
Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) Instrument. Val Health
2005;8(2):117-127.
D:\478174570.doc
Young DJ, Levy F, Martin NC, Hay DA. Attention deficit hyperactivity disorder: a Rasch analysis of
the SWAN Rating Scale. Child Psychiatry Hum Dev. 2009;40:543-559.
Young J, Harrison J, Solomon M, Butow P, Dennis R, Robson D, Auld S. Development and feasibility
assessment of telephone-delivered supportive care to improve outcomes for patients with colorectal
cancer: pilot study of the CONNECT intervention. Support Care in Cancer. 2010;18(4):461-470.
Young T, Yang Y, Brazier JE, Tsuchiya A, Coyne K. The first stage of developing preference-based
measures : constructing a health-state classification using Rasch Analysis. Qual Life Res.
2009;18(2):253-265.
Young GP. CBC or not CBC? That is the question. Ann Emerg Med. 1986;15(3):367-374.
Young M, Sparrow D, Gottlieb D, Selim A, Friedman R. A telephone-linked computer system for
COPD care. Chest. 2001;119(5):1565-1575.
Young T, Maher J. Collecting quality of life data in EORTC clinical trials – what happens in practice?
Psycho-Oncol. 1999;8(3):260-263.
Youngblood M, Williams PD, Eyles H, Waring J, Runyon S. A comparison of two methods of
assessing cancer therapy-related symptoms. Cancer Nurs. 1994;17(1):37-44.
Youngblut JM, Casper GR. Focus on psychometrics: single-item indicators in nursing research. Res
Nurs Hlth. 1993;16(6):459-465.
Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire
to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–
300.
Yount S, Cella D. The patient reported outcomes measurement information system (PROMIS): A
United States National Institutes of Health effort to build banks and bridges. ISOQOL Newsletter
2006;11(1):5, 12.
Yount S, Cella D, Banik D, Ashraf T, Shevrin D. Brief Assessment of priority symptoms in Hormone
Refractory Prostate Cancer: the FACT Advanced Prostate Symptom Index (FAPSI). Health and
Quality of Life Outcomes. 2003;69(1).
Yu Z, Liu W, Wang L, Liang H, Huang Y, Si X, Zhang H, Liu D, Zhang H. The efficacy and safety of
palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced
vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel,
comparative clinical trial. Supportive Care in Cancer. 2009;17(1):99-102.
Yun YH, Lee, CG, Kim S, et al. The attitudes of cancer patients and their families toward the
disclosure of terminal illness. J Clin Oncol. 2004;22:307–314.
Yun YH, Lee KS, Kim Y-W, Park SY, Lee ES, Noh D-Y, Kim S, Oh JH, Jung SY, Chung K-W, Lee YJ,
Jeong S-Y, Park KJ, Shim YM, Zo JI, Park JW, Kim YA, Shon EJ, Park S. Web-based tailored
education program for disease-free cancer survivors with cancer-related fatigue: a randomized
controlled trial. Journal of Clinical Oncology. 2012;30(12):1296-1303.
D:\478174570.doc
Yun YH, Lee MK, Chang YJ, You CH, Kim S, Choi JS, Lim HY, Lee CG, Choi YS, Hong YS, Kim SY, Heo
DS, Jeong HS. Supportive Care in Cancer. 2010;18(2):189-196.
Yvanes-Thomas M, Calmels P, Bethoux F, Richard A, Nayme P, Payre D, Laurent B. Validity of the
French-language version of the Quebec Back Pain Disability Scale in low back pain patients in France.
Joint Bone Spine. 2002;69:397-405.
Zabora J, BrintzenhofeSzoc K, Jacobsen P, et al. A new psychosocial screening instrument for use
with cancer patients. Acad Psychosom Med. 2001;42(3):241-246.
Zacharias DR, Gilg CA, Foxall MJ. Quality of life and coping in patients with gynecological cancer and
their spouses. Oncol Nurs Forum. 1994;21:1699-1706.
Zafar SY, Alexander SC, Weinfurt KP, Schulman KA, Abernethy AP. Decision making and quality of
life in the treatment of cancer: a review. Supportive Care in Cancer. 2009;17(2):117-127.
Zahner J, Meran J, Karthaus M. Exhaustion and fatigue – a neglected problem in hematolgic
Oncology. Wien Med Wochenschr. 2001;151:89–93.
Zanetti O, Geroldi C, Frisoni GB, Bianchetti A, Trabucchi M. Contrasting results between caregiver’s
report and direct assessment of activities of daily living in patients affected by mild and very mild
dementia: the contribution of the caregiver’s personal characteristics. J Am Geriatr Soc.
1999;47:196-202.
Zaza C, Sellick SM, Hillier LM. Coping with cancer: what do patients do? J Psychosocial Oncol.
2005;23(1):55-73.
Zebracki K, Palermo TM, Hostoffer R, Duff K, Drotar D. Health-related quality of life of children with
primary immunodeficiency disease: a comparison study. Ann Allergy asthma Immunol.
2004;93:557-561.
Zee B, Cole B, Li T, et al. Quality-adjusted time without symptoms or toxicity analysis of interferon
maintenance in multiple myeloma. J Clin Oncol. 1998;16:2834-2839.
Zee BC, Mok TS. Methodology for quality of life assessment: a critical appraisal. Thorac Surg Clin.
2004;14(3):305-315.
Zee BC. Growth curve model analysis for quality of life data. Stats Med. 1998;17:757-766.
Zeltzer LK, Richie DM, LeBaron S, Reed D. Can children understand and use a rating scale to
quantify somatic symptoms? Assessment of nausea and vomiting as a model. J Cons Clin Psychol.
1988;56(4):567-572.
Zeltzer LK, Recklitis C, Buchbinder D, Zebrack B, Casillas J, Tsao JCI, Lu Q, Krull K. Psychological
status in childhool cancer survivors: a report from the childhood cancer survivor study. Journal of
Clinical Oncology. 2009;27(14):2396-2404.
D:\478174570.doc
Zendejas B, Moriarty JP, O’Byrne J, Degnim AC, Farley DR, Boughey JC. Cost-effectiveness of
contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast
cancer. Journal of Clinical Oncology. 2011;29(22):2993-3000.
Zeng L, Chow E, Zhang L, Tsesng L-M, Hou M-F, Fairchild A, Vassiliou V, Jesus-Garcia R, El-Din MAA,
Kumar A, Forges F, Chie W-C, Bedard G, Bottomley A. An international prospective study
establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer
patients with bone metastases. Supportive Care in Cancer. 2012;20(12):3307-3313.
Zeng L, Koo K, Zhang L, Jon F, Dennis K, Holden L, Nguyen J, Tsao M, Barnes E, Danjoux C, Sahgal
A, Chow E. Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic
as screened by the Edmonton Symptom Assessment System. Supportive Care in Cancer.
2012;20(5):1037-1042.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social
Support. J Pers Assess. 1988;52(1):30–41.
Zimmer JG, Groth Juncker A, McCusker J. A randomized controlled study of a home health care
team. Am J Public Hlth. 1985;75:134–141.
Zimmer JG, Groth Juncker A, McCusker J. Effects of a physician-led home care team on terminal
care. J Am Geriatr Soc. 1984;32:288–292.
Zimmerman M, Ruggero CJ, Chelminski I, Young D, Posternak MA, Friedman M, Boerescu D, Attiullah
N. Developing Brief Scales for Use in Clinical Practice: The Reliability and Validity of Single-Item SelfReport Measures of Depression Symptom Severity, Psychosocial Impairment Due to Depression, and
Quality of Life. Journal of Clinical Psychiatry. 2006;67(10):1536-1541.
Zimmerman L. Symptom Clusters. Journal of Cardiovascular Nursing. 2010;25(4):261-262.
Zimmermann C, Burman D, Bandukwala S, Seccareccia D, Kaya E, Bryson J, Rodin G, Lo C. Nurse
and physician inter-rater agreement of three performance status measures in palliative care
outpatients. Supportive Care in Cancer. 2010;18(5):609-616.
Zittoun R, Achard S, Ruszniewski. Assessment of quality of life during intensive chemotherapy or
bone marrow transplantation. Psycho-Oncol. 1999;8:64-73.
Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Ann Rev Physiol.
2002;64:681-708.
Zung WWK, Magill M, Moore JT, George T. Recognition and treatment of depression in a family
medicine practice. J Clin Psychiatry. 1983;44:3-6.
Zweibel NR. Measuring quality of life near the end of life. JAMA. 1988;260:839-840.
Zwinderman AH. Statistical analysis of longitudinal quality of life data with missing measurements.
Qual Life Res. 1992;1:219-224.
D:\478174570.doc
D:\478174570.doc
Book Chapters
Baumeister RF. Meanings of Life. New York: Guilford, 1991.
Berzon RA, Simeon G, Mauskopf J. Choosing a Health Profile and/or a Patient Preference Measure
for a Clinical Trial. In: Spilker B, ed., Quality of Life and Pharmacoeconimics in Clinical Trials (2nd Ed).
New York: Lippincott-Raven Publishers; 1996.
Berzon RA. Quality of Life Determinations in Chronic Conditions: Perspectives of the Pharmaceutical
Industry. In: Trimble MR and Dodson WE, eds., Epilepsy and Quality of Life. New York: Raven
Press; 1994.
Berzon RA. Understanding and Using Health-Related Quality of Life Instruments within Clinical Trial
Research. Quality of Life Assesment in Clinical Trials: Methods and Practices. Oxford: Oxford
University Press; 1998:1–15.
Brady MJ, Cella D. Assessing quality of life in palliative care. In Von Gunten C. (Ed.): Palliative Care
and Rehabilitation of Cancer Patients Boston: Dluwer Academic Press, 1999:203-216.
Bullinger M, Anderson R, Cella D, Aaronson N. Developing and evaluating cross-cultural instruments:
From minimum requirements ot optimal models. In Shumaker SA & Berzon R. (Eds.): the
International Assessment of Health-Related Quality of Life: Theory, Translation, Measurement and
Analysis Oxford: Rapid Communications, 1995:83-92.
Cain J, Wenzel LB, Monk BJ, Cella D. Palliative Care and Quality of Life considerations in the
Management of Ovarian Cancer. In Gershenson DM and McGuire WP (Eds.): Ovarian Cancer
Controversies in Management New York: Churhill Livingstone, 1998:281-307.
Cella D. Metodos de evaluacion de la calidad de vida en psico-oncologia. In Maria Die Trill (eds):
Psico-Oncolgia Aula de Estudios Sanitarios (ADES ediciones, SL) 2003:779-786.
Cella D. Psychological Issues in Patients with Cancer. In Ettinger DS. (Section Ed.): Oncology in
Bone R and Fitzgerald F. (eds.): Current Practice of Medicine, (2nd ed.) Philadelphia: Current Science,
Inc. 1997.
Cella D. Quality of Life. In Holland J. (Ed.): Pshycho-Oncology New York: Oxford University Press,
1998:1135-1146.
Cella D. Quality of life in lung cancer: The balidity and cross-culture applicability of the functional
assessment of Cancer Therapy-Lung (FACT-L) Scale Hematology/Oncology Clinics of North America
Cella D. Quality-of-Life Measurement in Oncology. In Baum A, Anderson BL (Ed): Psychosocial
interventions for Cancer Washington: American Psychological Association 2001:57-76.
Cella D, Calhoun B, Roland P. quality of life among women with gynecologic malignancies. In
Hoskins WJ, Perez CA & Young RC: Principles and Practice of Gynecologic Oncology (3rd ed.)
Philadelphia: Lippincott Williams & Wilkins, 2000:571-585.
D:\478174570.doc
Cella D, Chang C-H, Heinemann AW. Item Response Theory (IRT): Applications in quality of life
measurement, analysis and interpretation. In Mesbah M, Cole B, & Lee M-LT. (Eds.): Statistical
Methods for Quality of Life Studies: Design, Measurement and Analysis 2002:169-186.
Cella D, Lai J-S, David K, Dineen K, Hudgens S, Gershon R. Developing a questionnaire using item
response theory: a case study of fatigue. In Fayers P, hays R (Eds.): Assessing Quality of Life in
Clinical Trials Oxford University Press, 2005:113-130.
Cella D, Peterman A. Evaluation of quality of life. In Rose BD (ed): UpToDate Wellesley, MA 2002.
Cella DF. Evaluating methods to measure quality of life. In Zittoun R. (Ed.): Quality of Life of Cancer
Patients: A Review Paris: Laboratoire roger Bellon, 1992:65-72.
Cella DF. Health promotion in oncology: A Cancer Wellness Doctine. In Burton LA & Handzo G,
(Eds.): Health Care Chaplaincy in Oncology Binghampton, NY: The Haworth Press, 1992:87-101.
Cella DF. Psychological issues in patients with cancer. Section XII: Oncology (Ettinger DS, Ed.), in
Bone RC: Burrent Practice of Medicine (Vol. 3) Current Medicine, Inc., Philadelphia, PA (distributed
by Churchill Livingstone, Inc., NY, NY): XII: 1996:19.119.7.
Cella DF. Psychological sequelae in the cured cancer patient. In Higby DJ, (Ed.) Issues in Supportive
Care of Cancer Patients Boston: Martinus Nijhoff, 1986:149-171.
Cella DF. Psychological treatment as an adjunct to cancer surgery. In Economou SG, Witt TR, Deziel
DJ, Saclarides TJ, Staren ED, Bines SD (Eds.): Adjuncts to Cancer Therapy Philadelphia: Lea &
Febiger, 1991:657-660.
Cella DF. Quality of life as an outcome of cancer treatment. In Groenwald SL, Frogge MH, Goodman
ML & Yarbro CH (Eds.): Cancer Nursing: Principles and Practice (3rd ed. Boston: Jones & Bartlett,
1993:197-207.
Cella DF. Quality of life as an outcome of cancer treatment. In Groenwald SL, Frogge MH, Goodman
ML & Yarbro CH (Eds.): Cancer Nursing: Principles and Practice (4th ed.) Boston: Jones & Bartlett,
1997:203-213.
Cella DF. Using quality of life and cost-utility assessments in cancer treatment decisions. In Skeel RT
& Lachant NA (Eds.): Handbook of Cancer Chemotherapy, 4th ed. Boston: Little, Brown & Co.
1995:80-94.
Cella DF, Bonomi AE. The Functional Assessment of Cancer Therapy (FACT) and Functional
Assessment of HIV Infection (FAHI) quality of life measurement system. Quality of Life and
Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers;
1996:203-214.
Cella DF, Bonomi AE. Measuring quality of life. In Pazdur R, Coia LR, Hoskins WJ, Wagman LD.
(Eds.): Cancer Managerment: A Multidisciplinary Approach (2nd ed) Huntington, NY: PRR, Inc., 1998:
807-814.
D:\478174570.doc
Cella DF, Bonomi AE. Measuring quality of life. In Pazdur R, Coia LR, Hoskins WJ, Wagman LD.
(Eds.): Cancer Managerment: A Multidisciplinary Approach (1st Edition) Huntington, NY: PRR, Inc.,
1996: 773-787.
Cella DF, Holland JC. Methodological considerations in studying the stress-illness connection in
women with breast cancer. In Cooper CL, (Ed.): Stress and Breast Cancer Chichester, England:
Wiley Press, 1988:197-214.
Cella DF, Jacobson PB, Lesko LM. Research methods in psycho-oncology. In Holland JC, Rowland
JH. (Ed.): Handbook of Psycho-Oncology: Psychological Care of the Patient With Cancer New York:
Oxford University Press, 1989:737-749.
Cella DF, Lesko LM, Evans S, Raduns C. Deanthanxiety and exposure to one’s mortality. In
Klagsbrun S, Goldberg I, Rawnsley M, Kutscher A, Marcus E, Siegel M. (Eds.): Psychiatric Aspects of
Terminal Illness Philadelphia, The Charles Press, 1988:76-80.
Cella DF, Lloyd SR, Wright BD. Cross-cultural instrument equating: Current research and future
directions. In Spilker B (Ed.): Quality of Life and Pharmacoeconomics in Clinical Trials New York:
Raven Press, 1996:707-715.
Cella DF, Perry SW. Depression and physical illness. In Mann JJ, (Ed.): Depression and Depressive
Illness: Desctiptive Aspects and Models New York: Human Science Press, 1988:221-239.
Cella DF, Wiklund I, Shumaker SA, Aaronson NK. Integrating health-related quality of life into crossnational clinical trials. In Shumaker SA & Berzon R. (Eds.): The International Assessment of HealthRelated Quality of Life: Theory, Translation, measurement and Analysis Oxford: Rapid
Communications 1995:75-82.
Cella DF, Yellen SB. Quality of life assessment methods specific to oncology. In Ziottun R, (Ed.):
Qualify of Life of Cancer Patients: A Review Paris: laboratoire Roger Bellon, 1992:87-94.
Chang C, Cella D, Wright B. Measurement consistency for different language versions of healthrelated quality of life instruments. In Bezruczko N (Ed.): Rasch Measurement in Health Sciences JAM
Press 2005:152-160.
Cherny NI. Chapter 1. Cancer Pain: Principles of Assessment and Syndromes. Principles of Practice
and Supportive Oncology. Ed. Ann Berger et al. Philadelphia, Pa:Lippincott-Raven Publisher; 1998.
Cleeland CS, Syrjala KL. How to assess cancer pain. Handbook of Pain Assessment. The Guilford
Press, 1992.
Cleeland CS. Measurement of Pain by Subjective Report. Issues in Pain Management. Chapman CR,
Loeser JD (ed). New York, NY:Raven Press, Ltd. 1989.
Cleeland CS. Pain Assessment in Cancer. Effect of Cancer on Quality of Life. Osoba D (ed). CRC
Press Inc, 1991.
Cohen S, Williamson G. Perceived Stress in a Probability Sample of the United States. Spacapan S
and Oskamp S. (Eds). The Social Psychology of Health. Newbury Park, CA: Sage 1988.
D:\478174570.doc
Dineen K, Cella D, Davis K. Quality-of-Life Measurement. In Budman D, Calvert A, Rowinsky E.
(Eds.): Handbook of Anticancer Drug Development Lippincott Williams & Wilkins, 2003:425-432.
Eremenco S, Chang C-H, Webster K, Cella D. quality of Life Evaluation in Chronic Illness Across
Cultures: The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System and
Its Use in India. In Chaturvedi SK and Chandra PS (Eds.): Quality of Life in Health and Disease
Malalur Printers: Bangalore, India, 2000:69-81.
Eremenco S, Webster K, Cella D. quality of life evaluation in chronic illness across cultures. In
Current Perspectives in Palliative Medicine Tokyo: Springer-Verlag 1998:171-175.
Ferrans CE. Definitions and conceptual models of quality of life. Outcomes Assessment in Cancer.
Edited by: Joseph Lipscomb, Carolyn C. Gotay, and Claire Snyder. Cambridge Press: 14-30 2004.
Gelber RD, Cole BF, Gelber S, Goldhirsch A. The Q-Twist Method. In: Spilker B (ed.) Quality of life
and Pharmacoeconomics in Clinical Trials (2nd ed.). Chapter 46, 4. 1996; Philadelphia,
PA:Lippincott Williams & Wilkins.
Hahn E, Cella D. Measuring patient satisfaction and dissatisfaction. In Bezruczko N (Ed.): Rasch
Measurement in Health Sciences JAM Press, 2005:132-151.
Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials.
In: Assessment in Clinical Trials: Methods and practice. Oxford, England:Oxford University Press.
1998;Chapter 10:169-182.
Holland J, Silberfarb P, Tross S, Cella D. Psychosocial research in cancer: The Cancer and Leukemia
Group B (CALGB) Experience. In Ventafridda V, Van Dam FSAM, Yancik R & Tamburini M (Eds.).
Assessment of Quality of Life and Cancer Treatment Amsterdam: Elsevier, 1986:89-101.
Ingham J, Portenoy R. Chapter 6: the measurement of pain and other symptoms.
Kaplan RM, Anderson JP. The general health policy model: An integrated approach. In: Spilker B.
(ed.) Quality of Life and pharmacoeconomics in Clinical Trials. (2nd ed). Lippincott-Raven Publishers,
1996.
Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer.
Evaluation of Chemotherapeutic Agents. MacLeod CM (ed). New York: Columbia University 191-205,
1949.
King CR. Overview of Quality of Life and Controversial Issues. In: Quality of life from nursing and
patient perspective, theory, research and practice (King CR, Hinds PS eds). Sudbury, MA: Jones and
Bartleet, 1997:29–42.
Kornblith A. Psychosocial adapatation of cancer survivors. Chapter 20 in Psycho-Oncology. Holland
JC (ed). New York, NY:Oxford University Press; 1998.
Loprinzi CL. The Art of Oncology: Introduction. In: Decades of Progress 1983-2003:
Accomplishments in Cancer Control. Pgs. 17-19.
D:\478174570.doc
Maslach C, Jackson SE, Leiter MP. Maslach Burnout Inventory Manual. 3 rd Edition. Palo Alta, CA:
Consulting Psychologists Press. 1996.
Moinpour C, Hayden KA, Thompson IM, Feigl P, Metch B. Quality of life assessment in Southwest
Oncology Group Trials. In: Quality of Life in Oncology Practice and Research. Tchekmedyian MS,
Cella D (eds). Williston Park, NJ: Cominus Publishing;1991;43-49.
Mor V, Greer D, Kastenbaum R. The Hospice Experiment. Baltimore and London: Johns Hopkins
University Press; 1988.
Patrick DL, Erickson P. Assessing health-related quality of life for clinical decision making. In:
Walker SR, Rosser RM (eds). Quality of Life: Assessment and Applications. Boston, MS: MTP Press,
Ltd.;1988:9-49.
Payne DK, Massie MJ. Chapter 37. Depression and Anxiety. In: Berger A, et al (ed.) Principles of
Practice of Supportive Oncology. Philadelphia, PA:Lippincott-Raven Publishers; 1998.
Peterman A, Cella D. Adherence issues among cancer patients. In Shumaker S, Schron E, Ockene J
& McBee W. (Eds.): Handbook of Health Behavior Change (2nd ed.) New York: Springer Publishing
Co., 1998:462-482.
Peterman AH, Cella D. Quality of life. In Kazdin AI (ed.): Encyclopedia of Psychology Washington,
D.C.: American Psychological Association, 2000:(6),491-495.
Reuters Health Information. Parents Correct on Quality of Life in Young Cancer Patients. Cancer.
2006;106 published by Reuters 2006.
Robbins MA. 2.5 The Economics of Palliative Care. In: The Challenge of Palliative Medicine. pp. 5565.
Salisbury C. Question 7. Impact on quality of life. Providing a Palliative Care Service. In:
Bosanquet N, Salisbury C (ed). Towards an Evidence Base. New York:Oxford University press; pp.
131–162.
Spilker. Quality of Life and Pharmacoeconomics in Clinical Trials. (2nd ed.) Philadelphia: LippincottRaven. 1996.
Tchekmedyian NS, Cella D, Heber D. Nutritional support and Quality of life. In Heber D. Blackburn
GL, Go VL, & Milner J (Eds): Nutritional Oncology(Second Edition) Elsevier, Inc, 2006:713-719.
Tchekmedyian NS, Hickman M, Zahyna D, Cella D. Effects of megestrol acetate on cancer patients:
impact on palliative care and quality of life. In: Hartenstein R, Tchekmedyian NS, (Eds.): Hormones
in Cancer Cachexia: Megestrol Acetate Munich, Germany: W. Zuckschwerdt Verlag, 1991:59-67.
Tulsky DS, Cella DF. Pilots in gliders: The professional’s role in a cancer wellness group. In Katz AH,
et al. (Eds.): Self help: Concepts and Applications Philadelphia: The Charles Press, 1992:250-256.
Ventegodt S. Measuring Quality of Life: From Theory to Practice. Copenhagan, Denmark:
Forskningscentrets Forlag, 1996.
D:\478174570.doc
Victorson D, Cella D, Wagner L, Kramer L, Smith M. Measuering Quality of Life in Cancer Survivors.
In: Handbood of Cancer Survivorship (Ed. Feuerstein), Springer 2006:79-110.
Wagner L, Cella D. Quality of life and psychococial issues. In Bonadonna G, Hortobagyi G,
Valagussa P. (eds): Textbood of Breast Cancer: A Clinical Guide to Therapy Taylor and Francis,
2006:345-362.
Wagner LI, Cella D, Doninger. Fatigue. In Voltz R, Bernat J, Borasio G, Maddocks I, Oliver D,
Portenoy R. (eds): Palliative Care in Neurology Oxford University Press, 2004:221-240.
Wagner LI, Cella D, Peterman AH. Methodological considerations in the treatment of fatigue. In
Portenoy R. (eds): Issues in Palliative Care Research Oxford, England: Oxford University Press,
2003:173-185.
Wagner-Raphael L, Cella D. Cancer-Related fatigue: clinical screening, assessment and
management. In M Marty & S Pecorelli (eds): ESO Scientific updates: Fatigue, Asthenia, Exhaustion
and Cancer Oxford, England: Elsevier Science, 2001:(5),201-214.
Waternaux C, WareJ. Unconditional linear models for analysis of longitudinal data. In: Dwyer JH,
Feinleib M, Lippert P, Hoffmeister H. (eds.) Statistical Models for Longitudinal Studies of Health.
New York: Oxford University Press; 1992:99-114.
Wee CC, Davis RB, Hamel MB. Comparing the SF-12 and SF-36 health status questionnaires in
patients with and without obesity. Health Qual Life Outcomes. 2008;6:1-7, doi:10.1186/1477-75256-11.
Wenzel L, Cella D, Gallup D. Chapter Eight: Investigating Quality of Life. In: DiSaia PJ (ed.) The
Gynecologic Oncology Group: Report of 35 Years of Excellence in Clinical Research. 2006.
Wenzel L, Cella D, Gallup D. Investigating quality of life. Gynocologic Oncology Group: Report of 35
Years of Excellence in Clinical Research (Chapter 8) 58-60 (monograph).
Zebrack B, Cella D. Evaluating quality of life in cancer survivors. COMWG Cambridge University
Press, 2004:241-263.
Edited Volumes/Books
Cella D. (Ed.) Item response theory modeling at CORE: Center on Outcomes, Research and
Education, Evanston IL. 2003.
Cella D. (Ed.) Methodological issues related to QOL measurement. Evaluation & the Health
Professions 2005:28(2):entire volume.
Crawford J, Cella D, Sonis S. Managing Chemotherapy-related side effects: Trends in the use of
cytokines and othe growth factors. 2006:20(3)Supplement No. 1.
FDA Final PRO Guidance. Guidance for Industry. Patient-Reported Outcome Measures: Use in
Medical Product Development to Support Labeling Claims. December 2009. Clinical/Medical.
D:\478174570.doc
Tchekmedyian NS, Cella DF. (Eds) Qality of life in current oncology practice and research. Oncology
1990;4,5,entire volume.
Tchedkmedyian NS, Cella DF. (Eds) Quality of life in current oncology practice and research. Williston
Park, NY: dominus Publishing. 1991
Tchekmedyian NS, Cella DF, Moradian A. (Eds) Care of the older cancer patient: Clinical and quality
of life issues. Oncology 1992;2(Suppl):entire volume.
Tchekmedyian NS, Heber D, Cella DF. (Eds) New strategies in cancer prevention and therapy: The
role of nutrition. Oncology 1993;711(Suppl):entire volume.
Tchekmedyian NS, Cella DF Winn RJ. Economic and quality of life outcomes in oncology. Oncology
1995;9,11(Suppl):entire volume.
Tchekmedyian NS, Cella DF, Glaspy JA. Management of Anemia inpatients with Cancer: Optimizing
patient outcomes and Quality of Life. Oncology 2002;16,9(Suppl. 10):13-15.
Letters/Comments/Editorials
Bonomi AE, Cella DF. A Cross-Cultural Adaptation of the Functional Assessment of Cancer Therapy
(FACT) Quality of Life Measurement System for use in European oncology clinical trials. Quality of
Life Newsletter. 1995;12(Feb-May):5,7.
Brady MJ, Cella DF. The Baker article reviewed: “Quality of life after bone marrow transplantation,
Oncology 1994;8(10):98-101.
Browman GP, Berrang T, Smith S. Prognostic tools for cancer survival: a secondary role for qualityof-life measurement. Journal of Clinical Oncology. 2009;27(18):2902-2904.
Cella D. Age Matters…or Does It? Oncology. 2007;21(1):90,100.
Cella D. Commentary on Management of Fatigue in the Cancer Patient. Oncology. 2002;16(3):381385.
Cella D. Current comments of quality of life research. Journal of Clinical Oncology. 1999;4(2):535539.
Cella d. Quality of life outcomes: measurement and intervention. Supportive Oncology.
2005;3(2):133-134.
Cella D. The FDA and the person with cancer: give PROS a chance. Oncology. 2006;20(4):436.
Cella D. What do global quality-of-life questions really measure? Insights from Hobday et al. and the
“Do Something” rule. Journal of Clinical Oncology. 2003;21(16):3178-3179.
Cella D, Dobrez D. Comparing treatment using utility assessment for health-related quality of life.
Oncology. 2003;17(12):1697-1702.
D:\478174570.doc
Cella D, Fallowfield L. Glaxo-Wellcome introduces the Benefact quality of life (QOL) database. Quality
of Life Newsletter. 1996-1997;16:13-14.
Cella DF. Comment on Osoba et al., “Quality of life, appetite and weight change in patients receiving
dose-intensive, weekly chemotherapy.” Oncology 1994;8(4):69.
Cella DF. Commentary on building quality of life assessment into cancer treatment studies.
Oncology 1992;6(6):30-32.
Cella DF. Description of the Fumtional Assessment of Cancer Therapy (FACT) scales. Quality of Life
Newsletter. 1992;1(4):5.
Cella DF. Helping patients cope with cancer: The article reviewed. Oncology 1989:3,11:129-130.
Cella DF. Psychological adjustment and cancer outcome: Levy versus Taylor. American Psychologist
1985;40:1275-1276.
Cella DF. Quality of life assessment. New Developments in Medicine and Drug Therapy.
1992;1(2):22.
Cella DF, Cobleigh M. Comment on collichio & Pandya, “Ammenorrhea following chemotherapy for
breast cancer, incidence and disease free survival,” Oncology. 1994;8(12):52.
Cella DF, Najavitis L. Denial of infertility in patients with Hdgkin’s disease. Psychosomatics.
1986;27,1:71.
Ganz PA, Moinpour CM, Cella DF, Fetting JH. Quality of life assessment in cancer clinical trials: A
status report. Journal of the Ntional Cancer Institute. 1992;84(13):994-995.
Gradishar W, Cella D. Selective estrogen receptor modulators and prevention of invasive breast
cancer. Journal of American Medical Association. 2006;295(23):2784-2786.
Perry SW, Cella DF. Overdiagnosis of depression in the medically ill. American Journal of Psychiatry.
1987;144:1,125-126.
Perry SW, Cella DF. Missed diagnosis of OMS in hospitalized medical patients. American Journal of
Psychiatry. 1985;142:525-526.
Pickard S, Dobrez D, Cella D. Eliciting social preference weights for Functional Assessment of Cancer
Therapy-Lung Health States. Pharmacoeconomics. 2006;4(3):293-294.
Rizzo JD, Cella D, Seidenfeld J. In reply to Bottomley et al., Ng and Daniell. Journal of Clinical
Oncology. 2003;21(11):2224-2225.
Sloan J, Cella D, Hays R. clinical significance of patient-reported questionnaire data: another step
toward concensus. Journal of Clinical Epidemiology. 2005;58:1217-1219.
D:\478174570.doc
ABSTRACTS
Kamal AH, Swetz KM, Liu H, Ruegg SR, Carey EC, Whitford K, Bock FA, Creagan ET, Myonihan TJ,
Kaur JS. Survival trends in palliative care patients with cancer: a Mayo Clinic 5-year review.
American Society of Clinical Oncology 2009. Abstract 9592. J Clin Oncol 27:15s, 2009 (supplement).
Sloan JA, Cella D, Frost M, Guyatt G, Sprangers M, Symonds T, and the Clinical Significance
Consensus Writing Team. Methods for assessing clinical significance in quality of life measurement.
Cochrane abstract. 2002.
Sloan JA, Vargas-Chanes D, Kamath CC, Sargent DJ, Novotny PJ, Atherton P, Allmer C, Fridley BL,
Frost MH, Loprinzi CL. A simple approach for defining clinically relevant effects in quality of life
measures (or a treatise regarding worms, ducks, and elephants). Cochrane abstract. 2002.
D:\478174570.doc
Related documents